Sentence,class,file
"102:1341– 1351. http://dx.doi.org/10.1016/j.bpj.2012.02.009 Laird, D.W. 2010.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
http://dx.doi.org/10.1016/ j.tcb.2009.11.001,OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1016/j.bbamem.2005.04.001 Tang, Q., T.L.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1085/ jgp.200910207 Thimm, J., A. Mechler, H. Lin, S. Rhee, and R. Lal.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"280:10646– 10654. http://dx.doi.org/10.1074/jbc.M412749200 Trexler, E.B., M.V.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi .org/10.1073/pnas.93.12.5836 Unwin, P.N., and P.D.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1083/jcb.97.5.1459 Unwin, P.N., and P.D.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi .org/10.1038/307609a0 Vargas, E., F. Bezanilla, and B. Roux.",Non-OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1016/j.neuron.2011 .09.024 Verselis, V.K., and M. Srinivas.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1085/ jgp.200810029 Verselis, V.K., C.S.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1038/368348a0 Verselis, V.K., M.P.",Non-OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1074/jbc .M807430200 Vilariño, T., I. Brandariz, S. Fiol, J. López Fonseca, and M. Sastre  De Vicente.",Non-OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi .org/10.1002/bscb.19931021104 Yellen, G. 1998.",OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
"http://dx.doi.org/10.1017/ S0033583598003448 Zonta, F., G. Polles, G. Zanotti, and F. Mammano.",Non-OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
29:985– 998. http://dx.doi.org/10.1080/073911012010525027,Non-OADS,/arxiv_data1/oa_pdf/a1/20/JGP_201210839.PMC3557306.pdf
© 2013 Clausen  This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/ 10.1183/09031936.00119007 Buchanan, R., O.B.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1113/ jphysiol.2002.023325 Cairns, S.P., and M.I.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"586:4039– 4054. http://dx.doi.org/10.1113/jphysiol.2008.155424 Cairns, S.P., W.A.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi .org/10.1152/ajpcell.00589.2003 Clausen, T. 1998.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1042/ CS19970254 Clausen, T. 2003.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/ 10.1111/j.1748-1716.1965.tb04089.x Kotchen, T.A., J.H.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1038/ ki.1978.30 Krnjevic, K., and R. Miledi.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1152/ajpheart .00139.2004 Macdonald, W.A., O.B.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1113/jphysiol.2004.067199 Mikkelsen, U.R., H. Gissel, A. Fredsted, and T. Clausen.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1152/ajpregu.00392.2005 Murphy, K.T., W.A.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1152/ajpregu.00707.2005 Murphy, K.T., O.B.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1113/expphysiol .2008.042457 Nielsen, O.B., and T. Clausen.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1113/ jphysiol.2003.050658 Nørgaard, A., K. Kjeldsen, and T. Clausen.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1038/293739a0 Overgaard, K., O.B.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1007/s004240050421 Palade, P.T., and R.L.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1085/jgp.69.3.325Clausen, T. 2008a.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1085/jgp.200809971 Clausen, T. 2008b.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi .org/10.1111/j.1748-1716.2007.01798.x Clausen, T. 2011.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi .org/10.1111/j.1365-201X.2004.01394.x Clausen, T., M.E.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1111/j.0001-6772 .2003.01251.x de Paoli, F.V., M. Broch-Lips, T.H.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1152/ajpheart .00216.2009 Dutka, T.L., R.M.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1113/ jphysiol.2007.144667 Everts, M.E., and T. Clausen.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
http://dx.doi.org/10.1111/j.1748-1716.1992.,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1152/japplphysiol.01558.2011 Gissel, H., and T. Clausen.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1002/mus.880030304 Hník, P.M., M. Holas, I. Krekule, N. Kŭriz, J. Mejsnar, V. Smiesko,  E. Ujec, and F. Vyskocil.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/10.1085/ jgp.200409173 Pedersen, T.H., W.A.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"134:525) http://dx.doi.org/10.1085/jgp .200910291 Ruff, R.L., L. Simoncini, and W. Stühmer.",Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
"http://dx.doi.org/ 10.1002/mus.880110514 Sacco, P., D.B.",OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
http://dx.doi.org/10.1152/ajpregu.00066.2011,Non-OADS,/arxiv_data1/oa_pdf/7c/6e/JGP_201210892.PMC3557307.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1016/ 0896-6273(92)90160-F Bouzat, C., F. Gumilar, G. Spitzmaul, H.L.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/ nature02753 Brayden, J.E., and M.T.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1126/science.1373909 Butler, A., S. Tsunoda, D.P.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1126/ science.7687074 Chen, R.-S., Y. Geng, and K.L.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/jgp.201110707 Cui, J., and R.W.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1021/ bi001509+ Cui, J., H. Yang, and U.S. Lee.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1007/s00018-008-8609-x Dudev, T., and C. Lim.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1021/cr020467n Elinder, F., R. Männikkö, and H.P.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/ jgp.118.1.1 Golowasch, J., A. Kirkwood, and C. Miller.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1016/S0896-6273(00)80951-4 Hazes, B., and B.W.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1093/protein/2.2.119 Horrigan, F.T., and R.W.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/jgp.20028605interacts with R213 in the S4 segment to favor voltage- sensor activation, and this interaction is stronger when the channel is at the open state (Yang et al., 2007).",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/ jgp.114.2.277 Hu, L., J. Shi, Z. Ma, G. Krishnamoorthy, F. Sieling, G. Zhang, F.T.",Non-OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/ 417515a Kawate, T., J.C. Michel, W.T.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/nature08198 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1038/nature06265 Meredith, A.L., S.W.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/ nn1740 Niu, X., X. Qian, and K.L.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1016/j.neuron.2004.05.001 Oberhauser, A., O. Alvarez, and R. Latorre.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/ jgp.92.1.67 Robitaille, R., M.L.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1016/0896-6273(93)90076-4 Schreiber, M., and L. Salkoff.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/ 10.1016/S0006-3495(97)78168-2 Shi, J., and J. Cui.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1085/jgp.118.5.589 Shi, J., G. Krishnamoorthy, Y. Yang, L. Hu, N. Chaturvedi, D. Harilal,  J. Qin, and J. Cui.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/nmeth.1341 Unwin, N. 2005.",Non-OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1016/j.jmb.2004.12.031 Wu, D., K. Delaloye, M.A.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"135:595– 606. http://dx.doi.org/10.1085/jgp.201010408 Wu, Y., Y. Yang, S. Ye, and Y. Jiang.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/nature09252 Xia, X.-M., X. Zeng, and C.J.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1038/nature00956 Yang, H., L. Hu, J. Shi, K. Delaloye, F.T.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"15:1152– 1159. http://dx.doi.org/10.1038/nsmb.1507 Yang, J., G. Krishnamoorthy, A. Saxena, G. Zhang, J. Shi, H. Yang, K.  Delaloye, D. Sept, and J. Cui.",Non-OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/10.1016/ j.neuron.2010.05.009 Yuan, P., M.D.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1126/science.1190414 Yuan, P., M.D.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi.org/ 10.1038/nature10670 Zhang, G., and F.T.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1085/jgp.200409149 Zhang, G., S.Y.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
"http://dx.doi .org/10.1073/pnas.1010124107 Zhang, X., C.R.",OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
http://dx.doi.org/10.1085/jgp.118.5.607,OADS,/arxiv_data1/oa_pdf/c2/1f/JGP_201210794.PMC3557308.pdf
© 2013 Gustina and Trudeau  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
S1 is available at http://www.jgp.org/cgi/content/full/jgp.201210870/DC1.,Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1007/s00249-009-0408-2 Baukrowitz, T., and G. Yellen.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/0896-6273(95) 90185-X Brelidze, T.I., A.E.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1074/ jbc.M109.016337 Brelidze, T.I., A.E.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1038/nature10735 Chen, J., A. Zou, I. Splawski, M.T.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/ 10.1074/jbc.274.15.10113 Chiesa, N., B. Rosati, A. Arcangeli, M. Olivotto, and E. Wanke.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"502:715) http://dx.doi.org/10.1111/ j.1469-7793.1997.313bn.x Fernández-Trillo, J., F. Barros, A. Machín, L. Carretero, P. Domínguez,  and P. de la Peña.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi .org/10.1074/jbc.M110.205948 Gustina, A.S., and M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1073/ pnas.0900180106 Gustina, A.S., and M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1085/jgp .201010582 Gustina, A.S., and M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"24:1592– 1598. http://dx.doi.org/10.1016/j.cellsig.2012.04.004 Herzberg, I.M., M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.003bi.xin time to peak, voltage dependence, and inward current  at 100 mV were recovered by coexpression of N-deleted  channels with eag domain–containing fragments.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1161/CIRCRESAHA.108.185249 Sanguinetti, M.C., and N.K.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"96:195– 215. http://dx.doi.org/10.1085/jgp.96.1.195 Sanguinetti, M.C., C. Jiang, M.E.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90340-2 Schönherr, R., and S.H.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1038/379833a0 Spector, P.S., M.E.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10 .1085/jgp.107.5.611 Trudeau, M.C., J.W.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1126/ science.7604285 Trudeau, M.C., S.A. Titus, J.L.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1085/jgp.201110683 Viloria, C.G., F. Barros, T. Giráldez, D. Gómez-Varela, and P. de  la Peña.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/ S0006-3495(00)76286-2 Wang, J., M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"113:359) http://dx.doi.org/10.1085/jgp.112.5.637 Wang, J., C.D.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi .org/10.1085/jgp.115.6.749 Warmke, J.W., and B. Ganetzky.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/ 10.1126/science.2122520 Zagotta, W.N., N.B.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1038/nature01922 Zhou, M., J.H.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi .org/10.1038/35079500 Zhou, Z., Q. Gong, B. Ye, Z.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/S0006-3495(98)77782-3Hoshi, T., W.N.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1126/science.2122519 Hoshi, T., W.N.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/ 10.1016/0896-6273(91)90367-9 Jones, E.M., E.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1371/journal.pone.0009021 Lees-Miller, J.P., C. Kondo, L. Wang, and H.J.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1161/01.RES.81.5.719 Li, Q., S. Gayen, A.S. Chen, Q. Huang, M. Raida, and C. Kang.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/j.bbrc.2010.10.132 London, B., M.C.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1161/ 01.RES.81.5.870 López-Barneo, J., T. Hoshi, S.H.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1016/S0092- 8674(00)81635-9 Muskett, F.W., S. Thouta, S.J.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1074/jbc.M110.199364 Ng, C.A., M.J. Hunter, M.D.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1371/ journal.pone.0016191 Pessia, M., I. Servettini, R. Panichi, L. Guasti, S. Grassi, A. Arcangeli,  E. Wanke, and V.E.",Non-OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1152/ jn.00104.2003 Saenen, J.B., A.J.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"http://dx.doi.org/10.1529/ biophysj.106.087247 Sale, H., J. Wang, T.J. O’Hara, D.J.",OADS,/arxiv_data1/oa_pdf/27/d3/JGP_201210870.PMC3557309.pdf
"This  model implies that inhibition of MLCP could increase  the magnitude of smooth muscle contraction at any  Ca2+ concentration.A Ca2+- and PKC-driven regulatory network in airway smooth muscle Rose E. Dixon and Luis F. Santana Department of Physiology and Biophysics, University of Washington School of Medicine, Seattle, WA 98195 © 2013 Dixon and Santana  This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"7:34. http://dx.doi.org/10.1186/1465-9921-7-34 Bergner, A., and M.J. Sanderson.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1085/ jgp.119.2.187 Cheng, E.P., C. Yuan, M.F.",OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/ 10.1161/CIRCRESAHA.111.248252 Cooper, P.R., B.E.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1016/ j.pupt.2008.09.008 Dixon, R.E., C. Yuan, E.P.",OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1586/ erm.10.21 Mukherjee, S., J. Trice, P. Shinde, R.E.",OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1139/y05-090 Navedo, M.F., M. Nieves-Cintrón, G.C.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi .org/10.1161/CIRCRESAHA.107.167809 Navedo, M.F., E.P .",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"106:748– 756. http://dx.doi.org/10.1161/CIRCRESAHA.109.213363 Perez, J.F., and M.J. Sanderson.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1085/jgp .200409216 Sanderson, M.J. 2011.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1152/ physrev.00034.2007 Wang, I., A.Z.",OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"http://dx.doi.org/10.1529/ biophysj.107.113977 Wright, D.B., S. Tripathi, A. Sikarwar, K.T.",Non-OADS,/arxiv_data1/oa_pdf/3b/b0/JGP_201210953.PMC3557310.pdf
"16:1169– 1177. http://dx.doi.org/10.1016/S0896-6273(00)80143-9 Alabi, A.A., M.I.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10 .1038/nature06266 Armstrong, C.M.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1017/S0033583500001402 Bezanilla, F. 2008.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/ nrm2376 Bezanilla, F., E. Perozo, and E. Stefani.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1016/S0006-3495(94)80882-3 Bosmans, F., and K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"31:175– 182. http://dx.doi.org/10.1016/j.tips.2009.12.007 Bosmans, F., M.F.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/ nature07473 Bosmans, F., M. Milescu, and K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1073/pnas.1108497108 Bosmans, F., M. Puopolo, M.F.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1085/jgp.201110614 Campos, F.V., B. Chanda, P.S.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.200809995 Catterall, W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1113/jphysiol.2011.224204 Catterall, W.A., S. Cestèle, V. Yarov-Yarovoy, F.H.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1016/j.toxicon.2006.09.022and voltage sensor paddle motifs (Milescu et al., 2009).",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.2337/diabetes .55.04.06.db05-0788 Holmgren, M., K.S.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1016/S0896-6273(00)80571-1 Horn, R., S. Ding, and H.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.116.3.461 Hoshi, T., W.N.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1126/ science.2122519 Hoshi, T., W.N.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.103.2.249 Jiang, Y., A. Lee, J. Chen, M. Cadene, B.T.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/417523a Jung, H.J., J.Y.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1021/bi0477034 Jung, H.H., H.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.04.061 Kamb, A., J. Tseng-Crank, and M.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/ 0896-6273(88)90192-4 Kubo, Y., T.J. Baldwin, Y.N.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/ 362127a0 Labro, A.J., J.J. Lacroix, C.A.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"140:481– 493. http://dx.doi.org/10.1085/jgp.201210817 Lacroix, J.J., and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1085/jgp.113.3.389 Lee, S.Y., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/ nature02632 Lee, H.C., J.M.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1021/bi100246uCestèle, S., and W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"82:883– 892. http://dx.doi.org/10.1016/S0300-9084(00)01174-3 Cestèle, S., Y. Qu, J.C. Rogers, H. Rochat, T. Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80606-6 Cestèle, S., V. Yarov-Yarovoy, Y. Qu, F. Sampieri, T. Scheuer, and  W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1074/jbc .M603814200 Cha, A., and F. Bezanilla.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.112.4.391 Chanda, B., and F. Bezanilla.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1085/jgp.20028679 Chanda, B., O.K.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1074/jbc.M603212200 Corzo, G., N. Gilles, H. Satake, E. Villegas, L. Dai, T. Nakajima, and  J. Haupt.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0014-5793(03)00666-5 Corzo, G., J.K. Sabo, F. Bosmans, B. Billen, E. Villegas, J. Tytgat, and  R.S.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1074/jbc.M605403200 del Camino, D., and G. Yellen.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0896-6273(01)00487-1 del Camino, D., M. Kanevsky, and G. Yellen.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10 .1085/jgp.200509385 Frech, G.C., A.M. VanDongen, G. Schuster, A.M. Brown, and R.H.  Joho.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/340642a0 French, R.J., and H. Terlau.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"11:3053– 3064. http://dx.doi.org/10.2174/0929867043363866 French, R.J., and G.W.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1109/TNB.2004 .842500 Garcia, M.L., M. Garcia-Calvo, P .",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1021/bi00188a012 Herrington, J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
http://dx.doi .org/10.1016/j.toxicon.2006.09.012,OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1074/jbc.271.27 .15950 Ruta, V., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.4161/chan.3.6.10201 Schoppa, N.E., and F.J. Sigworth.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/ jgp.111.2.271 Schoppa, N.E., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.111.2.295 Schoppa, N.E., and F.J. Sigworth.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1085/jgp.111.2.313 Seoh, S.A., D. Sigg, D.M.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0896- 6273(00)80142-7 Sheets, M.F., J.W.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0006-3495(99)76929-8 Sheets, M.F., J.W.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/ jgp.115.5.609 Smith, J.J., S. Alphy, A.L.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1085/jgp.111.3.399 Smith-Maxwell, C.J., J.L.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0006-3495(94) 80881-1 Swartz, K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1016/j.toxicon.2006.09.024 Swartz, K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/nature07620 Swartz, K.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/0896-6273(95) 90184-1 Swartz, K.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80306-2 Swartz, K.J., and R. MacKinnon.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.201110720 Li-Smerin, Y., and K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1073/pnas.95.15.8585 Li-Smerin, Y., and K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"117:205– 218. http://dx.doi.org/10.1085/jgp.117.3.205 Liu, Y., M. Holmgren, M.E.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80357-8 Long, S.B., X. Tao, E.B.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1038/nature06265 Lu, Z., A.M. Klem, and Y. Ramu.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.20028696 Mannuzzu, L.M., M.M.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1126/science.271.5246.213 Milescu, M., J. Vobecky, S.H.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/nsmb.1679 Miller, C. 1995.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/0896-6273 (95)90057-8 Pathak, M., L. Kurtz, F. Tombola, and E. Isacoff.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.200409197 Payandeh, J., T. Scheuer, N. Zheng, and W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1038/nature10238 Perozo, E., R. MacKinnon, F. Bezanilla, and E. Stefani.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/ jgp.201010517 Phillips, L.R., M. Milescu, Y. Li-Smerin, J.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1038/nature03873 Rogers, J.C., Y. Qu, T.N.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/ S0896-6273(00)80307-4 Takahashi, H., J.I.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1006/jmbi.2000.3609 Tao, X., A. Lee, W. Limapichat, D.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1126/science.1185954 Vargas, E., F. Bezanilla, and B. Roux.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.09.024 Villalba-Galea, C.A., W. Sandtner, D.M.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1073/pnas.0807387105 Wang, J.M., S.H.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/jgp.200309005 Wang, J., V. Yarov-Yarovoy, R. Kahn, D. Gordon, M. Gurevitz, T.  Scheuer, and W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1038/nature02468Winterfield, J.R., and K.J.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1085/ jgp.116.5.637 Yang, N., and R. Horn.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi .org/10.1126/science.2122520 Zagotta, W.N., T. Hoshi, and R.W.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1085/jgp.103.2.321 Zagotta, W.N., T. Hoshi, J. Dittman, and R.W.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/ 10.1085/jgp.103.2.279 Zhang, J.Z., V. Yarov-Yarovoy, T. Scheuer, I. Karbat, L. Cohen, D.  Gordon, M. Gurevitz, and W.A.",OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
"http://dx.doi.org/10.1074/jbc.M111.282509 Zhang, J.Z., V. Yarov-Yarovoy, T. Scheuer, I. Karbat, L. Cohen,  D. Gordon, M. Gurevitz, and W.A.",Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
http://dx.doi.org/10.1074/jbc.M112 .370742,Non-OADS,/arxiv_data1/oa_pdf/56/c8/JGP_201210914.PMC3557313.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi .org/10.1038/9195 Amaya, F., H. Wang, M. Costigan, A.J.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4015-06.2006 Baker, M.D.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1113/ jphysiol.2005.089771 Baker, M.D., S.Y.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1113/jphysiol .2003.039131 Benn, S.C., M. Costigan, S. Tate, M. Fitzgerald, and C.J.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1038/nature01085 Coste, B., N. Osorio, F. Padilla, M. Crest, and P. Delmas.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1016/j.mcn.2004.01.015 Cummins, T.R., S.D.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1038/358761a0 Dib-Hajj, S.D., L. Tyrrell, J.A.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10 .1073/pnas.95.15.8963 Dib-Hajj, S., J.A.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1016/S0166-2236(02)02150-1 Fang, X., L. Djouhri, J.A.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1007/BF00656997 Herzog, R.I., T.R.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1146/annurev.pharmtox.44 .101802.121627 Liu, C.J., S.D.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1074/jbc.M108699200 Lossin, C., D.W. Wang, T.H.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"34:877– 884. http://dx.doi.org/10.1016/S0896-6273(02)00714-6 Maingret, F., B. Coste, J. Hao, A. Giamarchi, D. Allen, M. Crest, D.W.  Litchfield, J.P. Adelman, and P. Delmas.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi .org/10.1016/j.neuron.2008.05.026 Maingret, F., B. Coste, F. Padilla, N. Clerc, M. Crest, S.M.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/ 10.1085/jgp.200709935 Matzel, L.D., R.F.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi .org/10.1111/j.1528-1167.2008.01619.xO’Brien, B.J., J.H.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1002/cne.21701 Ostman, J.A., M.A.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1016/j.mcn.2007.02.008 Persson, A.K., J.A.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1016/ j.brainres.2004.07.042 Rush, A.M., M.J. Craner, T. Kageyama, S.D.",OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi.org/10.1111/j.1460-9568.2005.04186.x Tate, S., S. Benn, C. Hick, D. Trezise, V. John, R.J. Mannion, M.  Costigan, C. Plumpton, D. Grose, Z. Gladwell, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"http://dx.doi .org/10.1038/3652 Tyrrell, L., M. Renganathan, S.D.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"15:139– 145. http://dx.doi.org/10.1038/sj.mt.6300028 Yusa, K., L. Zhou, M.A.",Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
http://dx.doi.org/10.1074/jbc.274 .44.31123,Non-OADS,/arxiv_data1/oa_pdf/06/e7/JGP_201210919.PMC3557314.pdf
"Sleep duration as a correlate of smoking, alcohol use, leisure-time physical inactivity, and obesity among adults: United States, 2004-2006 CDCAvailable at: http://www.cdc.gov/nchs/data/hestat/sleep04-06/sleep04-06.htmAccessed June 10 2012.",Non-OADS,/arxiv_data1/oa_pdf/08/be/nutd201233a.PMC3557370.pdf
"Energy intakes: percentages of energy from protein, carbohydrate, fat, and alcohol, bygender and age, What We Eat in America, NHANES 2007-2008Available at: http://www.ars.usda.gov/ba/bhnrc/fsrgAccessed 10 June 2012.",Non-OADS,/arxiv_data1/oa_pdf/08/be/nutd201233a.PMC3557370.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Food intake, alcohol consumption and sleep G Galli et al 8 Nutrition and Diabetes (2013), 1 – 8 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/08/be/nutd201233a.PMC3557370.pdf
"Howard; (Stanford Prevention Research Center, Stanford, CA) Marcia L. Stefanick; (The Ohio State University, Columbus, OH) Rebecca Jackson; (University of Arizona, Tucson/Phoenix, AZ) Cynthia A. Thomson;(University at Buffalo, Buffalo, NY) Jean Wactawski-Wende; (Universityof Florida, Gainesville/Jacksonville, FL) Marian Limacher; (University of Iowa, Iowa City/Davenport, IA) Robert Wallace; (University of Pitts- burgh, Pittsburgh, PA) Lewis Kuller; (Wake Forest University School ofMedicine, Winston-Salem, NC) Sally Shumaker Women's Health Initiative Memory Study: (Wake Forest University School of Medicine, Winston-Salem, NC) Sally Shumaker For a list of all the investigators who have contributed to WHI science, please visit: https://cleo.whi.org/researchers/Documents%20%20Wri te%20a%20Paper/WHI%20Investigator%20Long%20List.pdf Funding/Support This work was partially supported by a grant from the National Osteoporosis Foundation.",Non-OADS,/arxiv_data1/oa_pdf/26/1b/198_2012_Article_2224.PMC3557387.pdf
"The geographical position data is provided by the open source Geometry Engine GEOS (http://trac.osgeo.org/geos) (date of access: Jan 14, 2013).www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1159 | DOI: 10.1038/srep01159 3",OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
Available online at http://www.jec.senate.gov (May 22.,Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"ICCSAI Fact Book on Air Transport in Europe , Available online at http://www.iccsai.eu (2007–2011).",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"Eurocontrol Annual report , Available online at http://www.eurocontrol.int (2008–2011).",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
Available online at http://www.ecu.edu/cs-educ/econ/upload/ecu0707.pdf (2007).,Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
Available online at http://www.bts.gov.,Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"BTS press release of March 22, 2011, Available online at http://www.rita.dot.gov/ sites/default/files/rita_archives/bts_press_releases/2011/bts017_11/html/bts017_11.html.",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"Severe weather occurred on October 27, see NOAA http://www.spc.noaa.gov/ climo/reports/101027_rpts.html.",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"Severe weather occurred on October 27, see CNN http://articles.cnn.com/2010- 10-27/us/us.weather_1_tornado-damage-tornado-sightings-airport- delays?_s 5PM%3AUS.",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fleurquin, P., Ramasco, J.J. & Eguiluz, V.M.",Non-OADS,/arxiv_data1/oa_pdf/80/51/srep01159.PMC3557445.pdf
5. http://www.kbr.com/Newsroom/Publications/Articles/Carbon-Dioxide- Capture-and-Storage-in-the-Nitrogen-Syngas-Industries.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/76/srep01145.PMC3557446.pdf
6. http://www.decc.gov.uk/assets/decc/11/stats/climate-change/4282-statistical- release-2010-uk-greenhouse-gas-emissi.pdf.,Non-OADS,/arxiv_data1/oa_pdf/eb/76/srep01145.PMC3557446.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/eb/76/srep01145.PMC3557446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Lan, R., Irvine, J.T.S.",Non-OADS,/arxiv_data1/oa_pdf/eb/76/srep01145.PMC3557446.pdf
"The average length of sequence reads was 228 bp, and they were classified into different taxonomy using MGRAST 15(http://metagenomics.anl.gov/).",OADS,/arxiv_data1/oa_pdf/77/4c/srep01163.PMC3557447.pdf
The metagenome sequences used in this paper are publicly available from the MGRAST (http://metagenomics.anl.gov/).,OADS,/arxiv_data1/oa_pdf/77/4c/srep01163.PMC3557447.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/77/4c/srep01163.PMC3557447.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zhao, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/77/4c/srep01163.PMC3557447.pdf
UAS:FNDY-B8-NLS flies were crossed to the apterous-Gal4 and MS1096-Gal4 drivers (Gal4 drivers are described at http://flybase.org/).,Non-OADS,/arxiv_data1/oa_pdf/9a/50/srep01156.PMC3557448.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/50/srep01156.PMC3557448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yeh, J.T.-H. Binari, R., Gocha, T., Dasgupta, R. & Perrimon, N. PAPTi: A Peptide Aptamer Interference Toolkit for Perturbation of Protein-Protein Interaction Network.",Non-OADS,/arxiv_data1/oa_pdf/9a/50/srep01156.PMC3557448.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Astle, A.T., Li, R.W., Webb, B.S., Levi, D.M.",Non-OADS,/arxiv_data1/oa_pdf/7a/70/srep01158.PMC3557449.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cc/cf/srep01162.PMC3557450.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Gunnarsen, K.S.",Non-OADS,/arxiv_data1/oa_pdf/cc/cf/srep01162.PMC3557450.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fang, A.F., Xu, G., Dong, T., Zheng, P. & Wang, N.L.",Non-OADS,/arxiv_data1/oa_pdf/08/05/srep01153.PMC3557451.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/7c/srep01157.PMC3557452.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, J. et al.In vivo self-bio-imaging of tumors through in situ biosynthesized fluorescent gold nanoclusters.",Non-OADS,/arxiv_data1/oa_pdf/4d/7c/srep01157.PMC3557452.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/cc/01/srep01160.PMC3557454.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yamaki, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/cc/01/srep01160.PMC3557454.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society Biochemical Journal    www.biochemj.org © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"However, IL-1- stimulated NO synthesis exhibits a time lag due to the requirement c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"CYP2B protein was signiﬁcantly down- regulated within 6 h of arginine addition (Figures 2B and 2C), and was maximally suppressed by 12 h. These results demonstratethat, when NO is rapidly produced by NOS2 in the cell after prior IL-1 stimulation, CYP2B proteins are rapidly degraded with an apparent half-life of approximately 4–6 h. The slowdecline in CYP2B protein in the control cells treated with L- NAME is attributed to the slow phase of transcriptional down- regulation caused by IL-1 treatment for 12–24 h. Neither L- NAME nor L-Arg treatment of hepatocytes for 24 h signiﬁcantly affected CYP2B protein levels (Supplementary Figure S1A at http://www.BiochemJ.org/bj/445/bj4450377add.htm).",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"We haveobserved this effect at 12 h in two other experiments, whereas in a fourth experiment the results were equivocal (results not c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"167, 6859–6868 Received 16 May 2012; accepted 22 May 2012 Published as BJ Immediate Publication 22 May 2012, doi:10.1042/BJ20120820 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2012 Biochemical Society © 2012 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/10/33/bj4450377.PMC3557507.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
2011. http://ec.europa.,Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"2011. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2011:088:0045:0065:EN: PDF (12 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"2010. http://www.drfosterhealth.co.uk/ docs/hospital-guide-2010.pdf (12 August 2011, date last accessed).8.",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"http://www.hpa.org.uk/Topics/InfectiousDiseases/InfectionsAZ/HCAI/ (12 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
Avaliação do Desempenho dos Hospitais Públicos em Portugual Continental 2007. http://www.ensp.unl.,Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"2011. http://english.skl.se/ (12 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"http://nesstar2.shdir.no/kvalind/ (12 August 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"Cornwall, UK: MPG Books Ltd, 2008 http://www.euro.who.",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
2011. http://www.oecd.,Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"http://www.cqc.org.uk/publications.cfm?fde_id= 12319 (12 August 2011, date last accessed).28.",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"http://en.niaz.nl/ (12 August 2011, date last accessed).Prospects for comparing European hospitals in terms of quality and safety International comparisons 7",Non-OADS,/arxiv_data1/oa_pdf/31/51/mzs079.PMC3557961.pdf
"See Executive By-Law of the Law of Registration  of Inventions, Industrial Designs and Trade Marks  (the 2009 By-Law), acce ssed on http://www.sabt.",Non-OADS,/arxiv_data1/oa_pdf/bf/3d/AJMB-1-89.PMC3558128.pdf
"Law of Registration of Inventions, Industrial  Designs and Trade Marks (the 2008 Law), acces- sed on http://tarh.majlis.ir/?ShowRule&Rid=1f8b f399-3aa9-495e-b09c-382ed357c865, Sec.",Non-OADS,/arxiv_data1/oa_pdf/bf/3d/AJMB-1-89.PMC3558128.pdf
"Agreement on Trade-Relate d Aspects of Intellec- tual Property Rights (TRIPS), (1994), accessed on http://www.wto.org/english/tratop_e/trips_e/t_agm 0_e.html, Part II; Convention Establishing the  World Intellectual Property Organization (the  WIPO Convention), 14 July 1967, accessed on  http://www.wipo.int/treaties/ en/convention, Article  2; Paris Convention for the Protection of Industrial  Property (the Paris Convention), 20 March 1883,  accessed on http://www.wipo.int/treaties/en/ip/ paris/trtdocs_wo.20.html, Article 1; and WIPO  Intellectual Property Handbook: Policy, Law and  Use, WIPO Publication, accessed on 2009 on http://www.Wipo.int/export/sites/www/about- ip/en/ iprm/pdf, Article 2.",Non-OADS,/arxiv_data1/oa_pdf/bf/3d/AJMB-1-89.PMC3558128.pdf
Available from: http://www.ncbi.,Non-OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
Available from: http://www.ensembl.,Non-OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
McPromoter MM:II- The Markov Chain promoter                                                              Prediction Server [internet] Nuremberg [updated  2005 August 15; cited 2009 April 18] Available  from: http://tools.genom e.duke.edu/generegula- tion/McPromoterMMII/.,OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
Available from: http://asp.ii.uib.no:8090/cg i-in/CONSITE/consite/.,Non-OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
Avail- able from: http://tandem.bu.edu/trf/trf.,Non-OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
Available from: http://frodo.wi.mit.edu/.,Non-OADS,/arxiv_data1/oa_pdf/d7/95/AJMB-1-117.PMC3558130.pdf
Guidelines and policies    [cited; Available from:  http://www.sfn.org/index.,Non-OADS,/arxiv_data1/oa_pdf/9d/91/AJMB-2-47.PMC3558143.pdf
Following servers were used for similarity search: http://pubchem.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/d5/84/AJMB-2-93.PMC3558151.pdf
"nih.gov, http://cactus.nci.nih.gov.",OADS,/arxiv_data1/oa_pdf/d5/84/AJMB-2-93.PMC3558151.pdf
Available from: http://www.daylight.com/  smiles/.,Non-OADS,/arxiv_data1/oa_pdf/d5/84/AJMB-2-93.PMC3558151.pdf
"In this regard internet-based online databases such as Ensembl (http://www.ensembl.org/ index.html), and CBS prediction server (http: //www.cbs.dtu.",Non-OADS,/arxiv_data1/oa_pdf/a5/d8/AJMB-2-69.PMC3558152.pdf
Available from: http://www.fermentas.com/  templates/files/tiny_mce/media_pdf/broch_turbofec t_P26.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a5/1e/AJMB-2-123.PMC3558158.pdf
Available from: http://eppendorf-can.com/  utilities/downloa d_pdf.asp?DR=downloads%2Fpdf %2Fapplications%2FBS%2Fecet-protocols&FN=  4308915-026.pdf    22.,OADS,/arxiv_data1/oa_pdf/a5/1e/AJMB-2-123.PMC3558158.pdf
11. http://www.physik3.gwdg.de/tstool/.,Non-OADS,/arxiv_data1/oa_pdf/81/24/AJMB-3-25.PMC3558171.pdf
Available from: http://www.climate changecorp.com/content.asp?ContentID=5157.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available  from: http://dsp-psd.pwgsc.gc.ca/Collection/C2- 589-2001-1E.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.ask-force.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.i-sis.org.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from:  http://www.biosafety.be/ARGMO/Documents/EFB _AntibioticRM_English.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.who.int/foodsafety/  publications/micro/en/amr.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available  from: http://www.biosicherh eit.de/pdf/aktuell/zen- tek_studie_2008.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.globalresearch.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.i-sis.org.uk/gm ProtestsIndia.php    35.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available  from: http://www.ext.colostate.edu/pubs/foodnut/ 09371.html.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.cbc.ca/news/  background/genetics_modification/.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.food.gov.uk.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
Available from: http://www.i-sis.org.uk/SLBFTS.php.,Non-OADS,/arxiv_data1/oa_pdf/ce/bb/AJMB-3-109.PMC3558185.pdf
"Materials and Methods     Multiple sequence alignment   Protein sequence alignments and compare- sons were performed using a Basic Local Alignment Search Tool  (BLAST)  program,  blastp, against database specification of non-redundant proteins which were available at the National Center for Biotechnology Infor-mation  (NCBI)  Web server, [http://www.ncbi.",OADS,/arxiv_data1/oa_pdf/c1/fd/AJMB-3-167.PMC3558196.pdf
"Multiple sequence alignments were performed using ClustalW2 [http://www.ebi.ac.uk/clustalw/], available at the European Bioinformatics Institute (EBI) Web server  (13).",OADS,/arxiv_data1/oa_pdf/c1/fd/AJMB-3-167.PMC3558196.pdf
Consensus of amino acid se- quence was obtained from  Boxshade available  at the European Molecular Biology Network (EMBnet) Web server[http://www.ch.embnet.,OADS,/arxiv_data1/oa_pdf/c1/fd/AJMB-3-167.PMC3558196.pdf
Structural presentation of  1JFF and 1TVK  and  modeled yeast tubulin was made by using Swiss-Pdb Viewer and  PyMOL  (Version 0.99)  [http://pymol.sourceforge.net] programs (21).,OADS,/arxiv_data1/oa_pdf/c1/fd/AJMB-3-167.PMC3558196.pdf
The three-di- mensional (3D) structures of the studied pro-teins were obtained fr om Protein Data Bank  (http://www.rcsb.org/) at RCSB  (8).,OADS,/arxiv_data1/oa_pdf/91/75/AJMB-4-23.PMC3558204.pdf
Using motif finding shareware (http://myhits.isb-sib.ch/cgi-bin/ motif_scan) the amplified sequence was ana-lyzed.,OADS,/arxiv_data1/oa_pdf/b1/80/AJMB-4-131.PMC3558215.pdf
"http://www.gene.com (Accessed July 1, 2012).",Non-OADS,/arxiv_data1/oa_pdf/28/b3/AJMB-4-113.PMC3558216.pdf
http://www.webcitation.org/ (Accessed July 2012).,Non-OADS,/arxiv_data1/oa_pdf/28/b3/AJMB-4-113.PMC3558216.pdf
http://www.who.int/en/ (Accessed July 2012).,OADS,/arxiv_data1/oa_pdf/28/b3/AJMB-4-113.PMC3558216.pdf
"ZINC is a free database for virtual screen- ing that contains over 4.6 million compounds  in ready-to-dock, 3D formats, available at the URL http://zinc.docking.org.",OADS,/arxiv_data1/oa_pdf/39/75/AJMB-4-121.PMC3558217.pdf
"Materials and Methods    Bioinformatics studies  To predict putative promoter regions of  mouse PPARγ1 isoform, approximately 200 kb  upstream region of PPAR γ gene (NC_0000  72.5) was selected for analysis by Genomatix software (http://www.genomatix.",OADS,/arxiv_data1/oa_pdf/25/65/AJMB-4-160.PMC3558222.pdf
"Fur-thermore, presence of Transcription Factor Binding Sites (TFBS) in predicted PPAR γ1  promoter region was analyzed by several online softwares including Genomatix, TESS (http://www.cbil.upenn.",OADS,/arxiv_data1/oa_pdf/25/65/AJMB-4-160.PMC3558222.pdf
"edu), Gene Builder (http://www.itb.cnr.it/sun/ webgene) and TFS EARCH (http://www.cbrc.jp/research/db/TF SEARCH.html).",OADS,/arxiv_data1/oa_pdf/25/65/AJMB-4-160.PMC3558222.pdf
***Matrix similarity: The matrix simila rity is calculated as described in  http://www.genomatix.de/online_help/help/scores .html?s=b66803c222e3ce9257cd2e748b244230#msim.,OADS,/arxiv_data1/oa_pdf/25/65/AJMB-4-160.PMC3558222.pdf
"4, October-December  2012       Virtual Institute of Medical Biotechn ology (VIMB) (http://vimb.ir) is a website designed and developed in  Iran to dedicate itself to providing the latest world ne ws related to medical biotechn ology.",Non-OADS,/arxiv_data1/oa_pdf/16/73/AJMB-4-159.PMC3558224.pdf
3. http://www.fao.org/biotech /fao-statement-on-bio- technology/en/ [Online].,Non-OADS,/arxiv_data1/oa_pdf/11/df/AJMB-4-200.PMC3558225.pdf
"4, October-December 2012  207Materials and Methods   To predict a potential promoter region of mouse PeP  (Accession No: NC_000070), approximately 2x104 bp  upstream of the PeP gene was submitted to the Geno- matix (http://www.Geno-matix.de/en/index.html) (13)  and Proscan (http://www.proscan.co.za/) (Version 1.7) software programs.",Non-OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
Secondary structures  predictions of the putative promoter of PeP and other  amplified loci were assessed by Mfold web server (http://mfold.Bio-info.rpi.edu/)  (14).,OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
B) Genetyx software was  used to plot the GC-graph and Cp G plot programs (http://www.ebi.ac.,OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
15. http://www.med.yale.edu/genetics/ward/tavi/p08.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
16. http://www.protocol-on line.org/biology-forum s/posts/4854.html.,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
17. http://wiki.answers.com/Q/why is a variable in PCR.,Non-OADS,/arxiv_data1/oa_pdf/d3/4c/AJMB-4-206.PMC3558226.pdf
"Blasting of the human IgG protein sequence with those of the other animals reveals approximately 90% homology with monkey, 50-70% homology with other mammals and 30% with avian im-munoglobulin (http://blast.ncbi.nlm.nih.gov/ blast.cgi).",Non-OADS,/arxiv_data1/oa_pdf/9d/8f/AJMB-4-170.PMC3558227.pdf
Available: http://dsp-psd.pwgsc.gc.ca/ Collection/H115-16-2005E.pdf  (ac- cessed 2006 Nov 20).,Non-OADS,/arxiv_data1/oa_pdf/da/e5/AIM-20-244.PMC3558290.pdf
Available: http://www.euro.,Non-OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.euro.who.,Non-OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.who.int/reproductive-health/ impac/index.html).,Non-OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.eu - ro.who.int/en/what-we-do/health- topics/Life-stages/maternal-and- newborn-health/policy-and-tools/effective-perinatal-care-training- package-epc).,Non-OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.who.int/whr/2000/en/index.html).,OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.euro.who.int/InformationSources/Publica - tions/Catalogue/20090122_1).,OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.euro.who.int/docu - ment /e87577.pdf ).,Non-OADS,/arxiv_data1/oa_pdf/c3/76/AIM-20-226.PMC3558291.pdf
Available: http://www.icmje.org/.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/AIM-20-208.PMC3558294.pdf
Available: http://www.wame.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/AIM-20-208.PMC3558294.pdf
http://www.elsevier.com/vps/find/au - thorsview.authors/rights.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/AIM-20-208.PMC3558294.pdf
24. http://www.en.wikipedia.org/Plagia - rism.,Non-OADS,/arxiv_data1/oa_pdf/9b/d1/AIM-20-208.PMC3558294.pdf
Retrieved 17  August 2012. http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/43/d7/AIM-20-264.PMC3558305.pdf
"Magnesium sulfate  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 1-2  http://dx.doi.org/10.4097/kjae.2013.64.1.1 Editorial",Non-OADS,/arxiv_data1/oa_pdf/e2/2c/kjae-64-1.PMC3558641.pdf
"Tel: 82-51-240-5390, Fax: 82-51-247-7819, E-mail: pain1013@dau.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 12-18  http://dx.doi.org/10.4097/kjae.2013.64.1.12",Non-OADS,/arxiv_data1/oa_pdf/3b/ab/kjae-64-12.PMC3558642.pdf
"Tel: 82-63-859-1564, Fax: 82-63-857-5472, E-mail: ironyii@wku.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 19-24  http://dx.doi.org/10.4097/kjae.2013.64.1.19",Non-OADS,/arxiv_data1/oa_pdf/6e/89/kjae-64-19.PMC3558643.pdf
"Tel: 82-53-420-5998, Fax: 82-53-426-2760, E-mail: kwakkh@knu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 25-28  http://dx.doi.org/10.4097/kjae.2013.64.1.25",Non-OADS,/arxiv_data1/oa_pdf/66/17/kjae-64-25.PMC3558644.pdf
"Tel: 82-42-280-7840, Fax: 82-42-280-7968, E-mail: yhkim0404@cnu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 29-33  http://dx.doi.org/10.4097/kjae.2013.64.1.29",Non-OADS,/arxiv_data1/oa_pdf/84/29/kjae-64-29.PMC3558645.pdf
"Tel: 82-2-3779-1164, Fax: 82-2-783-0368, E-mail: anestha@ catholic.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 3-5  http://dx.doi.org/10.4097/kjae.2013.64.1.3  The time to practically use Sugammadex throughout Korea  has come.",Non-OADS,/arxiv_data1/oa_pdf/3f/fc/kjae-64-3.PMC3558646.pdf
"Tel: 82-61-379-8750, Fax: 82-62-232-6294, E-mail: anesman@jnu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 34-39  http://dx.doi.org/10.4097/kjae.2013.64.1.34",Non-OADS,/arxiv_data1/oa_pdf/39/e7/kjae-64-34.PMC3558647.pdf
"Tel: 82-2-3010-3865, Fax: 82-2-470-1363, E-mail:  hsyang@amc.seoul.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 40-46  http://dx.doi.org/10.4097/kjae.2013.64.1.40",Non-OADS,/arxiv_data1/oa_pdf/44/11/kjae-64-40.PMC3558648.pdf
"Tel: 82-2-2072-2567, Fax: 82-2-747-5639, E-mail: leekh@snu.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2013 January 64(1): 47-53  http://dx.doi.org/10.4097/kjae.2013.64.1.47",Non-OADS,/arxiv_data1/oa_pdf/3a/a9/kjae-64-47.PMC3558649.pdf
"Tel: 82-2-2290-8680, Fax: 82-2-2299-8692, E-mail: jksuh@hanyang.ac.kr     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CCKorean J Anesthesiol 2013 January 64(1): 54-60  http://dx.doi.org/10.4097/kjae.2013.64.1.54",Non-OADS,/arxiv_data1/oa_pdf/ef/cb/kjae-64-54.PMC3558650.pdf
"Tel: 82-2-2639-5507, Fax: 82-2-2631-4387, E-mail: baejjy@naver.com     This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium,  provided the original work is properly cited.CC Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 6-11  http://dx.doi.org/10.4097/kjae.2013.64.1.6  Introduction Since heating and humidification are not physiologically  available in patients who received endotracheal intubation, cold  and dry gas mixtures directly reach the bottom of the airway as  inspired gases pass through the upper airway of the mucosal  lumen.",Non-OADS,/arxiv_data1/oa_pdf/fa/91/kjae-64-6.PMC3558651.pdf
"He developed severe scar contractures involving neck,  face, anterior chest, and both shoulders including upper arms  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 61-64  http://dx.doi.org/10.4097/kjae.2013.64.1.61 Case Report",Non-OADS,/arxiv_data1/oa_pdf/bb/ea/kjae-64-61.PMC3558652.pdf
"We herein report and discuss a case in which a patient  who had shown a negative response in the first preoperative  unexpected antibody screening test was given a blood  transfusion for intraoperative bleeding and who later required  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 65-68  http://dx.doi.org/10.4097/kjae.2013.64.1.65 Case Report",Non-OADS,/arxiv_data1/oa_pdf/bd/cb/kjae-64-65.PMC3558653.pdf
"The results of the preoperative laboratory tests were  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 69-72  http://dx.doi.org/10.4097/kjae.2013.64.1.69 Case Report",Non-OADS,/arxiv_data1/oa_pdf/f5/a8/kjae-64-69.PMC3558654.pdf
"Pericardial effusion  may restrict left ventricular volume and therefore result in  hyperdynamic left ventricle which may predispose to LVOT  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 73-76  http://dx.doi.org/10.4097/kjae.2013.64.1.73 Case Report",Non-OADS,/arxiv_data1/oa_pdf/bd/78/kjae-64-73.PMC3558655.pdf
"Sudden parasympathetic activation (also known as vago - tonia) and sympathetic withdrawal can cause vasovagal  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 77-81  http://dx.doi.org/10.4097/kjae.2013.64.1.77 Case Report",Non-OADS,/arxiv_data1/oa_pdf/34/39/kjae-64-77.PMC3558656.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 82-83  http://dx.doi.org/10.4097/kjae.2013.64.1.82 Letter to the Editor Fig.",Non-OADS,/arxiv_data1/oa_pdf/da/05/kjae-64-82.PMC3558657.pdf
"For anesthesia maintenance, 2% propofol and remifentanil  were administered using a computer-controlled infusion pump  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 84-86  http://dx.doi.org/10.4097/kjae.2013.64.1.84 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/a4/ad/kjae-64-84.PMC3558658.pdf
"The second patient was a 71-yr-old woman (153 cm, 48 kg),  who was scheduled with an operation for a wide excision of  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 87-88  http://dx.doi.org/10.4097/kjae.2013.64.1.87 Letter to the Editor Fig.",Non-OADS,/arxiv_data1/oa_pdf/f8/f6/kjae-64-87.PMC3558659.pdf
"She suddenly complained of palpitation and her  ECG indicated ventricular bigeminy, ventricular tachycardia,  Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 89-90  http://dx.doi.org/10.4097/kjae.2013.64.1.89 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/4a/01/kjae-64-89.PMC3558660.pdf
"Guillermo Lema Division of Anesthesiology, Pontificia Universidad Católica de  Chile, Marcoleta 367, Santiago, Chile E-mail: glema@med.puc.cl Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 91-92  http://dx.doi.org/10.4097/kjae.2013.64.1.91 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/2c/fc/kjae-64-91.PMC3558661.pdf
"Copyright ⓒ the Korean Society of Anesthesiologists, 2013 www.ekja.orgKorean J Anesthesiol 2013 January 64(1): 93-94  http://dx.doi.org/10.4097/kjae.2013.64.1.93 Letter to the Editor",Non-OADS,/arxiv_data1/oa_pdf/c1/76/kjae-64-93.PMC3558662.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ideta, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/e2/63/srep01173.PMC3558692.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Cho, D., Tappertzhofen, S., Waser, R. & Valov, I. Chemically-inactive interfaces in thin film Ag/AgI systems for resistive switching memories.",Non-OADS,/arxiv_data1/oa_pdf/59/70/srep01169.PMC3558693.pdf
The Webometrics rank measures the visibility of academic institutions in terms of web links to their web domains (see http://www.webometrics.info/Distribution_by_Country.asp).,OADS,/arxiv_data1/oa_pdf/d9/37/srep01167.PMC3558694.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/d9/37/srep01167.PMC3558694.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Mazloumian, A., Helbing, D., Lozano, S., Light, R.P.",Non-OADS,/arxiv_data1/oa_pdf/d9/37/srep01167.PMC3558694.pdf
Molecular dynamics (MD) simulation .All ligands are prepared by using web server SwissParam (http://swissparam.ch/)32prior to MD simulation.,OADS,/arxiv_data1/oa_pdf/f8/90/srep00844.PMC3558695.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Tou, W.I., Chang, S., Lee, C. & Chen, C.Y.",Non-OADS,/arxiv_data1/oa_pdf/f8/90/srep00844.PMC3558695.pdf
The density (1.01198 g ml 21) and viscosity (0.01020 P) of the buffer as well as the partial specific volume of the proteins were estimated at 20 uC by employing the Sednterp 1.09 software (http://www.jphilo.mailway.com/download.htm).,OADS,/arxiv_data1/oa_pdf/9d/4a/srep01171.PMC3558696.pdf
Sedimentation coefficient distributions c(s) were determined using the Sedfit 12.0 (http://www.analyticalultracentrifugation.com) software.,OADS,/arxiv_data1/oa_pdf/9d/4a/srep01171.PMC3558696.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9d/4a/srep01171.PMC3558696.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Perdomo, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/9d/4a/srep01171.PMC3558696.pdf
"Populations v. 1.2.30. http://bioinformatics.org/ ,tryphon/populations/ (Accessed November 6, 2012) (1999).",Non-OADS,/arxiv_data1/oa_pdf/15/61/srep01165.PMC3558697.pdf
"40.Fluxus Engineering ,,http://www.fluxus-engineering.com/sharenet.htm .",Non-OADS,/arxiv_data1/oa_pdf/15/61/srep01165.PMC3558697.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Taylor, S.M.",Non-OADS,/arxiv_data1/oa_pdf/15/61/srep01165.PMC3558697.pdf
"http://www.cdc.gov/nchs/data/nvsr/nvsr56/nvsr56_10.pdf, 2008 (accessed on21 December 2010).",OADS,/arxiv_data1/oa_pdf/97/f1/jp2011125a.PMC3558698.pdf
http://premierinc.com/quality-safety/tools-services/prs/data/perspective.jsp(accessed on 12 December 2010).,OADS,/arxiv_data1/oa_pdf/97/f1/jp2011125a.PMC3558698.pdf
http://www.premierinc.com/quality-safety/tools-services/prs/published-research/index.jsp (accessed on 10 February 2011).,OADS,/arxiv_data1/oa_pdf/97/f1/jp2011125a.PMC3558698.pdf
"3M Health Information Systems: Saltlake City, UT, 2003, http://solutions.3m.com/3MContentRetrievalAPI/BlobServlet?locale ¼it_IT&lmd ¼ 1218718280000&assetId ¼1180603360910&assetType ¼MMM_Image&blob- Attribute¼ImageFile (accessed on 10 February 2011).",OADS,/arxiv_data1/oa_pdf/97/f1/jp2011125a.PMC3558698.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/ by-nc-nd/3.0/Neonatal mortality with animal-derived surfactant use R Ramanathan et al 125 Journal of Perinatology",Non-OADS,/arxiv_data1/oa_pdf/97/f1/jp2011125a.PMC3558698.pdf
"EEA Technical Report 12, (2011) (http://www.eea.europa.eu/ publications/air-quality-in-europe-2011) accessed 30th August 2012.",Non-OADS,/arxiv_data1/oa_pdf/0a/98/srep01161.PMC3558699.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/98/srep01161.PMC3558699.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Lazzerini, G.M., Strambini, L.M.",Non-OADS,/arxiv_data1/oa_pdf/0a/98/srep01161.PMC3558699.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Trepanier, C., Lei, G., Xie, Y.",Non-OADS,/arxiv_data1/oa_pdf/c0/86/srep00926.PMC3558700.pdf
"10       http://www.medsci.org  206  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):206-221. doi: 10.7150/ ijms.5529  Review  Systematic Reviews of Animal Models: Methodology  versus  Epistemology   Ray Greek, Andre Menache  Americans For Medical Advancement, 2251  Refugio Rd, Goleta, CA 93117 , USA.",Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  207  about outcomes or practice.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  208  Table 1.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
"10     http://www.medsci.org  209  characteristics of animals used (including sp e- cies, stra in, sex, and genetic background); d e- tails of housing and husbandry; and the e x- perimental, statistical, and analytical methods  (including details of methods used to reduce  bias such as randomization  and blinding) [39].",Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  210  ed.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
"10     http://www.medsci.org  211  tomorrow, the animal model per se  would not be pr e- dictive for humans as the PPV would be somewhere  in the 0.01 area.",Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  212    Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  213  Monozygotic twins have also been discovered to r e- spond di fferently to perturbations because of small  differences in genetic make -up [150-154].,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10       http://www.medsci.org  214    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  215  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  216    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
"10     http://www.medsci.org  217  investment by the private and public sectors,  however, the limited availability of predictive  preclinical systems obscures our ability to select  the therapeutics that might succeed or fail du r- ing clinica l investigation.",Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  218  the axioms underlying such  practices are not usually  discussed among scientists (being I the realm of ph i- losophy of science) and the result is that challenging  the axioms upon which these  practices are based b e- comes almost impossible.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  219  56.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  220  130.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
10     http://www.medsci.org  221  confirmation to clinical utility.,Non-OADS,/arxiv_data1/oa_pdf/59/b2/ijmsv10p0206.PMC3558708.pdf
"10       http://www.medsci.org  222  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):222-229.  doi: 10.7150/ ijms.5373  Research Paper   Anterior Versus Posterolateral Approach for  Total  Laparoscopic Splenectomy: A Comparative Study   Bai Ji*, Yingchao Wang*, Ping  Zhang,  Guangyi Wang , Yahui Liu  Department of Hepatobiliary and Pancreatic Surgery, the First Bethune Hospital , Jilin University, Jilin 130021, China .",Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
"10     http://www.medsci.org  223  with massive splenomegaly due to portal hyperte n- sion, even without hand assistance5.",Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  224  additional 5 mm port was sited at the inferior pole of  the spleen on the left midaxillary line to retract the  spleen  (Fig.1).,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  225  Postoperative care and follow -up  Platelet counts were assessed routinely.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  226  Table 1 .,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  227  Procedural safety and complications   No major intraoperative event occurred in either  group.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  228  vantages of LS compared with open splenectomy i n- clude longer opera tion time and higher bleeding  risk21.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
10     http://www.medsci.org  229  laparoscopic splenectomy.,Non-OADS,/arxiv_data1/oa_pdf/a7/8f/ijmsv10p0222.PMC3558709.pdf
"10       http://www.medsci.org  230  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):230-234.  doi: 10.7150/ ijms.5278  Research Paper   Detection of Hypermethylated  Spastic Paraplegia -20 in  Stool Samples of Patients with Colorectal Cancer   Hao Zhang , Yong -Chun Song , Cheng -Xue Dang  Department of Surgical Oncology the First Affiliated Hospital, Xi'an Jiaotong University College of Medicine, Xi'an, Shaanxi 710061, China .",Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
"10     http://www.medsci.org  231  Metho ds  Patients and collection of tissue and stool  samples   In order to avoid bias, we performed this re- search as a blinded assay.",Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
10     http://www.medsci.org  232  of SPG20.,Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
10     http://www.medsci.org  233  Discussion   Stool DNA tests required the collection of only a  single stool sample per round and no diet or medic a- tion restrictions.,Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
10     http://www.medsci.org  234  2.,Non-OADS,/arxiv_data1/oa_pdf/5c/50/ijmsv10p0230.PMC3558710.pdf
"10       http://www.medsci.org  235  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):235-242.  doi: 10.7150/ ijms.5524  Research Paper   An Association Study on Genetic Polymorphisms of  Rab37  Gene with the Risk of Esophageal Squamous Cell  Carcinoma in a Chinese Han Population   Xiaofeng Xu1, Xingying Guan1, Huansheng Tao1, Kang Y ang2, Yun Bai1  1.",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
"10     http://www.medsci.org  236  intracellular traffics from trans- Golgi to plasma  membrane, the functions of Rab37 in oncology were  not well unknown.",OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
"10     http://www.medsci.org  237  Genotyping   The 3 Tag SNPs in Rab37  gene were enrolled in  this study, which were rs9904078G>A, rs2034310T>C,  rs5018106T>C , respectively.",OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
"10     http://www.medsci.org  238  Association analysis between the polymor- phisms of Rab37 and the risk of ESCC   As the expression of Rab37  mRNA was found in  ESCC, we wondered whether its polymorphisms  would be associated with ESCC.",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
10     http://www.medsci.org  239  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
"10       http://www.medsci.org  240  The association analysis between the pol y- morphisms of Rab37 and  the clinic TNM stage  of ESCC   In addition, we analyzed the association between  the polymorphisms of Rab37 and the clinic TNM stage of ESCC patients in Table 4.",Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
10     http://www.medsci.org  241  the expression of Rab37 has obvious cell specificity.,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
10     http://www.medsci.org  242  11.,Non-OADS,/arxiv_data1/oa_pdf/26/b9/ijmsv10p0235.PMC3558711.pdf
"10       http://www.medsci.org  243  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):243-249.  doi: 10.7150/ ijms.3971  Research Paper   Comparison of Natural Course, Intravitreal Triamci n- olone and Macular laser photocoagulation for Trea t- ment of Mild Diabetic Macular Edema   Soon Il Kwon , Sung Uk Baek , In Won Park  Department of Ophthalmology , Hallym University Sacred Heart Hospital, Anyang, Korea .",Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
10     http://www.medsci.org  244  lows quantitative measurements of retinal volume.,Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
"10     http://www.medsci.org  245  tion Retreatment, when indicated, was performed  within four weeks after the follow -up visit (usually on  the same day as the follow -up visit).",Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
10     http://www.medsci.org  246  Table 2.,Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
10     http://www.medsci.org  247    Fig 3.,Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
"10     http://www.medsci.org  248  thickening of 300 to 400  µm showed significant r e- duction in CMT with slight improvement in BCVA by  laser treatment, while patient with mild mac ular  edema of <300 µm showed statistically insignificant  worsening of visual acuity with increased thickening,  implying poor response to laser treatment.",Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
10     http://www.medsci.org  249  10.,Non-OADS,/arxiv_data1/oa_pdf/30/51/ijmsv10p0243.PMC3558712.pdf
"10       http://www.medsci.org  250  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):250-254.  doi: 10.7150/ ijms.5511  Research Paper   Recipient Cytotoxic T L ymphocyte Antigen 4 +49    Single-Nucleotide Polymorphism Is Not Associated with  Acute Rejection after Liver Transplantation in Chinese  Population   Zhijun Jiang, Ying Chen, Xiaonin Feng, Haiyang Xie, Lin Zhou, Shusen Zheng  Division of  Hepatobiliary  Pancreatic Surgery, Department of Surgery, First Affiliated Hospital, School of Medicine,  Zhejiang University ,  Hangzhou Zhejiang 310003, P.R.",Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
10     http://www.medsci.org  251  tion caused by engagement of CTLA -4: the compet i- tive antagonist of CD28 for B7 as well as the direct  inhibitory signals mediated by CTLA -4 cytoplasmatic  tail [9].,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
10     http://www.medsci.org  252  dy-Weinberg equilibrium (bioinfo.iconcologia.net/   snpstats/start.htm) .,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
10     http://www.medsci.org  253  The continuous use of immunosuppression might be  a reasonable explanation for the different effects  CTLA -4 +49 A allele has in acute rejection and aut o- immune diseases.,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
10     http://www.medsci.org  254  free maintenance regimen in renal transplant: 6 -month efficacy and  safety.,Non-OADS,/arxiv_data1/oa_pdf/ae/51/ijmsv10p0250.PMC3558713.pdf
"10       http://www.medsci.org  255  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):255-264.  doi: 10.7150/ ijms.5383  Research Paper   Gender -Specific Prognosis and Risk Impact of  C-Reactive Protein, Hemoglobin and P latelet in the  Development  of Coronary Spasm   Ming -Yow Hung1,2,3, Kuang -Hung Hsu4, Wei -Syun Hu2, Nen- Chung Chang1,5, Chun -Yao Huang1,5,  Ming -Jui Hung6  1.",Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  256  are unlikely to constitute major dir ect causes of CAS  in the whole population of patients with this disease  [2].,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
"10     http://www.medsci.org  257  of nitroglycerin (Millisrol®; G. Pohl- Boskamp, H o- henlockstedt, Germany).",Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
"10     http://www.medsci.org  258  and low Hb levels in the  highest tertile of hs- CRP had  a 5.9- fold (95% CI 1.57-22.37) and a 3.9- fold (95% CI  1.52- 9.74) higher risk for CAS, respectively, than those  with low Hb levels in the lowest hs- CRP tertile.",Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  259  Table 1 .,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  260  Table 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  261  nonfatal myocardial infar ction events were identified  in the spasm group (0.6%).,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  262    Figure 3.,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
"10     http://www.medsci.org  263  highest hs -CRP tertile than those with low Hb levels  (44% and 35%, respectively), suggesting Hb may i n- crease the role of high hs -CRP levels in the develo p- ment of CAS in women, contributing to the threshold  effect of hs -CRP in women with low Hb levels.",Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
10     http://www.medsci.org  264  CAS: coronary artery spasm; CI: confidence interval;  D: at discharge;  Hb: hemoglobin; hs-CRP: high sens i- tivity C -reactive protein; LVEF: left ventricular ejec- tion fraction;  MACE : major adverse cardiovascular  event ; OR: odds ratio.,Non-OADS,/arxiv_data1/oa_pdf/a0/69/ijmsv10p0255.PMC3558714.pdf
"10       http://www.medsci.org  265  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):265-275.  doi: 10.7150/ ijms.5344  Research Paper   Pharmacophore Modeling, Virtual Screening, and Mo- lecular Docking Studies f or Discovery of Novel Akt2  Inhibitors  Jia Fei1, Lu Zhou1, Tao Liu1, Xiang -Yang Tang2   1.",Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
This is an open -access article distributed under the terms of the Cr eative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  266  phore models are expected to identify the crucial  pharmacophore features of potent Akt2 inhibitors.,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  267  and have good predicted activity and good ADMET  properties can be considered as hits.,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
"10       http://www.medsci.org  268  Results and discussion   Structure -based pharmacophore generation  and validation  The final structure -based pharmacophore h y- pothesis (PharA ) comprised seven pharmacophoric  features (Figure 2), two hydrogen bond acceptors, one  hydrogen bond donor and four hydrophobic groups,  besides, eighteen exclusion volume spheres are also  taken into consideration.",Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10       http://www.medsci.org  269  3D-QSAR pharmacophore  generation and  validation   Ten top -score pharmacophore hypotheses were  generated based on the activity values of 23 training  set compounds.,OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  270    Figure 4 .,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
"10     http://www.medsci.org  271  Virtual screening   Nature Products (199,806) and Asinex database  (508494) downloaded from Zinc database were used  for virtual screening in our study.",OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  272    Figure 6 .,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
"10     http://www.medsci.org  273  six-membered ring forms two hydrogen bonds with  the protein, one is with E279 and another one is with  E236.",Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  274      Figure 7 .,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
10     http://www.medsci.org  275  the target protein.,Non-OADS,/arxiv_data1/oa_pdf/d7/9f/ijmsv10p0265.PMC3558715.pdf
"10       http://www.medsci.org  276  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):276-285. doi: 10.7150/ ijms.5185  Research Paper   Increased Co-Expression of Macrophage Migration I n- hibitory Factor and Matrix Metalloproteinase 9 Is As- sociated with Tumor Recurrence of Meningioma   Quan Huang1*, Song -Li Zhao2,3* , Xiao -Ying Tian4, Bin Li2, Zhi Li2  1.",Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
"10     http://www.medsci.org  277  (grade I) [ 3], and the ideal treatment for these tumors  is complete surgical resection but, when invasion of  the adjacent structures, including dura mater, bone,  and brain parenchyma, is present (these are not  prognostic  factors in the WHO criteria), this aim is  often not achieved.",Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  278  ther analysis.,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  279  ble 1).,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  280  Table 1 .,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  281  of tu mors .,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  282    Figure 2.,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
"10     http://www.medsci.org  283  of the relationship between MIF high expression and  MVD of tumor indicated  that MIF might be a possible  mediator to contribute to the neovascularization of  meningioma and influence the recurrence of meni n- giomas, b ecause t he amount of tumour vasculariz a- tion has been proposed to affect the degree of cerebral  edema and also  disease recurrence [24].",Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
"10     http://www.medsci.org  284  despite the recent rapid proliferation of literature on  the early prediction of meningioma recurrence, a re- liable factor on the prognostic value of the recurrence  rate in histological benign meningiomas has not yet  been identified.",Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
10     http://www.medsci.org  285  38.,Non-OADS,/arxiv_data1/oa_pdf/9c/1f/ijmsv10p0276.PMC3558716.pdf
"10       http://www.medsci.org  286  IInntteerrnnaattiioonnaall  JJoouurrnnaall  ooff  MMeeddiiccaall  SScciieenncceess   2013; 10(3):286-291. doi: 10.7150/ ijms.5343  Research Paper   Emulsified Isoflurane  Preconditioning Protects Isolated  Rat Kupffer Cells against Hypoxia/Reoxygenation -  Induced Injury   Zhenmeng Wang1,*, Hao Lv2,*, Shaohua Song3, Xiaoyun Shen4, Liqun Yang1, Weifeng Yu1   1.",Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
10     http://www.medsci.org  287  coronary artery occlus ion.,Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
10     http://www.medsci.org  288  chamber.,Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
10     http://www.medsci.org  289    Fig.,Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
"10     http://www.medsci.org  290  Discussion   In the present study, we investigat ed the effect of  emulsified isoflurane  preconditioning on hypox- ia/reoxygenation -induced injury to primarily cu l- tured KCs .",Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
10     http://www.medsci.org  291  tion Committee.,Non-OADS,/arxiv_data1/oa_pdf/99/53/ijmsv10p0286.PMC3558717.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Fujioka, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/54/b4/srep01170.PMC3558719.pdf
"In Equity Symposium on The Social Costs of Inadequate Education at Teachers College, Columbia University , edited by Clive Belfield and Henry M. Levin (Washington: Brookings Institution Press,2007).Available: http://devweb.tc.columbia.edu/manager/symposium/Files/ 77_Rouse_paper.pdf Last visited: 4-1-2013 3.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/srep01174.PMC3558720.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0a/74/srep01174.PMC3558720.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Vaquero, L.M.",Non-OADS,/arxiv_data1/oa_pdf/0a/74/srep01174.PMC3558720.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gavazzi, G., Bisio, A.",Non-OADS,/arxiv_data1/oa_pdf/56/b3/srep01168.PMC3558721.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/b9/srep01177.PMC3558722.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Chen, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/68/b9/srep01177.PMC3558722.pdf
The online version of this article is published within an Open Access environment subject to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence /http://creativecommons.org/ licenses/by-nc-sa/2.5/ S. The written permission of Cambridge University Press must be obtained for commercial re-use.Primary Health Care Research & Development 2013; 14:21–28 doi:10.1017/S1463423612000047DEVELOPMENT,Non-OADS,/arxiv_data1/oa_pdf/a6/15/S1463423612000047a.PMC3558728.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/02/bc/bio-01-12-1273.PMC3558749.pdf
Available at http://www.cancer.gov/cancertopics/types/ovarian.,Non-OADS,/arxiv_data1/oa_pdf/ee/e4/jls511.PMC3558884.pdf
http://www.ahrq.gov/research/hysterec.htm.,OADS,/arxiv_data1/oa_pdf/6d/5c/jls519.PMC3558885.pdf
"Available at: http://www.fda.gov/MedicalDevices /Safety/ AlertsandNotices/ucm197339.htm Accessed May 9, 2010.",Non-OADS,/arxiv_data1/oa_pdf/ca/7d/jls559.PMC3558892.pdf
"Available at: http://www.endoscopy-sages.com/2011/resource/posters.php?id /H1100536229, Accessed October 11, 2012.",Non-OADS,/arxiv_data1/oa_pdf/78/44/jls569.PMC3558894.pdf
Medscape Reference [updated 2007 Jul 7; cited 2011 Sep 10].Available at: http://emedicine.medscape.com/article/1005815-overview.html.,OADS,/arxiv_data1/oa_pdf/87/92/jls671.PMC3558913.pdf
Supplementary material For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291712001298.,Non-OADS,/arxiv_data1/oa_pdf/57/94/S0033291712001298a.PMC3558981.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/19/25/hys205.PMC3559015.pdf
http://ganjoho.jp/public/statistics/pub/ statistics01.html.,OADS,/arxiv_data1/oa_pdf/19/25/hys205.PMC3559015.pdf
http://www.hpcj.org/what/aboutpcu.html.4.,Non-OADS,/arxiv_data1/oa_pdf/19/25/hys205.PMC3559015.pdf
http://www.jspm-peace.jp/seminar.html.15.,Non-OADS,/arxiv_data1/oa_pdf/19/25/hys205.PMC3559015.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Dickson, J.L., Head, J.W., Levy, J.S.",Non-OADS,/arxiv_data1/oa_pdf/bd/34/srep01166.PMC3559074.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/d8/83/JAPTR-3-200.PMC3560124.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.AnnouncementHow to cite this article:  Veeresham C. Natural products derived  from plants as a source of drugs.,Non-OADS,/arxiv_data1/oa_pdf/d8/83/JAPTR-3-200.PMC3560124.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/b6/5d/JAPTR-3-202.PMC3560125.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/97/dc/JAPTR-3-210.PMC3560126.pdf
Parasitol Int  Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/a8/71/NAJMS-5-10.PMC3560132.pdf
The application can be downloaded  from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/a2/60/NAJMS-5-22.PMC3560134.pdf
"(Accessed October  1, 2012, at http://www2.gsu.edu/~wwwfit/bodycomp.",Non-OADS,/arxiv_data1/oa_pdf/4d/fc/NAJMS-5-28.PMC3560135.pdf
The application can be downloaded  from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/31/d2/NAJMS-5-32.PMC3560136.pdf
Start a QR-code reading  software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the  journal.,Non-OADS,/arxiv_data1/oa_pdf/6b/a5/NAJMS-5-47.PMC3560139.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.Announcement,Non-OADS,/arxiv_data1/oa_pdf/6b/a5/NAJMS-5-47.PMC3560139.pdf
"(Accessed September 1, 2021, at http://www.acns.org/ pdfs/Guideline%209C1.pdf).",Non-OADS,/arxiv_data1/oa_pdf/18/7b/NAJMS-5-60.PMC3560142.pdf
"(Accessed December 1, 2012, at http://www.idf.org/ diabetesatlas/5e/Update2012).",Non-OADS,/arxiv_data1/oa_pdf/b0/85/NAJMS-5-66.PMC3560143.pdf
"(Accessed April  20, 2010, at http://www.cdc.gov/hipac/pdf/guidelines/ Disinfection_ Nov_2008.pdf).",Non-OADS,/arxiv_data1/oa_pdf/d0/93/NAJMS-5-68.PMC3560144.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.1 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/30/d8/kjfm-34-1.PMC3560333.pdf
Available from: http://en.wikipedia.org/wiki/Clinical_trials_registry.,Non-OADS,/arxiv_data1/oa_pdf/30/d8/kjfm-34-1.PMC3560333.pdf
Available from: http://www.icmje.org/publishing_10register.html.,Non-OADS,/arxiv_data1/oa_pdf/30/d8/kjfm-34-1.PMC3560333.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.11 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/b1/b5/kjfm-34-11.PMC3560334.pdf
"Keywords:  Alcohol; Mass Screening; Primary Health Care Received: October 30, 2012,  Accepted: December 28, 2012 *Corresponding Author: Eunju Sung T el: +82-2-2001-2277, Fax: +82-2-2001-1280E-mail: eunjusung68@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The proportion of Korean adults who drink alcohol is among  the world ’s highest and is increasing —from 45.8% in 1989 to  59.2% in 2005.1,2) According to the Korean national health and  nutrition examination survey, the overall age-adjusted prevalence of alcohol use disorder (AUD: alcohol abuse and alcohol dependence) in 2009 was 38.8%.",Non-OADS,/arxiv_data1/oa_pdf/b1/b5/kjfm-34-11.PMC3560334.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.19 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjfm-34-19.PMC3560335.pdf
"Keywords:  Metabolically Healthy Obese; Criteria; Prevalence; Korean Received: August 31, 2011,  Accepted: November 29, 2012 *Corresponding Author: Eun Y oung Choi T el: +82-41-550-3998, Fax: +82-41-550-7136E-mail: choiey@dku.edu Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Recently, due to excessive intake of food and drink coupled  with physical inactivity, the prevalence of obesity has been increasing in the world.",Non-OADS,/arxiv_data1/oa_pdf/c0/68/kjfm-34-19.PMC3560335.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.2 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/a7/a9/kjfm-34-2.PMC3560336.pdf
"Keywords:  Probiotics; Common Cold; Meta-Analysis Received: August 25, 2011,  Accepted: October 12, 2012 *Corresponding Author: Soo Y oung Kim T el: +82-2-2224-2406, Fax: +82-2-2224-2409E-mail: hallymfm@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION The common cold is an upper respiratory tract infection and  is one of the most common diseases occurring in all ages.",Non-OADS,/arxiv_data1/oa_pdf/a7/a9/kjfm-34-2.PMC3560336.pdf
Available from: http://www.cochrane-handbook.org.,OADS,/arxiv_data1/oa_pdf/a7/a9/kjfm-34-2.PMC3560336.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.27 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/d5/23/kjfm-34-27.PMC3560337.pdf
"Keywords:  Education; Cardiovascular Diseases; Risk Factors; Quality of Health Care Received: August 31, 2011,  Accepted: November 29, 2012 *Corresponding Author: Sang Min Park T el: +82-2-2072-3331, Fax: +82-2-766-3276E-mail: sangmin.park.snuh@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Cardiovascular diseases have been well studied, and their  risk factors have been well established.",Non-OADS,/arxiv_data1/oa_pdf/d5/23/kjfm-34-27.PMC3560337.pdf
Available from: http://kosis.kr/abroad/abroad_01List.jsp.,Non-OADS,/arxiv_data1/oa_pdf/d5/23/kjfm-34-27.PMC3560337.pdf
Available from: http://www.health.gov/paguidel ines/guidelines/default.aspx.,Non-OADS,/arxiv_data1/oa_pdf/d5/23/kjfm-34-27.PMC3560337.pdf
Available from: http://kosis.kr/abroad/abroad_01List.jsp.,Non-OADS,/arxiv_data1/oa_pdf/d5/23/kjfm-34-27.PMC3560337.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.36 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/49/b2/kjfm-34-36.PMC3560338.pdf
"Keywords:  Burnout; Resident; Medical Errors Received: July 29, 2011,  Accepted: January 4, 2013 *Corresponding Author: Eun-Hee Kong T el: +82-51-990-6476, Fax: +82-51-990-3045E-mail: kosinfm@hanmail.net Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and residents must pass intense training courses to acquire the  required skills.",Non-OADS,/arxiv_data1/oa_pdf/49/b2/kjfm-34-36.PMC3560338.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.43 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/c6/61/kjfm-34-43.PMC3560339.pdf
"Keywords:  Osteoporosis; Bone Density; Proteins Received: August 30, 2011,  Accepted: December 28, 2012 *Corresponding Author: Byungsung Kim T el: +82-2-958-8700, Fax: +82-2-958-8699E-mail: byungskim@naver.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.to an increased risk of fracture.1) As the older adult population  increases, the incidence of osteoporosis and osteoporotic fractures have continued to increase.",Non-OADS,/arxiv_data1/oa_pdf/c6/61/kjfm-34-43.PMC3560339.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.49 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/cc/d9/kjfm-34-49.PMC3560340.pdf
"Keywords:  Stress; Signs and Symptoms; Family Physicians; Internship and Residency; Questionnaires Received: August 26, 2010,  Accepted: November 27, 2012 *Corresponding Author: Jun-Hyun Y oo T el: +82-2-3410-2449, Fax: +82-2-3410-2459E-mail: drjohn.yoo@samsung.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.so-called ‘stress ’ denotes a biological, psychological, or behavioral  reaction that occurs in the body in response to mental and physical stimuli impinging on a living body.",Non-OADS,/arxiv_data1/oa_pdf/cc/d9/kjfm-34-49.PMC3560340.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.58 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/f9/2a/kjfm-34-58.PMC3560341.pdf
"Keywords:  Motor Activity; Environment; Public Health Received: August 30, 2009,  Accepted: November 6, 2012 *Corresponding Author: Belong Cho T el: +82-2-2072-2195, Fax: +82-2-766-3276E-mail: belong@snu.ac.kr Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.INTRODUCTION Modern medicine has emphasized the importance of  personalized access for health promotion.",Non-OADS,/arxiv_data1/oa_pdf/f9/2a/kjfm-34-58.PMC3560341.pdf
Available from: http://www.cdc.gov/healthyplaces/terminology.htm.,Non-OADS,/arxiv_data1/oa_pdf/f9/2a/kjfm-34-58.PMC3560341.pdf
Available from: http://www.cdc.gov/physicalactivity/everyone/health/index.html.,OADS,/arxiv_data1/oa_pdf/f9/2a/kjfm-34-58.PMC3560341.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.64 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/dd/38/kjfm-34-64.PMC3560342.pdf
 http://dx.doi.org/10.4082/kjfm.2013.34.1.66 Korean J Fam Med.,Non-OADS,/arxiv_data1/oa_pdf/a0/73/kjfm-34-66.PMC3560343.pdf
"In this regard, the blood counts should be repeated to see if the high hematocrit is due to a transient decrease of plasma volume (dehydration and diuretics use), Gaisbock syndrome (pseudopolycythemia/apparent polycythemia), or if the  *Corresponding Author: Rodrigo Lopes da Silva T el: +351-965602341, Fax: +351-965602341E-mail: ronolosi@gmail.com Korean Journal of Family Medicine Copyright © 2013 The Korean Academy of Family Medicine  This is an open-access article distributed under the terms of  the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/lice nses/by-nc/3.0) which permits  unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a0/73/kjfm-34-66.PMC3560343.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Liu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/4a/29/srep01185.PMC3560354.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yang, L., Yang, N. & Li, B.",Non-OADS,/arxiv_data1/oa_pdf/c4/4b/srep01143.PMC3560355.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Edwards, L.M.",Non-OADS,/arxiv_data1/oa_pdf/7b/36/srep01182.PMC3560356.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Soma, S., Shimegi, S., Suematsu, N. & Sato, H. Cholinergic modulation of response gain in the rat primary visual cortex.",Non-OADS,/arxiv_data1/oa_pdf/a0/14/srep01138.PMC3560357.pdf
"wrote the paper with contribution from all authors.Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: All authors are current fulltime employees of Fate Therapeutics, San Diego, CA.",Non-OADS,/arxiv_data1/oa_pdf/05/a3/srep01179.PMC3560358.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Abujarour, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/05/a3/srep01179.PMC3560358.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Alexandrov, B.S.",Non-OADS,/arxiv_data1/oa_pdf/26/98/srep01184.PMC3560359.pdf
KRS and BVP arepartly supported by EU grant FP7-261504 EDENext and this paper is catalogued by the EDENext Steering Committee as EDENext084 (http://www.edenext.eu).,Non-OADS,/arxiv_data1/oa_pdf/77/02/srep01178.PMC3560360.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 3 : 1178 | DOI: 10.1038/srep01178 9,Non-OADS,/arxiv_data1/oa_pdf/77/02/srep01178.PMC3560360.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/How to cite this article: Bessell, P.R.",Non-OADS,/arxiv_data1/oa_pdf/77/02/srep01178.PMC3560360.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wang, Z., Szolnoki, A.",Non-OADS,/arxiv_data1/oa_pdf/fc/a3/srep01183.PMC3560361.pdf
"This is an Open Access article distributed under the terms of the Creativ e Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and repro duction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/sfs169.PMC3560378.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2f/ae/sft002.PMC3560379.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ishida, N., Byrnes, T., Nori, F. & Yamamoto, Y. Photoluminescence of a microcavity quantum dot system in the quantum strong-coupling regime.",Non-OADS,/arxiv_data1/oa_pdf/e6/24/srep01180.PMC3560380.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a2/36/srep01176.PMC3560382.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/36/srep01176.PMC3560382.pdf
"M. ferrooxydans strain PV-1 was obtained from the Provasoli-Guillard National Center for Marine Algae and Microbiota (NCMA), located at the Bigelow Laboratory (East Boothbay, ME),and grown on zero-valent iron (ZVI) plates with an overlay ofNCMA-1 minimal medium (as described by Bigelow Laboratoryprotocols [ http://ncma.bigelow.org ]).",OADS,/arxiv_data1/oa_pdf/d8/3c/mBio.00420-12.PMC3560526.pdf
http://dx.doi.org/10.1371/journal.pone.0000667 .,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/mBio.00420-12.PMC3560526.pdf
http://dx.doi .org/10.1371/journal.pone.0025386 .,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/mBio.00420-12.PMC3560526.pdf
http://dx.doi.org/10.1371 /journal.pone.0016649 .,Non-OADS,/arxiv_data1/oa_pdf/d8/3c/mBio.00420-12.PMC3560526.pdf
"Using the Javaplex software package at http://code.google.com/p /javaplex , we implemented a witness stream to ﬁlter different strains of inﬂuenza virus.",OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://www.who.int/whr /2004/en/ .,OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://dx.doi.org/doi:10 .1371/journal.pcbi.1001005 .,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
arXiv:.4568. http://arxiv.org/ftp /arxiv/papers/1104/1104.4568.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
BMC Proc 5:1.http://dx.doi.org/doi:10.1111/j.1863-2378 .2011.01439.x .,OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://www.who.int/csr/disease/swineﬂu/Inﬂuenza _transmission_zones.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://www.usda.gov/wps/portal/usda/usdahome?contentid /H110052006/08/0296.xml .,OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://dx.doi.org/doi:10.1371 /journal.pntd.0000890 .,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
7:670 – 674. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2631746 /pdf/11585530.pdf .,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://comptop.stanford.edu/u/preprints /witness.pdf .Chan and Rabadan 10®mbio.asm.org January/February 2013 Volume 4 Issue 1 e00524-12,Non-OADS,/arxiv_data1/oa_pdf/87/6f/mBio.00524-12.PMC3560527.pdf
http://dx.doi.org/10.1111/j.1462-2920.2012 .02846.x .,Non-OADS,/arxiv_data1/oa_pdf/05/44/mBio.00526-12.PMC3560528.pdf
http://dx.doi.org/10 .1128/JB.02273-12 .,Non-OADS,/arxiv_data1/oa_pdf/05/44/mBio.00526-12.PMC3560528.pdf
http://dx.doi.org /10.1128/mBio.00134-11 .,Non-OADS,/arxiv_data1/oa_pdf/7a/04/mBio.00549-12.PMC3560529.pdf
http://dx.doi.org/10.1128/mBio.00198-11 .,Non-OADS,/arxiv_data1/oa_pdf/7a/04/mBio.00549-12.PMC3560529.pdf
http://dx.doi.org/10.1371/journal.pbio.1000238 .,Non-OADS,/arxiv_data1/oa_pdf/7a/04/mBio.00549-12.PMC3560529.pdf
Cancer 10:38.http://dx.doi.org /10.1186/1476-4598-10-38 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
http://dx.doi.org/10.1371/journal .ppat.1002772/ .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
7:48.http://dx.doi.org/10.1186 /1741-7015-7-48 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 8:55.http://dx.doi.org/10.1186/1742-4690 -8-55 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 7:114. http://dx.doi.org/10.1186/1742-4690-7-S1-P114 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 5:117. http://dx.doi.org/10.1186/1742 -4690-5-117 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
mBio 1(5):e00206- 10.http://dx.doi/org/10.1128/mBio.00206-10 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 8:61. http://dx.doi.org/10.1186/1742-4690-8-61 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 8:60.http://dx.doi .org/10.1186/1742-4690-8-S1-A60 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
BMC Genomics8:39.http://dx.doi.org/10.1186/1471-2164-8-39 .,OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
http://dx.doi.org/10 .1371/journal.pbio.0030156 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
19:92.http://dx.doi.org/10.1186/1423-0127-19-92 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Retrovirology 6:26.http://dx.doi.org/10.1186/1742-4690-6-S2-O26 .,Non-OADS,/arxiv_data1/oa_pdf/05/3c/mBio.00596-12.PMC3560530.pdf
Sequences were aligned using Dnadot ( http://www.vivo.colostate.edu/molkit/dnadot/index.html ) with a window size of 15.,OADS,/arxiv_data1/oa_pdf/09/2b/mBio.00572-12.PMC3560662.pdf
http://dx.doi.org/10.1371 /journal.ppat.1002701 .,Non-OADS,/arxiv_data1/oa_pdf/09/2b/mBio.00572-12.PMC3560662.pdf
http://dx.doi.org/10.1371/journal.pgen .1001052 .,Non-OADS,/arxiv_data1/oa_pdf/09/2b/mBio.00572-12.PMC3560662.pdf
http://dx.doi.org/10.1371/journal .pgen.1002436 .,Non-OADS,/arxiv_data1/oa_pdf/09/2b/mBio.00572-12.PMC3560662.pdf
http://dx.doi .org/10.1371/journal.pone.0002879 .,Non-OADS,/arxiv_data1/oa_pdf/09/2b/mBio.00572-12.PMC3560662.pdf
2:118. http://dx.doi.org/10.3389/fmicb.2011.00118 .,Non-OADS,/arxiv_data1/oa_pdf/52/fc/mBio.00631-12.PMC3560663.pdf
"Ask the wise man: History isn’t always clear St. Anthony Messenger Magazine, May, from http://www.americancatholic.org/Messenger/May1996/Wiseman.asp#F3 .",Non-OADS,/arxiv_data1/oa_pdf/01/25/10943_2011_Article_9471.PMC3560953.pdf
"Retrieved April, 2010, from http://www.creeds.net/ index.htm .",Non-OADS,/arxiv_data1/oa_pdf/01/25/10943_2011_Article_9471.PMC3560953.pdf
"Retrieved April, 2010, from http://www.kapc.org/gb/aboutus.php .",Non-OADS,/arxiv_data1/oa_pdf/01/25/10943_2011_Article_9471.PMC3560953.pdf
"The catholic encyclopedia retrieved July 14, 2010, from http://www.newadvent.org/cathen/09212a.htm .",Non-OADS,/arxiv_data1/oa_pdf/01/25/10943_2011_Article_9471.PMC3560953.pdf
Available from:http://www.chp.gov.hk/en/content/116/16787.html .,Non-OADS,/arxiv_data1/oa_pdf/cd/8a/10995_2011_Article_943.PMC3560965.pdf
"[updated July 27, 2009; Acces- sed 2011 May 24]; Available from: http://www.cdc.gov/h1n1ﬂu/ clinician_pregnant.html .",OADS,/arxiv_data1/oa_pdf/cd/8a/10995_2011_Article_943.PMC3560965.pdf
Accessed 2011 October 12; Available from: http://www.chp.gov.hk/en/data/1/26/44/292/378.html .,OADS,/arxiv_data1/oa_pdf/cd/8a/10995_2011_Article_943.PMC3560965.pdf
Accessed 2011 October 12; Available from: http://www.chp.gov.hk/en/data/1/26/44/292/420.html .52.,OADS,/arxiv_data1/oa_pdf/cd/8a/10995_2011_Article_943.PMC3560965.pdf
The atomic coordinates and structure factors (code 4H56 ) have been deposited in the Protein Data Bank ( http://wwpdb.org/ ).,OADS,/arxiv_data1/oa_pdf/c6/f3/zbc3512.PMC3561570.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/MSCs and damaged ovaries Y Takehara et al www.laboratoryinvestigation.org | Laboratory Investigation | Volume 93 February 2013 193",Non-OADS,/arxiv_data1/oa_pdf/50/1b/labinvest2012167a.PMC3561594.pdf
"To view acopy of this license, visit http://creativecommons.org/licenses/by-nc- nd/3.0/ Supplementary Information accompanies this paper on the Clinical and Tr anslationalGastroenterology website (http://www.nature.com/ctg)Metabolite Proﬁling In Crohn’s Disease Preter et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/03/ctg201224a.PMC3561595.pdf
"NRC , Washington  2009; available at: http://pbadupws.nrc.gov/docs/ML0807/ ML080710054.pdf (accessed 31/08/12).",OADS,/arxiv_data1/oa_pdf/34/2d/JCB-4-19999.PMC3561606.pdf
2010; Avail- able from URL: http://www.forbes.com/2010/05/11/narcotic- painkiller-vicodin-business-healthcare-popular-drugs.html .,Non-OADS,/arxiv_data1/oa_pdf/81/91/40261_2012_Article_49.PMC3561611.pdf
"2008; Available from URL: http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2007.pdf [Accessed July 9, 2011].",OADS,/arxiv_data1/oa_pdf/81/91/40261_2012_Article_49.PMC3561611.pdf
"None of the guidance iden-tiﬁed included an explicit consideration of the likelihood of the technology being cost effective based on the further evidence within the rationale for the OIR recommendation.The review did, however, identify occasional use of OIRTable 7 New evidence on the OIR/AWR recommendation provided at a review of theguidance For further information about the TAs and CGs listed in thistable, visit the NICE website: http://www.nice.org.uk/ ACD Appraisal Consultation Document, AWR approval with research, CCBT computerized cognitive behavioural therapy, CGclinical guideline, FAD Final Appraisal Determination, OIR only in research, RCT randomized controlled trial, TAtechnology appraisalOriginal Review Additional evidence provided for the OIR/AWR indication?Summary of change to OIR/AWR guidance TA5 TA69 New evidence available (requested pilot implementation databecame available)OIR removed Technology recommended TA6 TA30 No additional evidence presented OIR amended OIR recommendation for a more restricted indication TA16 TA89 Updated RCT data and new non- RCT evidenceOIR unchanged (Some amendments to types of evidence required) TA17 TA105 New evidence (RCTs) available OIR removed Technology recommended TA30 CG81 New evidence (RCT and registry data) availableOIR removed CG81 did not include the OIR indication in the scope of the guideline TA33 TA93 No new RCTs, but updated adverse effect dataOIR unchanged TA36 TA130 (only in ACD)New RCT and registry data availableAWR removed Technologies recommended.",Non-OADS,/arxiv_data1/oa_pdf/d1/01/40273_2012_Article_13.PMC3561612.pdf
London: NICE; 2012. http://www.nice.org.,Non-OADS,/arxiv_data1/oa_pdf/d1/01/40273_2012_Article_13.PMC3561612.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Chitin-glucan effects on oxidized LDL HE Bays et al 7 &2013 Macmillan Publishers Limited European Journal of Clinical Nutrition (2013) 2 – 7",Non-OADS,/arxiv_data1/oa_pdf/54/65/ejcn2012121a.PMC3561615.pdf
Available at http://www.wagnerproducts.com.au/products-and-supplements/product-list/product-details/_prod_/Kyolic-High-Potency-Everyday-Formula.,Non-OADS,/arxiv_data1/oa_pdf/22/43/ejcn2012178a.PMC3561616.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Aged garlic extract for hypertension K Ried et al 70 European Journal of Clinical Nutrition (2013) 64 – 70 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/22/43/ejcn2012178a.PMC3561616.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dd/b7/srep01191.PMC3561619.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yoshimoto, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/dd/b7/srep01191.PMC3561619.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/38/fd/srep01194.PMC3561620.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wu, Y.R., Hollowell, A.E., Zhang, C. & Guo, L.J.",Non-OADS,/arxiv_data1/oa_pdf/38/fd/srep01194.PMC3561620.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Thacker, S.A., Robinson, P., Abel, A.",Non-OADS,/arxiv_data1/oa_pdf/26/9a/srep01187.PMC3561621.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/4d/c6/srep01190.PMC3561622.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Matsusaka, S., Kobayakawa, M., Mizutani, M., Imran, M. & Yasuda, M. Bubbling behavior of a fluidized bed of fine particles caused byvibration-induced air inflow.",Non-OADS,/arxiv_data1/oa_pdf/4d/c6/srep01190.PMC3561622.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Sharma, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/71/20/srep01188.PMC3561623.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/84/c0/srep01195.PMC3561624.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Cong, C., Li, K., Zhang, X.X.",Non-OADS,/arxiv_data1/oa_pdf/84/c0/srep01195.PMC3561624.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/19/srep01197.PMC3561625.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Katsuda, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/db/19/srep01197.PMC3561625.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/f7/61/srep01189.PMC3561626.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Lafuerza, L.F. & Toral, R. On the effect of heterogeneity in stochastic interacting-particle systems.",Non-OADS,/arxiv_data1/oa_pdf/f7/61/srep01189.PMC3561626.pdf
"(2013) 41, 213–217; doi:10.1042/BST20120319C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2013 Biochemical SocietyBiochemical Society Transactions     www.biochemsoctrans.org © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"Taken together, all these signalling-sensitive amino acids residues (extracted from http://www.SSFA-GPHR.de [25] and summarized inTable 1) indicate locations where SMLs may shift the receptor to either an inactive or an active conformation.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"Based on our three-dimensional homology C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2013 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"The alanine substitution at this highly conserved position C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2013 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"21, 574–580 C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2013 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"155 , 535–545 Received 5 November 2012 doi:10.1042/BST20120319 C/circlecopyrtThe Authors Journal compilationC/circlecopyrt2013 Biochemical Society © 2011 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/e2/bst0410213.PMC3561627.pdf
"Methods The Community Earth System Model (CESM) version 1.0.4 of the National Center for Atmospheric Research (NCAR, http://www.cesm.ucar.edu) was integrated with fully active and coupled atmosphere, ocean, sea ice, and land components18,19.A l l integrations were performed using the finite volume dynamical core at 0.9 31.25 u horizontal resolution with 26 vertical levels.",OADS,/arxiv_data1/oa_pdf/7e/3d/srep01192.PMC3561641.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Boos, W.R. & Kuang, Z.",Non-OADS,/arxiv_data1/oa_pdf/7e/3d/srep01192.PMC3561641.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ba/9d/srep01196.PMC3561642.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ueda, O. et al.",Non-OADS,/arxiv_data1/oa_pdf/ba/9d/srep01196.PMC3561642.pdf
"The data were collected from the Gene Ex- pression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/), a public repository of microarray data sets (Barrett et al.",OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.140301.112.",OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
The segmentation profiles of all tumor samplesand other analysis files are available at http://compbio.med.,OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
"In addition, when we measured the overlap between pan-lineage MCRs and known germline copy number variations (CNVs) obtained from the Data- base of Genomic Variants (DGV) (http://projects.tcag.ca/variation/), eight MCRs showed substantially elevated CNV density ( >100 CNVs/Mb; mean of all MCRs was 36.2 CNVs/Mb), indicative of potential germline origins for these recurrent alterations.",OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
Methods Compendium of human cancer genome copy number profiles We collected human cancer array-CGH data sets from a public microarray database (GEO; http://www.ncbi.nlm.nih.gov/geo/)(Barrett et al.,OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
We also processed the normal HapMap population CEL files (available inhttp://www.affymetrix.com).,OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
The processed seg- mentation profiles and associated analysis files are available athttp://compbio.med.harvard.edu/metaCGH/.,OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
"We also sele cted 421 and 156 genes associated with pan-lineage amplification and deletion MCRs, respectively,and measured the enrichment with GO functional categories(http://www.broadinstitute.org/gsea/msigdb/index.jsp; c5 GO cat- egories) (Subramanian et al.",OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
We also downloaded a list of hg18- compatible CNVs from a public database (variation.hg18.v10.nov.2010; http://projects.tcag.ca/variation/).,OADS,/arxiv_data1/oa_pdf/81/f6/217.PMC3561863.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.141382.112.",OADS,/arxiv_data1/oa_pdf/92/a8/228.PMC3561864.pdf
Software availability BreakPointer is available at http://www.broadinstitute.org/cancer/ cga/BreakPointer.,OADS,/arxiv_data1/oa_pdf/92/a8/228.PMC3561864.pdf
The remarkable genetic heterogeneity (179 genes as of January 2012; https://sph.uth.tmc.edu/Retnet/sum-dis.htm) and the poor predictive value of the clinical assessment to the specific genetic etiology (at least in nonsyndromic cases) make it extremely chal-15These authors contributed equally to this work.,Non-OADS,/arxiv_data1/oa_pdf/3c/e6/236.PMC3561865.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.144105.112.",OADS,/arxiv_data1/oa_pdf/3c/e6/236.PMC3561865.pdf
The reads were mapped against UCSC hg19 (http://genome.ucsc.edu/) by BWA (http://bio-bwa.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/3c/e6/236.PMC3561865.pdf
The SNPs and indels weredetected by SAMtools (http://samtools.sourceforge.net/).,OADS,/arxiv_data1/oa_pdf/3c/e6/236.PMC3561865.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.141945.112.",Non-OADS,/arxiv_data1/oa_pdf/43/66/248.PMC3561866.pdf
"Datahave been deposited at NCBIs Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/; accession no: GSE37066).",OADS,/arxiv_data1/oa_pdf/43/66/248.PMC3561866.pdf
"These calcula-tions can also be performed with the online calculator, which isaccessible under http://www.molcell.rwth-aachen.de/dms/.",Non-OADS,/arxiv_data1/oa_pdf/43/66/248.PMC3561866.pdf
"Unsupervised hierarchical clustering according to Euclidian Distance (with Ward’s Minimum Variance Method) was performed using the MultiExperiment Viewer (MeV, TM4.7.4; http://www.tm4.org/mev/) or R. SA-DNAm changes were calculated by the limmapackage in R with adjusted P-values <0.05 and >20% change in DNAm level between early and late passages.",OADS,/arxiv_data1/oa_pdf/43/66/248.PMC3561866.pdf
Data access The microarray data from this study have been submitted to theNCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/43/66/248.PMC3561866.pdf
"Article, supplemental material, and publi- cation date are at http://www.gen ome.org/cgi/doi/10.1101/gr.141028.112.",Non-OADS,/arxiv_data1/oa_pdf/ab/bd/270.PMC3561868.pdf
"To perform the actual mapping, we usedthe UCSC liftOver tool (http://hgdownload.cse.ucsc.edu/admin/exe/) together with liftOver-compatible chain files.",OADS,/arxiv_data1/oa_pdf/ab/bd/270.PMC3561868.pdf
"These files were obtained from UCSC (http://hgdownload.cse.ucsc.edu/ goldenPath/mm9/liftOver/) and converted to reciprocal bestchain files using code based on Jim Kent’s source tree (http://hgdownload.cse.ucsc.edu/admin/ jksrc.zip, doRecipBest.pl).",OADS,/arxiv_data1/oa_pdf/ab/bd/270.PMC3561868.pdf
"Paralog analysis Within-species paralog information was obtained from BioMart (http://www.biomart.org; obtained on Oct 10, 2011).",OADS,/arxiv_data1/oa_pdf/ab/bd/270.PMC3561868.pdf
Data access Human lamin A (HT1080) and lamin B1 (ESC and HT1080) data are available from the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accession numberGSE22428.,OADS,/arxiv_data1/oa_pdf/ab/bd/270.PMC3561868.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.142968.112.",OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
Results U1 snRNA class I pseudogenes are transcriptionally active in vivo We searched the human genome for sequences similar to the prototypical human HU1.1 snRNA gene (Lund and Dahlberg 1984) using the UCSC Genome Browser BLAST-like alignment tool (BLAT) (http://genome.ucsc.edu/).,OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
Datafrom four biological repeats (each for vU1.8 snRNA knock-down and control) were processed by Affymetrix Power tools (http://www.affymetrix.com) using DABG and RMA algorithms for back-ground correction and quantile normalization.,OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
"Gene annotations All analysis was performed using RefSeq annotation of NCBI36 (hg18) human genome assembly, downloaded from UCSC Genome Browser (http://genome.ucsc.edu/).",OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
Data access The data discussed in this publication have been deposited in the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.,OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
"GenBank (http://www.ncbi.nlm.nih.gov/ genbank/) accession numbers assigned to the vU1 snRNA genes are: vU1.2 JQ988795, vU1.2a JQ988796, vU1.7 JQ988801, vU1.8JQ988802, vU1.9 JQ988803, vU1.11 JQ988805, vU1.13 JQ988807,vU1.18 JQ988812.",Non-OADS,/arxiv_data1/oa_pdf/3b/07/281.PMC3561869.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.137224.112.",OADS,/arxiv_data1/oa_pdf/0a/e8/292.PMC3561870.pdf
Data access Small RNA sequence data have been deposited in the DDBJ Se- quence Read Archive (DRA) (http://trace.ddbj.nig.ac.jp/) under accession no.,OADS,/arxiv_data1/oa_pdf/0a/e8/292.PMC3561870.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.146662.112.",OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
of PPIs ‡5bIntrinsic protein disorder ( ‡150)cYeast ohnologsdEssential genese Yeast DSGf (limit #10)69.6% (80/115) 75.7% (87/115) 36.5% (42/115) 23.5% (27/115) 34.8% (40/115) 26.1% (30/115) P-value 9.05 310/C077.80310/C0101.310/C0103.43310/C072.21310/C05— gTOW6000 786 genes61.5% (483/786) 60.3% (474/786) 25.7% (202/786) 24.8% (195/786) 27.2% (214/786) 27.4% (215/786) P-value <2.2310/C0169.37310/C015<2.2310/C016<2.2310/C0163.23310/C0109.90310/C08 Overlapped 161 genes62.7% (101/161) 64.6% (104/161) 29.8% (48/161) 32.3% (52/161) 34.8% (56/161) 28.0% (45/161) P-value 4.06 310/C051.37310/C051.40310/C074.91310/C0123.75310/C070.01705 Sopko 767 genes 46.0% (353/767) 57.4% (440/767) 21.1% (162/767) 26.2% (201/767) 21.8% (167/767) 20.9% (160/767) P-value — 3.92 310/C093.08310/C07<2.2310/C0163.91310/C02— All genes 46.5% (2690/5783) 47.4% (2742/5783) 14.9% (863/5783) 13.6% (786/5783) 19.0% (1098/5783) 20.2% (1168/5783) aProtein complex components (mips; ftp://ftpmips.gsf.de/yeast/catalogues/complexcat/complexcat_data_18052006).,Non-OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
bProtein–protein interactions (dip; http://dip.doe-mbi.ucla.edu).,OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
dYeast ohnolog (http://wolfe.gen.tcd.ie/ygob/).,OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
eEssential genes (http://www-deletion.stanford.edu/YDPM/YDPM_index.html).,OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
"According to theSaccharomyces Genome Database (SGD; http://www.yeastgenome.org), the over- expression of ;1900 genes was reported to cause lethality or decreased cell growth.",Non-OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
The interaction data were obtained from BioGRID (http://thebiogrid.org/).,OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
Individual plasmid ingTOW6000 is available from National BioResource Project-Yeast (http://yeast.lab.nig.ac.jp/).PCR All DNA fragments were amplified by PCR using the high-fidelity DNA poly-merase KODplus (Toyobo) according to the method described in the manufac- turer’s protocol.,OADS,/arxiv_data1/oa_pdf/95/7a/300.PMC3561871.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.141952.112.",OADS,/arxiv_data1/oa_pdf/9a/4c/312.PMC3561872.pdf
"Samples were then subjected to electrophoresis through 2% agarose, and the DNA from eacharray of time points migrating near the 150-bp mark was excised,combined, and purified by using the QIAGEN gel extraction kit (QIAGEN) and then subjected to another round of phenol: chloroform extraction.Nucleosome occupancy calculation Short sequencing reads were mapped to the S. cerevisiae reference genome (version SGD/sacCer1, UCSC Oct 2003) by ELAND andthen analyzed based on DANPOS (http://code.google.com/p/ danpos/) (Chen et al.",OADS,/arxiv_data1/oa_pdf/9a/4c/312.PMC3561872.pdf
Data access All data have been submitted to the NCBI Gene Expression Om-nibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) under accessionnumber GSE37467.,OADS,/arxiv_data1/oa_pdf/9a/4c/312.PMC3561872.pdf
"Article, supplemental material, and publi-cation date are at http://www.genome.org/cgi/doi/10.1101/gr.141978.112.",OADS,/arxiv_data1/oa_pdf/d4/94/323.PMC3561873.pdf
"For this analysis, we benefited from a French national supercomputing resource for research, JADE, currently the 43rdlargest supercomputer in the world ( T o p 5 0 0N o v e m b e r2 0 1 1s u p e r c o m p u t e r list, http://www.top500.org), and used 3000 processes in parallel.",Non-OADS,/arxiv_data1/oa_pdf/d4/94/323.PMC3561873.pdf
"Second, we par-allelized the computations (see next section) using the Message Passing Interface (MPI) as implemented in the Boost libraries (Boost C++ source libraries, http://www.boost.org).",OADS,/arxiv_data1/oa_pdf/d4/94/323.PMC3561873.pdf
Data access Our implementation of PHYLDOG is available at: http://pbil.univ-lyon1.fr/software/phyldog/.,Non-OADS,/arxiv_data1/oa_pdf/d4/94/323.PMC3561873.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.134874.111.",OADS,/arxiv_data1/oa_pdf/cf/cb/331.PMC3561874.pdf
"Article, supplemental material, and publi- cation date are at http://www.genome .org/cgi/doi/10.1101/gr.142067.112.",OADS,/arxiv_data1/oa_pdf/73/85/341.PMC3561875.pdf
Human and mouse nucleosome data were downloaded from GEO with accession numbers GSM651558 and GSM651559.Gene-related analyses were based on the yeast Ensembl Genes andhuman RefSeq Genes downloaded from the UCSC Genome Browser (http://genome.ucsc.edu).,OADS,/arxiv_data1/oa_pdf/73/85/341.PMC3561875.pdf
"To compare with the negative binomial model as implemented in the EdgeR package (http://www.bioconductor.org/packages/2.3/ bioc/html/edgeR.html), we generated a read count table in which Table 1.",OADS,/arxiv_data1/oa_pdf/73/85/341.PMC3561875.pdf
"Data access The source code is provided in the Supplemental Material, and new versions will be frequently released at http://code.google.com/p/ danpos/.",Non-OADS,/arxiv_data1/oa_pdf/73/85/341.PMC3561875.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.144949.112.",Non-OADS,/arxiv_data1/oa_pdf/c6/e9/352.PMC3561876.pdf
We provide GATE as a fully documented program at http://biocomp.bioen.uiuc.edu/GATE.,Non-OADS,/arxiv_data1/oa_pdf/c6/e9/352.PMC3561876.pdf
Data access All sequencing data are accessible from the NCBI Gene ExpressionOmnibus (GEO) (http://www.ncbi .nlm.nih.gov/geo/) under Super- Series accession no.,OADS,/arxiv_data1/oa_pdf/c6/e9/352.PMC3561876.pdf
"Article, supplemental material, and pub- lication date are at http://www.genome.org/cgi/doi/10.1101/gr.138628.112.",OADS,/arxiv_data1/oa_pdf/4d/dd/365.PMC3561877.pdf
An open source software implementation of SDREM is available from http://sb.cs.cmu.edu/sdrem.,OADS,/arxiv_data1/oa_pdf/4d/dd/365.PMC3561877.pdf
"Osmotic and rapamycin stress data The osmotic stress response analysis source proteins were Cdc42,M s b 2 ,S h o 1 ,S l n 1 ,a n dS t e 5 0( Science Signaling Database of Cell Sig- naling, http://stke.sciencemag.org /cgi/cm/stkecm;C MP_14620).",OADS,/arxiv_data1/oa_pdf/4d/dd/365.PMC3561877.pdf
ImageJ (http://rsbweb.nih.gov/ij/) was used for all im-age post-processing and analysis (see Supplemental Methods;Supplemental Fig.,OADS,/arxiv_data1/oa_pdf/4d/dd/365.PMC3561877.pdf
Data access Gene expression data have been deposited in the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/)under accession number GSE28213.Acknowledgments We thank Jason Ernst for his assistance with DREM as well as Itay Tirosh and Yoav Voichek for their helpful microarray normalization discussions.,Non-OADS,/arxiv_data1/oa_pdf/4d/dd/365.PMC3561877.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.138545.112.",OADS,/arxiv_data1/oa_pdf/d2/51/377.PMC3561878.pdf
SeqFold can be freely downloaded from http://www.stanford.edu/ ;zouyang/seqfold.,Non-OADS,/arxiv_data1/oa_pdf/d2/51/377.PMC3561878.pdf
We downloaded base-level read count data as well as the original PARS scores of more than 3000 transcripts in yeastfrom http://genie.weizmann.ac.il/pubs/PARS10/.,OADS,/arxiv_data1/oa_pdf/d2/51/377.PMC3561878.pdf
Implementation and software availability SeqFold is implemented in Python and Perl scripts and can befreely downloaded at http://www.stanford.edu/ ;zouyang/seqfold.,OADS,/arxiv_data1/oa_pdf/d2/51/377.PMC3561878.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.143198.112.",OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
Methods Definition of Y-specific unique regions We identified unique regions within the male-specific part of the Y chromosome reference sequence (GRCh37 http://www.ncbi.nlm.nih.gov/projects/genome/assembly/grc/human/) where we expected read mapping and variant detection to escape compli- cations introduced by repeated sequences.,Non-OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
"Sequence alignments were built using CLUSTALW2 (http://www.clustal.org/), and a maximum parsimony (MP) phylogenetic tree was created using the PHYLIP software (http://evolution.gs.",OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
BEAST We also used BEAST version 1.7.2 (http://beast.bio.ed.ac.uk) toestimate the TMRCA and divergence time for each branch of in-terest.,Non-OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
"Tracer version 1.5(http://beast.bio.ed.ac.uk/Trac er) was used to analyze the output file and times (Table 1, BEAST), and TreeAnnotator version 1.7.2 to obtain an estimate of the phylogenetic tree.",OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
"Finally, we viewed the tree in FigTree (http://beast.bio.ed.ac.uk/FigTree) (SupplementalFig.",Non-OADS,/arxiv_data1/oa_pdf/58/b0/388.PMC3561879.pdf
"Article, supplemental material, and pub-lication date are at http://www.genome.org/cgi/doi/10.1101/gr.144311.112.",OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
2009) (http://circos.ca) was used for constructing this diagram.,OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
Genome assembly and SNP calling The pear genome was assembled using short-read assembly soft- ware SOAPdenovo (http://soap.genomics.org.cn/) and sequencealignment software BLAT (Kent 2002).,OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
"By use of NUCmer soft-ware (http://mummer.sf.net/) to identify the scaffold related to theBAC, BACs were aligned to scaffolds using BLAST (Altschul et al.",OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
The SOAPaligner (http://soap.genomics.org.cn/soapaligner.,OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
"About 7.8 Gb transcriptome sequence, of mixed multiple tissues generated by Illumina RNA-seq, was used to predict tran- scripts with TopHat (http://tophat.cbcb.umd.edu) and Cufflinks (http://cufflinks.cbcb.umd.edu).",OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
project have been deposited at GenBank (http://www.ncbi.nlm.nih.gov/genbank) under accession no.,Non-OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
The data are also available at our professional website (http://peargenome.njau.edu.cn).,OADS,/arxiv_data1/oa_pdf/49/e7/396.PMC3561880.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e3/2f/gks1247.PMC3561940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/6a/gks1251.PMC3561941.pdf
"MATERIALS AND METHODS Sample selection and processing In total, 18 well-studied viral species with solved RNA polymerase structures and four viral species with solvedDNA polymerase structures were selected for analysis.We used the StralSV algorithm (http://proteinmodel.org/), described in detail previously (1), to perform the analyses.",OADS,/arxiv_data1/oa_pdf/8e/6a/gks1251.PMC3561941.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/12/gks1254.PMC3561942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b1/bd/gks1191.PMC3561943.pdf
"In our study, we used the randomForest inter-face in R to the Fortran programs by Breiman andCutler (http://www.stat.berkeley.edu/ /C24breiman/Random Forests/cc_home.htm).",Non-OADS,/arxiv_data1/oa_pdf/b1/bd/gks1191.PMC3561943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ed/8e/gks1250.PMC3561944.pdf
"For longer 75–95 nt probes, the publiclyavailable UMelt software developed by the Wittwer la- boratory (http://dna.utah.edu/umelt/umelt.html) was ini- tially used to predict T m. The optimal Tcwas experimentally derived using high-resolution melting(HRM) analysis on the LightScanner HR96 system (Idaho Technologies Inc.).",OADS,/arxiv_data1/oa_pdf/ed/8e/gks1250.PMC3561944.pdf
The algorithm is availableas a web server at http://ipht.cea.fr/rna/mcgenus.,OADS,/arxiv_data1/oa_pdf/b5/aa/gks1204.PMC3561945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/aa/gks1204.PMC3561945.pdf
A server implementation of McGenus can be found at http://ipht.cea.fr/rna/mcgenus.php.,OADS,/arxiv_data1/oa_pdf/b5/aa/gks1204.PMC3561945.pdf
"In order to further improve the performance of McGenus, we see three main directions: (i) improvement on the computing techniques, in particular on the paral-lelization of the algorithm; (ii) improvement of the func- tional form and parametrization of the energy model (likely to have an impact also on the parametrization of pseudoknot-free methods such as UNAFold) and (iii) in- clusion of steric constraints.ACKNOWLEDGEMENTS The authors wish to thank A. Capdepon for setting up the McGenus server at http://ipht.cea.fr/rna/mcgenus.php.",Non-OADS,/arxiv_data1/oa_pdf/b5/aa/gks1204.PMC3561945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/71/b1/gks1272.PMC3561946.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/b8/gks1277.PMC3561947.pdf
"We focused on two substitutions: P511R, which would be analogous to the ubiquitin-binding-deﬁcient, but pol Z-binding-proﬁcient P692R mutant in UBM2, and F507S, as this is a naturally occurring single nucleo-tide polymorphism (SNP) found in /C243% of humans (http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=321 8786).",Non-OADS,/arxiv_data1/oa_pdf/94/b8/gks1277.PMC3561947.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/05/40/gks1295.PMC3561948.pdf
The quaternary structure of Mos1 transposase was modelled with SASREF (35) on the ATSAS server (http://www.embl-hamburg.de/biosaxs/atsas-online).,OADS,/arxiv_data1/oa_pdf/05/40/gks1295.PMC3561948.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/36/gks1302.PMC3561949.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c1/c8/gks1267.PMC3561950.pdf
"Protein structure prediction of a truncated SprT domain Because the sequence similarity between the human SprT domain and any of the protein structures reported to date is less than 40%, we submitted the SprT domain amino acid sequence to the Phyre server (http://www.sbg.bio.ic.ac.uk/ /C24phyre/) for protein-fold recognition and obtained 10 different models of the SprT domain fragments.",OADS,/arxiv_data1/oa_pdf/c1/c8/gks1267.PMC3561950.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/5f/gks1274.PMC3561951.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/ad/gks1271.PMC3561952.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0b/7c/gks1307.PMC3561953.pdf
It has been estimated that approxi- mately one-third of the world’s population comprises latent carriers of M. tuberculosis (http://www.who.int/ gtb).,Non-OADS,/arxiv_data1/oa_pdf/0b/7c/gks1307.PMC3561953.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/85/gks1280.PMC3561954.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9d/6d/gks1340.PMC3561955.pdf
"(16) hybrid microarray were remapped to more recent versions of the Plasmodium berghei (July 2011; http://www.genedb.org) and mouse (NCBIM37; http://ensembl.org) genome assemblies using SMALT (Ponstingl, unpublished; http://www.sanger.ac.uk/resources/software/smalt/).",OADS,/arxiv_data1/oa_pdf/9d/6d/gks1340.PMC3561955.pdf
project website (http://hugheslab.ccbr.utoronto.ca/ supplementary-data/malaria/extra_material/GEO_info_allProbes.txt).,Non-OADS,/arxiv_data1/oa_pdf/9d/6d/gks1340.PMC3561955.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/2d/gks1359.PMC3561956.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/7d/65/gks1110.PMC3561957.pdf
"Structural visualization was per- formed using PyMOL molecular visualization software(version 0.99, http://www.pymol.org/).",OADS,/arxiv_data1/oa_pdf/7d/65/gks1110.PMC3561957.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/29/36/gks1214.PMC3561958.pdf
EMdeCODE has been implemented in Python and can be downloaded from http://seaseq.unige.ch/ /C24fsantoni/ EMdeCODE.,OADS,/arxiv_data1/oa_pdf/29/36/gks1214.PMC3561958.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d7/25/gks1291.PMC3561959.pdf
"Subsequent grid searches were carried out varying the binding con- stants until Equation 11 (33) was satisﬁed for the 68%conﬁdence boundary ( s 68%): /C2768%¼/C27best/C1ð1+ðp=ðn/C0pÞÞ /C1Fp,n/C0p,0:32Þ0:5ð11Þ with n data points, p parameters, and the critical F value was calculated using an online F distribution calculator (http://www.danielsoper.com/statcalc3/calc.aspx?id=4) with p degrees of freedom in the numerator and (n /C0p) degrees of freedom in the denominator.",OADS,/arxiv_data1/oa_pdf/d7/25/gks1291.PMC3561959.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/gks1309.PMC3561960.pdf
"To identify genes that were differentially expressed in thesta1-1 mutant versus WT, we ﬁrst used the geneﬁlter package in Bioconductor (http://www.bioconductor.org/)to remove genes that showed low expression level(normalized signal intensity was <100 in all samples) and genes that showed little change in gene expression across samples (interquartile range of log 2intensities was <0.5).",OADS,/arxiv_data1/oa_pdf/33/f0/gks1309.PMC3561960.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/84/0b/gks1190.PMC3561961.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly c ited.",Non-OADS,/arxiv_data1/oa_pdf/15/ee/gks1242.PMC3561963.pdf
"In the case of A. castellanii , we have previously emphasized that the lack of an identiﬁable Thg1 gene in this organism is unlikely to be due to incomplete genome data, given the extensive genomic andtranscriptomic coverage in the genome project for this organism (http://www.hgsc.bcm.tmc.edu/projects/micro- bial/microbial-pubPreview.xsp?project_id=163).",Non-OADS,/arxiv_data1/oa_pdf/15/ee/gks1242.PMC3561963.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/65/gks1207.PMC3561964.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/45/gks1273.PMC3561965.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/fe/gks986.PMC3561966.pdf
"S35- labeled products were visualized on a phosphorimager(Typhoon, Amersham Biosciences) and analysed using ImageJ software (http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/76/fe/gks986.PMC3561966.pdf
Human codon usage for all human genes was obtained from the Codon Usage Database (http://www.kazusa.or.jp/codon/).,OADS,/arxiv_data1/oa_pdf/76/fe/gks986.PMC3561966.pdf
One sample t-tests were performed using GraphPad QuickCalcs (http://graphpad.com/quickcalcs/ OneSampleT1.cfm).,OADS,/arxiv_data1/oa_pdf/76/fe/gks986.PMC3561966.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a5/a9/gks1287.PMC3561968.pdf
"tRNA expression plasmid construction P. abyssi (Pa) and E. coli (Ec) tRNA gene sequences PaVal (GAC), PaLys (UUU), PaIle (GAU), PaAsn (GUU),PaMet (CAU), EcVal (GAC), EcLys (UUU), EcIle (GAU) and EcAsn (GUU) were retrieved from the Genomic tRNA Database (http://gtrnadb.ucsc.edu/) (25).",OADS,/arxiv_data1/oa_pdf/a5/a9/gks1287.PMC3561968.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
A user-friendly and computationally efﬁcient implementa- tion of our complete analytic protocol is freely availableat https://sourceforge.net/projects/genseng/.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
The complete genome sequence data were obtained in the form of ‘.bam’ alignment ﬁles from ftp://ftp.ncbi.nlm.nih.gov/1000genomes/ftp/pilot_data/data/.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
Reads were aligned to the human reference genome NCBI37 using BWA (37) (v.0.5.5) as described in the online documentation: ftp://ftp.ncbi.nlm.nih.gov/ 1000genomes/ftp/README.alignment_data.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
The complete data set was downloaded from ftp://ftp.broadinstitute.org/pub/svtoolkit/misc/1 kg/ NGPaper/ and included deletions for the three aforemen- tioned HapMap individuals.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
"In the second study, we downloaded (ftp://ftp-mouse.sanger.ac.",OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
We also downloaded the releasedSV calls for these strains from ftp://ftp-mouse.sanger.ac.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
Reference genomes The human reference genome NCBI37 was obtained from ftp://ftp.ncbi.nlm.nih.gov/1000genomes/ftp/technical/ref erence/human_g1k_v37.fasta.gz.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
The mouse referencegenome NCBI37 was obtained from ftp://ftp-mouse.sanger.ac.uk/ref/NCBIM37_um.fa.,OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
"Second,using the DownsampleSam.jar tool from Picard (http://picard.sourceforge.net), we down-sampled the high-cover-age 1000GP data from NA12878 and achieved a series ofsequencing coverage of 5 /C2,1 0/C2,2 0/C2,3 0/C2and 40 /C2.",OADS,/arxiv_data1/oa_pdf/14/69/gks1363.PMC3561969.pdf
The miTEA web application is available at http://cbl-gorilla.cs.technion.ac.il/ miTEA/.,Non-OADS,/arxiv_data1/oa_pdf/03/29/gks1142.PMC3561970.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/29/gks1142.PMC3561970.pdf
"Tool description (website) A web-based application miTEA is publically available, free for non-commercial use, at http://cbl-gorilla.cs.",OADS,/arxiv_data1/oa_pdf/03/29/gks1142.PMC3561970.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/b4/gks1329.PMC3561971.pdf
"binary classiﬁcation in the QiSampler procedure were derived from the v1.2 release of the Human IntegratedProtein–Protein Interaction rEference (HIPPIE)database (26), available at http://cbdm.mdc-berlin.de/tools/hippie.",OADS,/arxiv_data1/oa_pdf/c3/b4/gks1329.PMC3561971.pdf
"Sets of geneIDs, associated with speciﬁcGO-terms were downloaded from the Gene Ontologybrowser AmiGo (http://amigo.geneontology.org).Network graphs are drawn with Cytoscape 2.7.0.",OADS,/arxiv_data1/oa_pdf/c3/b4/gks1329.PMC3561971.pdf
Venndiagrams were constructed with BioVenn online tool (http://www.cmbi.ru.nl/cdd/biovenn).,OADS,/arxiv_data1/oa_pdf/c3/b4/gks1329.PMC3561971.pdf
"GO-term enrich- ment was determined using the human Consensus PathDatabase (CPDB; http://cpdb.molgen.mpg.de) (27,28).For CPDB analysis, P<0.01 were considered signiﬁcant for the enrichment for a pathway or a functional groupdeﬁned by GO.",OADS,/arxiv_data1/oa_pdf/c3/b4/gks1329.PMC3561971.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5b/e8/gks1326.PMC3561972.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5a/8f/gks1290.PMC3561973.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0c/a4/gks1339.PMC3561974.pdf
Implementation of random forest classi- ﬁer for eQTL target prediction can be found at http://sysbio.mrc-bsu.cam.ac.uk/eqtlPredictor.,Non-OADS,/arxiv_data1/oa_pdf/0c/a4/gks1339.PMC3561974.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b7/1d/gks1312.PMC3561975.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/9b/1e/gks1335.PMC3561976.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/15/50/gks1278.PMC3561977.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/b6/gks1203.PMC3561978.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/b7/gks1310.PMC3561979.pdf
The total number of themapped reads on each gene was calculated with theHTSeq program (http://www-huber.embl.de/users/anders/HTSeq/).,OADS,/arxiv_data1/oa_pdf/20/b7/gks1310.PMC3561979.pdf
"Clearly, many pathway resources are now available including KEGG (1,2), Reactome (3,4) and Biocarta (http://www.biocarta.com).",OADS,/arxiv_data1/oa_pdf/e8/d0/gks1299.PMC3561980.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/d0/gks1299.PMC3561980.pdf
"Thus, to detect active subpathways underlying biological processes, we developed the innovative Topology Enrichment Analysis frameworK (TEAK), which is freelyavailable at http://code.google.com/p/teak/ for Windows and MAC.",OADS,/arxiv_data1/oa_pdf/e8/d0/gks1299.PMC3561980.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2c/3e/gks1327.PMC3561981.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/7a/gks1261.PMC3561982.pdf
Annotation of CpG islands CpG islands (28 691) in the human genome (HG19) were obtained from http://genome.ucsc.edu/.,OADS,/arxiv_data1/oa_pdf/3a/7a/gks1261.PMC3561982.pdf
"To search forCpG islands that do not contain coding exons, we removed CpG islands that overlap UCSC known genes, human mRNAs from GenBank, expressed sequence tag orYale pseudogenes (Release 60), also obtained from http://genome.ucsc.edu/.",OADS,/arxiv_data1/oa_pdf/3a/7a/gks1261.PMC3561982.pdf
"Inﬂuenza A virus sequences Nucleotide sequences of 4222 human, 411 swine and 89 avian H1N1 inﬂuenza A viruses were obtained from theNCBI Inﬂuenza Virus Resource (22) (http://www.ncbi.nlm.nih.gov/genomes/FLU/).",OADS,/arxiv_data1/oa_pdf/3a/7a/gks1261.PMC3561982.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/91/gks1206.PMC3561983.pdf
",, http://arxiv.org/abs/0907.4601 (13 November 2012, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/70/91/gks1206.PMC3561983.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/14/d1/gks1269.PMC3561984.pdf
"Subsequently, the volume ratios between the globules in an intracondensate were scrutinized for each of the 2565 image samples by usingthe Gwyddion software (http://www.gwyddion.net/) andonly deﬁned samples (2469 images) were left for the popu-lation calculation.",OADS,/arxiv_data1/oa_pdf/14/d1/gks1269.PMC3561984.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/dd/a9/gks1286.PMC3561985.pdf
The PreCisIon software is made available at http://www.noraybio.com/en/gennetec.asp.,OADS,/arxiv_data1/oa_pdf/dd/a9/gks1286.PMC3561985.pdf
end For Final hypothesis: HðiÞ¼signðPkmax k¼1/C11/C3 kC/C3kðiÞÞ Implementation A public version of the PreCisIon tool is available at http://www.noraybio.com/en/gennetec.asp.,OADS,/arxiv_data1/oa_pdf/dd/a9/gks1286.PMC3561985.pdf
"The tool‘retrieve-seq’ of the ‘Regulatory Sequence AnalysisTools’ [(29), http://rsat.ulb.ac.be/rsat/] was used toretrieve upstream regulatory sequences (‘promoters’)deﬁned here by the DNA sequence between position /C0400 and /C01.",OADS,/arxiv_data1/oa_pdf/dd/a9/gks1286.PMC3561985.pdf
"For each of the ﬁve TFs with the highest number of targets in RegulonDB (CRP, FNR, IHF, FIS and ArcA), the analysis was carried out using UniProt GO annotations from the European Bioinformatics Institute at http://www.ebi.ac.uk/GOA/ proteomes.html and the GO enrichment analysis software DAVID (35).",OADS,/arxiv_data1/oa_pdf/dd/a9/gks1286.PMC3561985.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/8e/c1/gks1270.PMC3561987.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/56/83/gks1282.PMC3561988.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/f5/gks1197.PMC3561989.pdf
MATERIALS AND METHODS Synthesis of pre-miRNAs Pre-miR sequences were extracted from information provided in reference (20) and the miRBase database (21)(http://www.mirbase.org/).,OADS,/arxiv_data1/oa_pdf/4b/f5/gks1197.PMC3561989.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e7/f2/gks1440.PMC3561990.pdf
"Nucleosome species were separated by native acrylamide electrophoresis (5% acrylamide for dinucleosomes, 7% for mononucleosomes, each with 60:1 acrylamide to bis-acrylamide and run in 0.25 /C2 TBE at 150 V for 2–2.5 h), detected by ﬂuorescence using a Typhoon 9410 variable mode imager (GEHealthcare) and analyzed by ImageJ (http://imagej.nih.",OADS,/arxiv_data1/oa_pdf/e7/f2/gks1440.PMC3561990.pdf
"After incubation with or without re- modelers, APB-labelled nucleosomes were ultraviolet (UV) irradiated to form DNA cross-links, heat- and NaOH-treated to resolve cross-links into DNA nicks andthen separated on 8% polyacrylamide (19:1), 8 M urea sequencing gels run at 65 W. Fluorescent DNA was visualized using Typhoon 9410 variable mode imager and ImageJ (http://imagej.nih.gov/ij/), with each nicked position indicative of histone octamer placement on DNA.",OADS,/arxiv_data1/oa_pdf/e7/f2/gks1440.PMC3561990.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/1e/gks1296.PMC3561991.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3e/59/gks1252.PMC3561992.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fd/2f/gks1232.PMC3561993.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/4b/3a/gks1305.PMC3561994.pdf
"Our goals are (i) to test TFcompare (http://floresta.eead.csic.es/tfcompare), a structural alignment method forprotein–DNA complexes; (ii) to benchmark thepairwise alignment of regulatory elements; (iii) to define the confidence limits and the twilight zone of such alignments and (iv) to evaluate the relevanceof these thresholds with elements obtained experi-mentally.",Non-OADS,/arxiv_data1/oa_pdf/c4/6e/gks1301.PMC3561995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/6e/gks1301.PMC3561995.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/d1/gks1333.PMC3561996.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/a1/gks1306.PMC3561997.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6b/01/gks1276.PMC3561998.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/2d/gks1275.PMC3561999.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/66/7b/gks1337.PMC3562000.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/51/gks1143.PMC3562001.pdf
The software is available from http://soap.genomics.,OADS,/arxiv_data1/oa_pdf/0e/51/gks1143.PMC3562001.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d5/d8/gks902.PMC3562002.pdf
"The program was written in Common Lisp (LispWorks, Cambridge,UK) and calls upon two external programs, UNAFold (http://mfold.rna.albany.edu/) and RNAforester (http:// bibiserv.techfak.uni-bielefeld.de/rnaforester/), and a Perl script from the Vienna RNA Package.",OADS,/arxiv_data1/oa_pdf/d5/d8/gks902.PMC3562002.pdf
The program used for comparison was the Soligo partition of Sfold (http://sfold.wadsworth.org/cgi-bin/index.pl) (12–14).,OADS,/arxiv_data1/oa_pdf/d5/d8/gks902.PMC3562002.pdf
Actual se- quences were taken from the EcoCyc Database (http://www.ecocyc.org) (30) using the putative transcription start and end sites of the homologous and well-characterized ldrD gene.,OADS,/arxiv_data1/oa_pdf/d5/d8/gks902.PMC3562002.pdf
"As a result, it may be possible to search this volatile region for optimum hy-bridization while also utilizing equilibrium concentrationdata to identify the utmost effective antisense sequence.Programs such as Ensemble_Calc (http://mfold.rna.albany.edu/?q=DINAMelt/Ensemble-calc) (41) may aidin this task.",Non-OADS,/arxiv_data1/oa_pdf/d5/d8/gks902.PMC3562002.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/12/d5/gks1285.PMC3562003.pdf
"APO and BPO orders for a number of genomes, arranged by the increasing genome length Genome (UCSC Version) Length (Mb)APO orderBPO order Yeast (sacCer2) 12.2 7 4 Nematode (ce6) 100.3 10 7Fruitﬂy (dm3) 120.3 9 7Fugu (fr2) 351.2 11 8Stickleback (gasAcu1) 446.6 11 8Chicken (galGal3) 984.9 11 8Zebra Finch (taeGut1) 1112.7 11 8 Xenopus (xenTro2) 1359.4 12 10 Zebraﬁsh (danRer5) 1523.3 13 10Cat (felCat3) 1642.7 12 10Lizard (anoCar1) 1741.5 12 10Platypus (ornAna1) 1842.2 12 10Dog (canFam2) 2385.0 12 10 Horse (equCab2) 2428.8 12 10 Rat (rn4) 2533.3 12 10Mouse (mm9) 2558.5 12 10Macaque (rheMac2) 2646.7 12 10Guinea pig (cavPor3) 2663.4 13 10Cow (bosTau4) 2731.8 12 10 Orangutan (ponAbe2) 2788.0 12 10 Chimp (panTro2) 2802.8 12 10Human (hg18) 2858.0 12 10Marmoset (calJac1) 2929.1 12 10Opossum (monDom5) 3501.7 13 11 Genome source: UCSC Genome Browser (http://genome.ucsc.edu/).",Non-OADS,/arxiv_data1/oa_pdf/12/d5/gks1285.PMC3562003.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5c/a0/gks1128.PMC3562004.pdf
The rat whole body RNA were agenerous donation from Dr. Alistair Forrest and are com-mercially available from BioChain (http://www.biocat.com/products/R4434567-1-BC).,Non-OADS,/arxiv_data1/oa_pdf/5c/a0/gks1128.PMC3562004.pdf
"Using the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/), we ex-tracted raw tags and distributed them into their respectivesamples based on their barcode sequence.",OADS,/arxiv_data1/oa_pdf/5c/a0/gks1128.PMC3562004.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1c/72/gks978.PMC3562059.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Wu, S. State tomography via weak measurements.",Non-OADS,/arxiv_data1/oa_pdf/b9/0b/srep01193.PMC3562073.pdf
"However, the 5-year survivalrate for patients with metastatic CRC remains approximately 10 % www.clinsci.org 567Clinical Science     	www.clinsci.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"Recurrence wasdeﬁned as the time from remission to initial tumour recurrence.Metastasis or local recurrence was considered evidence of tumour 568 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"To www.clinsci.org 569 © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"The typical nuclear RRM2 (positive or 570 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
Further analysis also indicated that nuclearRRM2 signiﬁcantly related to TNM stage (Supplementary TableS1 at http://www.clinsci.org/cs/124/cs1240567add.htm).,OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"The hMLH1, hMSH2 and hMSH6 were scored as pos- itive and negative based on staining of nucleus (SupplementaryFigure S1 at http://www.clinsci.org/cs/124/cs1240567add.htm).",OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"Higher expression of RRM2 was signiﬁcantly related to www.clinsci.org 571 © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"572 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"In the COH set, the high RRM2 www.clinsci.org 573 © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"Kaplan–Meier analysis conﬁrms that RRM2 ex-pression has an negative impact on survival in patients with CRC 574 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"Using a well-validated antibody directedagainst RRM2 and used previously in other publications [12,24], www.clinsci.org 575 © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"AUTHOR CONTRIBUTION Xiyong Liu conceived the study design, performed the data collec- tion and analysis, and wrote the paper; Hang Zhang conducted the 576 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"28, 3210–3212 www.clinsci.org 577 © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"284, 18085–18095 Received 16 May 2012/11 September 2012; accepted 1 November 2012 Published as Immediate Publication 1 November 2012, doi: 10.1042/CS20120240 578 C/circlecopyrtThe Authors Journal compilation C/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"Correspondence: Dr Yun Yen (email yyen@coh.org).Received 16 May 2012/11 September 2012; accepted 1 November 2012 Published as Immediate Publication 1 November 2012, doi: 10.1042/CS20120240 www.clinsci.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/cb/cs1240567.PMC3562074.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
The consent and local review board approval were in accordance with the UK10K project ethical framework (http://www.uk10k.org/ethics.html).,Non-OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
"The Burrows–Wheeler Aligner (Li and Durbin, 2009) was used for alignment to the human reference genome build UCSC hg19, followed by the removal of polymerase chain reaction (PCR) duplicates using Picard (http://picard.sourceforge.net).",OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
The 1000 Genomes frequencies are taken from the June 2011 data release (http://www.1000genomes.org/data).,OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
"Web resources The Variant Call Format and VCFtools, Petr Danecek, Adam Auton, Goncalo Abecasis, Cornelis A. Albers, Eric Banks, Mark A. DePristo,Robert Handsaker, Gerton Lunter, Gabor Marth, Stephen T. Sherry,Gilean McVean, Richard Durbin and 1000 Genomes Project Analysis Group, Bioinformatics, 2011, http://vcftools.sourceforge.net/; Tennessen JA, Bigham AW, O’Connor TD, Fu W, Kenny EE,Gravel S, McGee S, Do R, Liu X, Jun G, Kang HM, Jordan D,Leal SM, Gabriel S, Rieder MJ, Abecasis G, Altshuler D, NickersonDA, Boerwinkle E, Sunyaev S, Bustamante CD, Bamshad MJ, AkeyJM; Broad GO; Seattle GO; NHLBI Exome Sequencing Project.Evolution and functional impact of rare coding variation fromdeep sequencing of human exomes.",OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
"PubMed PMID:22604720. http://evs.gs.washington.edu/EVS/ References Baur S, Marles-Wright J, Buckenmaier S, Lewis RJ, Vollmer W. Synthesis of CDP-activated ribitol for teichoic acid precursors in Streptococcuspneumoniae.",OADS,/arxiv_data1/oa_pdf/33/f3/aws312.PMC3562076.pdf
http://dx.doi.org/10.1371/journal.pone .0013418 .,Non-OADS,/arxiv_data1/oa_pdf/3c/26/mBio.00597-12.PMC3562125.pdf
http://dx.doi.org/10.1371/journal.ppat.1000976 .,Non-OADS,/arxiv_data1/oa_pdf/3c/26/mBio.00597-12.PMC3562125.pdf
"Published  in Biomaterials, Dr Parker’s group used  micropatterned surfaces to build 2-dimen- sional engineered cardiac muscle from neo - natal rat ventricular myocytes with distinct architectures that mimic in vivo hierarchal Organogenesis News and Views Biomimicry in biomedical research Ge Zhang; Department of Biomedical Engineering; The University of Akron; Akron, OH USA; Email: gezhang@uakron.edu; http://dx.doi.org/10.4161/org.23395 structures and electromechanical function of heart.",Non-OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Cell 2006; 126:677-89;   PMiD:16923388; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Macromol Biosci 2012; 12:286-311; PM iD:22278779; http://dx.doi.org/10.1002/ mabi.201100325.,OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
a dv Drug Deliv Rev 2007; 59:360- 73; PMiD:17513003; http://dx.doi.org/10.1016/j.addr.2007.03.018.,Non-OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Wound Repair Regen 2012;  PMiD:23126632; http://dx.doi.org/10.1111/j.1524- 475X.2012.00861.x.,Non-OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Curr Stem Cell Res Ther 2009;  4:318-29; PM iD:19804369; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Biomaterials 2012; 33:5732-41;  PMiD:22594976; http://dx.doi.org/10.1016/j.bioma-terials.2012.04.043.,OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
PLoS One 2012; 7:e48483; PMiD:23152776; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
Sci Transl Med 2012; 4:ra147;  PMiD:23136042; http://dx.doi.org/10.1126/scitrans- lmed.3004249.,OADS,/arxiv_data1/oa_pdf/89/bc/org-8-101.PMC3562250.pdf
"www.landesbioscience.com Organogenesis 125Organogenesis 8:4, 125–136; October/November/December 2012; © 2012 Landes Bioscience ReseaR ch papeR ReseaR ch papeR *Correspondence to: Patricia Murray; Email: p.a.murray@liv.ac.uk Submitted: 10/19/12; Revised: 09/13/12; Accepted: 10/18/12http://dx.doi.org/10.4161/org.22597Introduction Pluripotent embryonic stem cells (ESCs) exist within, and can  be isolated from, the inner cell mass of the mouse and human blastocyst.",Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Kidney  Int 2007; 72:26-36; PMID:17457377; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Development 2007; 134:2533- 9; PMID:17537789; http://dx.doi.org/10.1242/dev.006155.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
J Am Soc Nephrol 2010; 21:803-10; PMID:20299358; http://dx.doi.org/10.1681/ ASN.2009040353.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Nature 1988; 336:684-7;  PMID:3143916; http://dx.doi.org/10.1038/336684a0.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Am J Surg Pathol 2004;  28:935-40; PMID:15223965; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Interact Cardiovasc  Thorac Surg 2009; 8:393-7; PMID:19126554; http://dx.doi.org/10.1510/icvts.2008.193995.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Differentiation 2012; 83:128- 37; PMID:22364880; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Stem Cells 2006; 24:1185-93;  PMID:16410390; http://dx.doi.org/10.1634/stem - cells.2005-0265.16.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Stem Cells  2007; 25:2128-38; PMID:17495112; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
PLoS  One 2012; 7:e32650; PMID:22403689; http://dx.doi.org/10.1371/journal.pone.0032650.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
BMC  Biotechnol 2007; 7:67; PMID:17925032; http://dx.doi.org/10.1186/1472-6750-7-67.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Hum Mol Genet 2010; 19:3320-31;  PMID:20542987; http://dx.doi.org/10.1093/hmg/ ddq236.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Kidney Int 2010; 77:407- 16; PMID:20016472; http://dx.doi.org/10.1038/ ki.2009.482.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Kidney Int 2006; 69:837- 45; PMID:16518343; http://dx.doi.org/10.1038/ sj.ki.5000170.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Eur J Pharmacol  2008; 585:245-55; PMID:18417112; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Dev Biol  2004; 271:176-89; PMID:15196959; http://dx.doi.org/10.1016/j.ydbio.2004.03.034.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Dev Biol  2008; 324:88-98; PMID:18835385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
EMBO J 2006; 25:5214-28; PMID:17036046; http://dx.doi.org/10.1038/sj.emboj.7601381.References 1.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Nature  1981; 292:154-6; PMID:7242681; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Science  1998; 282:1145-7; PMID:9804556; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Mol Hum Reprod  1998; 4:1021-31; PMID:9835353; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Dev Biol 2005; 288:363- 71; PMID:16289026; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
J Biol Chem 2007; 282:29701- 11; PMID:17690109; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Stem Cells 2009; 27:2126-35; PMID:19521979; http://dx.doi.org/10.1002/ stem.149.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
J Am Soc Nephrol 2005; 16:3527- 34; PMID:16267156; http://dx.doi.org/10.1681/ ASN.2005050544.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
J  Am Soc Nephrol 2005; 16:1623-31; PMID:15872079;  http://dx.doi.org/10.1681/ASN.2004070584.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Development 2003; 130:4217-27; PMID:12874139; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Dev Dyn 1997; 210:446-62; PMID:9415429;  http://dx.doi.org/10.1002/(SICI)1097- 0177(199712)210:4<446::AID-AJA8>3.0.CO;2-G. 51.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Dev Dyn 1994; 199:45- 51; PMID:8167378; http://dx.doi.org/10.1002/ aja.1001990105.48.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Biochem Biophys Res Commun  1998; 247:361-6; PMID:9642132; http://dx.doi.org/10.1006/bbrc.1998.8768.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Proc Natl Acad Sci U S A 2007; 104:20938- 43; PMID:18087037; http://dx.doi.org/10.1073/ pnas.0710428105.45.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
PLoS  One 2009; 4:e4159; PMID:19132093; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Differentiation 2010; 79:272- 84; PMID:20163909; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
Development 2004; 131:1651-62; PMID:14998924;  http://dx.doi.org/10.1242/dev.01044.,OADS,/arxiv_data1/oa_pdf/cf/b6/org-8-125.PMC3562253.pdf
"During reprogramming, each factor  either alone or in combination with the other factors contributes to the conversion by initiating a unique process that controls Transdifferentiation by defined factors   as a powerful research tool to address   basic biological questions yosef Buganim1 and r udolf Jaenisch1,2 1Whitehead i nstitute for Biomedical r esearch; Cambridge, M a usa ; 2Department of Biology; Massachusetts i nstitute of t echnology; Cambridge, M a usa *Correspondence to: Yosef Buganim and Rudolf Jaenisch; Email: yossib@wi.mit.edu and jaenisch@wi.mit.edu Submitted: 10/11/12; Accepted: 10/15/12http://dx.doi.org/10.4161/cc.22665Comment on: Buganim Y, et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Cell Stem Cell 2012; 11:373-86; PMID:22958931; http://dx.doi.org/10.1016/j.stem.2012.07.019.the transformation.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Mol Cell 2012; 47:827-38;  PMID:23020854; http://dx.doi.org/10.1016/j.mol- cel.2012.09.008.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Cell Stem Cell 2012; 11:373- 86; PMID:22958931; http://dx.doi.org/10.1016/j.stem.2012.07.019.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Cells Tissues Organs 2007;  185:7-19; PMID:17587803; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Cell Stem Cell 2010; 7:51-63; PMID:20621050; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Nat Biotechnol 2008; 26:101-6; PMID:18059259; http://dx.doi.org/10.1038/nbt1374.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Nat Cell Biol 2008; 10:353-60; PMID:18264089; http://dx.doi.org/10.1038/ ncb1698.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
BMC Mol Biol 2008; 9:44;  PMID:18445271; http://dx.doi.org/10.1186/1471- 2199-9-44.,Non-OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
Dev Biol 2011; 353:229-41; PMID:21385577; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5a/d9/cc-11-4485.PMC3562283.pdf
"Wigge2 and Varodom Charoensawan3,4,* 1MrC Laboratory of Molecular Biology; Cambridge, u K; 2sainsbury Laboratory; u niversity of Cambridge; Cambridge, u K; 3Department of Biochemistry; f aculty of s cience;  Mahidol u niversity; Bangkok, t hailand; 4integrative Computational Bio science ( iCBs) Center; Mahidol u niversity; Nakhon Pathom, t hailand *Correspondence to: Sarah A. Teichmann and Varodom Charoensawan; Email: sat@mrc-lmb.cam.ac.uk and varodom.cha@mahidol.ac.th Submitted: 09/24/12; Accepted: 10/16/12http://dx.doi.org/10.4161/cc.22666Comment on: Charoensawan V, et al.",Non-OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Mol Cell 2012; 47:183-92; PMID:22841002; http://dx.doi.org/10.1016/j.molcel.2012.06.028.specificities of yeast TFs and histones  influence their actual binding positions in a population of cells.,Non-OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Genome Res 2012; 22:84-94;  PMID:21930892; http://dx.doi.org/10.1101/ gr.124099.111.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Mol Cell 2012; 47:183-92;  PMID:22841002; http://dx.doi.org/10.1016/j.mol-cel.2012.06.028.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Mol Cell 2011; 42:465-76;  PMID:21596311; http://dx.doi.org/10.1016/j.mol- cel.2011.03.028.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Nucleic Acids Res 2011; 39:2032-44; PMID:21081559; http://dx.doi.org/10.1093/nar/ gkq1161.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Genome Biol 2005; 6:R103; PMID:16356266; http://dx.doi.org/10.1186/gb-2005- 6-12-r103.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Mol Cell 2011; 42:826-36; PMID:21700227; http://dx.doi.org/10.1016/j.mol-cel.2011.05.025.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Proc Natl Acad Sci USA 2010; 107:22534- 9; PMID:21149679; http://dx.doi.org/10.1073/ pnas.0913805107.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
PLoS Genet 2012; 8:e1002771; PMID:22737086; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
Nucleic Acids Res 2011; 39(Database issue):D871-5; PMID:21037257; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
PLoS Biol 2008; 6:e65;  PMID:18351804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
"Nature 2012; 484:242-5;  PMID:22437497; http://dx.doi.org/10.1038/nature10928.transcriptional rate of genes in response  to changes in environmental conditions.8  Combinatorial binding of eukaryotic TFs might be employed to increase affinity and specificity and, thus, help minimize non-functional binding.",Non-OADS,/arxiv_data1/oa_pdf/71/6d/cc-11-4487.PMC3562284.pdf
"1 The  Arabidopsis seed coat consists of an outer layer of dead tissue, the testa, and a single Control of seed germination in the shade Keun Pyo Lee and Luis Lopez-Molina* Département de Botanique et de Biologie Végétale; u niversité de Genève; Geneva, s witzerland Abbreviations:  SCBA, seed coat bedding assay; ABA, abscisic acid; GA, gibberellic acid; phyA, phytochrome A;   phyB, phytochrome B *Correspondence to: Luis Lopez-Molina; Email: luis.lopezmolina@unige.ch Submitted: 10/08/12; Accepted: 10/16/12http://dx.doi.org/10.4161/cc.22667Comment on: Lee KP , et al.",Non-OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Genes Dev 2012; 26:1984-96; PMID:22948663; http://dx.doi.org/10.1101/gad.194266.112cell layer of living endosperm tissue sur - rounding the embryo ( Fig.,Non-OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
New Phytol 2006; 171:501- 23; PMID:16866955; http://dx.doi.org/10.1111/ j.1469-8137.2006.01787.x.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Genes Dev 2012; 26:1984-96;  PMID:22948663; http://dx.doi.org/10.1101/ gad.194266.112.synthesis in the embryo.,Non-OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Curr Top Dev Biol 2010; 91:29-66;  PMID:20705178; http://dx.doi.org/10.1016/S0070- 2153(10)91002-8.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Proc Natl Acad Sci USA 1996; 93:8129-33; PMID:8755615; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Mathews S. Mol Ecol 2006; 15:3483-503; PMID:17032252; http://dx.doi.org/10.1111/j.1365- 294X.2006.03051.x.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
Plant Cell 2008; 20:2729-45; PMID:18941053; http://dx.doi.org/10.1105/ tpc.108.061515.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
EMBO J 2009; 28:2259-71;  PMID:19556968; http://dx.doi.org/10.1038/emboj.2009.170.,OADS,/arxiv_data1/oa_pdf/1b/f5/cc-11-4489.PMC3562285.pdf
"The mitochondrial function of Yorkie requires Oncogenic pathway utilizes mitochondial fusion  machinery to support growth shubha Gururaja r ao1 and u tpal Banerjee1,2,3,4,* 1Department of Molecular, Cell and Developmental Biology; u niversity of California Los a ngeles; Los a ngeles, C a usa ; 2Department of Biological Chemistry;   university of California Los a ngeles; Los a ngeles, C a usa ; 3Molecular Biology i nstitute; u niversity of California Los a ngeles; Los a ngeles, C a usa ;   4Broad s tem Cell r esearch Center; u niversity of California Los a ngeles; Los a ngeles, C a usa *Correspondence to: Utpal Banerjee; Email: banerjee@mbi.ucla.edu Submitted: 10/03/12; Accepted: 10/16/12http://dx.doi.org/10.4161/cc.22668Comment on: Nagaraj R, et al.",Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Genes Dev 2012; 26:2027-37; PMID:22925885; http://dx.doi.org/10.1101/gad.183061.111.the TEAD domain protein Scalloped  through direct transcriptional activation of genes encoding mitochondrial fusion proteins such as Opa1-like and Marf.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Dev Cell 2005; 9:843-54; PMID:16326395; http://dx.doi.org/10.1016/j.dev-cel.2005.11.006.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Nat Genet 2008; 40:356- 61; PMID:18246068; http://dx.doi.org/10.1038/ ng.2007.50.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Mol Cancer 2002; 1:9; PMID:12513701; http://dx.doi.org/10.1186/1476-4598-1-9.,Non-OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
T rends Mol Med 2011; 17:641-9; PMID:21764377; http://dx.doi.org/10.1016/j.mol-med.2011.06.001.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Cell 2012; 148:1132-44; PMID:22424225; http://dx.doi.org/10.1016/j.cell.2012.02.032.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Genes Dev 2012; 26:2027-37;  PMID:22925885; http://dx.doi.org/10.1101/ gad.183061.111.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Curr Opin Cell Biol 2008; 20:638-46; PMID:18955139; http://dx.doi.org/10.1016/j.ceb.2008.10.001.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Annu Rev Cell Dev Biol 2006; 22:79-99; PMID:16704336; http://dx.doi.org/10.1146/annurev.cellbio.22.010305.104638.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
Development 2008; 135:1081-8; PMID:18256197; http://dx.doi.org/10.1242/dev.015255.,OADS,/arxiv_data1/oa_pdf/3f/be/cc-11-4491.PMC3562286.pdf
"To elucidate the mechanism of rep - lication timing control in euchromatin Telomere-binding proteins play roles in control   of replication timing atsutoshi t azumi and Hisao Masukata* Department of Biological s ciences; Graduate s chool of s cience; o saka u niversity; t oyonaka, o saka, Japan *Correspondence to: Hisao Masukata; Email: masukata@bio.sci.osaka-u.ac.jp Submitted: 10/27/12; Accepted: 10/30/12http://dx.doi.org/10.4161/cc.22727Comment on: Tazumi A, et al.",OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
"Genes Dev 2012; 26:2050-62; PMID:22987637; http://dx.doi.org/10.1101/gad.194282.112.regions, we examined whether a late origin  is associated with an element that controls late replication timing by translocating a late origin fragment into the proximity of an early origin on the chromosome.",Non-OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Genes Dev 2004; 18:3094- 105; PMID:15601823; http://dx.doi.org/10.1101/ gad.1246404.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Cold Spring Harb Symp Quant Biol  2010; 75:143-53; PMID:21139067; http://dx.doi.org/10.1101/sqb.2010.75.011.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Mol Cell 1999; 4:983-93;  PMID:10635323; http://dx.doi.org/10.1016/S1097- 2765(00)80227-0.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Proc Natl Acad Sci USA 2004; 101:16861-6; PMID:15557005; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Genes Dev 2003; 17:330-5; PMID:12569122; http://dx.doi.org/10.1101/ gad.1046203.,Non-OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
EMBO J 2007; 26:1327-39; PMID:17304213; http://dx.doi.org/10.1038/ sj.emboj.7601585.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Nat Cell Biol 2009; 11:357-62; PMID:19182789; http://dx.doi.org/10.1038/ ncb1845.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Genes Dev 2012; 26:2050-62; PMID:22987637; http://dx.doi.org/10.1101/ gad.194282.112.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
Genes Dev 2012; 26:137-50;  PMID:22279046; http://dx.doi.org/10.1101/gad.178491.111.,OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
EMBO J 2012; 31:3667-77; PMID:22850674; http://dx.doi.org/10.1038/ emboj.2012.180.,Non-OADS,/arxiv_data1/oa_pdf/2b/a9/cc-11-4492.PMC3562287.pdf
"Cell Cycle 2012; 11:3926–31;   PMID:22987149; http://dx.doi.org/10.4161/cc.21908 Zbigniew Darzynkiewicz; Brander Cancer Research Institute and Department of Pathology; New York Medical College; Valhalla, NY USA;   Email: darzynk@NYMC.edu; http://dx.doi.org/10.4161/cc.22932 replication stress, manifested by markers of  DNA damage signaling.",Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
"Cell Cycle 2012; 11:3792–800;   PMID:23070520; http://dx.doi.org/10.4161/cc.21987 Patrice Y. Ohouo and Marcus B. Smolka*; Cornell University; Ithaca, NY USA; *Email: mbs266@cornell.edu; http://dx.doi.org/10.4161/cc.22933This led to their senescence and irreversible  loss of reproductive capability.10 The induction  of cell senescence by the low doses of DNA  damaging drugs or other means of arresting  the cell cycle rather than induction of apop - tosis by high drug doses, typical of standard  chemotherapy, may be therefore more effec - tive in treatment of cancers characterized by  high level of mTOR signaling, with less side  effects for the patient.",Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Biochem J 2012; 441:1-21;  PMID:22168436; http://dx.doi.org/10.1042/ BJ20110892.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
J Cell Physiol 1967; 69:331-9; PMID:4230858; http://dx.doi.org/10.1002/ jcp.1040690309.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2008; 7:3344-54;  PMID:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2011; 10:4230-6;  PMID:22107964; http://dx.doi.org/10.4161/ cc.10.24.18486.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell 2012; 149:275-93; http://dx.doi.org/10.1016/j.cell.2012.03.017.6.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2012; 11:3926-31; PMID:22987149; http://dx.doi.org/10.4161/ cc.21908.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Proc Natl Acad Sci USA 1979; 76:358-62; PMID:284352; http://dx.doi.org/10.1073/ pnas.76.1.358.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell 2011; 146:682-95; PMID:21884931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2012; 11:3792-800;  PMID:23070520; http://dx.doi.org/10.4161/ cc.21987.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
EMBO J 1998; 17:5679-88; PMID:9755168; http://dx.doi.org/10.1093/ emboj/17.19.5679.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Mol Cell Biol 2005; 25:8430-43;  PMID:16166626; http://dx.doi.org/10.1128/MCB.25.19.8430-8443.2005.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
"Cell Cycle 2012; 11:4266–74;   PMID:23095635; http://dx.doi.org/10.4161/cc.22613 Gargi Ghosal and Junjie Chen*; Department of Experimental Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  *Email: jchen8@mdanderson.org; http://dx.doi.org/10.4161/cc.229344.",OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
EMBO Rep 2007; 8:851-7;  PMID:17721446; http://dx.doi.org/10.1038/ sj.embor.7401036.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Mol Cell Biol 2008; 28:4782-93;  PMID:18541674; http://dx.doi.org/10.1128/MCB.00330-08.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
PLoS Genet 2010; 6:e1001047;  PMID:20700441; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
EMBO J 2011; 30:4897-907; PMID:21946560; http://dx.doi.org/10.1038/ emboj.2011.345.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Nature 2004; 432:406-11;  PMID:15525939; http://dx.doi.org/10.1038/ nature03114.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Nature 2012; 481:287-94;  PMID:22258607; http://dx.doi.org/10.1038/ nature10760.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Nat Rev Mol Cell Biol 2007; 8:284-95; PMID:17380162; http://dx.doi.org/10.1038/nrm2145.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Mol Cell 2010; 37:469-80;  PMID:20188666; http://dx.doi.org/10.1016/j.mol- cel.2010.01.020.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
J Biol Chem 2004; 279:54230- 40; PMID:15496419; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
J Biol Chem 2002; 277:45611-8; PMID:12235159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
J Biol Chem 2007; 282:8812-20; PMID:17272277; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
J Biol Chem 2012; 287:29442-56; PMID:22736770; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2012; 11:4266-74; PMID:23095635; http://dx.doi.org/10.4161/cc.22613.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Trends Cell Biol 2010; 20:402-9;  PMID:20444606; http://dx.doi.org/10.1016/j.tcb.2010.04.002.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
"Cell Cycle 2012; 11:4352–65;   PMID:23111389; http://dx.doi.org/10.4161/cc.22670  Yanmei Li1 and David E. Spaner1,2,*; 1Division of Molecular and Cellular Biology; Sunnybrook Research Institute; Toronto, ON Canada;  2Department of Medical Biophysics; University of Toronto; Toronto, ON Canada; *Email: spanerd@sri.utoronto.ca; http://dx.doi.org/10.4161/cc.22935 Studies of microRNA (miRNA) in cancer are  relatively recent but have exciting possibilities  to improve our understanding and treatment of this disease.",Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Nat Rev Drug Discov 2010; 9:775- 89; PMID:20885409; http://dx.doi.org/10.1038/ nrd3179.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Blood 2012; 119:4486-98; PMID:22451425;  http://dx.doi.org/10.1182/blood-2011-09-378687.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell 2007; 131:1109-23; PMID:18083101;  http://dx.doi.org/10.1016/j.cell.2007.10.054.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2012; 11:4352-65;  PMID:23111389; http://dx.doi.org/10.4161/cc.22670.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2010; 9:3892-903;  PMID:20935475; http://dx.doi.org/10.4161/ cc.9.19.13386.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Oncogene 1999; 18:2015-21;  PMID:10208423; http://dx.doi.org/10.1038/ sj.onc.1202519.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Nature 2012; 490:61- 70; PMID:23000897; http://dx.doi.org/10.1038/nature11412.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
"Cell Cycle 2012; 11:4242–51;   PMID:22185777; http://dx.doi.org/10.4161/cc.22543  Mohammad Kohandel; Department of Applied Mathematics; University of Waterloo; Waterloo, ON Canada and Centre for Mathematical Medicine; Fields Institute;  Toronto, ON Canada; Email: kohandel@uwaterloo.ca; http://dx.doi.org/10.4161/cc.22936 MS-proficient conditions (suspension).",Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Proc Natl Acad Sci USA 2003;  100:3983-8; PMID:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Genes Dev 2003; 17:1253-70; PMID:12756227; http://dx.doi.org/10.1101/ gad.1061803.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cancer Res 2005; 65:5506-11;  PMID:15994920; http://dx.doi.org/10.1158/0008-5472.CAN-05-0626.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Semin Cancer Biol 2012; 22:396- 403; PMID:22554795; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
PLoS One 2008; 3:e2888; PMID:18682804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cancer Res 2009; 69:4116-24; PMID:19435916; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3441.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Cell Cycle 2012; 11:1-10; PMID:22185777; http://dx.doi.org/10.4161/ cc.22543.,OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
Semin Cancer Biol 2012; 22:374-8;  PMID:22609094; http://dx.doi.org/10.1016/j.sem-cancer.2012.04.005.,Non-OADS,/arxiv_data1/oa_pdf/33/40/cc-11-4494.PMC3562288.pdf
"Cell Cycle 2012; 11:3926–31;   PMID:22987149; http://dx.doi.org/10.4161/cc.21908 Zbigniew Darzynkiewicz; Brander Cancer Research Institute and Department of Pathology; New York Medical College; Valhalla, NY USA;   Email: darzynk@NYMC.edu; http://dx.doi.org/10.4161/cc.22932 replication stress, manifested by markers of  DNA damage signaling.",Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
"Cell Cycle 2012; 11:3792–800;   PMID:23070520; http://dx.doi.org/10.4161/cc.21987 Patrice Y. Ohouo and Marcus B. Smolka*; Cornell University; Ithaca, NY USA; *Email: mbs266@cornell.edu; http://dx.doi.org/10.4161/cc.22933This led to their senescence and irreversible  loss of reproductive capability.10 The induction  of cell senescence by the low doses of DNA  damaging drugs or other means of arresting  the cell cycle rather than induction of apop - tosis by high drug doses, typical of standard  chemotherapy, may be therefore more effec - tive in treatment of cancers characterized by  high level of mTOR signaling, with less side  effects for the patient.",Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Biochem J 2012; 441:1-21;  PMiD:22168436; http://dx.doi.org/10.1042/ BJ20110892.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
J Cell Physiol 1967; 69:331-9; PMiD:4230858; http://dx.doi.org/10.1002/ jcp.1040690309.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2008; 7:3344-54;  PMiD:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2011; 10:4230-6;  PMiD:22107964; http://dx.doi.org/10.4161/ cc.10.24.18486.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell 2012; 149:275-93; http://dx.doi.org/10.1016/j.cell.2012.03.017.6.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2012; 11:3926-31; PMiD:22987149; http://dx.doi.org/10.4161/ cc.21908.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Proc Natl Acad Sci USA 1979; 76:358-62; PMiD:284352; http://dx.doi.org/10.1073/ pnas.76.1.358.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell 2011; 146:682-95; PMiD:21884931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2012; 11:3792-800;  PMiD:23070520; http://dx.doi.org/10.4161/ cc.21987.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
eMBO J 1998; 17:5679-88;  PMiD:9755168; http://dx.doi.org/10.1093/ emboj/17.19.5679.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Mol Cell Biol 2005; 25:8430-43;  PMiD:16166626; http://dx.doi.org/10.1128/MCB.25.19.8430-8443.2005.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
"Cell Cycle 2012; 11:4266–74;   PMID:23095635; http://dx.doi.org/10.4161/cc.22613 Gargi Ghosal and Junjie Chen*; Department of Experimental Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  *Email: jchen8@mdanderson.org; http://dx.doi.org/10.4161/cc.229344.",OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
eMBO Rep 2007; 8:851-7;  PMiD:17721446; http://dx.doi.org/10.1038/ sj.embor.7401036.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Mol Cell Biol 2008; 28:4782-93;  PMiD:18541674; http://dx.doi.org/10.1128/MCB.00330-08.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
PLoS Genet 2010; 6:e1001047;  PMiD:20700441; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
eMBO J 2011; 30:4897-907; PMiD:21946560; http://dx.doi.org/10.1038/ emboj.2011.345.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Nature 2004; 432:406-11;  PMiD:15525939; http://dx.doi.org/10.1038/ nature03114.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Nature 2012; 481:287-94;  PMiD:22258607; http://dx.doi.org/10.1038/ nature10760.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Nat Rev Mol Cell Biol 2007; 8:284-95; PMiD:17380162; http://dx.doi.org/10.1038/nrm2145.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Mol Cell 2010; 37:469-80;  PMiD:20188666; http://dx.doi.org/10.1016/j.mol- cel.2010.01.020.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
J Biol Chem 2004; 279:54230- 40; PMiD:15496419; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
J Biol Chem 2002; 277:45611-8; PMiD:12235159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
J Biol Chem 2007; 282:8812-20; PMiD:17272277; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
J Biol Chem 2012; 287:29442-56; PMiD:22736770; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2012; 11:4266-74; PMiD:23095635; http://dx.doi.org/10.4161/cc.22613.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Trends Cell Biol 2010; 20:402-9;  PMiD:20444606; http://dx.doi.org/10.1016/j.tcb.2010.04.002.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
"Cell Cycle 2012; 11:4352–65;   PMID:23111389; http://dx.doi.org/10.4161/cc.22670  Yanmei Li1 and David E. Spaner1,2,*; 1Division of Molecular and Cellular Biology; Sunnybrook Research Institute; Toronto, ON Canada; 2Department of Medical  Biophysics; University of Toronto; Toronto, ON Canada; *Email: spanerd@sri.utoronto.ca; http://dx.doi.org/10.4161/cc.22935 Studies of microRNA (miRNA) in cancer are  relatively recent but have exciting possibilities  to improve our understanding and treatment of this disease.",Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Nat Rev Drug Discov 2010; 9:775- 89; PMiD:20885409; http://dx.doi.org/10.1038/ nrd3179.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Blood 2012; 119:4486-98; PMiD:22451425;  http://dx.doi.org/10.1182/blood-2011-09-378687.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell 2007; 131:1109-23; PMiD:18083101;  http://dx.doi.org/10.1016/j.cell.2007.10.054.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2012; 11:4352-65;  PMiD:23111389; http://dx.doi.org/10.4161/cc.22670.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2010; 9:3892-903;  PMiD:20935475; http://dx.doi.org/10.4161/ cc.9.19.13386.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Oncogene 1999; 18:2015-21;  PMiD:10208423; http://dx.doi.org/10.1038/ sj.onc.1202519.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Nature 2012; 490:61- 70; PMiD:23000897; http://dx.doi.org/10.1038/nature11412.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
"Cell Cycle 2012; 11:4242–51;   PMID:22185777; http://dx.doi.org/10.4161/cc.22543  Mohammad Kohandel; Department of Applied Mathematics; University of Waterloo; Waterloo, ON Canada and Centre for Mathematical Medicine; Fields Institute;  Toronto, ON Canada; Email: kohandel@uwaterloo.ca; http://dx.doi.org/10.4161/cc.22936 MS-proficient conditions (suspension).",Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Proc Natl Acad Sci USA 2003;  100:3983-8; PMiD:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Genes Dev 2003; 17:1253-70; PMiD:12756227; http://dx.doi.org/10.1101/ gad.1061803.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cancer Res 2005; 65:5506-11;  PMi D:15994920; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0626.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Semin Cancer Biol 2012; 22:396- 403; PMiD:22554795; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell 2008; 133:704-15; PMiD:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
PLoS One 2008; 3:e2888; PMiD:18682804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cancer Res 2009; 69:4116-24; PMi D:19435916; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3441.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Cell Cycle 2012; 11:1-10;  PMiD:22185777; http://dx.doi.org/10.4161/ cc.22543.,OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
Semin Cancer Biol 2012; 22:374-8;  PMiD:22609094; http://dx.doi.org/10.1016/j.sem-cancer.2012.04.005.,Non-OADS,/arxiv_data1/oa_pdf/06/5b/cc-11-4495.PMC3562289.pdf
"Cell Cycle 2012; 11:3926–31;   PMID:22987149; http://dx.doi.org/10.4161/cc.21908 Zbigniew Darzynkiewicz; Brander Cancer Research Institute and Department of Pathology; New York Medical College; Valhalla, NY USA;   Email: darzynk@NYMC.edu; http://dx.doi.org/10.4161/cc.22932 replication stress, manifested by markers of  DNA damage signaling.",Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
"Cell Cycle 2012; 11:3792–800;   PMID:23070520; http://dx.doi.org/10.4161/cc.21987 Patrice Y. Ohouo and Marcus B. Smolka*; Cornell University; Ithaca, NY USA; *Email: mbs266@cornell.edu; http://dx.doi.org/10.4161/cc.22933This led to their senescence and irreversible  loss of reproductive capability.10 The induction  of cell senescence by the low doses of DNA  damaging drugs or other means of arresting  the cell cycle rather than induction of apop - tosis by high drug doses, typical of standard  chemotherapy, may be therefore more effec - tive in treatment of cancers characterized by  high level of mTOR signaling, with less side  effects for the patient.",Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Biochem J 2012; 441:1-21;  PMiD:22168436; http://dx.doi.org/10.1042/ BJ20110892.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
J Cell Physiol 1967; 69:331-9; PMiD:4230858; http://dx.doi.org/10.1002/ jcp.1040690309.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2008; 7:3344-54;  PMiD:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2011; 10:4230-6;  PMiD:22107964; http://dx.doi.org/10.4161/ cc.10.24.18486.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell 2012; 149:275-93; http://dx.doi.org/10.1016/j.cell.2012.03.017.6.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2012; 11:3926-31; PMiD:22987149; http://dx.doi.org/10.4161/ cc.21908.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Proc Natl Acad Sci USA 1979; 76:358-62; PMiD:284352; http://dx.doi.org/10.1073/ pnas.76.1.358.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell 2011; 146:682-95; PMiD:21884931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2012; 11:3792-800;  PMiD:23070520; http://dx.doi.org/10.4161/ cc.21987.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
eMBO J 1998; 17:5679-88;  PMiD:9755168; http://dx.doi.org/10.1093/ emboj/17.19.5679.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Mol Cell Biol 2005; 25:8430-43;  PMiD:16166626; http://dx.doi.org/10.1128/MCB.25.19.8430-8443.2005.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
"Cell Cycle 2012; 11:4266–74;   PMID:23095635; http://dx.doi.org/10.4161/cc.22613 Gargi Ghosal and Junjie Chen*; Department of Experimental Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  *Email: jchen8@mdanderson.org; http://dx.doi.org/10.4161/cc.229344.",OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
eMBO Rep 2007; 8:851-7;  PMiD:17721446; http://dx.doi.org/10.1038/ sj.embor.7401036.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Mol Cell Biol 2008; 28:4782-93;  PMiD:18541674; http://dx.doi.org/10.1128/MCB.00330-08.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
PLoS Genet 2010; 6:e1001047;  PMiD:20700441; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
eMBO J 2011; 30:4897-907; PMiD:21946560; http://dx.doi.org/10.1038/ emboj.2011.345.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Nature 2004; 432:406-11;  PMiD:15525939; http://dx.doi.org/10.1038/ nature03114.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Nature 2012; 481:287-94;  PMiD:22258607; http://dx.doi.org/10.1038/ nature10760.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Nat Rev Mol Cell Biol 2007; 8:284-95; PMiD:17380162; http://dx.doi.org/10.1038/nrm2145.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Mol Cell 2010; 37:469-80;  PMiD:20188666; http://dx.doi.org/10.1016/j.mol- cel.2010.01.020.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
J Biol Chem 2004; 279:54230- 40; PMiD:15496419; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
J Biol Chem 2002; 277:45611-8; PMiD:12235159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
J Biol Chem 2007; 282:8812-20; PMiD:17272277; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
J Biol Chem 2012; 287:29442-56; PMiD:22736770; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2012; 11:4266-74; PMiD:23095635; http://dx.doi.org/10.4161/cc.22613.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Trends Cell Biol 2010; 20:402-9;  PMiD:20444606; http://dx.doi.org/10.1016/j.tcb.2010.04.002.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
"Cell Cycle 2012; 11:4352–65;   PMID:23111389; http://dx.doi.org/10.4161/cc.22670  Yanmei Li1 and David E. Spaner1,2,*; 1Division of Molecular and Cellular Biology; Sunnybrook Research Institute; Toronto, ON Canada; 2Department of Medical  Biophysics; University of Toronto; Toronto, ON Canada; *Email: spanerd@sri.utoronto.ca; http://dx.doi.org/10.4161/cc.22935 Studies of microRNA (miRNA) in cancer are  relatively recent but have exciting possibilities  to improve our understanding and treatment of this disease.",Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Nat Rev Drug Discov 2010; 9:775- 89; PMiD:20885409; http://dx.doi.org/10.1038/ nrd3179.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Blood 2012; 119:4486-98; PMiD:22451425;  http://dx.doi.org/10.1182/blood-2011-09-378687.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell 2007; 131:1109-23; PMiD:18083101;  http://dx.doi.org/10.1016/j.cell.2007.10.054.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2012; 11:4352-65;  PMiD:23111389; http://dx.doi.org/10.4161/cc.22670.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2010; 9:3892-903;  PMiD:20935475; http://dx.doi.org/10.4161/ cc.9.19.13386.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Oncogene 1999; 18:2015-21;  PMiD:10208423; http://dx.doi.org/10.1038/ sj.onc.1202519.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Nature 2012; 490:61- 70; PMiD:23000897; http://dx.doi.org/10.1038/nature11412.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
"Cell Cycle 2012; 11:4242–51;   PMID:22185777; http://dx.doi.org/10.4161/cc.22543  Mohammad Kohandel; Department of Applied Mathematics; University of Waterloo; Waterloo, ON Canada and Centre for Mathematical Medicine; Fields Institute;  Toronto, ON Canada; Email: kohandel@uwaterloo.ca; http://dx.doi.org/10.4161/cc.22936 MS-proficient conditions (suspension).",Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Proc Natl Acad Sci USA 2003;  100:3983-8; PMiD:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Genes Dev 2003; 17:1253-70; PMiD:12756227; http://dx.doi.org/10.1101/ gad.1061803.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cancer Res 2005; 65:5506-11;  PMi D:15994920; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0626.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Semin Cancer Biol 2012; 22:396- 403; PMiD:22554795; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell 2008; 133:704-15; PMiD:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
PLoS One 2008; 3:e2888; PMiD:18682804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cancer Res 2009; 69:4116-24; PMi D:19435916; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3441.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Cell Cycle 2012; 11:1-10;  PMiD:22185777; http://dx.doi.org/10.4161/ cc.22543.,OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
Semin Cancer Biol 2012; 22:374-8;  PMiD:22609094; http://dx.doi.org/10.1016/j.sem-cancer.2012.04.005.,Non-OADS,/arxiv_data1/oa_pdf/5f/16/cc-11-4496.PMC3562290.pdf
"Cell Cycle 2012; 11:3926–31;   PMID:22987149; http://dx.doi.org/10.4161/cc.21908 Zbigniew Darzynkiewicz; Brander Cancer Research Institute and Department of Pathology; New York Medical College; Valhalla, NY USA;   Email: darzynk@NYMC.edu; http://dx.doi.org/10.4161/cc.22932 replication stress, manifested by markers of  DNA damage signaling.",Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
"Cell Cycle 2012; 11:3792–800;   PMID:23070520; http://dx.doi.org/10.4161/cc.21987 Patrice Y. Ohouo and Marcus B. Smolka*; Cornell University; Ithaca, NY USA; *Email: mbs266@cornell.edu; http://dx.doi.org/10.4161/cc.22933This led to their senescence and irreversible  loss of reproductive capability.10 The induction  of cell senescence by the low doses of DNA  damaging drugs or other means of arresting  the cell cycle rather than induction of apop - tosis by high drug doses, typical of standard  chemotherapy, may be therefore more effec - tive in treatment of cancers characterized by  high level of mTOR signaling, with less side  effects for the patient.",Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Biochem J 2012; 441:1-21;  PMiD:22168436; http://dx.doi.org/10.1042/ BJ20110892.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
J Cell Physiol 1967; 69:331-9; PMiD:4230858; http://dx.doi.org/10.1002/ jcp.1040690309.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2008; 7:3344-54;  PMiD:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2011; 10:4230-6;  PMiD:22107964; http://dx.doi.org/10.4161/ cc.10.24.18486.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell 2012; 149:275-93; http://dx.doi.org/10.1016/j.cell.2012.03.017.6.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2012; 11:3926-31; PMiD:22987149; http://dx.doi.org/10.4161/ cc.21908.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Proc Natl Acad Sci USA 1979; 76:358-62; PMiD:284352; http://dx.doi.org/10.1073/ pnas.76.1.358.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell 2011; 146:682-95; PMiD:21884931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2012; 11:3792-800;  PMiD:23070520; http://dx.doi.org/10.4161/ cc.21987.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
eMBO J 1998; 17:5679-88;  PMiD:9755168; http://dx.doi.org/10.1093/ emboj/17.19.5679.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Mol Cell Biol 2005; 25:8430-43;  PMiD:16166626; http://dx.doi.org/10.1128/MCB.25.19.8430-8443.2005.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
"Cell Cycle 2012; 11:4266–74;   PMID:23095635; http://dx.doi.org/10.4161/cc.22613 Gargi Ghosal and Junjie Chen*; Department of Experimental Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  *Email: jchen8@mdanderson.org; http://dx.doi.org/10.4161/cc.229344.",OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
eMBO Rep 2007; 8:851-7;  PMiD:17721446; http://dx.doi.org/10.1038/ sj.embor.7401036.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Mol Cell Biol 2008; 28:4782-93;  PMiD:18541674; http://dx.doi.org/10.1128/MCB.00330-08.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
PLoS Genet 2010; 6:e1001047;  PMiD:20700441; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
eMBO J 2011; 30:4897-907; PMiD:21946560; http://dx.doi.org/10.1038/ emboj.2011.345.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Nature 2004; 432:406-11;  PMiD:15525939; http://dx.doi.org/10.1038/ nature03114.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Nature 2012; 481:287-94;  PMiD:22258607; http://dx.doi.org/10.1038/ nature10760.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Nat Rev Mol Cell Biol 2007; 8:284-95; PMiD:17380162; http://dx.doi.org/10.1038/nrm2145.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Mol Cell 2010; 37:469-80;  PMiD:20188666; http://dx.doi.org/10.1016/j.mol- cel.2010.01.020.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
J Biol Chem 2004; 279:54230- 40; PMiD:15496419; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
J Biol Chem 2002; 277:45611-8; PMiD:12235159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
J Biol Chem 2007; 282:8812-20; PMiD:17272277; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
J Biol Chem 2012; 287:29442-56; PMiD:22736770; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2012; 11:4266-74; PMiD:23095635; http://dx.doi.org/10.4161/cc.22613.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Trends Cell Biol 2010; 20:402-9;  PMiD:20444606; http://dx.doi.org/10.1016/j.tcb.2010.04.002.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
"Cell Cycle 2012; 11:4352–65;   PMID:23111389; http://dx.doi.org/10.4161/cc.22670  Yanmei Li1 and David E. Spaner1,2,*; 1Division of Molecular and Cellular Biology; Sunnybrook Research Institute; Toronto, ON Canada; 2Department of Medical  Biophysics; University of Toronto; Toronto, ON Canada; *Email: spanerd@sri.utoronto.ca; http://dx.doi.org/10.4161/cc.22935 Studies of microRNA (miRNA) in cancer are  relatively recent but have exciting possibilities  to improve our understanding and treatment of this disease.",Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Nat Rev Drug Discov 2010; 9:775- 89; PMiD:20885409; http://dx.doi.org/10.1038/ nrd3179.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Blood 2012; 119:4486-98; PMiD:22451425;  http://dx.doi.org/10.1182/blood-2011-09-378687.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell 2007; 131:1109-23; PMiD:18083101;  http://dx.doi.org/10.1016/j.cell.2007.10.054.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2012; 11:4352-65;  PMiD:23111389; http://dx.doi.org/10.4161/cc.22670.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2010; 9:3892-903;  PMiD:20935475; http://dx.doi.org/10.4161/ cc.9.19.13386.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Oncogene 1999; 18:2015-21;  PMiD:10208423; http://dx.doi.org/10.1038/ sj.onc.1202519.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Nature 2012; 490:61- 70; PMiD:23000897; http://dx.doi.org/10.1038/nature11412.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
"Cell Cycle 2012; 11:4242–51;   PMID:22185777; http://dx.doi.org/10.4161/cc.22543  Mohammad Kohandel; Department of Applied Mathematics; University of Waterloo; Waterloo, ON Canada and Centre for Mathematical Medicine; Fields Institute;  Toronto, ON Canada; Email: kohandel@uwaterloo.ca; http://dx.doi.org/10.4161/cc.22936 MS-proficient conditions (suspension).",Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Proc Natl Acad Sci USA 2003;  100:3983-8; PMiD:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Genes Dev 2003; 17:1253-70; PMiD:12756227; http://dx.doi.org/10.1101/ gad.1061803.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cancer Res 2005; 65:5506-11;  PMi D:15994920; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0626.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Semin Cancer Biol 2012; 22:396- 403; PMiD:22554795; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell 2008; 133:704-15; PMiD:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
PLoS One 2008; 3:e2888; PMiD:18682804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cancer Res 2009; 69:4116-24; PMi D:19435916; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3441.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Cell Cycle 2012; 11:1-10;  PMiD:22185777; http://dx.doi.org/10.4161/ cc.22543.,OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
Semin Cancer Biol 2012; 22:374-8;  PMiD:22609094; http://dx.doi.org/10.1016/j.sem-cancer.2012.04.005.,Non-OADS,/arxiv_data1/oa_pdf/1d/11/cc-11-4497.PMC3562291.pdf
"Cell Cycle 2012; 11:3926–31;   PMID:22987149; http://dx.doi.org/10.4161/cc.21908 Zbigniew Darzynkiewicz; Brander Cancer Research Institute and Department of Pathology; New York Medical College; Valhalla, NY USA;   Email: darzynk@NYMC.edu; http://dx.doi.org/10.4161/cc.22932 replication stress, manifested by markers of  DNA damage signaling.",Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
"Cell Cycle 2012; 11:3792–800;   PMID:23070520; http://dx.doi.org/10.4161/cc.21987 Patrice Y. Ohouo and Marcus B. Smolka*; Cornell University; Ithaca, NY USA; *Email: mbs266@cornell.edu; http://dx.doi.org/10.4161/cc.22933This led to their senescence and irreversible  loss of reproductive capability.10 The induction  of cell senescence by the low doses of DNA  damaging drugs or other means of arresting  the cell cycle rather than induction of apop - tosis by high drug doses, typical of standard  chemotherapy, may be therefore more effec - tive in treatment of cancers characterized by  high level of mTOR signaling, with less side  effects for the patient.",Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Biochem J 2012; 441:1-21;  PMID:22168436; http://dx.doi.org/10.1042/ BJ20110892.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
J Cell Physiol 1967; 69:331-9; PMID:4230858; http://dx.doi.org/10.1002/ jcp.1040690309.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2008; 7:3344-54;  PMID:18971624; http://dx.doi.org/10.4161/cc.7.21.6965.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2011; 10:4230-6;  PMID:22107964; http://dx.doi.org/10.4161/ cc.10.24.18486.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell 2012; 149:275-93; http://dx.doi.org/10.1016/j.cell.2012.03.017.6.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2012; 11:3926-31; PMID:22987149; http://dx.doi.org/10.4161/ cc.21908.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Proc Natl Acad Sci USA 1979; 76:358-62; PMID:284352; http://dx.doi.org/10.1073/ pnas.76.1.358.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell 2011; 146:682-95; PMID:21884931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2012; 11:3792-800;  PMID:23070520; http://dx.doi.org/10.4161/ cc.21987.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
EMBO J 1998; 17:5679-88; PMID:9755168; http://dx.doi.org/10.1093/ emboj/17.19.5679.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Mol Cell Biol 2005; 25:8430-43;  PMID:16166626; http://dx.doi.org/10.1128/MCB.25.19.8430-8443.2005.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
"Cell Cycle 2012; 11:4266–74;   PMID:23095635; http://dx.doi.org/10.4161/cc.22613 Gargi Ghosal and Junjie Chen*; Department of Experimental Radiation Oncology; The University of Texas MD Anderson Cancer Center; Houston, TX USA;  *Email: jchen8@mdanderson.org; http://dx.doi.org/10.4161/cc.229344.",OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
EMBO Rep 2007; 8:851-7;  PMID:17721446; http://dx.doi.org/10.1038/ sj.embor.7401036.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Mol Cell Biol 2008; 28:4782-93;  PMID:18541674; http://dx.doi.org/10.1128/MCB.00330-08.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
PLoS Genet 2010; 6:e1001047;  PMID:20700441; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
EMBO J 2011; 30:4897-907; PMID:21946560; http://dx.doi.org/10.1038/ emboj.2011.345.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Nature 2004; 432:406-11;  PMID:15525939; http://dx.doi.org/10.1038/ nature03114.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Nature 2012; 481:287-94;  PMID:22258607; http://dx.doi.org/10.1038/ nature10760.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Nat Rev Mol Cell Biol 2007; 8:284-95; PMID:17380162; http://dx.doi.org/10.1038/nrm2145.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Mol Cell 2010; 37:469-80;  PMID:20188666; http://dx.doi.org/10.1016/j.mol- cel.2010.01.020.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
J Biol Chem 2004; 279:54230- 40; PMID:15496419; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
J Biol Chem 2002; 277:45611-8; PMID:12235159; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
J Biol Chem 2007; 282:8812-20; PMID:17272277; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
J Biol Chem 2012; 287:29442-56; PMID:22736770; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2012; 11:4266-74; PMID:23095635; http://dx.doi.org/10.4161/cc.22613.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Trends Cell Biol 2010; 20:402-9;  PMID:20444606; http://dx.doi.org/10.1016/j.tcb.2010.04.002.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
"Cell Cycle 2012; 11:4352–65;   PMID:23111389; http://dx.doi.org/10.4161/cc.22670  Yanmei Li1 and David E. Spaner1,2,*; 1Division of Molecular and Cellular Biology; Sunnybrook Research Institute; Toronto, ON Canada;  2Department of Medical Biophysics; University of Toronto; Toronto, ON Canada; *Email: spanerd@sri.utoronto.ca; http://dx.doi.org/10.4161/cc.22935 Studies of microRNA (miRNA) in cancer are  relatively recent but have exciting possibilities  to improve our understanding and treatment of this disease.",Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Nat Rev Drug Discov 2010; 9:775- 89; PMID:20885409; http://dx.doi.org/10.1038/ nrd3179.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Blood 2012; 119:4486-98; PMID:22451425;  http://dx.doi.org/10.1182/blood-2011-09-378687.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell 2007; 131:1109-23; PMID:18083101;  http://dx.doi.org/10.1016/j.cell.2007.10.054.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2012; 11:4352-65;  PMID:23111389; http://dx.doi.org/10.4161/cc.22670.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2010; 9:3892-903;  PMID:20935475; http://dx.doi.org/10.4161/ cc.9.19.13386.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Oncogene 1999; 18:2015-21;  PMID:10208423; http://dx.doi.org/10.1038/ sj.onc.1202519.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Nature 2012; 490:61- 70; PMID:23000897; http://dx.doi.org/10.1038/nature11412.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
"Cell Cycle 2012; 11:4242–51;   PMID:23095640; http://dx.doi.org/10.4161/cc.22543  Mohammad Kohandel; Department of Applied Mathematics; University of Waterloo; Waterloo, ON Canada and Centre for Mathematical Medicine; Fields Institute;  Toronto, ON Canada; Email: kohandel@uwaterloo.ca; http://dx.doi.org/10.4161/cc.22936 MS-proficient conditions (suspension).",Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Proc Natl Acad Sci USA 2003;  100:3983-8; PMID:12629218; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Genes Dev 2003; 17:1253-70; PMID:12756227; http://dx.doi.org/10.1101/ gad.1061803.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cancer Res 2005; 65:5506-11;  PMID:15994920; http://dx.doi.org/10.1158/0008-5472.CAN-05-0626.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Semin Cancer Biol 2012; 22:396- 403; PMID:22554795; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell 2008; 133:704-15; PMID:18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
PLoS One 2008; 3:e2888; PMID:18682804; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cancer Res 2009; 69:4116-24; PMID:19435916; http://dx.doi.org/10.1158/0008- 5472.CAN-08-3441.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Cell Cycle 2012; 11:1-10; PMID:22185777; http://dx.doi.org/10.4161/ cc.22543.,OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
Semin Cancer Biol 2012; 22:374-8;  PMID:22609094; http://dx.doi.org/10.1016/j.sem-cancer.2012.04.005.,Non-OADS,/arxiv_data1/oa_pdf/e1/2c/cc-11-4498.PMC3562292.pdf
"Do not distribute.www.landesbioscience.com  C ell Cycle  1Cell Cycle 11:24, 1–8; December 15, 2012; © 2012 Landes Bioscience Extra vi Ew Extra viEw Keywords:  glycerophosphodiesterase,  phosphatidic acid, lysophosphatidic acid,  choline metabolism, signaling networks Submitted: 09/20/12Accepted: 10/12/12http://dx.doi.org/10.4161/cc.22544 *Correspondence to: Rosemarie Marchan;   Email: marchan@ifado.deRecently, EDI3 was identified as a  key factor for choline metabolism  that controls tumor cell migration and is associated with metastasis in endometrial carcinomas.",Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Int J Cancer 2007; 120:1721-30; PMID:17236204; http://dx.doi.org/10.1002/ijc.22293.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Invest Radiol 1999; 34:230-5; PMID:10084669; http://dx.doi.org/10.1097/00004424-199903000-00013.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
NMR Biomed 1992; 5:114-20; PMID:1322688; http://dx.doi.org/10.1002/nbm.1940050303.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
BMC Cancer 2012; 12:39; PMID:22277092; http://dx.doi.org/10.1186/1471-2407-12-39.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Proteome Res 2010; 9:972-9; PMID:19994911; http://dx.doi.org/10.1021/pr9008783.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
NMR Biomed 2012; 25:1033-42; PMID:22279038; http://dx.doi.org/10.1002/nbm.2766.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
BMC Cancer 2010; 10:433; PMID:20716336; http://dx.doi.org/10.1186/1471-2407-10-433.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Proteome Res 2010; 9:319-32; PMID:19908917; http://dx.doi.org/10.1021/pr9006574.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Leuk Res 2002; 26:919-26; PMID:12163053; http://dx.doi.org/10.1016/S0145-2126(02)00035-8.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
NMR Biomed 2011; 24:691-9; PMID:21793074; http://dx.doi.org/10.1002/nbm.1738.16.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Science 2001; 294:1942-5; PMID:11729323; http://dx.doi.org/10.1126/sci - ence.1066015.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Biol Chem 1999; 274:1131-9; PMID:9873061; http://dx.doi.org/10.1074/jbc.274.2.1131.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Am Chem Soc 2011; 133:880-7; PMID:21141956; http://dx.doi.org/10.1021/ja107532q.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Am Chem Soc 2009; 131:1557-64; PMID:19133719; http://dx.doi.org/10.1021/ja808691r.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Br J Cancer 2010; 102:941-6; PMID:20234370; http://dx.doi.org/10.1038/sj.bjc.6605588.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Adv Enzyme Regul 2011; 51:183-94; PMID:21035492; http://dx.doi.org/10.1016/j.adven - zreg.2010.09.010.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Cancer Res 2005; 65:9369-76; PMID:16230400; http://dx.doi.org/10.1158/0008-5472.CAN-05-1146.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Biochim Biophys Acta 1993; 1225:71-7; PMID:8241291; http://dx.doi.org/10.1016/0925-4439(93)90124-J.References 1.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Annu Rev Pharmacol Toxicol 2010; 50:157-86; PMID:20055701; http://dx.doi.org/10.1146/annurev.pharmtox.010909.105753.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Nat Rev Cancer 2003; 3:582-91; PMID:12894246; http://dx.doi.org/10.1038/nrc1143.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
PLoS One 2011; 6:e18932; PMID:21533082; http://dx.doi.org/10.1371/journal.pone.0018932.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Front Biosci 2012; 17:1816-34; PMID:22201838; http://dx.doi.org/10.2741/4021.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Physiol Rev 2008; 88:1341-78; PMID:18923184; http://dx.doi.org/10.1152/phys - rev.00034.2007.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Biol Chem 2007; 282:826-30; PMID:17071619; http://dx.doi.org/10.1074/jbc.C600268200.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Biochim Biophys Acta 2009; 1791:949-55; PMID:19264150; http://dx.doi.org/10.1016/j.bbalip.2009.02.009.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
ScientificWorldJournal 2010; 10:1356-69; PMID:20623096; http://dx.doi.org/10.1100/tsw.2010.116.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Cancer Res 2011; 71:293-7; PMID:21224347; http://dx.doi.org/10.1158/0008-5472.CAN-10-2463.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Cancer Lett 2000; 161:207-14; PMID:11090971; http://dx.doi.org/10.1016/S0304-3835(00)00612-1.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Future Oncol 2009; 5:1477-86; PMID:19903073; http://dx.doi.org/10.2217/fon.09.110.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Mol Biol Cell 2008; 19:3111-23; PMID:18480413; http://dx.doi.org/10.1091/mbc.E07-04-0337.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Nat Cell Biol 2007; 9:706-12; PMID:17486115; http://dx.doi.org/10.1038/ncb1594.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
J Magn Reson Imaging 2011; 33:808-16; PMID:21448944; http://dx.doi.org/10.1002/jmri.22517.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
NMR Biomed 2009; 22:629-37; PMID:19322812; http://dx.doi.org/10.1002/nbm.1377.,OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Magn Reson Med 2008; 60:33-40; PMID:18581409; http://dx.doi.org/10.1002/mrm.21647.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
Magn Reson Med 2005; 53:22-9; PMID:15690498; http://dx.doi.org/10.1002/mrm.20312.,Non-OADS,/arxiv_data1/oa_pdf/85/27/cc-11-4499.PMC3562293.pdf
"Do not distribute.www.landesbioscience.com  C ell Cycle  1Cell Cycle 11:24, 1–10; December 15, 2012; © 2012 Landes Bioscience Extra vi Ew Extra viEw Keywords:  cell cycle, differentiation,  OID, DNA damage, replication stress,  epidermis, stem cells, MYC, cancer,  leukemia Abbreviations:  UV, ultraviolet radia - tion; HPV, human papilloma virus; cdk,  Cyclin-dependent kinase; OID, onco - gene-induced differentiation; MYCER, fusion protein made of MYC and a mutant ligand binding domain of  estrogen receptor Submitted: 09/14/12Revised: 10/10/12Accepted: 10/12/12http://dx.doi.org/10.4161/cc.22529 Correspondence to: Alberto Gandarillas;   Email: ifimav.agandarillas@fmdv.orgFifteen years ago, we reported that  proto-oncogene MYC promoted  differentiation of human epidermal stem cells, a finding that was surpris - ing to the MYC and the skin research communities.",Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Photodermatol  Photoimmunol Photomed 2000; 16:195-201; PMID:11068857; http://dx.doi.org/10.1034/j.1600-0781.2000.160501.x.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Cell Biol 1981; 90:732-7; PMID:6895225; http://dx.doi.org/10.1083/jcb.90.3.732.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2004; 23:5923-30; PMID:15208685; http://dx.doi.org/10.1038/sj.onc.1207796.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Development 2003; 130:2793-808; PMID:12736221; http://dx.doi.org/10.1242/dev.00462.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Cell Biol 2006; 172:139-49; PMID:16391002; http://dx.doi.org/10.1083/jcb.200506057.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2000; 19:3278-89; PMID:10918584; http://dx.doi.org/10.1038/sj.onc.1203630.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 2001; 105:297-306; PMID:11348589; http://dx.doi.org/10.1016/S0092-8674(01)00334-8.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Trends Plant Sci 2011; 16:624-34; PMID:21889902; http://dx.doi.org/10.1016/j.tplants.2011.07.001.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Genesis 2004; 39:52-7; PMID:15124227; http://dx.doi.org/10.1002/gene.20025.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Cell Sci 2005; 118:1693-704; PMID:15797928; http://dx.doi.org/10.1242/jcs.02298.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nature 2003; 421:290-4; PMID:12529648; http://dx.doi.org/10.1038/nature01327.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Genes Dev 2006; 20:2024-9; PMID:16882980; http://dx.doi.org/10.1101/gad.381206.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nat Rev Cancer 2008; 8:976-90; PMID:19029958;  http://dx.doi.org/10.1038/nrc2231.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Genes  Dev 2008; 22:2755-66; PMID:18923074; http://dx.doi.org/10.1101/gad.1712408.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Cycle 2002; 1:103-10; PMID:12429916; http://dx.doi.org/10.4161/cc.1.2.108.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Science 1992; 257:212-4; PMID:1378649; http://dx.doi.org/10.1126/science.1378649.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Curr Opin Genet Dev 1993; 3:44-9; PMID:8453273; http://dx.doi.org/10.1016/S0959-437X(05)80339-9.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Cycle 2009; 8:1148-57; PMID:19282668; http://dx.doi.org/10.4161/cc.8.8.8126.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Cycle 2011; 10:592-7; PMID:21293186; http://dx.doi.org/10.4161/cc.10.4.14792.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nat Genet 2001; 28:165-8; PMID:11381265; http://dx.doi.org/10.1038/88889.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Genes Dev 1997; 11:2869-82; PMID:9353256; http://dx.doi.org/10.1101/gad.11.21.2869.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Curr Biol 2001; 11:558-68; PMID:11369200; http://dx.doi.org/10.1016/S0960-9822(01)00154-3.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 1998; 16:431-41; PMID:9484832; http://dx.doi.org/10.1038/sj.onc.1201558.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Div 2009; 4:10; PMID:19490616; http://dx.doi.org/10.1186/1747-1028-4-10.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Biol Chem 2005; 280:18120-9; PMID:15746092; http://dx.doi.org/10.1074/jbc.M500758200.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Cell Physiol 2012; 227:2069-78; PMID:21769863; http://dx.doi.org/10.1002/jcp.22935.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2000; 19:1820-33; PMID:10777216; http://dx.doi.org/10.1038/sj.onc.1203494.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 1999; 98:779-90; PMID:10499795; http://dx.doi.org/10.1016/S0092-8674(00)81512-3.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Dev Dyn 1994; 199:176-88; PMID:7517223; http://dx.doi.org/10.1002/aja.1001990303.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Exp Gerontol 2000; 35:53-62; PMID:10705039; http://dx.doi.org/10.1016/S0531-5565(99)00088-1.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
PLoS Biol 2004; 2:e332; PMID:15455033; http://dx.doi.org/10.1371/journal.pbio.0020332.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 2010; 142:480-93; PMID:20691906; http://dx.doi.org/10.1016/j.cell.2010.06.037.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Cycle 2012; 11:1757-64; PMID:22510570; http://dx.doi.org/10.4161/cc.19883.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Cell Biol 2006; 172:115-25; PMID:16380437; http://dx.doi.org/10.1083/jcb.200507106.41.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Mol Carcinog 1992; 6:18-25; PMID:1380247; http://dx.doi.org/10.1002/mc.2940060105.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Biol Chem 2002; 277:35371-7; PMID:12119299; http://dx.doi.org/10.1074/jbc.M205143200.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
PLoS One 2012; 7:e39371; PMID:22724006; http://dx.doi.org/10.1371/journal.pone.0039371.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2005; 24:2765-75; PMID:15838513; http://dx.doi.org/10.1038/sj.onc.1208610.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2012; PMID:22349815; http://dx.doi.org/10.1038/onc.2012.22.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Science 2008; 319:1352-5; PMID:18323444; http://dx.doi.org/10.1126/science.1140735.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10.1038/nature05327.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Trends Cell Biol 2002; 12:509-16; PMID:12446112; http://dx.doi.org/10.1016/S0962-8924(02)02380-2.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 2011; 145:435-46; PMID:21529715; http://dx.doi.org/10.1016/j.cell.2011.03.044.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 2000; 19:3693-705; PMID:10949923; http://dx.doi.org/10.1038/sj.onc.1203695.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 1995; 80:83-93; PMID:7813021; http://dx.doi.org/10.1016/0092-8674(95)90453-0.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Curr Biol 2006; 16:1685-93; PMID:16950104; http://dx.doi.org/10.1016/j.cub.2006.07.056.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nature 2009; 459:857-60; PMID:19474789; http://dx.doi.org/10.1038/nature08074.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nature 2005; 437:275-80; PMID:16094321; http://dx.doi.org/10.1038/nature03922.28.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Stem Cells 2012; 30:1246-54; PMID:22438054; http://dx.doi.org/10.1002/stem.1090.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
PLoS One 2010; 5:e15701; PMID:21187932; http://dx.doi.org/10.1371/journal.pone.0015701.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Science 1998; 280:1069-72; PMID:9582119; http://dx.doi.org/10.1126/science.280.5366.1069.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 1998; 17:3083-92; PMID:9872324; http://dx.doi.org/10.1038/sj.onc.1202235.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Am J Pathol 2000; 157:1039-50; PMID:10980142; http://dx.doi.org/10.1016/S0002-9440(10)64616-0.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Oncogene 1999; 18:1419-34; PMID:10050879; http://dx.doi.org/10.1038/sj.onc.1202448.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Am J Pathol 2001; 159:369-79; PMID:11438484; http://dx.doi.org/10.1016/S0002-9440(10)61703-8.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cancer Res 2008; 68:162-71; PMID:18172308; http://dx.doi.org/10.1158/0008-5472.CAN-07-2461.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Invest Dermatol 1986; 87:472-6; PMID:2428884; http://dx.doi.org/10.1111/1523-1747.ep12455517.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Curr Opin Genet Dev 2006; 16:518-24; PMID:16919447; http://dx.doi.org/10.1016/j.gde.2006.08.006.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
"Gastroenterology 2011; 141:1003-13, e1-10; PMID:21699772; http://dx.doi.org/10.1053/j.gas - tro.2011.05.007.",Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Carcinogenesis 2005; 26:1657-67; PMID:15905207; http://dx.doi.org/10.1093/carcin/bgi123.76.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 2012; 148:1001-14; PMID:22385964; http://dx.doi.org/10.1016/j.cell.2012.01.040.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Mol Cell Biol 2011; 31:4129-43; PMID:21791608; http://dx.doi.org/10.1128/MCB.05723-11.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Nat Genet 2002; 32:585-93; PMID:12415271; http://dx.doi.org/10.1038/ng1023.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell Cycle 2011; 10:2355-63; PMID:21685725; http://dx.doi.org/10.4161/cc.10.14.15948.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Cell 1985; 42:841-8; PMID:2996779; http://dx.doi.org/10.1016/0092-8674(85)90280-6.70.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
J Exp Med 1996; 183:1923-8; PMID:8666950; http://dx.doi.org/10.1084/jem.183.4.1923.,Non-OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
Genes Dev 2005; 19:3070-82; PMID:16357222; http://dx.doi.org/10.1101/gad.359305.,OADS,/arxiv_data1/oa_pdf/47/5b/cc-11-4507.PMC3562294.pdf
"Cell Cycle 11:24, 4530–4535; December 15, 2012; © 2012 Landes Bioscience PersPeC tive 4530 Cell Cycle volume 11 issue 24Keywords:  HIF, Sharp1, hypoxia,   metastasis, cancer metabolism, breast  cancer, angiogenesis, VHL, p63 Submitted: 11/05/12Accepted: 11/06/12http://dx.doi.org/10.4161/cc.22820 *Correspondence to: Gerry Melino;   Email: gm89@le.ac.ukHypoxia-inducible factors (HIFs)  control cellular adaptation to oxy - gen deprivation.",Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2006; 66:3567-75;  PMID:16585181; http://dx.doi.org/10.1158/0008- 5472.CAN-05-2670.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2010; 17:319- 32; PMID:20385358; http://dx.doi.org/10.1016/j.ccr.2010.02.030.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Mol Cell 2011; 43:811-22;  PMID:21884981; http://dx.doi.org/10.1016/j.mol - cel.2011.07.012.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e179; PMID:21734725; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nature 2006; 440:1222-6; PMID:16642001; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Oncogene 2012; 31:1757-70; PMID:21860410;  http://dx.doi.org/10.1038/onc.2011.365.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nature 2012; 487:380- 4; PMID:22801492; http://dx.doi.org/10.1038/ nature11207.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Genes Dev 1997; 11:72-82; PMID:9000051; http://dx.doi.org/10.1101/gad.11.1.72.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Mech  Dev 1997; 63:51-60; PMID:9178256; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2007; 11:407- 20; PMID:17482131; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2007; 12:230- 8; PMID:17785204; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Metab 2010; 11:364-78; PMID:20399150;  http://dx.doi.org/10.1016/j.cmet.2010.03.001.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:465-78; PMID:20885442; http://dx.doi.org/10.1038/ cdd.2010.119.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2010;  1:e52; PMID:21364657; http://dx.doi.org/10.1038/ cddis.2010.29.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Mol Cell Biol 2004; 24:2875-89; PMID:15024076;  http://dx.doi.org/10.1128/MCB.24.7.2875- 2889.2004.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:551- 61; PMID:19798106; http://dx.doi.org/10.1038/ cdd.2009.141.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:700- 11; PMID:21072058; http://dx.doi.org/10.1038/cdd.2010.144.in cancer cell reprogramming to sustain  adverse growth condition.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nat Rev Cancer 2009; 9:302-12;  PMID:19308069; http://dx.doi.org/10.1038/ nrc2627.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nat Clin Pract Oncol 2008; 5:206- 19; PMID:18253104; http://dx.doi.org/10.1038/ ncponc1066.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ  2011; 18:1470-7; PMID:21617693; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:565-70; PMID:21212794; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nature 1998; 394:485-90; PMID:9697772; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Proc Natl Acad Sci USA  2009; 106:17910-5; PMID:19805192; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2009; 15:232-9; PMID:19249681; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2009; 15:167- 70; PMID:19249675; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:499-512;  PMID:19834490; http://dx.doi.org/10.1038/ cdd.2009.152.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:1711- 25; PMID:21546903; http://dx.doi.org/10.1038/ cdd.2011.47.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:1025- 33; PMID:20075941; http://dx.doi.org/10.1038/cdd.2009.204.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:1016- 23; PMID:21274009; http://dx.doi.org/10.1038/ cdd.2010.171.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2008; 68:7846-54;  PMID:18829540; http://dx.doi.org/10.1158/0008- 5472.CAN-08-1942.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
EMBO Rep 2010; 11:670-7; PMID:20706219; http://dx.doi.org/10.1038/ embor.2010.117.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2010; 9:3723-9; PMID:20890122;  http://dx.doi.org/10.4161/cc.9.18.12931.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nat Rev Cancer  2008; 8:967-75; PMID:18987634; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:338-49; PMID:20706275;  http://dx.doi.org/10.1038/cdd.2010.93.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2011; 10:4311-20; PMID:22134239; http://dx.doi.org/10.4161/cc.10.24.18663.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2011; 10:2287- 94; PMID:21670595; http://dx.doi.org/10.4161/ cc.10.14.16532.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Clin Cancer Res  2004; 10:8554-60; PMID:15623639; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e246;  PMID:22190005; http://dx.doi.org/10.1038/cddis.2011.128.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ  2010; 17:408-20; PMID:19834492; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death  Dis 2011; 2:e144; PMID:21490676; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
mTORC1  signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1 α. Mol  Cell 2010; 40:509-20; PMID:21095582; http://dx.doi.org/10.1016/j.molcel.2010.10.030.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2010;  1:e50; PMID:21480565; http://dx.doi.org/10.1038/cddis.2010.28.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2011; 71:4640-52; PMID:21712410; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nat Cell  Biol 2010; 12:1007-13; PMID:20852629; http://dx.doi.org/10.1038/ncb2102.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ  2011; 18:1757-70; PMID:21546908; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Proc Natl Acad Sci USA 1997; 94:4273-8; PMID:9113979; http://dx.doi.org/10.1073/ pnas.94.9.4273.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
J Biol Chem 1997; 272:8581- 93; PMID:9079689; http://dx.doi.org/10.1074/ jbc.272.13.8581.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell  2005; 8:131-41; PMID:16098466; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2010; 9:2814-22; PMID:20676049; http://dx.doi.org/10.4161/ cc.9.14.12253.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2010; 9:859-60;  PMID:20348840; http://dx.doi.org/10.4161/ cc.9.5.11183.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Mol Cell 2008; 30:393-402; PMID:18498744; http://dx.doi.org/10.1016/j.molcel.2008.04.009.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2006; 66:8814-21; PMID:16951198; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell 2002; 1:237-46; PMID:12086860; http://dx.doi.org/10.1016/S1535-6108(02)00043-0.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e149; PMID:21525936; http://dx.doi.org/10.1038/cddis.2011.31.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2011; 10:3920-8; PMID:22071692; http://dx.doi.org/10.4161/cc.10.22.18096.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Mol Cell 2010; 40:294-309; PMID:20965423;  http://dx.doi.org/10.1016/j.molcel.2010.09.022.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:1624-35; PMID:20431602;  http://dx.doi.org/10.1038/cdd.2010.41.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell  Death Differ 2011; 18:16-25; PMID:20798686;  http://dx.doi.org/10.1038/cdd.2010.103.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e185;  PMID:21796157; http://dx.doi.org/10.1038/ cddis.2011.64.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
PLoS One 2008; 3:e2762; PMID:18648504;  http://dx.doi.org/10.1371/journal.pone.0002762.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:271- 81; PMID:20689556; http://dx.doi.org/10.1038/ cdd.2010.94.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death  Dis 2011; 2:e164; PMID:21614094; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e243; PMID:22170099; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2011; 2:e162;  PMID:21614092; http://dx.doi.org/10.1038/ cddis.2011.45.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nature  2010; 467:986-90; PMID:20962848; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2007; 67:563-72; PMID:17234764; http://dx.doi.org/10.1158/0008- 5472.CAN-06-2701.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Genes Dev 2010; 24:491-501; PMID:20194441; http://dx.doi.org/10.1101/gad.1881410.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Proc Natl Acad Sci USA  2010; 107:4329-34; PMID:20142499; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell  Death Differ 2011; 18:1628-39; PMID:21527937;  http://dx.doi.org/10.1038/cdd.2011.42.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Cell  2004; 6:485-95; PMID:15542432; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nature 2006; 441:437-43;  PMID:16724055; http://dx.doi.org/10.1038/nature04871.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:1600- 12; PMID:20379195; http://dx.doi.org/10.1038/ cdd.2010.37.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell  Death Differ 2010; 17:246-54; PMID:19730444;  http://dx.doi.org/10.1038/cdd.2009.117.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
J Clin Oncol 2007; 25:4075-83; PMID:17827456; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Clin Cancer Res 2009; 15:7130-6; PMID:19903792;  http://dx.doi.org/10.1158/1078-0432.CCR-09- 0223.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Clin Cancer Res 2007; 13:7388-93; PMID:18094421;  http://dx.doi.org/10.1158/1078-0432.CCR-07-0411.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:985-95; PMID:21164520;  http://dx.doi.org/10.1038/cdd.2010.167.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cancer Res 2009; 69:1624-32;  PMID:19176399; http://dx.doi.org/10.1158/0008- 5472.CAN-08-0505.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:1815-24; PMID:21941372; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell  Death Differ 2010; 17:1211-20; PMID:20139893;  http://dx.doi.org/10.1038/cdd.2010.6.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Nat Rev Cancer 2003; 3:721-32; PMID:13130303;  http://dx.doi.org/10.1038/nrc1187.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ  2008; 15:678-85; PMID:18259193; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Proc Natl Acad Sci USA 2010; 107:14182-7; PMID:20660313; http://dx.doi.org/10.1073/ pnas.1001296107.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2010; 9:3515- 33; PMID:20855962; http://dx.doi.org/10.4161/ cc.9.17.12928.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Cycle 2010; 9:75-9; PMID:20016290;  http://dx.doi.org/10.4161/cc.9.1.10371.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell 2009; 137:87-98; PMID:19345189;  http://dx.doi.org/10.1016/j.cell.2009.01.039.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Genes Cells 2008; 13:131-44; PMID:18233956;  http://dx.doi.org/10.1111/j.1365-2443.2007.01153.x.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Biochem Biophys  Res Commun 2011; 414:451-5; PMID:21964290;  http://dx.doi.org/10.1016/j.bbrc.2011.09.081.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Biochem Biophys Res Commun 2011; 414:277-81; PMID:21963447; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2010; 17:901- 11; PMID:20379196; http://dx.doi.org/10.1038/ cdd.2010.35.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Proc Natl Acad Sci USA  2012; 109:15312-7; PMID:22949650; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2010; 1:e53; PMID:21364658; http://dx.doi.org/10.1038/cddis.2010.30.125.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Differ 2011; 18:248-58; PMID:20689555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death Dis 2010; 1:e74; PMID:21151771; http://dx.doi.org/10.1038/cddis.2010.49.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Cell Death  Differ 2010; 17:1896-907; PMID:20523354; http://dx.doi.org/10.1038/cdd.2010.59.,Non-OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
Biochem Biophys Res Commun  2010; 401:568-73; PMID:20888799; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a6/98/cc-11-4530.PMC3562297.pdf
*Correspondence to: Gerry Melino; Email: gm89@le.ac.uk Submitted: 11/05/12; Accepted: 11/06/12http://dx.doi.org/10.4161/cc.22819p63 is a transcriptional factor implicated in cancer and  development.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2010; 1:e35; PMID:21364642; http://dx.doi.org/10.1038/ cddis.2010.12.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death  Dis 2010; 1:e10; PMID:21364612; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2010; 17:901- 11; PMID:20379196; http://dx.doi.org/10.1038/ cdd.2010.35.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
T rends Mol Med  2010; 16:528-36; PMID:20932800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2011; 18:1130-9; PMID:21233848; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell  Death Dis 2010; 1:e29; PMID:21364637; http://dx.doi.org/10.1038/cddis.2010.7.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2010; 9:3328- 36; PMID:20703098; http://dx.doi.org/10.4161/ cc.9.16.12688.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:1046- 56; PMID:21233847; http://dx.doi.org/10.1038/ cdd.2010.177.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 2010; 468:519-20; PMID:21107421; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2012; 11:715-20;  PMID:22374670; http://dx.doi.org/10.4161/ cc.11.4.19154.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:248-58; PMID:20689555; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2010; 1:e41; PMID:21364648;  http://dx.doi.org/10.1038/cddis.2010.16.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death  Dis 2011; 2:e156; PMID:21562588; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2011;  2:e148; PMID:21509038; http://dx.doi.org/10.1038/ cddis.2011.33.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2010;  1:e43; PMID:21364649; http://dx.doi.org/10.1038/ cddis.2010.20.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Stem Cell 2009; 4:37-48; PMID:19128791;  http://dx.doi.org/10.1016/j.stem.2008.11.006.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:1434- 40; PMID:21394102; http://dx.doi.org/10.1038/ cdd.2011.20.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:666- 77; PMID:21072054; http://dx.doi.org/10.1038/cdd.2010.139.References 1.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:1815- 24; PMID:21941372; http://dx.doi.org/10.1038/ cdd.2011.120.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
J Exp Med 1998; 188:1763- 8; PMID:9802988; http://dx.doi.org/10.1084/jem.188.9.1763.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Biochem Pharmacol 2011; 82:1262- 8; PMID:21820419; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2010; 17:373-5; PMID:20062068;  http://dx.doi.org/10.1038/cdd.2009.73.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 2010; 468:572-5; PMID:21107428;  http://dx.doi.org/10.1038/nature09535.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 2010; 468:567-71; PMID:21107427;  http://dx.doi.org/10.1038/nature09526.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nat Rev Mol Cell Biol 2007; 8:275-83; PMID:17380161;  http://dx.doi.org/10.1038/nrm2147.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2011; 2:e162; PMID:21614092; http://dx.doi.org/10.1038/cddis.2011.45.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell  Death Differ 2011; 18:1736-45; PMID:21546907;  http://dx.doi.org/10.1038/cdd.2011.45.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2010; 17:255- 67; PMID:19927155; http://dx.doi.org/10.1038/ cdd.2009.173.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
J  Clin Invest 2010; 120:4493-506; PMID:21060154;  http://dx.doi.org/10.1172/JCI42674.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2011; 18:1393-402; PMID:21372847; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011;  18:1196-207; PMID:21252910; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2010; 17:699-709; PMID:19851330; http://dx.doi.org/10.1038/cdd.2009.156.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2010; 9:4269- 75; PMID:20980816; http://dx.doi.org/10.4161/cc.9.21.13666.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nat Cell Biol 2010; 12:993-8; PMID:20818388; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2010; 1:e15; PMID:21364616;  http://dx.doi.org/10.1038/cddis.2009.13.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death  Dis 2010; 1:e59; PMID:21364664; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:864-73; PMID:21113147;  http://dx.doi.org/10.1038/cdd.2010.152.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:1651-63; PMID:21660051; http://dx.doi.org/10.1038/cdd.2011.80.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2010; 9:947-52; PMID:20160496; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Br J Cancer  2010; 102:1254-64; PMID:20354524; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Mol Cell 2010; 40:687-8;  PMID:21145478; http://dx.doi.org/10.1016/j.mol- cel.2010.11.037.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
"Nat Med 2012; 18:1170-2, author reply  1172-4; PMID:22869179; http://dx.doi.org/10.1038/ nm.2889.65.",OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Biochem Biophys Res Commun 2010; 401:568- 73; PMID:20888799; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:887-96; PMID:21127502;  http://dx.doi.org/10.1038/cdd.2010.159.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Development 2012; 139:772-82; PMID:22274697; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 2006; 444:624- 8; PMID:17122775; http://dx.doi.org/10.1038/ nature05337.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell 2011; 144:566- 76; PMID:21335238; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle  2011; 10:1884-5; PMID:21555912; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:214- 21; PMID:20671749; http://dx.doi.org/10.1038/ cdd.2010.90.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nat Med 2009; 15:1179-85; PMID:19783996; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Mol Cell Biol  2005; 25:6154-64; PMID:15988026; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2010; 17:103-8; PMID:19557012; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2010; 17:86- 92; PMID:19543236; http://dx.doi.org/10.1038/ cdd.2009.77.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Proc Natl Acad Sci USA  2006; 103:12753-8; PMID:16908849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2010; 17:93- 102; PMID:19498444; http://dx.doi.org/10.1038/ cdd.2009.68.50.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Dis 2010;  1:e79; PMID:21368852; http://dx.doi.org/10.1038/ cddis.2010.55.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 1999; 398:708-13; PMID:10227293; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nature 1999; 398:714-8; PMID:10227294;  http://dx.doi.org/10.1038/19539.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:1924- 33; PMID:21637289; http://dx.doi.org/10.1038/ cdd.2011.73.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell  Death Differ 2010; 17:1600-12; PMID:20379195;  http://dx.doi.org/10.1038/cdd.2010.37.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2010; 9:4841- 7; PMID:21088498; http://dx.doi.org/10.4161/cc.9.24.14093.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Biochem Biophys  Res Commun 2010; 394:824-8; PMID:20298673;  http://dx.doi.org/10.1016/j.bbrc.2010.03.084.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
J Cell Biol 2012; 199:347-63; PMID:23071155; http://dx.doi.org/10.1083/ jcb.201203134.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell 2007; 129:523-36; PMID:17482546;  http://dx.doi.org/10.1016/j.cell.2007.02.045.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Genes Dev  2006; 20:3185-97; PMID:17114587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Proc Natl Acad Sci USA  2011; 108:3624-9; PMID:21300884; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2011; 10:1905-11; PMID:21558811;  http://dx.doi.org/10.4161/cc.10.12.15838.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2010; 17:1392-408; PMID:20094059; http://dx.doi.org/10.1038/cdd.2009.216.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Biochem Biophys Res Commun 2011; 414:277-81; PMID:21963447; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2011; 18:1904-13; PMID:21637290; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Proc Natl Acad Sci USA 2011; 108:557- 62; PMID:21178074; http://dx.doi.org/10.1073/ pnas.1015520107.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Proc Natl Acad Sci USA 2011; 108:563- 8; PMID:21178072; http://dx.doi.org/10.1073/ pnas.1016020107.106.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Reproduction  2006; 131:641-9; PMID:16595715; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nat Med 2012; 18:1172-4; PMID:22869180; http://dx.doi.org/10.1038/nm.2852.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Nat Chem Biol 2006; 2:95-102; PMID:16415863; http://dx.doi.org/10.1038/nchem- bio760.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2008; 7:2846- 55; PMID:18769144; http://dx.doi.org/10.4161/ cc.7.18.6627.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2011; 18:1664-74; PMID:21475302; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
J Biol Chem 2008; 283:15754-61; PMID:18411264;  http://dx.doi.org/10.1074/jbc.M801394200.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Int J Radiat Biol 2006; 82:771-80; PMID:17148261; http://dx.doi.org/10.1080/09553000600960019.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
J Cell Physiol 2007; 210:87-98; PMID:16998800; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Mol Cell Biochem  2011; 350:71-80; PMID:21153863; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Mol  Cell 2012; In press; PMID:23000175; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Science 2001; 294:591-5; PMID:11557844;  http://dx.doi.org/10.1126/science.1065486.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ  2011; 18:1140-9; PMID:21233842; http://dx.doi.org/10.1038/cdd.2010.180.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:2-4;  PMID:21151157; http://dx.doi.org/10.1038/ cdd.2010.132.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Death Differ 2011; 18:874- 86; PMID:21127500; http://dx.doi.org/10.1038/ cdd.2010.153.,Non-OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
Cell Cycle 2010; 9:3780- 91; PMID:20855963; http://dx.doi.org/10.4161/ cc.9.18.13002.,OADS,/arxiv_data1/oa_pdf/5c/59/cc-11-4545.PMC3562299.pdf
"Cell Cycle 11:24, 4642–4649; December 15, 2012; © 2012 Landes Bioscience RePORT 4642 Cell Cycle Volume 11 Issue 24*Correspondence to: Mikhail V. Blagosklonny; Email: blagosklonny@oncotarget.com Submitted: 09/10/12; Accepted: 10/20/12http://dx.doi.org/10.4161/cc.22937Introduction In cell culture, senescence is characterized by cellular hypertro - phy, SA- β-Gal staining, hyper-secretory phenotype and perma - nent loss of regenerative or replicative potential (RP), meaning  that cells cannot restart proliferation after release from cell cycle arrest.",Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Oncogene  1999; 18:4808-18; PMID:10490814; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Oncogene  2000; 19:2165-70; PMID:10815808; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2009;  8:1888-95; PMID:19471117; http://dx.doi.org/10.4161/cc.8.12.8606.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2009; 8:4112-8; PMID:19946210; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell  Prolif 2007; 40:1-13; PMID:17227291; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
EMBO Rep 2003; 4:358-62; PMID:12671679;  http://dx.doi.org/10.1038/sj.embor.embor806.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
J Biol Chem 2003; 278:3656- 63; PMID:12446670; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cancer Res 2005; 65:11354-60; PMID:16357142;  http://dx.doi.org/10.1158/0008-5472.CAN-05-2236.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2011; 10:57- 67; PMID:21200143; http://dx.doi.org/10.4161/ cc.10.1.14449.14.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Aging Cell 2012; 11:675-82;  PMID:22587563; http://dx.doi.org/10.1111/j.1474- 9726.2012.00832.x.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2006; 5:2087-102; PMID:17012837;  http://dx.doi.org/10.4161/cc.5.18.3288.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Drug Discov Today 2007; 12:112-24;  PMID:17275731; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Drug  Discov Today 2007; 12:218-24; PMID:17331886;  http://dx.doi.org/10.1016/j.drudis.2007.01.004.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Curr Opin Cell Biol 2011; 23:744-55; PMID:21963299;  http://dx.doi.org/10.1016/j.ceb.2011.09.003.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Am J Pathol  2012; 181:1142-6; PMID:22841821; http://dx.doi.org/10.1016/j.ajpath.2012.06.024.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Exp Gerontol 1996; 31:311-25; PMID:8706801;  http://dx.doi.org/10.1016/0531-5565(95)00025-9.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Ann N Y Acad Sci 2007; 1119:20- 31; PMID:18056951; http://dx.doi.org/10.1196/ annals.1404.026.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Exp Cell Res  1995; 217:205-16; PMID:7698220; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2008; 7:3355-61;  PMID:18948731; http://dx.doi.org/10.4161/ cc.7.21.6919.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Proc Natl Acad Sci USA 2012; 109:13314- 8; PMID:22847439; http://dx.doi.org/10.1073/ pnas.1205690109.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
J Gerontol A Biol Sci Med Sci  2011; 66:191-201; PMID:20974732; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2011; 10:4230-6; PMID:22107964; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Am J Pathol 2010; 176:2092- 7; PMID:20363920; http://dx.doi.org/10.2353/ ajpath.2010.091050.Live-cell multimode time-lapse imaging (video microscopy).,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2012; 11:554-68; PMID:22293404;  http://dx.doi.org/10.4161/cc.11.3.19062.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2012; 11:2681-90;  PMID:22751438; http://dx.doi.org/10.4161/cc.21019.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell  Cycle 2012; 11:3534; PMID:22951541; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Mol Cell Biol 2011; 31:3885-95; PMID:21746877; http://dx.doi.org/10.1128/MCB.05089-11.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cancer Res  2010; 70:5074-84; PMID:20530685; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cancer Res 2010; 70:5085-95; PMID:20530684;  http://dx.doi.org/10.1158/0008-5472.CAN-09-4095.50.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2010; 9:1934-41; PMID:20436277; http://dx.doi.org/10.4161/ cc.9.10.11582.,Non-OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2012; 11:1603- 10; PMID:22456337; http://dx.doi.org/10.4161/ cc.20009.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2003; 2:105-10; PMID:12695657;  http://dx.doi.org/10.4161/cc.2.2.341.57.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
J Biol Chem 2004;  279:5306-13; PMID:14634004; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Cell Cycle 2009; 8:1896-900; PMID:19478560;  http://dx.doi.org/10.4161/cc.8.12.8809.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
Oncogene 2008; 27:4402- 10; PMID:18469851; http://dx.doi.org/10.1038/ onc.2008.82.,OADS,/arxiv_data1/oa_pdf/7c/28/cc-11-4642.PMC3562309.pdf
"Cell Cycle 11:24, 4650–4660; December 15, 2012; © 2012 Landes Bioscience RePORT 4650 Cell Cycle Volume 11 Issue 24*Correspondence to: Jun-Yong Huang; Email: junyong.huang@newcastle.ac.uk Submitted: 08/23/12; Revised: 11/08/12; Accepted: 11/15/12http://dx.doi.org/10.4161/cc.22916Introduction The spindle assembly checkpoint (SAC) is a complex surveillance  mechanism that ensures faithful chromosome segregation dur - ing mitosis by monitoring the attachment of chromosomes to the spindle microtubules.",Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Nat Rev Mol Cell  Biol 2007; 8:379-93; PMID:17426725; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2004; 14:953- 64; PMID:15182668; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Dev Cell 2004; 7:45-60; PMID:15239953; http://dx.doi.org/10.1016/j.devcel.2004.06.006.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Genes Dev 2003; 17:101-14; PMID:12514103;  http://dx.doi.org/10.1101/gad.1040903.5.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Dev Cell 2009; 16:105- 17; PMID:19154722; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Eukaryot  Cell 2005; 4:867-78; PMID:15879521; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Genome Res 2011; 21:2096-113; PMID:21994247;  http://dx.doi.org/10.1101/gr.119974.110.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Nature 2001; 409:844-6; PMID:11237006;  http://dx.doi.org/10.1038/35057033.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
EMBO J  2002; 21:1723-32; PMID:11927556; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Cell 2008; 132:233- 46; PMID:18243099; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2005; 15:672-7; PMID:15823541; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Biol Cell 2007; 18:850-63; PMID:17182852;  http://dx.doi.org/10.1091/mbc.E06-07-0587.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Nat Cell Biol 2007; 9:565- 72; PMID:17417628; http://dx.doi.org/10.1038/ ncb1570.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Nat Cell Biol 2008; 10:1411- 20; PMID:18997788; http://dx.doi.org/10.1038/ ncb1799.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 2002; 157:1139- 49; PMID:12082076; http://dx.doi.org/10.1083/ jcb.200203035.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2006; 16:1764- 9; PMID:16950116; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Cell 2001; 106:83-93; PMID:11461704;  http://dx.doi.org/10.1016/S0092-8674(01)00410-X.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Biol Cell 2003; 14:1638-51; PMID:12686615;  http://dx.doi.org/10.1091/mbc.02-05-0074.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2012; 22:296- 301; PMID:22281223; http://dx.doi.org/10.1016/j.cub.2011.12.049.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 2010; 190:89- 100; PMID:20624902; http://dx.doi.org/10.1083/ jcb.201001050.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 2010; 190:25- 34; PMID:20624899; http://dx.doi.org/10.1083/ jcb.201002133.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Cell Biol  2010; 30:3384-95; PMID:20421417; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol  2008; 181:893-901; PMID:18541701; http://dx.doi.org/10.1083/jcb.200712028.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2005; 15:856- 61; PMID:15886105; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol  2001; 154:925-36; PMID:11535616; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Cell Biol  2002; 22:2728-42; PMID:11909965; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 2002; 158:487- 96; PMID:12163471; http://dx.doi.org/10.1083/ jcb.200204048.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Biol Cell 2002; 13:755-66; PMID:11907259;  http://dx.doi.org/10.1091/mbc.01-09-0437.,Non-OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 1995; 130:941-8; PMID:7642709; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2005; 15:R122-4; PMID:15723780; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2008; 18:R170-2; PMID:18302922; http://dx.doi.org/10.1016/j.cub.2007.12.023.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Curr Biol 2004; 14:2019-24; PMID:15556864;  http://dx.doi.org/10.1016/j.cub.2004.11.008.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol 1996; 132:111- 23; PMID:8567717; http://dx.doi.org/10.1083/ jcb.132.1.111.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
Mol Biol Cell  2004; 15:4584-96; PMID:15269280; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
J Cell Biol  2010; 190:73-87; PMID:20624901; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/99/2a/cc-11-4650.PMC3562310.pdf
"www.landesbioscience.com Cell Cycle 4661Cell Cycle 11:24, 4661–4672; December 15, 2012; © 2012 Landes Bioscience RePORT RePORT *Correspondence to: Kurt Engeland; Email: engeland@medizin.uni-leipzig.de Submitted: 11/14/12; Accepted: 11/15/12http://dx.doi.org/10.4161/cc.22917Introduction The p53 protein is an important tumor suppressor.1 Furthermore,  in recent years, other probably more fundamental functions like  its participation in controlling fertility have been discovered.2,3  Acting as a tumor suppressor, p53 can cause cell cycle arrest and is able to induce apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
J Biomed Biotechnol 2011;  2011:464916; PMID:21436991; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
T rends Cell Biol 2011; 21:344- 53; PMID:21601459; http://dx.doi.org/10.1016/j.tcb.2011.04.002.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Mol Cell Biol 2001; 21:1066-76; PMID:11158294; http://dx.doi.org/10.1128/ MCB.21.4.1066-1076.2001.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
J Biol Chem 2003; 278:32507- 16; PMID:12748190; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
J Biol Chem  2004; 279:50976-85; PMID:15371422; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell 1993; 75:817-25;  PMID:8242752; http://dx.doi.org/10.1016/0092- 8674(93)90500-P .,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nat Rev Mol  Cell Biol 2008; 9:402-12; PMID:18431400; http://dx.doi.org/10.1038/nrm2395.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene 2003; 22:3645- 54; PMID:12789273; http://dx.doi.org/10.1038/ sj.onc.1206477.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle  2010; 9:870-9; PMID:20160511; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nat Rev Cancer 2009; 9:724-37;  PMID:19776742; http://dx.doi.org/10.1038/nrc2730.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nucleic Acids  Res 2011; 39:440-53; PMID:20833636; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nat Rev Cancer 2009; 9:749-58;  PMID:19776744; http://dx.doi.org/10.1038/nrc2723.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:4203; PMID:22157227;  http://dx.doi.org/10.4161/cc.10.24.18412.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:4205; PMID:22157226; http://dx.doi.org/10.4161/ cc.10.24.18413.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nature 2000; 408:307-10; PMID:11099028;  http://dx.doi.org/10.1038/35042675.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Mol Cell Biol 2005; 25:3737- 51; PMID:15831478; http://dx.doi.org/10.1128/ MCB.25.9.3737-3751.2005.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell 2006; 124:207- 19; PMID:16413492; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nucleic Acids Res 2008; 36:3639-54;  PMID:18474530; http://dx.doi.org/10.1093/nar/gkn232.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:932- 50; PMID:21368573; http://dx.doi.org/10.4161/ cc.10.6.15012.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Proc Natl Acad Sci USA 1992; 89:9210- 4; PMID:1409626; http://dx.doi.org/10.1073/ pnas.89.19.9210.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Science  1998; 282:1497-501; PMID:9822382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle  2011; 10:3758-67; PMID:22032922; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2010; 9:2177- 88; PMID:20543567; http://dx.doi.org/10.4161/ cc.9.11.11844.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nucleic Acids Res 2008; 36:2969- 80; PMID:18388131; http://dx.doi.org/10.1093/nar/ gkn132.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene  2007; 26:2727-35; PMID:17072340; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
PLoS One 2012; 7:e37759;  PMID:22662213; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nature 1993; 366:707-10; PMID:8259216;  http://dx.doi.org/10.1038/366707a0.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2010; 9:4200-12;  PMID:20962589; http://dx.doi.org/10.4161/ cc.9.20.13532.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:4330- 40; PMID:22134238; http://dx.doi.org/10.4161/ cc.10.24.18682.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene  2007; 26:1949-53; PMID:17001315; http://dx.doi.org/10.1038/sj.onc.1209989.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:819-29; PMID:21325885; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell Cycle 2011; 10:3086- 94; PMID:21900750; http://dx.doi.org/10.4161/ cc.10.18.17350.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cancer Res  2009; 69:4073-80; PMID:19383908; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
J Biol Chem  2002; 277:26741-52; PMID:12006580; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell 1994; 76:1013-23;  PMID:8137420; http://dx.doi.org/10.1016/0092-8674(94)90379-4.20.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
FEBS J 2010; 277:877- 93; PMID:20015071; http://dx.doi.org/10.1111/ j.1742-4658.2009.07508.x.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Nucleic Acids Res  2012; 40:1561-78; PMID:22064854; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Cell 2004; 119:181-93; PMID:15479636; http://dx.doi.org/10.1016/j.cell.2004.09.034.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Mol Cell 2007; 26:539-51; PMID:17531812;  http://dx.doi.org/10.1016/j.molcel.2007.04.015.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene 2007; 26:7535-43;  PMID:17563750; http://dx.doi.org/10.1038/sj.onc.1210562.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene 2009; 28:1737-47; PMID:19252525;  http://dx.doi.org/10.1038/onc.2009.22.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
EMBO J 2007; 26:144- 57; PMID:17159899; http://dx.doi.org/10.1038/ sj.emboj.7601478.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Genes Dev  2012; 26:474-89; PMID:22391450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Biochim Biophys Acta 2012; 1819:855- 62; PMID:22513242; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Mol Cell Biol 2012; In press; PMID:23109430; http://dx.doi.org/10.1128/MCB.00881-12.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
The tumour suppres- sor protein p53 can repress transcription of cyclin B. Nucleic Acids Res 2000; 28:4410-8; PMID:11071927;  http://dx.doi.org/10.1093/nar/28.22.4410.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
Oncogene 1999; 18:1845- 53; PMID:10086339; http://dx.doi.org/10.1038/ sj.onc.1202494.,Non-OADS,/arxiv_data1/oa_pdf/a8/60/cc-11-4661.PMC3562311.pdf
"194–9 alfredo Criollo,1,2,3 Fanny Chereau,4,5,6 shoaib a hmad m alik,1,2,3 mireia Niso- santano,1,2,3 Guillermo m ariño,1,2,3  Lorenzo Galluzzi,1,2,3 maria Chiara m aiuri,1,2,3 Véronique Baud4,5,6 and Guido Kroemer1,2,6,7,8,9,* 1iNsErm; u848; Villejuif, France; 2institut Gustave r oussy; Villejuif, France; 3université Paris- sud 11; Le Kremlin-Bicêtre, France; 4iNsErm; u1016; i nstitut Cochin; Paris, France;  5CNrs; umr 8104; Paris, France; 6université Paris Descartes; s orbonne Paris Cité; Paris, France; 7metabolomics Platform; i nstitut Gustave r oussy; Villejuif, France; 8Centre de  recherche des Cordeliers; Paris, France; 9Pôle de Biologie; Hôpital Européen Georges Pompidou; a P-HP; Paris, France *Correspondence to: Guido Kroemer; Email: kroemer@igr.fr Submitted: 11/16/12; Accepted: 11/16/12http://dx.doi.org/10.4161/cc.23148Erratum to: Criollo A, et al.",Non-OADS,/arxiv_data1/oa_pdf/5d/b8/cc-11-4673.PMC3562312.pdf
Cell Cycle 2012; 11:194-9; PMID:22186785; http://dx.doi.org/10.4161/cc.11.1.18669.,OADS,/arxiv_data1/oa_pdf/5d/b8/cc-11-4673.PMC3562312.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/3b/ncomms2335.PMC3562444.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wang, C.Y.",Non-OADS,/arxiv_data1/oa_pdf/81/3b/ncomms2335.PMC3562444.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2335 ARTICLE NATURE COMMUNICATIONS | 4:1345 | DOI: 10.1038/ncomms2335 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/81/3b/ncomms2335.PMC3562444.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunicationsCompeting ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/2c/ncomms2353.PMC3562445.pdf
"Reprints and permissions information is available at http://npg.nature.com/ reprintsandpermissions How to cite this article: Kumada, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/47/2c/ncomms2353.PMC3562445.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2353 6 NATURE COMMUNICATIONS | 4:1363 | DOI: 10.1038/ncomms2353 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/47/2c/ncomms2353.PMC3562445.pdf
and M.B.Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5b/80/ncomms2341.PMC3562446.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zhang, R. et al.",Non-OADS,/arxiv_data1/oa_pdf/5b/80/ncomms2341.PMC3562446.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2341 10 NATURE COMMUNICATIONS | 4:1335 | DOI: 10.1038/ncomms2341 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5b/80/ncomms2341.PMC3562446.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gamfeldt, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/76/b0/ncomms2328.PMC3562447.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2328 8 NATURE COMMUNICATIONS | 4:1340 | DOI: 10.1038/ncomms2328 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/76/b0/ncomms2328.PMC3562447.pdf
"The DT length and diameter were deter- mined with ImageJ (NIH, http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/e5/d6/ncomms2347.PMC3562448.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ncomms2347.PMC3562448.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Dong, B. et al.",Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ncomms2347.PMC3562448.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2347 12 NATURE COMMUNICATIONS | 4:1358 | DOI: 10.1038/ncomms2347 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e5/d6/ncomms2347.PMC3562448.pdf
"of the laboratory andgrant that support this project, he initiated, discussed and coordinated the overalldirection of the project and wrote the ﬁrst draft of the paper based on the outline of results compiled by S.A. Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.",Non-OADS,/arxiv_data1/oa_pdf/20/4a/ncomms2348.PMC3562449.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Acar, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/20/4a/ncomms2348.PMC3562449.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2348 ARTICLE NATURE COMMUNICATIONS | 4:1343 | DOI: 10.1038/ncomms2348 | www.nature.com/naturecommunications 11 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/20/4a/ncomms2348.PMC3562449.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/7d/42/ncomms2358.PMC3562450.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Gobert, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/7d/42/ncomms2358.PMC3562450.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2358 8 NATURE COMMUNICATIONS | 4:1353 | DOI: 10.1038/ncomms2358 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/7d/42/ncomms2358.PMC3562450.pdf
"While CLPP is absent in several lower eukaryotes, including the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe6, the genome of P. anserina codes for a CLPP homologue, as well as for homologues of the CLP chaperones CLPA, CLPB and CLPX (http://podospora.igmors.u-psud.fr).",Non-OADS,/arxiv_data1/oa_pdf/0e/ca/ncomms2397.PMC3562451.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0e/ca/ncomms2397.PMC3562451.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Fischer, F. et al.",Non-OADS,/arxiv_data1/oa_pdf/0e/ca/ncomms2397.PMC3562451.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2397 6 NATURE COMMUNICATIONS | 4:1397 | DOI: 10.1038/ncomms2397 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0e/ca/ncomms2397.PMC3562451.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/72/c9/ncomms2354.PMC3562452.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Qutob, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/72/c9/ncomms2354.PMC3562452.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2354 6 NATURE COMMUNICATIONS | 4:1349 | DOI: 10.1038/ncomms2354 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/72/c9/ncomms2354.PMC3562452.pdf
The mean values of pH Twere calculated from hydrogen ion concentrations and then converted back to pH values39(available at http://cdiac.ornl.gov/oceans/ co2rprt.html).,OADS,/arxiv_data1/oa_pdf/d3/dd/ncomms2390.PMC3562453.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/d3/dd/ncomms2390.PMC3562453.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Prol-Ledesma, R.M.",Non-OADS,/arxiv_data1/oa_pdf/d3/dd/ncomms2390.PMC3562453.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2390 ARTICLE NATURE COMMUNICATIONS | 4:1388 | DOI: 10.1038/ncomms2390 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/d3/dd/ncomms2390.PMC3562453.pdf
"Weigend, A. S. & Gershenfeld, N. A.http://www-psych.stanford.edu/andreas/ Time-Series/SantaFe.html#setA (1991).",Non-OADS,/arxiv_data1/oa_pdf/28/cb/ncomms2368.PMC3562454.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Brunner, D. et al.",Non-OADS,/arxiv_data1/oa_pdf/28/cb/ncomms2368.PMC3562454.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2368 ARTICLE NATURE COMMUNICATIONS | 4:1364 | DOI: 10.1038/ncomms2368 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/28/cb/ncomms2368.PMC3562454.pdf
"Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Holmstro ¨m, K. M. et al.",Non-OADS,/arxiv_data1/oa_pdf/72/17/ncomms2364.PMC3562455.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2364 8 NATURE COMMUNICATIONS | 4:1362 | DOI: 10.1038/ncomms2364 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/72/17/ncomms2364.PMC3562455.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/82/1e/ncomms2386.PMC3562456.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Lei, N. et al.",Non-OADS,/arxiv_data1/oa_pdf/82/1e/ncomms2386.PMC3562456.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2386 ARTICLE NATURE COMMUNICATIONS | 4:1378 | DOI: 10.1038/ncomms2386 | www.nature.com/naturecommunications 7 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/82/1e/ncomms2386.PMC3562456.pdf
"24)), we reach a depth of 0.55 mm for HR with amber light and 0.9 mm for ChR2 with blue light (Deisseroth Lab online light transmission calculator, http://www.stanford.edu/ group/dlab/cgi-bin/graph/chart.php).",Non-OADS,/arxiv_data1/oa_pdf/bc/f9/ncomms2376.PMC3562457.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/bc/f9/ncomms2376.PMC3562457.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Krook-Magnuson, E. et al.",Non-OADS,/arxiv_data1/oa_pdf/bc/f9/ncomms2376.PMC3562457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2376 8 NATURE COMMUNICATIONS | 4:1376 | DOI: 10.1038/ncomms2376 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/bc/f9/ncomms2376.PMC3562457.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/2e/20/ncomms2356.PMC3562458.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Goldschen-Ohm, M.P.",Non-OADS,/arxiv_data1/oa_pdf/2e/20/ncomms2356.PMC3562458.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2356 10 NATURE COMMUNICATIONS | 4:1350 | DOI: 10.1038/ncomms2356 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/2e/20/ncomms2356.PMC3562458.pdf
"The most well-studied and promising of these small molecules are PRIMA-1 and PRIMA-1Met, currently in phase I/II clinical trials (APR-246-01, http://www.aprea.com/home/).",Non-OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
"Initially, 1,324 compounds from the NCI/DTP Open ChemicalRepository Diversity Set II were virtually screened (The NCI/DTP Open Chemical Repository, http://dtp.cancer.gov).",OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
"4 appear as Supplementary Data S1, and also have been deposited in the Protein Model DataBase (PMDB)47(http://mi.caspur.it/PMDB/; PMDB ID (a) PM0078199 for wt p53; (b) PM0078200 for R175H; (c) PM0078201 for G245S; and (d) PM0078202 for R273H) and in SourceForge (http://sourceforge.net/projects/p53cancerrescue/, in folder ‘Coordinates of p53 core domain’).",OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
"4 appear as Supplementary Data S1,and also have been deposited in the PMDB 47 (http://mi.caspur.it/PMDB/; PMDB ID (a) PM0078199 for wt p53; (b) PM0078200 for R175H; (c) PM0078201 for G245S; and (d) PM0078202 for R273H) and in SourceForge (http:// sourceforge.net/projects/p53cancerrescue/, in folder ‘Coordinates of p53 core domain’).",OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Wassman, C.D.",Non-OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2361 ARTICLE NATURE COMMUNICATIONS | 4:1407 | DOI: 10.1038/ncomms2361 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/e2/ff/ncomms2361.PMC3562459.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/33/f0/ncomms2403.PMC3562460.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Chen, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/ncomms2403.PMC3562460.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2403 8 NATURE COMMUNICATIONS | 4:1389 | DOI: 10.1038/ncomms2403 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/33/f0/ncomms2403.PMC3562460.pdf
The results of the de novo method for repeat annotation was analysed using RepeatMasker v3-2-9 (http://repeatmasker.org).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"Using BLAST and HMMER v3.0 (http://hmmer.janelia.org/), ORFs were annotated in the UniProt database, NCBI refseq fungi proteins and ORF domains were found in the Pfam database.",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"OrthoMCL (http://v2.orthomcl.org) was used to identify ortholog, co- ortholog and inparalog pairs as well as reciprocal better hits for each pair.",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
The codes indicating the enzyme classes were those deﬁned by the CAZyme database (http://www.cazy.org/).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"Using SMURF (http://jcvi.org/smurf/ run_smurf.php) and NRPSpredictor23, the secondary metabolite genes were predicted.",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
Cytochrome P450 genes are annotated in the P450 database with a threshold e-value of less than 1e /C050 (http://drnelson.uthsc.edu/ cytochromeP450.html).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
in the UniProt database (http://www.uniprot.org/) using BLASTP with an e-valuer8e/C014 and the TCDB with an e-valuer1e/C050.,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
The core elements of G-protein signalling pathway were predicted using BLASTP with a threshold e-value of less than 1e /C050 (http://www.genome.jp/kegg/ pathway/sce/sce04011.html).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"The GPCR-like proteins were evaluated to verify the presence of seven transmembrane (7-TM) helices with TMPRED (http://www.ch.embnet.org/ software/TMPRED_form.html), Phobius and TMHMM (http://phobius.sbc.su.se/,http://www.cbs.dtu.dk/services/TMHMM/).",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
SignalP3.0 (http://www.cbs.dtu.dk/services/SignalP- 3.0/) and Phobius (http://phobius.binf.ku.dk/) were used to perform signal peptidecleavage site prediction.,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
Transmembrane helices in the proteins were predicted using TMHMM (http://www.cbs.dtu.dk/services/TMHMM-2.0/).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"Proteins located in the mitochondria, as determined by TargetP (http://www.cbs.dtu.dk/services/ TargetP/), were removed.",Non-OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
GPI-anchoredproteins were identiﬁed using big-PI (http://mendel.imp.ac.at/gpi/fungi_server.,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
The domains of these proteins were predicted based on annotation in the Pfam database (http://pfam.sanger.ac.uk/).,OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"A neighbour-joining tree was produced based on the protein alignment using ClustalW v2.1, and protein distances were calculated using the PHYLIP (http://evolution.genetics.washington.edu/phylip/) Protdist programme with the JTT model60.",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"All of the data generated in this project, including those related to genome assembly, gene prediction, gene functional annotations andtranscriptomic data, may be accessed at the Sichuan Agricultural University (SICAU) ofﬁcial website: http://rice.sicau.edu.cn/sequence/fungi.zip.",OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Zheng, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2427 10 NATURE COMMUNICATIONS | 4:1424 | DOI: 10.1038/ncomms2427 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/5a/a6/ncomms2427.PMC3562461.pdf
Preprint at http://arXiv.org/abs/1207.1884(2012).,Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ncomms2412.PMC3562462.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ncomms2412.PMC3562462.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Cao, G. et al.",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ncomms2412.PMC3562462.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2412 6 NATURE COMMUNICATIONS | 4:1401 | DOI: 10.1038/ncomms2412 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9e/9d/ncomms2412.PMC3562462.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/9c/a5/ncomms2420.PMC3562463.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Nojima, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/ncomms2420.PMC3562463.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2420 10 NATURE COMMUNICATIONS | 4:1406 | DOI: 10.1038/ncomms2420 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/9c/a5/ncomms2420.PMC3562463.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Yong-Hong Zhang et al.,Non-OADS,/arxiv_data1/oa_pdf/a9/30/41467_2013_Article_BFncomms2433.PMC3562464.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2433 6 NATURE COMMUNICATIONS | 4:1418 | DOI: 10.1038/ncomms2433 | www.nature.com/naturecommunications &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/a9/30/41467_2013_Article_BFncomms2433.PMC3562464.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/92/77/ncomms2405.PMC3562465.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Li, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/92/77/ncomms2405.PMC3562465.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2405 ARTICLE NATURE COMMUNICATIONS | 4:1390 | DOI: 10.1038/ncomms2405 | www.nature.com/naturecommunications 9 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/92/77/ncomms2405.PMC3562465.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/59/ncomms2402.PMC3562466.pdf
"Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: van den Dries, K. et al.",Non-OADS,/arxiv_data1/oa_pdf/0c/59/ncomms2402.PMC3562466.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2402 ARTICLE NATURE COMMUNICATIONS | 4:1412 | DOI: 10.1038/ncomms2402 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/0c/59/ncomms2402.PMC3562466.pdf
Additional information Supplementary Information accompanies this paper on http://www.nature.com/ naturecommunications Competing ﬁnancial interests: The authors declare no competing ﬁnancial interests.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/ncomms2449.PMC3562467.pdf
Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ How to cite this article: Riglar D.T.,Non-OADS,/arxiv_data1/oa_pdf/c1/c4/ncomms2449.PMC3562467.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/NATURE COMMUNICATIONS | DOI: 10.1038/ncomms2449 ARTICLE NATURE COMMUNICATIONS | 4:1415 | DOI: 10.1038/ncomms2449 | www.nature.com/naturecommunications 13 &2013 Macmillan Publishers Limited.",Non-OADS,/arxiv_data1/oa_pdf/c1/c4/ncomms2449.PMC3562467.pdf
Available from:  http://www.ncbi.nlm.nih.gov/pubmed /16316848.,Non-OADS,/arxiv_data1/oa_pdf/5d/d1/MJIRI-26-185.PMC3562540.pdf
Available from: http://onlinelibrary.wiley.,Non-OADS,/arxiv_data1/oa_pdf/5d/d1/MJIRI-26-185.PMC3562540.pdf
Available from:  http://ovidsp.tx.ovid.com/sp-3.5.1a/ovidweb.cgi.,Non-OADS,/arxiv_data1/oa_pdf/5d/d1/MJIRI-26-185.PMC3562540.pdf
Available from: http://globocan.iarc.fr.,Non-OADS,/arxiv_data1/oa_pdf/13/3f/13668_2012_Article_36.PMC3562548.pdf
EditorialAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.1 Asia Pac Allergy 2013;3:1-2 Allergies in Asia: are we facing an allergy    epidemic?,Non-OADS,/arxiv_data1/oa_pdf/05/60/apa-3-1.PMC3563015.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/05/60/apa-3-1.PMC3563015.pdf
"apallergy.org Thalayasingam M, et al.Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.1 2   Likewise, a similar picture is emerging for food epidemiology in  Asia.",Non-OADS,/arxiv_data1/oa_pdf/05/60/apa-3-1.PMC3563015.pdf
"Current ReviewAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.15 Asia Pac Allergy 2013;3:15-22 IgE mediated food allergy in Korean children:   focused on plant food allergy Soo-Young Lee Department of Pediatrics, Ajou University School of Medicine, Suwon 443-721, Korea Food allergy (FA) is a worldwide problem, with increasing prevalence in many countries, and it poses a clearly increasing health problem  in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Lee SYAsia Pacific allergy 16 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15Epidemiologic studies of food allergy in children Food allergy (FA) is a worldwide problem, with increasing  prevalence in many countries, and it poses a clearly increasing  health problem in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Food allergy in Korean children 17   apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15aged 2-28 months were enrolled, 198 of which were moderate  to severe AD patients.",Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Lee SYAsia Pacific allergy 18 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15in children without previous exposure are a rising research area,  among others [29, 34-36].",Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
Food allergy in Korean children 19 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15prick test to BW were recruited.,Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Lee SYAsia Pacific allergy 20 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15SDS-PAGE protein bands observed in SGF-, SIF-, and heat treated  rice were 9, 14, and 31 kDa.",OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Food allergy in Korean children 21 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.15the Korean Academy of Pediatric Allergy and Respiratory Disease,  has initiated a nation wide survey of anaphylaxis, and we expect  that useful data and information will be elicited from this survey.",Non-OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
Lee SYAsia Pacific allergy 22 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.152007;119:1016-8.,OADS,/arxiv_data1/oa_pdf/f9/69/apa-3-15.PMC3563016.pdf
"Current ReviewAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.23 Asia Pac Allergy 2013;3:23-28 The management of food allergy in Indonesia Zakiudin Munasir* and Dina Muktiarti Division of Allergy and Immunology, Department of Child Health, Cipto Mangunkusumo Hospital - Faculty of Medicine, University of Indonesia,  Jakarta 10430, Indonesia Prevalence of allergic diseases is increasing worldwide, including food allergy.",Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Asia Pacific allergy 24 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.23due to methodology on how to diagnose food allergies.,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Management of food allergy in Indonesia 25 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.23placebo-control for children in our settings [11].,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Asia Pacific allergy 26 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.23Table 2.,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Management of food allergy in Indonesia 27 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.23CONCLUSION Food allergy is one of important problem in children and its  prevalence is increasing.,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Asia Pacific allergy 28 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.23consensus panel opinion.,Non-OADS,/arxiv_data1/oa_pdf/33/35/apa-3-23.PMC3563017.pdf
Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.29 Asia Pac Allergy 2013;3:29-34 Copyright © 2013.,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.29 30INTRODUCTION It is more than a decade since the first paediatric food  anaphylaxis series in Singapore highlighted the unique bird’s nest  allergen locally [1].,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.29Paediatric anaphylaxis in Singaporean children  31Statistical methods Statistical analysis was performed using SPSS for Windows  version 14.,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.29 32 occurring within 24 h of anaphylaxis.,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.29Paediatric anaphylaxis in Singaporean children  33 and bird’s nest anaphylaxis continues to be an important food  trigger in our local children consistent with the previous survey [1].,Non-OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.29 34 J, Gruchalla RS, Harlor AD Jr, Hepner DL, Lewis LM, Lieberman PL,  Metcalfe DD, O’Connor R, Muraro A, Rudman A, Schmitt C, Scherrer  D, Simons FE, Thomas S, Wood JP , Decker WW.",OADS,/arxiv_data1/oa_pdf/17/19/apa-3-29.PMC3563018.pdf
Current ReviewAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.3 Asia Pac Allergy 2013;3:3-14 Food allergy in Asia: how does it compare?,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Asia Pacific allergy 4 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3gene interactions seem to have resulted in a loss of oral/ gastrointestinal tolerance.,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
"Food allergy in Asia 5 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3the clinical manifestations, and searched records for allergy tests,  but OFC were not performed.",OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Asia Pacific allergy 6 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3Table 1.,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Food allergy in Asia 7 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3anaphylaxis and an important culprit in fatal anaphylaxis in other  Western populations including United Kingdom [20] and Australia  [21].,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
"Asia Pacific allergy 8 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3Firstly, resembling the oral allergy syndrome, prawn allergy  can result in mild oral symptoms such as itch and lip swelling  [45].",Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Food allergy in Asia 9 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3children [58].,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
"Asia Pacific allergy 10 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3irrespective of ethnicity, those born in Asia had lower risk of peanut  and tree nut compared to those born in Western countries [57].",Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Food allergy in Asia 11 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3Gastroenterol 2012;18:4335-41.,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Asia Pacific allergy 12 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3Holl JL.,OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Food allergy in Asia 13 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.357.,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Asia Pacific allergy 14 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.3prevalence of peanut allergy.,Non-OADS,/arxiv_data1/oa_pdf/51/18/apa-3-3.PMC3563019.pdf
Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.35 Asia Pac Allergy 2013;3:35-41 Copyright © 2013.,Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.35 36INTRODUCTION Most neonatal milk allergies are non-IgE-mediated and are  classified according to symptoms, into food protein-induced  proctocolitis syndrome, food protein-induced enterocolitis  syndrome (FPIES), and food protein-induced enteropathy [1-8], or  are assessed by cluster analysis according to clinical and laboratory  findings [9].",Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.35Milk allergy in the neonatal intensive care unit 37RESULTS Prevalence of milk allergy in the neonatal ward A total of 2,116 neonates (1,208 males, 905 females; mean  gestational age = 35 ± 4 weeks; mean birth weight = 2,137 ±  765 g) were admitted to the Department of Neonatology, Chiba  Kaihin Municipal Hospital, between 2001 and 2007.",OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.35 38    allergy in premature patients compare to full term patients.,Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.35Milk allergy in the neonatal intensive care unit 39    explain the difference in postnatal age between the 2 groups.,Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.35 40 report, NEC with a high eosinophil count showed a trend towards  a later time of onset compared with NEC without presentation of  systemic eosinophilia [23], suggesting that a Th2-type adaptive  immune response requires immune maturity.",Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.35Milk allergy in the neonatal intensive care unit 4117.,Non-OADS,/arxiv_data1/oa_pdf/00/df/apa-3-35.PMC3563020.pdf
Original ArticleAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.42 Asia Pac Allergy 2013;3:42-49 Copyright © 2013.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.42 Factors associated with asthma prevalence 43 INTRODUCTION Different studies carried out around the world have registered  an increase in the frequency of allergic diseases [1-3] and when the  corresponding social and economic impact is measured in terms  of the loss of school days, working days and likewise in the quality  of life, this is considerable [4, 5].",Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.42 44 parents in a face-to-face interview, reading the questions in  sequential form in order to avoid errors in the interpretation.",Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.42 Factors associated with asthma prevalence 45  associated with a greater frequency of wheezing during exercise  (p = 0.04) and that the obesity was the same with the presence of  nocturnal cough during the year prior to the study ( p = 0.001).,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.42 46  association with positive smoking or with obesity was found.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.42 Factors associated with asthma prevalence 47  medical services of the most important public medical institution,  the Mexican Institute of Social Security, where the annual  necessities of medical attention were retrospectively evaluated in  asthmatic subjects during a period of 11 years.",Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.42 48 for the meeting was explained to them and then the questionnaire  was applied by way of a collective interview.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
Available from:  http://www.insp.mx/ensanut/ensanut2006.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
Available from: http://apps.nccd.cdc.gov/dnpabmi/.,OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.42 Factors associated with asthma prevalence 49 American cities and world regions.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
Available from:  http://www.insp.mx/ensanut/centroocci/Jalisco.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ef/62/apa-3-42.PMC3563021.pdf
"Hypothesis & Experience Original Article http://dx.doi.org/10.5415/apallergy.2013.3.1.50 Asia Pac Allergy 2013;3:50-58 Murine subcutaneous immunotherapy models  with beneficial immunological and physiological  effects Yoon-Seok Chang1,2,3, Yoon-Keun Kim1,2,†, Sae-Hoon Kim1,2,3, Heung-Woo Park1,2, Kyung-Up Min1,2, You-Young Kim1,2,‡,  and Sang-Heon Cho1,2,* 1Department of Internal Medicine, Seoul National University College of Medicine and 2Institute of Allergy and Clinical Immunology,  Seoul National University Medical Research Center, Seoul 110-744, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-802, Korea Background: Immunotherapy was introduced 100 years ago and has a unique role in the treatment of allergic diseases in that only  immunotherapy can induce long-term immunological tolerance.",Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
"http://apallergy.org Received: November 11, 2012 Accepted: November 20, 2012",Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.50Subcutaneous immunotherapy models in mice 51 INTRODUCTION Asthma is chronic inflammatory allergic disorder which affects  numbers worldwide.,Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.50 52 week after the final injection of subcutaneous immunotherapy in  the same way of the initial OVA challenge (Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.50Subcutaneous immunotherapy models in mice 53Statistical analysis Statistical analyses were performed using the Kruskal-Wallis and  Mann-Whitney tests using SPSS version 12.0 (SPSS Inc, USA).",OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
"Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.50 54  AHR:  Prolonged immunotherapy showed a protective effect  on AHR; while AHR was increased in PBS treated group after  OVA rechallenge, there was no significant difference in AHR in  immunotherapy group (Fig.",Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
"apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.50Subcutaneous immunotherapy models in mice 55DISCUSSION Short term immunotherapy (10 times) with OVA at the maximal  safe and tolerable dose decreased IL-5 production, decreased  IL-5/INF-γ ratio, and increased IgG2a/IgG1 ratio but there was no  significant difference in AHR or airway inflammation.",Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.50 56  Fig.,Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.50Subcutaneous immunotherapy models in mice 57of asthma including eosinophilic airway inflammation and AHR.,Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
Asia Pacific allergy http://dx.doi.org/10.5415/apallergy.2013.3.1.50 58 10.,Non-OADS,/arxiv_data1/oa_pdf/cc/76/apa-3-50.PMC3563022.pdf
"Asia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.59 Asia Pac Allergy 2013;3:59-69Educational & Teaching Material Review Article Diagnosis of food allergies: the impact of oral  food challenge testing Komei Ito* Department of Allergy, Aichi Children’s Health and Medical Center, Aichi 474-8710, Japan A diagnosis of food allergies should be made based on the observation of allergic symptoms following the intake of suspected  foods and the presence of allergen-specific IgE antibodies.",Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
"Ito K  Asia Pacific allergy 60 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59help to control allergic conditions in infants; however, a proper  diagnosis of food allergies should be made after one year of age [6].",Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
"According to the database (http://www.foodallergy.jp/),  more than 100 hospitals currently perform more than 50 OFC tests  each year (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Diagnosis of food allergies 61 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59Milk Egg whites 1.0 0.8 0.60.4 0.2 0.0 0.3 1 3 10 30 100Probability1.00.8 0.60.4 0.2 0.0Probability 0.3 1 3 10 30 100 Egg whites  (n = 100)Ovomucoid (n = 80) 0.20.40.60.81.0 (UA/mL)0.3 0.7 3.5 17.5 50.0 100Probability of an egg allergy Specific IgE titer (kU A/L)1.0 0.8 0.6 0.4 0.2 0.0 0.0 0.2 0.4 0.6 0.8 1.0 1-Speci/f_icityROC curves Milk Caseinα-lactalbuminβ-lactoglobulinSensitivityFig.,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Ito K  Asia Pacific allergy 62 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59IgE epitopes exist in components that are not cross-reactive with  other cereals.,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Diagnosis of food allergies 63 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59can be definitive if the challenge yields either negative results  or positive results with objective symptoms.,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Ito K  Asia Pacific allergy 64 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59avoid overloading.,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Diagnosis of food allergies 65 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59Table 4.,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
"Ito K  Asia Pacific allergy 66 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59by local absorption of water soluble allergens, typically fruits or  vegetables [36].",Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Diagnosis of food allergies 67 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59complete elimination [40].,Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
Ito K  Asia Pacific allergy 68 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59Kikaku; 2011.,OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
"Diagnosis of food allergies 69 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.59Plaut M, Cooper SF, Fenton MJ, Arshad SH, Bahna SL, Beck LA, Byrd- Bredbenner C, Camargo CA Jr, Eichenfield L, Furuta GT, Hanifin  JM, Jones C, Kraft M, Levy BD, Lieberman P, Luccioli S, McCall KM,  Schneider LC, Simon RA, Simons FE, Teach SJ, Yawn BP , Schwaninger  JM.",Non-OADS,/arxiv_data1/oa_pdf/f5/98/apa-3-59.PMC3563023.pdf
"Case ReportAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.70 Asia Pac Allergy 2013;3:70-73 A case of taurine-containing drink induced    anaphylaxis Seung-Eun Lee1,2,3, Suh-Young Lee1,2,3, Eun-Jung Jo1,2,3, Mi-Young Kim1,2,3, Min-Suk Yang1,2,4, Yoon-Seok Chang1,2,3,   and Sae-Hoon Kim1,2,3,*  1Department of Internal Medicine, Seoul National University College of Medicine, Seoul 110-799, Korea 2Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Center, Seoul 110-799, Korea 3Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam 463-802, Korea 4Department of Internal Medicine, SMG-SNU Boramae Medical Center, Seoul 156-707, Korea Taurine is one of most abundant free amino acids in mammalian tissue.",Non-OADS,/arxiv_data1/oa_pdf/d8/47/apa-3-70.PMC3563024.pdf
http://apallergy.org,Non-OADS,/arxiv_data1/oa_pdf/d8/47/apa-3-70.PMC3563024.pdf
 Anaphylaxis to taurine-containing drink 71 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.70 by oral provocation with taurine-containing drinks and also with  synthetic taurine.,Non-OADS,/arxiv_data1/oa_pdf/d8/47/apa-3-70.PMC3563024.pdf
"Asia Pacific allergy 72 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.70DISCUSSION Taurine is one of the most abundant free amino acids in  all mammalian tissue, and it is not an amino acid in the usual  meaning as a component of protein, called an amino acid in the  meaning of an acid containing amino group [4, 5].",Non-OADS,/arxiv_data1/oa_pdf/d8/47/apa-3-70.PMC3563024.pdf
 Anaphylaxis to taurine-containing drink 73 apallergy.org http://dx.doi.org/10.5415/apallergy.2013.3.1.70amino acid concentrations in rats fed a high-cholesterol diet.,Non-OADS,/arxiv_data1/oa_pdf/d8/47/apa-3-70.PMC3563024.pdf
ErratumAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.74 Asia Pac Allergy 2013;3:74 Copyright © 2013.,Non-OADS,/arxiv_data1/oa_pdf/00/25/apa-3-74.PMC3563025.pdf
"http://apallergy.orgMeasurement of Hymenoptera venom specific  IgE by the IMMULITE 3gAllergy in subjects with  negative or positive results by ImmunoCAP  Mineaki Watanabe1, Hirokuni Hirata1, Masafumi Arima1,2, Yumeko Hayashi1, Kazuyuki Chibana1, Naruo Yoshida1,    Yoshihiko Ikeno1, Yasutsugu Fukushima1, Reiko Komura1, Kazumi Okazaki1, Kumiya Sugiyama1, and Takeshi Fukuda1 1Department of Pulmonary Medicine and Clinical Immunology, Dokkyo University School of Medicine, Tochigi 321-0293, Japan  2Department of Developmental Genetics, Chiba University Graduate School of Medicine, Chiba 263-8522, Japan http://dx.doi.org/10.5415/apallergy.2012.2.3.195 Asia Pac Allergy 2012;2:195-202 To the Editor, We would like to report the following errata in Table 4, and request that these items be revised appropriately.",Non-OADS,/arxiv_data1/oa_pdf/00/25/apa-3-74.PMC3563025.pdf
"ErratumAsia Pacific allergy pISSN 2233-8276 · eISSN 2233-8268 http://dx.doi.org/10.5415/apallergy.2013.3.1.75 Asia Pac Allergy 2013;3:75 Interferon-alpha inhibits airway eosinophila and  hyperresponsiveness in an animal asthma model  Yasuko Kikkawa, Kumiya Sugiyama, Kazuki Obara, Hirokuni Hirata, Yasutsugu Fukushima, Masao Toda, and Takeshi Fukuda Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University, 880 Kita-kobayashi, Mibu, Tochigi 321-0293, Japan http://dx.doi.org/10.5415/apallergy.2012.2.4.256 Asia Pac Allergy 2012;2:256-263 The title of the page 256 should be corrected as follows.",Non-OADS,/arxiv_data1/oa_pdf/88/6f/apa-3-75.PMC3563026.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/68/b0/srep01202.PMC3563029.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Vaquero-Sedas, M.I.",Non-OADS,/arxiv_data1/oa_pdf/68/b0/srep01202.PMC3563029.pdf
"Phylogenetic turnover .For all pairwise combinations of grid cells, the comdist metric48was calculated in R (http://www.r-project.org/).",OADS,/arxiv_data1/oa_pdf/dc/98/srep01164.PMC3563030.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/dc/98/srep01164.PMC3563030.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Eiserhardt, W.L., Svenning, J., Baker, W.J., Couvreur, T.L.P.",Non-OADS,/arxiv_data1/oa_pdf/dc/98/srep01164.PMC3563030.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/57/86/srep01206.PMC3563031.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Nanbo, A., Watanabe, S., Halfmann, P. & Kawaoka, Y.",Non-OADS,/arxiv_data1/oa_pdf/57/86/srep01206.PMC3563031.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/81/bc/srep01201.PMC3563032.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yang, Z., Watanabe, S. & Kato, T. The Irradiation Effect of a Simultaneous Laser and Electron Dual-beam on Void Formation.",Non-OADS,/arxiv_data1/oa_pdf/81/bc/srep01201.PMC3563032.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Yasuda, H., Kobayashi, M., Yasuda, Y.",Non-OADS,/arxiv_data1/oa_pdf/5c/b9/srep01199.PMC3563033.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/db/79/srep01210.PMC3563034.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Liu, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/db/79/srep01210.PMC3563034.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/c9/f8/srep01181.PMC3563035.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Ding, L.-X.",Non-OADS,/arxiv_data1/oa_pdf/c9/f8/srep01181.PMC3563035.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a9/51/srep01209.PMC3563036.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Vasileiadis, T., Dracopoulos, V., Kollia, M. & Yannopoulos, S.N.",Non-OADS,/arxiv_data1/oa_pdf/a9/51/srep01209.PMC3563036.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Cho, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/4d/e3/srep01208.PMC3563037.pdf
"Retrieved July 3, 2012, from NIST Chemistry WebBook, http://webbook.nist.gov/ chemistry/.",OADS,/arxiv_data1/oa_pdf/49/14/srep01203.PMC3563038.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Gorelli, F.A.",Non-OADS,/arxiv_data1/oa_pdf/49/14/srep01203.PMC3563038.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fe/a7/srep01207.PMC3563039.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: HuilongXu et al.",Non-OADS,/arxiv_data1/oa_pdf/fe/a7/srep01207.PMC3563039.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/0c/8a/srep01200.PMC3563040.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Jiang, W., Birk, F.T.",Non-OADS,/arxiv_data1/oa_pdf/0c/8a/srep01200.PMC3563040.pdf
The video itself can be viewed at http://www.youtube.com/watch?v= IGQmdoK_ZfY .,Non-OADS,/arxiv_data1/oa_pdf/4d/f0/i-perception-1-3.PMC3563049.pdf
The video used in this study was presented at the 2010 Best Illusion of the Year Contest hosted by the Neural Correlate Society ( http://illusioncontest.neuralcorrelate.com ).,OADS,/arxiv_data1/oa_pdf/4d/f0/i-perception-1-3.PMC3563049.pdf
My presentation of the video at the illusion contest can be viewed at http://www.youtube.com/watch?v=PWeUhRXohME .,Non-OADS,/arxiv_data1/oa_pdf/4d/f0/i-perception-1-3.PMC3563049.pdf
"(c) Comparison of Vincentiles [computed using the Matlab script kindly provided by Trisha van Zandt at http://maigret.psy.ohio-state.edu/~trish/ Downloads/matlab/index.html (Ratcliff 1979)] for the no-distractor onset (left) or no-distractor offset (right) conditions, with the conditions in which distractor onsets or offsets occurred.",OADS,/arxiv_data1/oa_pdf/3a/fa/i-perception-1-83.PMC3563056.pdf
"4      http://www.jcancer .org 96  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(2): 96-103. doi: 10.7150/ jca.5470   Mini-Review   Crosstalk between  Wnt Signaling and RNA Processing  in Colorectal Cancer   Michael Bordonaro   Department of Basic Sciences, The Commonwealth Medical College, 525 Pine Street, Scranton, PA 18509, USA .",Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
4    http://www.jcancer .org 97  motes tumorigenesis in the colon (8).,Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
"4    http://www.jcancer .org 98  exhibit alternative splicing, and microarray metho d- ologies have been developed to analyze the patterns  of pre -mRNA splicing in different cells and  under  varied conditions (16 -18).",Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
4    http://www.jcancer .org 99  alternative RNA splicing.,Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
4    http://www.jcancer .org 100  Tcf4 is a direct c -jun target gene (39).,Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
"4    http://www.jcancer .org 101  the shorter form (proximal site usage), resulting in   higher steady -state levels of the COX -2 protein that  may promote colonic neoplasia.",Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
"4    http://www.jcancer .org 102  Analysis of cancer -specific RNA metabolism is a  relatively unexplored area of research, with poten- tially significant implications for the prevention and  treatment of CRC.",Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
4    http://www.jcancer .org 103  33.,Non-OADS,/arxiv_data1/oa_pdf/3b/33/jcav04p0096.PMC3563071.pdf
"4      http://www.jcancer .org 104  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(2): 104-116. doi: 10.7150/ jca.5002  Research Paper   In Vitro Assessment of the Inflammatory Breast Cancer  Cell Line SUM 149: Discovery of 2 Single Nucleotide  Polymorphisms in the RNase L Gene   Brandon T. Nokes1, Heather E. Cunliffe2, Bonnie LaFleur3, David W. Mount1,4, Robert B. Livingston1,5,  Bernard W. Futscher1,6, Julie E. Lang7   1.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
"4    http://www.jcancer .org 105  non- inflammatory breast cancer (non- IBC), but r e- main poor for p atients with IBC despite aggressive  multimodal treatment 1-3.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
"4    http://www.jcancer .org 106  the immune response by inhibiting viral replication  within host cells, activating natural killer cells, and  increasing antigen presentation to lymphocytes 36,37.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
P values for the cell line SNP comparisons were ca l- culated using the online contingency table from Va s- sarStats (http://vassarstats.net).,OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 107  Bioinformatics Analysis  A comparative search  was performed on the NCBI GEO site  (http://www.ncbi.nlm.nih.gov/geo/) in order to  assess differences in expression of RNase L between  IBC and non- IBC tumor tissues.,OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
The script  was then independently verified using the Bioinfor- matics Institute’s (BII) Online Sample Size Estimator  (http://osse.bii.a -star.edu.sg/).,OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
Primer Design and PCR Putative HMTV s e- quence were obtained from the National Center for  Biotechnology Information website  (http://www.ncbi.nlm.nih.gov/sites/entrez).,OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 108  were excised from  agarose gels and the DNA purified  using the QIAquick gel extraction kit (Qiagen).,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
"4    http://www.jcancer .org 109  Detection Kit (MBI Fermentas), according to the  manufacturer’s directions.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 110  An evaluation of genotype frequency for these  RNa se L SNPs in IBC tumors is required in order to  define a statistically significant correlation with p o- tential risk of IBC in patient samples.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 111    Figure 4: Cell proliferation as a function of Interferon (IFN- α) dosing.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 112    Figure 5: IFN- α response abrog ated with antibody block.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 113  PCR -based analysis of HMTV sequences in  SUM149   The results of our PCR -based analysis to detect  the presence of HMTV sequences are shown in Figure  7.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
"4    http://www.jcancer .org 114  DISCUSSION    Our experimental analysis of IBC cell lines  SUM149 and SUM190, revealed 2 SNPs in the RNase  L gene with known association to prostate carcin o- genesis, particularly those of p ossible viral etiology.",Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 115  tection in our Southern blot assay being in the femt o- gram level 51.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
4    http://www.jcancer .org 116  correlate with overexpression of laminin receptor.,Non-OADS,/arxiv_data1/oa_pdf/8a/53/jcav04p0104.PMC3563072.pdf
"4      http://www.jcancer .org 117  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(2): 117-132. doi: 10.7150/ jca.4925  Review  Treating Breast Cancer in the 21st Century: Emerging  Biological Therapies   Gabriel Tinoco1*, Sean Warsch2*, Stefan Glück3, Kiran Avancha4, Alberto J. Mon tero3   1.",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 118  Over the past two decades, breast cancer mortality  rates have declined by approximately 30%,  with cor- responding improvements in 5 -year overall survival  rates to 90% (4).",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 119  sistance to trastuzumab (26, 47).",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 120  HER2+ MBC.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 121  Small molecule HER/EGFR  inhibitors  other than lapatinib   Afatinib (BIBW 2992) is an irreversible small  molecule inhibitor  of the ErbB -receptor family, ta r- geting the intracellular tyrosine kinase of the HER -2  molecule (79 -81).",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 122    Figure 1 .,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 123  vival from 3.6 months to 5.9 months (HR 0.59; P =  0.01) and the median overall survival from 7.7 months  to 12.3 months (HR 0.57; P= 0.01), with no significant  difference in the toxicity ( neutropenia and thromb o- cytopenia b eing the most common grade 3 or 4 toxic i- ties) between the two groups (105).",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 124  mTOR/PI3K   The mammalian target of rapamycin (mTOR) is a  kinase that is part of the PI3K -related kinase family  (119).,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 125  clinical benefit rate favored the everolimus -receiving  group, 12.0% vs.1.3% and 50.5% vs.25.5%, respe c- tively.",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 126  more often in the figitumumab arm included deh y- dration, hyperglycemia, and hemoptysis.",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 127  creased survival (161).,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 128  Table 6 .,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 129  7.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"[Internet] Package Insert Herceptin (Trastuzumab) Genetech, Inc.  http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/trasgen020900LB.htm   23.",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
NCCN Clinical  Practice Guidelines in Oncology ; Breast Cancer Version 2.2011.   http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf   39.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://us.gsk.com/pr oducts/assets/us_tykerb.pdf.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"4    http://www.jcancer .org 130  MX: Targeting HER2 -positive breast cancer with trastuzumab -DM1, an  antibody -cytotoxic drug conjugate.",Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 131  96.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov   137.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
http://clinicaltrials.gov   138.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
4    http://www.jcancer .org 132  model for anti -estrogen resistance.,Non-OADS,/arxiv_data1/oa_pdf/9b/9a/jcav04p0117.PMC3563073.pdf
"3, Issue 1       http://www.thno .org 1  TThheerraannoossttiiccss   2013; 3(1):1-2. doi: 10.7150/ thno .5760   Editorial   CXCR4 Chemokine  Receptor Overview: Biology, P a- thology and Applications in  Imaging and Therapy   Orit Jacobson1, Ido Dov Weiss2   1.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/thnov03p0001.PMC3563074.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e7/d5/thnov03p0001.PMC3563074.pdf
"3, Issue 1     http://www.thno .org 2  found to be essential is infection by human  immunodeficiency virus (HIV), and this finding  initiated vast research on the receptor.",Non-OADS,/arxiv_data1/oa_pdf/e7/d5/thnov03p0001.PMC3563074.pdf
"3, Issue 1       http://www.thno .org 3  TThheerraannoossttiiccss   2013; 3(1):3-10. doi: 10.7150/ thno .4621  Review  Innate Immunity Derived Factors as External Modul a- tors of the CXCL12 – CXCR4 Axis and Their Role in  Stem Cell Homing and Mobilization   Mariusz Z. Ratajczak1,2, Karol Serwin1, and Gabriela Schneider2   1.",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 4  the CXCR4 receptor is expressed both on short - and  long -term repopulating HSPCs [4, 18].",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 5  Pharmacologically enforced egress of HSPCs  from BM into PB, where the number of HSPCs circ u- lating in PB increases u p to 100 fold, is called ""mob i- lization"" [10, 25].",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 6    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 7  observed that both short -half-life C3a and  long -half-life des-ArgC3a significantly enhanced migr a- tion of HSPCs at a low or threshold level of CXCL12  in a Transwell migration assay [31].",OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 8  CC cleavage fragments, CAMPs, and molecules r e- lated to coagulation/inflammation (e.g., fibrinogen  and hyaluronic acid).",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 9  HSPC -priming approach.",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1     http://www.thno .org 10  CD34(+) progenitors is functional and is expressed a t higher level in  human malignant hematopoietic cells.",Non-OADS,/arxiv_data1/oa_pdf/47/b7/thnov03p0003.PMC3563075.pdf
"3, Issue 1       http://www.thno .org 11  TThheerraannoossttiiccss   2013; 3(1):11-17. doi: 10.7150/ thno .4806  Review  The Role of CXCL12 -CXCR4 Signaling Pathway in   Pancreatic Development   Keiichi Katsumoto 1,2,3 and Shoen Kume 2,3   1.",OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 12  et al .",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 13    Figure 2 .",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 14  blasts.",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 15  The role of the chemokine signals in the  early pancreatic differentiation   The CXCL12 -CXCR4 signaling pathway has key  roles in the vascular formation.",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 16    Figure 4.",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1     http://www.thno .org 17  13.",Non-OADS,/arxiv_data1/oa_pdf/e5/ad/thnov03p0011.PMC3563076.pdf
"3, Issue 1       http://www.thno .org 18  TThheerraannoossttiiccss   2013; 3(1):18-25. doi: 10.7150/ thno .5392  Review  The Puzzling Role of CXCR4 in Human Immunodef i- ciency Virus Infection   Elisa Vicenzi1, Pietro Liò2, and Guido Poli3,4   1.",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 19  still millions of individuals not receiving cART and in  whom the natural history of HIV disease repeats itself  monotonously.",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 20  tified molecule that conferred fusogenic competence  to cells expressing gp 120 Env on their surface [17] .",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 21  associated with a more rapid deteriorat ion of the  immune system and faster progression to AIDS [32] .",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 22  ciently replicate in Th2 and Th0 cells, but were r e- stricted in Th1 cells [52] .",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 23  Conclusions   As a lentivirus, HIV -1 has a “nat ural” propensity  to infect cells of the mononuclear phagocytic lineage  [62].",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 24  to human immunodeficiency virus infection.",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1     http://www.thno .org 25  56.",Non-OADS,/arxiv_data1/oa_pdf/38/a2/thnov03p0018.PMC3563077.pdf
"3, Issue 1       http://www.thno .org 26  TThheerraannoossttiiccss   2013; 3(1):26-33. doi: 10.7150/ thno .4922  Review  CXCR4/CXCL12 Axis in Non Small  Cell Lung Cancer  (NSCLC) Pathologic Roles and Therapeutic Potential   Ori Wald1,2,3, Oz M. Shapira1 and  Uzi Izhar1  1.",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 27  approach (9).",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 28  In addition to oncogenic alternations, the tumor mi- croenvironment may also greatly affect the tumor’s  CXCR4 e xpression levels (38) .",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 29  characterized in the past.",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 30  CXCR4 positive NSCLC cells are strong candidates  for tumorigenic stem- like cancer cells that maintain  stemness through a CXCR4 -mediated STAT3 pat h- way (65).",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 31  tasis formation may require long- term administration  of CXCR4 antagonist, which could possibly result in  significant side effect.",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 32  References   1.",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1     http://www.thno .org 33  49.",Non-OADS,/arxiv_data1/oa_pdf/06/65/thnov03p0026.PMC3563078.pdf
"3, Issue 1       http://www.thno .org 34  TThheerraannoossttiiccss   2013; 3(1):34-39. doi: 10.7150/ thno .5150  Review  Role of CXCR4 in the Pathogenesis of Acute Myeloid  Leukemia   Amnon Peled and Sigal Tavor  Goldyne Savad Institute of Gene Therapy, Hebrew University Hospital, P.O.B 12000, Jerusalem 91120 , Israel.",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/ by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1     http://www.thno .org 35  blasts showed no functional activity.",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1     http://www.thno .org 36  more generally with the risk of distant tissue infiltr a- tion by tumor cells [12] .",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1     http://www.thno .org 37  vascular cell adhesion molecule -1 (VCAM1).",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1     http://www.thno .org 38  This hypothesis was further tested by DiPe rsio,  et al., in a phase 1/2 study, in which 52 patients with  relapsed or refractory AML were treated with the  CXCR4 antagonist plerixafor (AMD3100) in combin a- tion with mitoxantrone, etoposide, and cytarabine.",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1     http://www.thno .org 39  independent of CXCR4 and predicts poor patient survival.",Non-OADS,/arxiv_data1/oa_pdf/4f/12/thnov03p0034.PMC3563079.pdf
"3, Issue 1       http://www.thno .org 40  TThheerraannoossttiiccss   2013; 3(1):40-46. doi: 10.7150/ thno .5135  Review  Involvement of CXCR4/CXCR7/CXCL12 Interactions  in Inflammatory Bowel Disease   Lael Werner1, Hanan Guzner -Gur2, Iris Dotan1  1.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
This is an open- access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 41  microenvironment [13], as well as adaptive immune  processes - for example, costimulation of  CD4+ T cel ls  activation and survival [14, 15] .",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 42  cal responses, suggesting anti- CXCL10 is a potentially  effective therapy for moderately -to-severely active  UC.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 43  As CXCR7 was reported to regulate  CXCL12 -mediated transendothelial migration [62] , it  is possible that the increased expression of CXCR7 in  the peripheral blood of IBD patients could foster i n- creased influx of T cells to sites of mucosal inflamm a- tion.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 44    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 45  [2]  Locati M, Murphy PM.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1     http://www.thno .org 46  [49]  Agace WW, Amara A, Roberts AI, Pablos JL, Thelen S, Uguccioni M, et  al.",Non-OADS,/arxiv_data1/oa_pdf/42/36/thnov03p0040.PMC3563080.pdf
"3, Issue 1       http://www.thno .org 47  TThheerraannoossttiiccss   2013; 3(1):47-75. doi: 10.7150/ thno .5376  Review   Small Molecule Inhibitors of CXCR4   Bikash Debnath1, Shili Xu1, Fedora Grande2, Antonio Garofalo2, and Nouri  Neamati1  1.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 48    Figure 1 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
: http://amazonia.transcriptome.eu [129] ).,Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 49  portion of the cavity, interacts with TMs I, II, II I and  VII, while, peptide CVX15 occupies the complete  binding cavity and makes contact with all TMs.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 50  Role of CXCR4 in Cancer Cell Metastasis   CXCR4 is found to be a prognostic marker in  many different cancers [22], including leukemia  [23-27], breast [28, 29] , lung [30, 31] , prostate [32] ,  ovarian [33] and colorectal cancers [34] , where the  SDF-1/CXCR4 axis plays an important role in cancer  progr ession [22] (Figure 3 ).",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 51  pressing cells towards cardiac tissues [47 -49].",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 52  Cyclic Pentapeptide -based Antagonists   Several earlier studies conducted over the last  ten years have led to the identification of a highly  potent CXCR4 antagonist, a β-sheet -like 14 -mer pep- tide with a single disulfide bridge, known as T140.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 53  In order to evaluate the electrostatic effects of the  amide carbonyl groups within the peptide bonds on  the activity of  FC131,  a comparative study using u n- substituted and fluorinated alkene isosteres has been attempted.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 54  These results suggest an improved activity of  amidine containing compounds due to a higher flex i- bility when c ompared with former cyclic pentapep- tides.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 55    Figure 7 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 56    Figure 8 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 57  solved in single enantiomers, compounds with  S-configuration at the chiral center showed higher  CXCR4 antagonistic activity with respect to the co r- responding R -isomers.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 58  tetrahydroquinoline core.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 59    Figure 10 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 60  with an IC 50 of 6 nM.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 61    Figure 12 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 62  135 with an IC 50 value of 2 nM.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 63    Figure 15 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 64    Figure 16 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 65  ring lowered the antiviral activity, although the  compound showed activity with an EC 50 value of  0.49  μ M .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 66    Figure 18 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 67    Figure 19 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 68  strains.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 69  Table 2.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 70  Previously, a low molecular weight non -peptide  compound 233, KRH -1636, was found to be a potent  and selective inhibitor of CXCR4 using X4 HIV -1  strains, but, its poor oral bioavailability limited fu r- ther clinical trials [113, 114] .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 71    Figure 23 .",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 72  Table 3.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 73  23.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 74  68.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1     http://www.thno .org 75  114.",Non-OADS,/arxiv_data1/oa_pdf/83/69/thnov03p0047.PMC3563081.pdf
"3, Issue 1       http://www.thno .org 76  TThheerraannoossttiiccss   2013; 3(1):76-84.  doi: 10.7150/ thno .4835  Review  Molecular Imaging of Chemokine R eceptor CXCR4   Ido.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 77  poor prognosis in several cancers [17, 18], making it a  potential target for anti -CXCR4 targeted therapy.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 78      SPECT tracers targeting CX CR4   Single photon emission computed tomography,  SPECT, is a technology that utilizes radioactive iso- topes which emit a photon upon decay.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 79  One of the first attempts to detect CXCR4 in tu- mors using a radiolabeled antagonist was done by  Hanaoka et al., who labeled the peptide antagonist  Ac-TZ14011 with Inidium -111 [ 20].",OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 80    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 81  In an attempt to limit undesired binding of l a- beled T140 to red blood cells, we synthesized the  peptide with DOTA or 1,4,7 -triazacyclononane -  N,N',N'' -triacetic acid (NOTA) chelators at the  N-terminus, replacing the fluoro -benzoyl group and  thereafter labeled the tracers with co pper -64.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 82  hand, requires the use of two transfected cell lines but  has low background and can also allow testing the  inhibition of CXCL12/CXCR7.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 83  targeting CXCR4 were done in the recent years.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"3, Issue 1     http://www.thno .org 84  29.",Non-OADS,/arxiv_data1/oa_pdf/59/03/thnov03p0076.PMC3563082.pdf
"Zoltewicz and others 410 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Densitometr ic analyses of the autoradio- graphs were performed usi ng NIH Image software.Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.411",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Zoltewicz and others 412 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Semi-quantitative analyses of five independent experiments reveal that over 80%of WT and C85S-PMP22 similarly achieve Endo H-resistance at steady-state ( C).Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.413",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Zoltewicz and others 414 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"5non-significant.Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.415",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Zoltewicz and others 416 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"V, vector control; AU, arbitrary units.Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.417",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Zoltewicz and others 418 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"J Neurochem 62:1163–1171.Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.419",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Zoltewicz and others 420 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
"Received 26 June 2012/1 November 2012; accepted 5 November 2012 Published as Immediate Publication 5 November 2012, doi 10.1042/AN20120045Palmitoylation of PMP22 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.421",Non-OADS,/arxiv_data1/oa_pdf/b2/03/an004e101.PMC3563111.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-002054).,Non-OADS,/arxiv_data1/oa_pdf/27/8d/bmjopen-2012-002054.PMC3563112.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002091).,Non-OADS,/arxiv_data1/oa_pdf/96/62/bmjopen-2012-002091.PMC3563115.pdf
Proyecto BIFAP http://www.bifap.org/summary.php (accessed 4 Sept 2012).,Non-OADS,/arxiv_data1/oa_pdf/96/62/bmjopen-2012-002091.PMC3563115.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002429).,Non-OADS,/arxiv_data1/oa_pdf/da/5c/bmjopen-2012-002429.PMC3563116.pdf
http://data.gov.uk/dataset/paediatric- national-diabetes-audit 4.,Non-OADS,/arxiv_data1/oa_pdf/da/5c/bmjopen-2012-002429.PMC3563116.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-002223).,Non-OADS,/arxiv_data1/oa_pdf/58/2a/bmjopen-2012-002223.PMC3563117.pdf
2. http://www.itqb.unl.pt/~ccr/quimicaemlinha/PDF%20files/ VIOXXmerck.pdf (accessed 25 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/02/96/bmjopen-2012-002295.PMC3563118.pdf
2007. http://www.pharmacoepi.org/resources/guidelines_08027.cfm (accessed 1 Oct2012).,Non-OADS,/arxiv_data1/oa_pdf/02/96/bmjopen-2012-002295.PMC3563118.pdf
35. http://clinicaltrials.gov/ct/show/NCT00346216 (accessed 25 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/02/96/bmjopen-2012-002295.PMC3563118.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002125).,Non-OADS,/arxiv_data1/oa_pdf/02/5e/bmjopen-2012-002125.PMC3563119.pdf
The study wasregistered on http://www.clinicaltrials.gov; unique iden- tiﬁer NCT01574040.,Non-OADS,/arxiv_data1/oa_pdf/02/5e/bmjopen-2012-002125.PMC3563119.pdf
Analyses were conducted with R statistical software V.2.11.1 (http://www.R-project.org).,OADS,/arxiv_data1/oa_pdf/02/5e/bmjopen-2012-002125.PMC3563119.pdf
†Local weather was recorded from http://www.meteogroup.com.,Non-OADS,/arxiv_data1/oa_pdf/02/5e/bmjopen-2012-002125.PMC3563119.pdf
http://www.voedingscentrum.nl/nl/service/english.,Non-OADS,/arxiv_data1/oa_pdf/02/5e/bmjopen-2012-002125.PMC3563119.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002211).,Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
"The full report with all the findings has now been published online at: http://www.netscc.ac.uk/ hsdr/files/project/SDO_FR_08-1819-213_V01.pdf (accessed November 2012).Further details are available from the Principal Investigator, Professor Jill Maben ( jill.maben@kcl.ac.uk).REFERENCES 1.",Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
2011. http://www.institute.nhs.uk/images/Patient_Experience/Final%20Policy%20Report%20pdf%20doc%20january%202012.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
2011. http://www.reallylearning.com/Free_Resources/MakingStrategyWork/reforming.pdf.,Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
"Warwick: NHS Institute for Innovation & Improvement, 2011. http://www.institute.nhs.uk/images/ Patient_Experience/Final%20Project%20Report%20pdf%20doc% 20january%202012.pdf.",Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
"Southampton: NIHR Service Delivery and Organisation Programme, 2012. http://www.netscc.ac.uk/hsdr/files/project/SDO_FR_08 –1819-213_V01.pdf.",Non-OADS,/arxiv_data1/oa_pdf/09/93/bmjopen-2012-002211.PMC3563120.pdf
"UK ESRD Prevalent Rates in 2008: national and centre-specific analyses, 2009. http://www.renalreg.com/Reports/2009.html (accessed 2 Jun 2011).",OADS,/arxiv_data1/oa_pdf/5d/b3/bmjopen-2012-002148.PMC3563121.pdf
2011. http://www.kidney.org.au(accessed 10 Jul 2012).,Non-OADS,/arxiv_data1/oa_pdf/5d/b3/bmjopen-2012-002148.PMC3563121.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-002308).,Non-OADS,/arxiv_data1/oa_pdf/e7/84/bmjopen-2012-002308.PMC3563122.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002423).,Non-OADS,/arxiv_data1/oa_pdf/4f/3b/bmjopen-2012-002423.PMC3563123.pdf
To view please visit the journalonline (http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/39/4e/bmjopen-2012-002050.PMC3563124.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001309).,Non-OADS,/arxiv_data1/oa_pdf/06/cc/bmjopen-2012-001309.PMC3563125.pdf
http://www.bnf.org/bnf/ (accessed 16 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/06/cc/bmjopen-2012-001309.PMC3563125.pdf
Final appraisal determination: Entecavir for the treatment of chronic hepatitis B.http://www.nice.org.uk/nicemedia/pdf/EntecavirFinalFAD.pdf(accessed 16 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/06/cc/bmjopen-2012-001309.PMC3563125.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002171).,Non-OADS,/arxiv_data1/oa_pdf/02/04/bmjopen-2012-002171.PMC3563126.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002218).,Non-OADS,/arxiv_data1/oa_pdf/9e/44/bmjopen-2012-002218.PMC3563127.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002296).,Non-OADS,/arxiv_data1/oa_pdf/03/36/bmjopen-2012-002296.PMC3563128.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001206).,OADS,/arxiv_data1/oa_pdf/4a/a6/bmjopen-2012-001206.PMC3563129.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002492).,Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"13–15 In response to the anomaly between continued UK gov- ernment support of self-management programmes andequivocal evidence of their effectiveness, the COPERS (coping with persistent pain, effectiveness research into self-management) study (http://blizard.qmul.ac.uk/research-generation/329-copers.html) was commissioned by the National Institute of Health Research (NIHR), as a 5-year programme grant to identify which components andcharacteristics of self-management and pain-management programmes are the most effective, as well as to evaluate these components in a trial, in order to inform both thedevelopment of a new pain self-management course and the next generation of self-management courses in general.",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Lay facilitators are recruited via local contacts with com- munity interest companies delivering self-managementtype programmes (typically the Expert Patient Programme, http://www.expertpatients.co.uk).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Randomisation The randomisation plan was developed by the PragmaticClinical Trials Unit (PCTU) at Queen Mary, University of London (http://blizard.qmul.ac.uk/pragmatic- clinical-trials-unit.html).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
Stationery Office; 2008. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/AnnualReports/DH_096206(accessed 17 Jan 2013).,OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Department of Health, Stationery Office; 2008. http://www.dh.",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Department of Health, Stationery Office; 2002. http://webarchive.nationalarchives.gov.uk/+/http://www.hm-treasury.gov.uk/consult_wanless_final.htm (accessed 17 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Department of Health, Stationery Office; 2001. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyandGuidance/DH_4006801(accessed 17 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
http://www.expertpatients.co.uk/ (accessed 17 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
2009. http://www.paintoolkit.org/ assets/downloads/Pain-Toolkit-Booklet-Nov-2012.pdf (accessed 17Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"Personal Social Services Research Unit (PSSRU), University of Kent, 2010. https://www.education.gov.uk/publications/eOrderingDownload/PSSRU-1368 –230X.pdf (accessed 17 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
"The Health and Social Care Information Centre, 2011. http://www.ic.nhs.uk/pubs/prescostanalysis2010 (accessed 17 Jan 2013).",Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
2011. http://www.dh.gov.uk/en/Publicationsandstatistics/Publications/PublicationsPolicyAndGuidance/DH_131140 (accessed 17 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
http://www.crd.unimelb.edu.au/heiq/ (accessed 17 Jan 2013).,Non-OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
2011. http://www.ons.gov.uk/census/2011-census (accessed 17 Jan 2013).,OADS,/arxiv_data1/oa_pdf/7c/1a/bmjopen-2012-002492.PMC3563130.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001720).,Non-OADS,/arxiv_data1/oa_pdf/43/72/bmjopen-2012-001720.PMC3563131.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002193).,Non-OADS,/arxiv_data1/oa_pdf/a5/16/bmjopen-2012-002193.PMC3563132.pdf
Med Ed Online 2010;10;15. http:// med-ed-online.net/index.php/meo/article/view/5212 (accessed 15Sep 2011) 20. http://unistats.direct.gov.uk/ (accessed 10 Oct 2011)21.,Non-OADS,/arxiv_data1/oa_pdf/a5/16/bmjopen-2012-002193.PMC3563132.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001138).,Non-OADS,/arxiv_data1/oa_pdf/68/07/bmjopen-2012-001138.PMC3563133.pdf
http://www.who.int/mental_health/evidence/en/ prevention_of_mental_disorders_sr.pdf (accessed 2 Dec 2010).,Non-OADS,/arxiv_data1/oa_pdf/68/07/bmjopen-2012-001138.PMC3563133.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002068).,Non-OADS,/arxiv_data1/oa_pdf/95/d8/bmjopen-2012-002068.PMC3563134.pdf
http://www.cbs.nl.,Non-OADS,/arxiv_data1/oa_pdf/95/d8/bmjopen-2012-002068.PMC3563134.pdf
Pharmaceutisch Weekblad 2008;38:13. http://www.pw.nl/archief/ 2008/2008 –38/2008pw38p13.pdf/view (accessed 4 Dec 2011) 56.,Non-OADS,/arxiv_data1/oa_pdf/95/d8/bmjopen-2012-002068.PMC3563134.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-002077).,Non-OADS,/arxiv_data1/oa_pdf/40/3d/bmjopen-2012-002077.PMC3563135.pdf
To view these files please visitthe journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001852).,Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
"The data were analysed using Stata V.11 (StataCorp, College Station, T exas, USA: http://www.stata.com).",OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
"pdf, http://www.childinfo.org/ and http://www.who.int/gho/countries/egy/country_profiles/en/index.html (accessed 31 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
2005. http://www.measuredhs.,Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
"WHO/UNICEF, Guidelines for follow-up after training in the WHO/UNICEF course on IMCI for first-level health workers , Geneva: World Health Organization, 1999. http://www.who.int/maternal_child_adolescent/documents/fch_cah_99_1a/en/index.html(accessed 31 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
"Geneva: World Health Organization, 2003. http://www.who.int/maternal_child_adolescent/documents/9241545860/en/index.html (accessed 31 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
"World Health Statistics 2006, Geneva : World Health Organization 2006 http://www.who.int/gho/publications/ world_health_statistics/en/index.html (accessed 31 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/6a/54/bmjopen-2012-001852.PMC3563136.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001847).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
March 2009 http://www.iacoc.org.uk/statements/documents/COC09S2UpdatestatementonCancerIncidenceandMSWIsMarch09.pdf (accessed 12Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
2010. http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1266228112244 (accessed 12 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
http://europa.eu/legislation_summaries/environment/waste_management/l28072_en.htm (accessed 26 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
2001. http://www.ons.gov.uk/ ons/guide-method/geography/products/area-classifications/ns-area-classifications/index/methodology-and-variables/local-authorities/index.html (accessed 12 Jun 2012).,OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
2001 http://www.ons.gov.uk/ons/guide-method/geography/products/area-classifications/ns-area-classifications/index/corresponding-authorities/local-authorities/index.html (accessed 8 Oct 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
http://www.who.int/classifications/icd/en (accessed 8 Oct2012).,OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
2007. http://www.communities.gov.uk/publications/communities/englishindices (accessed 12 Jun 2012).,Non-OADS,/arxiv_data1/oa_pdf/3e/4e/bmjopen-2012-001847.PMC3563137.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001800).,Non-OADS,/arxiv_data1/oa_pdf/0f/11/bmjopen-2012-001800.PMC3563138.pdf
To view these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002018).,Non-OADS,/arxiv_data1/oa_pdf/f7/d8/bmjopen-2012-002018.PMC3563139.pdf
http://www.ahrq.gov/data/hcup/icd10usrgd.htm (accessed 26 May 2010) 9.,OADS,/arxiv_data1/oa_pdf/f7/d8/bmjopen-2012-002018.PMC3563139.pdf
http://www.ic.nhs.,Non-OADS,/arxiv_data1/oa_pdf/f7/d8/bmjopen-2012-002018.PMC3563139.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001722).,Non-OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
Ageing Res 2009;1. http://www.pagepress.org/journals/index.php/ar/article/view/ar.2010.e1/1538 (accessed 30 Jan 2012).,Non-OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
http://www.wonder.cdc.gov/bridged-race-v2007.html (accessed 11 Dec 2011).,OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
11. http://www.surveillance.cancer.gov/joinpoint/ (accessed 1 Jan 2012).12.,Non-OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
http://www.hcup-us.ahrq.gov/reports/statbrief/sb80.pdf (accessed 1 Jan 2012).,OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
28. http://www.census.gov/newsroom/releases/archives/ international_population/cb09 –97.html (accessed 18 Feb 2012).,OADS,/arxiv_data1/oa_pdf/e7/b0/bmjopen-2012-001722.PMC3563140.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001915).,Non-OADS,/arxiv_data1/oa_pdf/39/22/bmjopen-2012-001915.PMC3563141.pdf
"Image analysis was con- ducted on a separate workstation by a single observer with 2 years of experience in MR-based fat quanti ﬁcation using an ImageJ (Rasband, 2004; V .1.45s11; available at http://rsbweb.nih.gov/ij/download.html) macro that quanti ﬁed fat pixels semi-automatically and histogram- based (methodical paper in preparation).",OADS,/arxiv_data1/oa_pdf/39/22/bmjopen-2012-001915.PMC3563141.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001842).,OADS,/arxiv_data1/oa_pdf/36/d4/bmjopen-2012-001842.PMC3563142.pdf
"The countries within EU27 were grouped into four regions, northern, western, eastern and southern Europe, according to theUnited Nations classi ﬁcation scheme (http://unstats.un.",Non-OADS,/arxiv_data1/oa_pdf/36/d4/bmjopen-2012-001842.PMC3563142.pdf
To view these filesplease visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-001881).,OADS,/arxiv_data1/oa_pdf/06/8d/bmjopen-2012-001881.PMC3563143.pdf
Toview these files please visit the journal online (http://dx.doi.org/10.1136/ bmjopen-2012-002034).,Non-OADS,/arxiv_data1/oa_pdf/ed/c8/bmjopen-2012-002034.PMC3563144.pdf
A full listing of the INMA project researchers can be found at http://www.proyectoinma.org/ presentacioninma/listado-investigadores/en_listado-investigadores.html.,Non-OADS,/arxiv_data1/oa_pdf/ed/c8/bmjopen-2012-002034.PMC3563144.pdf
http://www.proyectoinma.org/instituciones-participantes/ en_entidades-colaboradoras/.,Non-OADS,/arxiv_data1/oa_pdf/ed/c8/bmjopen-2012-002034.PMC3563144.pdf
To view these files please visit the journal online(http://dx.doi.org/10.1136/ bmjopen-2012-001986).,Non-OADS,/arxiv_data1/oa_pdf/34/fb/bmjopen-2012-001986.PMC3563145.pdf
18. http://www.diabetologists-abcd.org.uk/Objectives_Liraglutide_Audit.,Non-OADS,/arxiv_data1/oa_pdf/34/fb/bmjopen-2012-001986.PMC3563145.pdf
"The Cochrane Collaboration, 2011. http://www.cochrane-handbook.org (accessed15 Nov 2012).",OADS,/arxiv_data1/oa_pdf/34/fb/bmjopen-2012-001986.PMC3563145.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1174  TThheerraannoossttiiccss   2012; 2(12):1174-1184. doi: 10.7150/ thno .4410  Research Paper   Theranostic Oxygen Delivery Using Ultrasound and  Microbubbles  James  J. Kwan1, Mehmet Kaya2,3, Mark A. Borden1 and Paul A. Dayton2  1.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1175  In a review by Brown and Wilson [9], it was r e- ported that all human tumors have median oxygen  levels significantly lower than their normal tissue of  origin.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1176  gen-carrier microbubbles.",OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1177  chased from EMD Chemicals (Gibbstown, NJ, USA).",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1178  Table 1:  Gas properties used in modeling microbubble gas  exchange.",OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1179    Figure 1.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1180      Figure 3.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1181  layer did not play a significant role; the microbubble  did not present any significant growth and therefore  did not leave the linear elastic regime of the mon o- layer.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1182  The simulations also predicted that each 4 -µm  diameter bubble releases ~1 fmol of oxygen upon  contact with the air -saturated medium, and it retains  ~0.25 fmol of oxygen in the gas core.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1183  rats and dogs with doses corresponding to 50 to 250  times the expected imaging dose in humans, respe c- tively.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1184  21.",Non-OADS,/arxiv_data1/oa_pdf/8b/40/thnov02p1174.PMC3563146.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1127  TThheerraannoossttiiccss   2012; 2(12):1127-1139. doi: 10.7150/ thno .4307  Research Paper   Understanding the Structure and Mechanism of     Formation of a New Magnetic Microbubble Formulation   Joshua Owen1, Bin Zhou2, Paul Rademeyer1, Meng -Xing Tang2, Quentin Pankhurst3, Robert Eckersley4 and  Eleanor Stride1  1.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1128  creasing microbubble concentration can pose an i n- creased risk of embolism and shield target tissue from  ultrasound exposure (7).",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1129  1.2.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1130  fluorescent droplets prepared independently.",OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1131    Figure 2:  Schematic of the ultrasound flow phantom: a latex tube immersed in a water bath with a variable internal flow rate controlled   by a syringe pump.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1132  slide.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1133    Figure 5:  Optical microscope images (400x magnification) of: A) Non -magnetic droplets imaged at the top of the haemocytometer and  B) non -magnetic droplets mixed with microbubbles in the same focal plane.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1134  magnetic microbubbles was observed for flow rates of  up to ~6 cm/s (Figure 3).",OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1135    Figure 8: Microbubbles mixed with magnetic droplets in a 200 µm capillary tube before A) and B) after the application of a magnetic fie ld.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1136    Figure 10: Magnetic droplets and microbubbles being retained under flow in vitro : A) non -magnetic microbubbles  showing no retention  upon application of a magnetic field (distributed throughout the tube), B) magnetic droplets showing no ultrasound signal whe n flowing  through a latex tube (centre of the tube appears dark), C) a mixture of magnetic droplets and micro bubbles flowing through the tube  (again tube is filled with echogenic material) and D) being retained by a magnetic field.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1137  forces within an aqueous suspension.",Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1138  Optical images of the mixed suspension in a capillary  tube in the presence of a magnetic field however i n- dicated particles that were buoyant (and therefore not  magnetic liquid droplets) and did respond upon a p- plication of a magnetic field.",OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1139  and computational analysis of axial velocity profiles.",OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
http://www.kayelaby.npl.co.uk/ general_physics/   2_2/2_2_5.html   28.,Non-OADS,/arxiv_data1/oa_pdf/58/f8/thnov02p1127.PMC3563147.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1208  TThheerraannoossttiiccss   2012; 2(12):1208-1222. doi: 10.7150/ thno .4306  Review  Advances in Ultrasound Mediated Gene Therapy Using  Microbubble Contrast Agents   Shashank R. Sirsi, Mark A. Borden   Department of Mechanical Engineering, University of Colorado, Boulder, CO  80309, USA .",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
This is an open -access article distributed under the terms of the Creative C ommons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1209  trolled to improve localized tissue deposition of cir- culating nucleic acids for targeted gene therapy a p- plications.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1210    Figure 2.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1211  the lipid acyl chains (van der Waals dis persion forces)  in compar ison to bulk water mol ecules  ( hydrogen  bonding) [ 96].",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1212  Modulation of Vascular Integrity   Improving gene delivery to extravascular tissue  can also be acco mplished by a ltering the va scular in- tegrity.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1213   Stimulating Endocytotic Uptake   The effects of microbubble cavitation on intr a- cellular responses are often overlooked due to a  prevalent notion that membrane sonoporation or mechanical disruptions of vascular integrity are pr i- marily responsible for extravasation of circulating  agents.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1214  Similar in vitro studies by Lentacker et al.",OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1215  Actively delivering DNA vectors – Pr o- pelling beyond the  vasculature   The mechanisms of improving gene uptake that  have been discussed in the preceding sections utilize  MCA’s as independent agents which transiently i n- crease the vascular or cellular permeability to free- circulating agents in the blood, promoting pas- sive uptake.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1216  coronary artery increased β -galactosidase activity  nearly 5 -fold more than plasmid.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1217  slowed using US and plasmid loaded -MCA’s co m- pared to controls as well.",OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1218  noviral -coated microbubbles were systemically a d- ministered into rats while the heart was exposed to  US.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1219  Future Prospects    In this review, we have discussed the potential  mechanisms of DNA delivery and novel strategies  that have been developed to provide successful methods of target specific gene delivery.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1220  III.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1221  33.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1222  82.",Non-OADS,/arxiv_data1/oa_pdf/cf/61/thnov02p1208.PMC3563148.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1160  TThheerraannoossttiiccss   2012; 2(12):1160-1173. doi: 10.7150/ thno .4492  Research Paper   Generation of a Focused Poly(amino ether) Library:  Polymer -mediated  Transgene Delivery and  Gold- Nanorod based Theranostic Systems   Lucas Vu1, James Ramos2, Thrimoorthy Potta1, and Kaushal Rege1   1.",OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
This is an open -access  article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1161  cessful delivery vehic les are then able to escape en- dosomes, presumably in part due to endosomal buf f- ering by cationic polymers12-14.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1162  volume of 200 μL for each standard).",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1163    Figure 1: Amine monomers (A) and diglycidyl  ether monomers (B) used in the synthesis of the NPGDE and 1,4C libraries.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1164  for transfection were prepared by the drop wise a d- dition of 2000 ng (4 μ L) of each polymer on top of 200  ng (4 μ L) of pGL3 p lasmid DNA to form a pol y- mer:DNA weight ratio 10:1.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1165  optical density of 0.5 in 1.5 mL microcentrifuge tubes  were centrifuged at 6000 rcf for 10 minutes using a  Microfuge 18 centrifuge (Beckman Coulter) in order to  remove excess CTAB surfactant.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1166  allel nature of polymer synthesis.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1167  Both, NPGDE and 1,4C -based poly mers showed  the highest transgene expression in PC -3 cells co m- pared to other cell lines; transgene expression was  lowest in the PC3 -PSMA cell line as shown in Figure  2.",OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1168  ninhydrin assay; not shown) presumably due to r e- moval of unreacted monomers or smaller oligomers.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1169  Transfection efficacy decreased at higher pol y- mer:pDNA weight ratios for most polymers.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1170      Figure 4: Cytotoxicity data obtained from the MTT assay using the purified NPGDE polymers (A) and 1,4C polymers (B) at different  polymer:DNA weight ratios; 1:1, 5:1, 10:1, 20:1, 25:1, and 50:1, corresponding to 200 ng, 1000 ng, 2000 ng, 4000 ng, 5000 ng, and 10,000  ng of the lead polymers respectively, in the MIA PaCa -2 cell line (n = 3 * = p < 0.05 and ** = p < 0.01).",OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1171  and remains at 814 nm following NPGDE -6 coating.",OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1172    Figure 5:  UV-vis absorption spectra for CTAB -GNRs,  PSS-GNRs, and NPGDE -6-GNRs.",OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranosti cs 2012, 2(12)     http://www.thno .org 1173  and Reduces the Overall Cytotoxicity.",Non-OADS,/arxiv_data1/oa_pdf/8f/b5/thnov02p1160.PMC3563149.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1140  TThheerraannoossttiiccss   2012; 2(12):1140-1159. doi: 10.7150/ thno .4305  Review  Bursting Bubbles and Bilayers   Steven P. Wrenn1, Stephen M. Dicker1, Eleanor F. Small1, Nily R. Dan1, Michał Mleczko2, Georg Schmitz2,  and Peter A. Lewin3   1.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1141  Introduction   This paper reviews ultrasound- induced inertial  cavitation of phospholipid -coated microbubbles and  ultrasound -induced sonoporation of phos pholipid  bilayers.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1142  inertial cavitation of externally added, coated m i- crobubbles, as the theory of cavitation for intrinsic,  uncoated bubbles (i.e., those generated by nucleation  of dissolved gas or vaporization of liquid), is well  establishe d,[34, 35] as is the experimental methodo l- ogy for measuring inertial cavitation in vitro .",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1143  abatic processes (no heat transfer).",OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1144  to area, K A is a membrane property that describes  how surface tension varies w ith area.",OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1145  c h a i n  ( n o r m a l i z e d  b y  k T )  a n d  N  i s  t h e  n u m b e r  o f   freely rotating polymer segments; for PEG the molec- ular weight (MW) of a segment is 44 g/mol such that  N = MW/44.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1146  Predicting Inertial Cavitation Thresholds   While certainly a significant step forward, writ- ing a bubble physics model in terms of K A is not the  end of the story.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1147      Figure 3 .",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1148  4a shows predicted inertial cavitation profiles for a  range of experimentally relevant K A values; by co m- parison, the effects of surface tension (Fig.",OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1149  from experiment, but the values are not yet known for  the specific system studied here.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1150    Figure 6 .",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1151  liposomes can be tuned using bilayer phase  behavior.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1152    Figure 8 .",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1153  it is possible –  perhaps even probable -  to nucleate  dissolved gases (e.g., oxygen, carbon dioxide, nitr o- gen, etc.)",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1154  tinguish between the contributions of diffusion (Fig.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1155    Figure 10.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1156    Figure 12.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1157  References   1.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1158  46.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(11)     http://www.thno .org 1159  96.",Non-OADS,/arxiv_data1/oa_pdf/7c/81/thnov02p1140.PMC3563150.pdf
"Theranostics  2012, 2(12)      http://www.thno .org 1117  TThheerraannoossttiiccss   2012; 2(12):1117-1126. doi: 10.7150/ thno .4381  Review  Lipid- and Polymer -Based Nanostructures for Cancer  Theranostics   Brian T. Luk, Ronnie H. Fang, and Liangfang Zhang  Department  of NanoEngineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA.",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1118  disease sites, as the result of passive targeting through  enhanced permeability and reten tion (EPR) effect and  active targeting through selected surface ligands, has  been extensively explored [11, 12].",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1119  2.",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1120  labeling efficiency [37 -39].",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1121  et al.",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1122    Figure 3 .",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1123  lows researchers to monitor drug pharmacokinetics,  intratumoral dr ug distribution, and drug tumor a c- cumulation  in real -time [19].",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1124    Figure 5 .",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1125  [16] Zhang L, Gu FX, Chan JM, Wang AZ, Langer RS, Farokhzad OC.",Non-OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1126  [65] Guthi JS, Yang SG, Huang  G, Li SZ, Khemtong C, Kessinger CW, et al.",OADS,/arxiv_data1/oa_pdf/d1/da/thnov02p1117.PMC3563151.pdf
"Theranostics  2012, 2(12)      http://www.thno .org 1199  TThheerraannoossttiiccss   2012; 2(12):1199-1207. doi: 10.7150/ thno .4812  Research Paper   Dual-Modality, Dual -Functional Nanoprobes for Cell u- lar and Molecular Imaging   Jyothi U. Menon1, Praveen K. Gulaka2, Madalyn A. McKay1, Sairam Geethanath2, Li Liu1 and Vikram D.  Kodibagkar1,2,3,  1.",OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1200  tissue engineered constructs to determine their fate  after implantation.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1201  seeded in a 48 well plate at a de nsity of 105 cells per  well and incubated for 24 hours to allow the cells to  attach to the bottom of the wells.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1202  intensity was not observed to saturate till the end of  the observation period (30 min) indicating that further  uptake of nanoprobes wa s possible beyond 30 min.",OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1203          Figure 4: Live cell imaging: (A) Confocal microscopy composite images showing time -dependent uptake of t he nanoprobes by  MCF7 -GFP cells over a period of 30 mins.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1204              Figure 5:  Dual modality (MR and Fluorescence) imaging: (A)  White light (left) and fluorescence (right)  images of sample containing the  nanoprobes (N) and 5 X106 MCF7 cells (C) in separate layers.",OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1205  Discussion   In this study, Nile Red doped HMDSO based  nanoprobes were successfully formulated for flu o- rescence imaging and 1H MRI based oximetry.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1206  MR.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1207  [38]  Jain R, Patravale VB.",Non-OADS,/arxiv_data1/oa_pdf/64/82/thnov02p1199.PMC3563152.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1185  TThheerraannoossttiiccss   2012; 2(12):1185-1198. doi: 10.7150/ thno .4846  Review  Phase -Change Nanoparticles Using Highly Volatile Pe r- fluorocarbons: Toward a  Platform for Extravascular  Ultrasound Imaging   Terry O. Matsunaga1*  and Paul S. Sheeran2*, Samantha Luois3, Jason E. Streeter2, Lee B. Mullin2, Bhaskar   Banerjee4, and Paul A. Dayton2  1.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1186  the ability to use contrast agents for interrogation of  the interstitial space and the physiologic processes  occurring there.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1187  bons such as DFB and OFP [40].",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1188    Metastable Decafluorobutane nanopart i- cles  Initially, the approach to form stable DFB nano- particles was to condense the PFC compound at r e- duced temperatures and subsequently mix the r e- sulting liquid aliquot with a lipid cocktail consisting  of dipalmitoylphosphatidylcholine (DPPC), 1 - pal- mitoyl- 2-hydroxy -sn-glycero -3-phosphocholine (LPC)  and 1,2- dipalmitoyl- sn-glycero -3 phosphoethanol a- mine -N-[methoxy(polyethylene glycol) -2000] (DPPE -  PEG -2000).",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1189  cafluorobutane as a Phase -Change Contrast Agent for Low -Energy Extravascular Ultrasonic Imaging.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1190  vaporizable particle albeit at decreased stability at  physiologic temperatures, and confirming the signi f- icance of the extremely high Laplace pressures at the  nanoscale.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1191  cafluoropentane microbubbles that were intended for  use as a blood substitute [46, 47] as well as a nitrogen  “scrubber” for potentially treating underwater nitro- gen toxicity [48].",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1192  Interestingly, the above results demonstrate an  important phenomenon worth discussion at this time;  that being that combination of perfluorocarbon mi x- tures based upon their volatility allows one to mod u- late both the stability and the vaporization thresholds  of the PCNs.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1193    Targeted Delivery   Since PCNs formed by microbubble condens a- tion have lipid membranes stabilizing their surface,  they are also amenable to decoration by targetin g  ligands on their membrane surface - the same strategy  commonly applied to microbubble targeting schemes  [52].",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1194      Figure 10.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1195  apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1196  initiate therapy and follow regression of the disease.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1197  4.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1198  59.",Non-OADS,/arxiv_data1/oa_pdf/47/fa/thnov02p1185.PMC3563153.pdf
"Theranostics  2012, 2(12)       http://www.thno .org 1223  TThheerraannoossttiiccss   2012; 2(12):1223-1237. doi: 10.7150/ thno .5576  Review  Optimization of the Ultrasound -Induced Blood -Brain  Barrier Opening   Elisa E.  Konofagou1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1224  ble to treatment by therapeutic age nts because of the  BBB, the brain’s natural defense.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1225  (60-120 microbubbles per mg).",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1226  calized as the permeability of the drug increases not  only in the targeted region, but over the entire brain  and body.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1227  spatial resolution, and high temporal resolution.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1228        FIGURE 1.  a) Block diagram and illustration of the experimental setup.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1229  1.3.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1230    FIGURE 3.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1231    FIGURE 4.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1232    FIGURE 6.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1233  model absorption and speed of sound maps.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1234  7.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1235  tion.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1236  [9] Mesiwala AH, Farrell L, Wenzel HJ S, et al.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)     http://www.thno .org 1237  [61] Vlachos F, Tung YS and Konofagou EE.",Non-OADS,/arxiv_data1/oa_pdf/51/5a/thnov02p1223.PMC3563154.pdf
"Theranostics  2012, 2(12)      http://www.thno .org 1115  TThheerraannoossttiiccss   2012; 2(12):1115-1116. doi: 10.7150/ thno .5512  Editorial   Theranostic Biocolloids : Soft Matter Colloids for      Imaging and Therapy   Mark Borden1, Kaushal Rege2  1.",Non-OADS,/arxiv_data1/oa_pdf/91/2a/thnov02p1115.PMC3563155.pdf
This is an o pen-access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/91/2a/thnov02p1115.PMC3563155.pdf
"Theranostics  2012, 2(12)    http://www.thno .org 1116  view microbubbles used for gene therapy [8].",Non-OADS,/arxiv_data1/oa_pdf/91/2a/thnov02p1115.PMC3563155.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/84/ef/simycol_74_1_001.PMC3563288.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/8d/f7/simycol_74_1_002.PMC3563289.pdf
"In this study, all primers were designed according to the A. niger CBS 513.88 genome sequence  (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/8d/f7/simycol_74_1_002.PMC3563289.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/27/97/simycol_74_1_003.PMC3563290.pdf
The scripts of the Scilab functions are available at http://web.science.uu.nl/microbiology/links/index.htmL.,OADS,/arxiv_data1/oa_pdf/27/97/simycol_74_1_003.PMC3563290.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/3a/dd/simycol_74_1_004.PMC3563291.pdf
"For any reuse or distribution, you must make clear to others the license terms of this work, which can be found at http://creativecommons.org/licenses/by-nc-nd/3.0/legalcode.",Non-OADS,/arxiv_data1/oa_pdf/85/8a/simycol_74_1_005.PMC3563292.pdf
"Inordertoillustratethisholisticapproach,wehavelisted thetasksofthemonitoraccording toICHGCP5.18.4 (http://ichgcp.ne t/518-monitoring)anddescribed how weseetheseincomparisonwiththecurrentstandard tasks.Ineachcasewehavetakenintoaccount the technical supportoptionsthatshouldbeutilizedinthe contextofrisk-basedmonitoring.",OADS,/arxiv_data1/oa_pdf/b0/d0/GMS-11-04.PMC3563312.pdf
(p)Determingwhethertheinvestigatorismaintaining theessential documents (see8.Essential Documents fortheConduct ofaClinicalTrial(http://ichgcp.ne t/ 8-essential-documents-f or-the-conduct-of-a-clinical-trial ).,Non-OADS,/arxiv_data1/oa_pdf/b0/d0/GMS-11-04.PMC3563312.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.doi:10.1093/cercor/bhs048 Advance Access publication February 28, 2012Cerebral Cortex March 2013;23:615– 628",Non-OADS,/arxiv_data1/oa_pdf/42/84/bhs048.PMC3563340.pdf
Supplementary Material Supplementary material can be found at: http://www.cercor.,Non-OADS,/arxiv_data1/oa_pdf/42/84/bhs048.PMC3563340.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
Online supplemental material is avail - able at http://www.jcb.org/cgi/content/full/jcb.201207099/DC1.,Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/   10.1006/dbio.2002.082 0 Baker, C.V., and M. Bronner-Fraser.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1006/dbio   .2001.015 6 Balabanian, K., B. Lagane, S. Infantino, K.Y.C.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi   .org/10.1016/S0092-8674(01)00431- 7 Halloran, M.C., M. Sato-Maeda, J.T.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1126/science.106296 1 Kim, C.H., E. Ueshima, O. Muraoka, H. Tanaka, S.Y.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/   0304-3940(96)13021- 4 Kimmel, C.B., W.W. Ballard, S.R.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1002/aja.100203030 2 Knaut, H., C. Werz, R. Geisler, Tübingen 2000 Screen Consortium, and C.  Nüsslein-Volhard.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/353267a 0 Krauss, S., T. Johansen, V. Korzh, and A. Fjose.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4602-07.200 8 López-Bendito, G., J.A.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .4651-07.200 8 Marchese, A., and J.L.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1074/jbc.C10052720 0 Marchese, A., C. Raiborg, F. Santini, J.H.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/S1534-5807(03)00321- 6 Minina, S., M. Reichman-Fried, and E. Raz.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/j.cub.2007   .05.07 3 Miyasaka, N., H. Knaut, and Y. Yoshihara.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/7995 1 Naumann, U., E. Cameroni, M. Pruenster, H. Mahabaleshwar, E. Raz, H.-G.  Zerwes, A. Rot, and M. Thelen.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/   10.1371/journal.pone.000917 5 Ober, E.A., and S. Schulte-Merker.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1006/dbio   .1999.945 5 Oberlin, E., A. Amara, F. Bachelerie, C. Bessia, J.L.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/382833a 0 Paredes, M.F., G. Li, O. Berger, S.C. Baraban, and S.J.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
http://dx.doi.org/10.1371/   journal.pone.001430 4The chemokine SDF-1/CXCL12 binds to and signals through the orphan  receptor RDC1 in T lymphocytes.,Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1074/jbc.M50823420 0 Bartel, D.P.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/S0092-8674(04)00045- 5 Belmadani, A., P.B.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4631-04.200 5 Bernstein, E., A.A. Caudy, S.M.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/3505311 0 Blader, P., C. Plessy, and U. Strähle.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"120:211– 218. http://dx.doi.org/10.1016/S0925-4773(02)00413- 6 Blaser, H., S. Eisenbeiss, M. Neumann, M. Reichman-Fried, B. Thisse, C.  Thisse, and E. Raz.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1242/jcs.0252 2 Bleul, C.C., R.C.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi   .org/10.1084/jem.184.3.110 1 Boldajipour, B., H. Mahabaleshwar, E. Kardash, M. Reichman-Fried, H. Blaser,  S. Minina, D. Wilson, Q. Xu, and E. Raz.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/nn176 4 Busch-Nentwich, E., R. Kettleborough, F. Fenyes, C. Herd, J. Collins, S. Winkler,  M. Brand, E. de Bruijn, F. van Eeden, E. Cuppen, and D.L.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://zfin.org/cgi-bin/webdriver?MIval=aa-fxallfigures   .apg&OID=ZDB-PUB-100504-23 (accessed January 15, 2012).",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/nature0909 2 Choi, W.-Y., A.J.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1126/science.114753 5 Cifuentes, D., H. Xue, D.W. Taylor, H. Patnode, Y. Mishima, S. Cheloufi, E. Ma,  S. Mane, G.J.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1126/science.119080 9 Ciruna, B., G. Weidinger, H. Knaut, B. Thisse, C. Thisse, E. Raz, and A.F.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi   .org/10.1073/pnas.22245999 9 Cornell, R.A., and J.S.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/j.modgep.2004.10.00 7 Davies, A.M. 1988.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)01135- 2 Giraldez, A.J., R.M.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1126/science.110902 0 Giraldez, A.J., Y. Mishima, J. Rihel, R.J. Grocock, S. Van Dongen, K. Inoue,  A.J.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.12.00 6 Staton, A.A., H. Knaut, and A.J.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1038/ng.75 8 Stumm, R.K., C. Zhou, T. Ara, F. Lazarini, M. Dubois-Dalcq, T. Nagasawa, V.  Höllt, and S. Schulz.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1002/   cne.2133 6 Thermes, V., C. Grabher, F. Ristoratore, F. Bourrat, A. Choulika, J. Wittbrodt,  and J.-S. Joly.",Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/   S0925-4773(02)00218- 6 Tiveron, M.-C., and H. Cremer.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/   10.1016/j.conb.2008.06.00 4 Tiveron, M.-C., M. Rossel, B. Moepps, Y .L.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1523/JNEUROSCI   .4162-06.200 6 Trevarrow, B., D.L.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/   10.1016/0896-6273(90)90194- K Valentin, G., P. Haas, and D. Gilmour.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/j.cub   .2007.05.02 0 Van Haastert, P.J.M., and P.N.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/   10.1038/nrm143 5 Wang, Y., G. Li, A. Stanco, J.E.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.12.00 5 Warming, S., N. Costantino, D.L.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
"http://dx.doi.org/10.1093/nar/   gni03 5 Wienholds, E., M.J. Koudijs, F.J.M.",OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
http://dx.doi.org/   10.1038/ng125 1,Non-OADS,/arxiv_data1/oa_pdf/67/bf/JCB_201207099.PMC3563679.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
Online supplemental material is available at http://www.jcb.org/cgi/   content/full/jcb.201209113/DC1.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1242/jcs.0154 2 Allaire, P.D., B. Ritter, S. Thomas, J.L.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4608-06.200 6 Allaire, P.D., A.L.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.molcel.2009.12.03 7 Berrow, N.S., D. Alderton, S. Sainsbury, J. Nettleship, R. Assenberg, N. Rahman,  D.I.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1093/nar/gkm04 7 Brombacher, E., S. Urwyler, C. Ragaz, S.S. Weber, K. Kami, M. Overduin, and  H. Hilbi.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1074/ jbc.M80750520 0 Bubeck, P., S. Pistor, J. Wehland, and B.M.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi   .org/10.1016/0092-8674(92)90306- W Casey, P.J., and M.C.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1074/jbc.271.10.528 9 Castellano, F., P. Montcourrier, J.C. Guillemot, E. Gouin, L. Machesky, P.  Cossart, and P. Chavrier.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/   S0960-9822(99)80161- 4 Chavrier, P., R.G.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10   .1016/0092-8674(90)90369- P Chavrier, P., J.P. Gorvel, E. Stelzer, K. Simons, J. Gruenberg, and M. Zerial.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/353769a 0Protein expression and purification Rabex-5–VPS9 and Rabex-5–VPS9 point mutations were expressed in Esch- erichia coli  BL21 (DE3) RIL for 4 h at 37°C after induction with 1 mM IPTG  and purified by a combination of Ni-NTA and size exclusion chromatogra - phy in a final buffer consisting of 25 mM Hepes, pH 7.5, 40 mM NaCl,  and 1 mM TCEP.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.12.01 5 Sacher, M., J. Barrowman, W. Wang, J. Horecka, Y. Zhang, M. Pypaert, and  S. Ferro-Novick.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/   10.1016/S1097-2765(01)00190- 3 Schoebel, S., L.K.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/embor.2010.9 7 Silvius, J.R., P. Bhagatji, R. Leventis, and D. Terrone.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1091/mbc   .E05-05-040 8 Simonsen, A., R. Lippé, S. Christoforidis, J.M.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/2887 9 Sivars, U., D. Aivazian, and S.R.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi   .org/10.1038/nature0205 7 Stenmark, H., R.G.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10   .1074/jbc.271.39.2404 8 Tarafder, A.K., C. Wasmeier, A.C. Figueiredo, A.E.G.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
http://dx.doi.org/10.1111/j.1600-0854.2011.01216.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/nchembio.38 6 Yoshimura, S., A. Gerondopoulos, A. Linford, D.J.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10   .1083/jcb.20100805 1 Zhu, H.P ., G.Y .",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1091/mbc   .E07-02-010 0Costes, S.V., D. Daelemans, E.H. Cho, Z. Dobbin, G. Pavlakis, and S. Lockett.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10   .1529/biophysj.103.03842 2 Delprato, A., and D.G.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/nsmb123 2 Delprato, A., E. Merithew, and D.G.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi   .org/10.1016/j.cell.2004.08.00 9 Dirac-Svejstrup, A.B., T. Sumizawa, and S.R.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1093/emboj/16.3.46 5 Dong, G., M. Medkova, P. Novick, and K.M.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.molcel.2007.01   .013 Hattula, K., J. Furuhjelm, A. Arffman, and J. Peränen.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi   .org/10.1091/mbc.E02-03-014 3 Horiuchi, H., R. Lippé, H.M. McBride, M. Rubino, P. Woodman, H. Stenmark,  V. Rybin, M. Wilm, K. Ashman, M. Mann, and M. Zerial.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)80380- 3 Hutagalung, A.H., and P.J.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi   .org/10.1152/physrev.00059.200 9 Kunita, R., A. Otomo, H. Mizumura, K. Suzuki-Utsunomiya, S. Hadano, and  J.E.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1074/jbc.M61068220 0 Machner, M.P., and R.R.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.devcel.2006.05.01 3 Marat, A.L., and P.S.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1074/jbc.M109   .05093 0 Mattera, R., and J.S.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/emboj.2008.17 7 Mizuno-Yamasaki, E., M. Medkova, J. Coleman, and P. Novick.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.03.01 6 Murata, T., A. Delprato, A. Ingmundson, D.K.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/ncb146 3 Nordmann, M., M. Cabrera, A. Perz, C. Bröcker, C. Ostrowicz, S. Engelbrecht- Vandré, and C. Ungermann.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/j.cub.2010.08.00 2 Ohya, T., M. Miaczynska, U. Coskun, B. Lommer, A. Runge, D. Drechsel, Y.  Kalaidzidis, and M. Zerial.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"459:1091– 1097. http://dx.doi.org/10.1038/nature0810 7 Ortiz, D., M. Medkova, C. Walch-Solimena, and P. Novick.",Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1083/jcb.20020100 3 Pan, X., S. Eathiraj, M. Munson, and D.G.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1038/nature0484 7 Pistor, S., T. Chakraborty, K. Niebuhr, E. Domann, and J. Wehland.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
"http://dx.doi.org/10.1016/S0960-9822(95)00104- 7 Rivera, V.M., T. Clackson, S. Natesan, R. Pollock, J.F.",OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
http://dx.doi.org/10.1038/nm0996-102 8Note: The Acknowledgements section of this article has been edited in the html  and PDF versions since initial publication.,Non-OADS,/arxiv_data1/oa_pdf/9a/42/JCB_201209113.PMC3563681.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"450:695– 701. http://dx.doi.org/10.1038/nature0640 5 Ayscough, K.R., J. Stryker, N. Pokala, M. Sanders, P. Crews, and D.G.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1083/jcb.137.2.39 9 Balasubramanian, M.K., E. Bi, and M. Glotzer.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/j.cub.2004.09.02 2 Barr, F.A., and U. Gruneberg.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/j.cell.2007.11.01 1 Bi, E. 2001.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1247/csf.26.52 9 Bi, E. 2010.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"11:606. http://dx.doi   .org/10.1038/nrm295 3 Bi, E., and J.R. Pringle.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.142.5.130 1 Boyd, C., T. Hughes, M. Pypaert, and P. Novick.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/   10.1083/jcb.20040812 4 Boyne, J.R., H.M. Yosuf, P. Bieganowski, C. Brenner, and C. Price.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1083/jcb.20030103 5 Buttery, S.M., S. Yoshida, and D. Pellman.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc   .E06-09-082 0 Carvalho, A., A. Desai, and K. Oegema.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/j.cell.2009.03.02 1 Caviston, J.P., M. Longtine, J.R. Pringle, and E. Bi.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc   .E03-04-024 7 Chuang, J.S., and R.W.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.135.3.59 7 Cid, V.J., L. Adamiková, M. Sánchez, M. Molina, and C. Nombela.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb   .20070906 0 Dobbelaere, J., and Y. Barral.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
Online supplemental material is available at  http://www.jcb.org/cgi/content/full/jcb.201208030/DC1.,Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1002/(SICI)1097- 0061(199807)14:10<953::AID-YEA293>3.0.CO;2- U Lord, M., E. Laves, and T.D.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc.E05-07-060 1 Luo, J., E.A.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.20040104 0 Maupin, P., and T.D.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/0889-1605(86)90055- 8 Meitinger, F., B. Petrova, I.M.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1242/jcs.06389 1 Mendes Pinto, I., B. Rubinstein, A. Kucharavy, J.R. Unruh, and R. Li.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/   j.devcel.2012.04.01 5 Mizuguchi, S., T. Uyama, H. Kitagawa, K.H.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1038/nature0163 5 Moseley, J.B., and B.L.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"70:605– 645. http://dx.doi.org/10.1128/MMBR.00013-0 6 Murthy, K., and P. Wadsworth.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"185:995– 1012. http://dx.doi.org/10.1083/jcb.20090312 5 Pelham, R.J., and F. Chang.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10   .1038/nature0099 9 Pollard, T.D.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1042/BST036042 5 Pruyne, D., M. Evangelista, C. Yang, E. Bi, S. Zigmond, A. Bretscher, and C. Boone.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1126/science.107230 9 Pruyne, D., L. Gao, E. Bi, and A. Bretscher.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc.E04-04-029 6 Sagot, I., A.A. Rodal, J. Moseley, B.L.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1038/ncb170 1 Sandquist, J.C., and A.R.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc.E08-05-053 3 Sanger, J.M., and J.W.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1083/jcb.86.2.56 8 Satterwhite, L.L., and T.D.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/0955-0674(92)90057- J Sburlati, A., and E. Cabib.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.53.2.41 9 Shannon, K.B., and R. Li.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1146/annurev.biochem.74.082803.13342 5 Epp, J.A., and J. Chant.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1016/S0960-9822(06)00411- 8 Fang, X., J. Luo, R. Nishihama, C. Wloka, C. Dravis, M. Travaglia, M. Iwase,  E.A.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.20100513 4 Gao, X.D., L.M.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/mbc.E06-09-082 2 Gietz, R.D., and A. Sugino.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/0378-1119   (88)90185- 0 Goldbach, P., R. Wong, N. Beise, R. Sarpal, W.S.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1091/ mbc.E09-08-071 4 Guha, M., M. Zhou, and Y.L.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/   10.1016/j.cub.2005.03.04 2 Guo, W., M. Sacher, J. Barrowman, S. Ferro-Novick, and P. Novick.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/S0962-8924(00)01754- 2 Guthrie, C., and G.R.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"164:1356– 1365. http://dx.doi.org/10.1126/science.164.3886.135 6 Izumikawa, T., N. Kanagawa, Y. Watamoto, M. Okada, M. Saeki, M. Sakano, K.  Sugahara, K. Sugihara, M. Asano, and H. Kitagawa.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"178:765– 771. http://dx.doi.org/10.1083/jcb.20061201 8 Kamei, T., K. Tanaka, T. Hihara, M. Umikawa, H. Imamura, M. Kikyo, K. Ozaki,  and Y. Takai.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1074/jbc   .273.43.2834 1 Kondo, T., K. Hamao, K. Kamijo, H. Kimura, M. Morita, M. Takahashi, and  H. Hosoya.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1042/BJ2010083 7 Korinek, W.S., E. Bi, J.A.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/S0960-9822(00)00626- 6 Lee, P.R., S. Song, H.S.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/   10.1128/MCB.22.19.6906-6920.200 2 Lillie, S.H., and J.R. Pringle.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/   jcb.140.2.35 5 Lippincott, J., and R. Li.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.143.7.194 7 Lippincott, J., K.B.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
4:19. http://dx.doi.org/10.1186/1741-7007-4-1 9,Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/   S0960-9822(00)00539- X Stevens, R.C., and T.N.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1083/jcb.142.3.71 1 Strickland, L.I., and D.R.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/   10.1016/j.tcb.2004.01.00 6 Tan, J.L., S. Ravid, and J.A.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/   10.1146/annurev.bi.61.070192.00344 5 Tolliday, N., L. VerPlank, and R. Li.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"12:1864– 1870. http://dx.doi.org/10.1016/S0960-9822(02)01238- 1 Trybus, K.M.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/0955-0674   (91)90172- U Tully, G.H., R. Nishihama, J.R. Pringle, and D.O.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1091/mbc.E08-08-082 2 Uehara, R., G. Goshima, I. Mabuchi, R.D.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1016/j.cub.2010.04.05 8 Vallen, E.A., J. Caviston, and E. Bi.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"16:2529– 2543. http://dx.doi.org/10.1091/mbc.E04-12-109 0 Wagner, W., P. Bielli, S. Wacha, and A. Ragnini-Wilson.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi.org/10.1093/   emboj/cdf65 0 Wloka, C., R. Nishihama, M. Onishi, Y. Oh, J. Hanna, J.R. Pringle, M. Krauss,  and E. Bi.",Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1515/BC.2011.08 3 Yang, S.S., E. Yeh, E.D.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1126/science.112674 7 Yumura, S. 2001.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
"http://dx.doi   .org/10.1083/jcb.20001101 3 Yumura, S., M. Ueda, Y. Sako, T. Kitanishi-Yumura, and T. Yanagida.",OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
http://dx.doi.org/10.1111/ j.1600-0854.2008.00837.,Non-OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
http://dx.doi.org/10.1016/   j.cub.2010.09.04 8,OADS,/arxiv_data1/oa_pdf/54/49/JCB_201208030.PMC3563683.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the  publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as  described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1107/S090744490905292 5 Alexander, J.E., D.F.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1007/978-1-59745-442-1_ 2 Arce, C.A., J.A.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
http://dx.doi   .org/10.1111/j.1432-1033.1975.tb02435.,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1038/336185a 0 Barbier, P., A. Dorléans, F. Devred, L. Sanz, D. Allegro, C. Alfonso, M.  Knossow, V. Peyrot, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1074/   jbc.M110.14192 9 Barra, H.S., C.A.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1007/BF0293534 3 Berezniuk, I., H.T.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1074/jbc.M111.30913 8 Bieling, P., S. Kandels-Lewis, I.A.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1083/jcb.20080919 0 Brummelkamp, T.R., R. Bernards, and R. Agami.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1126/science.106899 9 Buey, R.M., J.F.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1021/bi060334 m Davis, I.W., L.W.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1093/nar/gkh39 8 Dorleans, A., M. Knossow, and B. Gigant.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1242/jcs.02649 2Expression constructs and TTL shRNA pactin-HA- -galactosidase was generated by ligating -galactosidase in  the AscI and SalI sites in a modified p -actin-16pl vector (Kaech et al.,  1996).",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201211017/DC1.,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
Additional data are available in the  JCB DataViewer at http://dx.doi.org/10.1083/jcb.201211017.dv.,OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/   10.1038/nn.231 4 Konno, A., M. Setou, and K. Ikegami.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/   10.1016/B978-0-12-394305-7.00003- 3 Kreitzer, G., G. Liao, and G.G.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1093/hmg/ddq18 2 Lacroix, B., and C. Janke.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1007/978-1-61779-252-6_ 4 Lafanechère, L., C. Courtay-Cahen, T. Kawakami, M. Jacrot, M. Rüdiger, J.  Wehland, D. Job, and R.L.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1006/jmbi.2001.507 7 Ludueña, R.F.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/0014-5793(94)01018- 8 Mialhe, A., L. Lafanechère, I. Treilleux, N. Peloux, C. Dumontet, A. Brémond,  M.H.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/j.jmb.2011.07.02 9 Nogales, E., S.G. Wolf, and K.H.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/   10.1016/S0092-8674(00)80961- 7 Paturle, L., J. Wehland, R.L.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/ 10.1073/   pnas.120412910 9 Peris, L., M. Thery, J. Fauré, Y. Saoudi, L. Lafanechère, J.K. Chilton, P. Gordon- Weeks, N. Galjart, M. Bornens, L. Wordeman, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1083/jcb.20051205 8 Peris, L., M. Wagenbach, L. Lafanechère, J. Brocard, A.T. Moore, F. Kozielski,  D. Job, L. Wordeman, and A. Andrieux.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"185:1159– 1166. http://dx.doi.org/10.1083/jcb.20090214 2 Poirier, K., Y. Saillour, F. Fourniol, F. Francis, I. Souville, S. Valence, I.  Desguerre, J. Marie Lepage, N. Boddaert, M. Line Jacquemont, et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1126/   science.123058 2 Ravelli, R.B., B. Gigant, P.A.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1038/nature0239 3 Regnard, C., S. Audebert, P. Desbruyères, P. Denoulet, and B. Eddé.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1021/bi980413 1Eddé, B., J. Rossier, J.P.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"247:83– 85. http://dx.doi.org/10.1126/science.196719 4 Eddé, B., J. Rossier, J.P.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1021/bi00117a01 4 Emsley, P., and K. Cowtan.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"120:725– 732. http://dx.doi.org/10.1083/jcb.120.3.72 5 Fan, C., P.C.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1126/science.793968 4 Field, J.J., A.J.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/ 10.1021/   jm901249 g Galperin, M.Y., and E.V.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1002/pro.556006121 8 Hammond, J.W., D. Cai, and K.J.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1016/j.ceb.2007.11.01 0 Hara, T., H. Kato, Y. Katsube, and J. Oda.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1021/bi960524 5 Hoogenraad, C.C., and F. Bradke.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.08.00 6 Howard, J., and A.A. Hyman.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1038/nature0160 0 Idriss, H.T.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0169   (200005)46:1<1::AID-CM1>3.0.CO;2- 6 Ikegami, K., M. Mukai, J. Tsuchida, R.L.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1074/jbc.M60398420 0 Infante, A.S., M.S.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1038/nrm322 7 Janke, C., K. Rogowski, D. Wloga, C. Regnard, A.V.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1126/science.111301 0 Kabsch, W. 2010.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1107/S090744490904733 7 Kaech, S., B. Ludin, and A. Matus.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80249- 4 Kapitein, L.C., K.W.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1016/S0091-679X(10)97007- 6 Kato, C., K. Miyazaki, A. Nakagawa, M. Ohira, Y .",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1002/ijc.2043 1 Kimura, Y., N. Kurabe, K. Ikegami, K. Tsutsumi, Y. Konishi, O.I.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
http://dx.doi.org/10.1074/jbc.C110.12828 0,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/j.cell.2009.05.02 0 Rogowski, K., J. van Dijk, M.M.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/j.cell.2010.10.01 4 Rüdiger, M., U. Plessman, K.D.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1016/0014-5793(92)81061- P Rüdiger, M., J. Wehland, and K. Weber.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
220:309– 320. http://dx.doi.org/10.1111/j.1432-1033.1994.tb18627.,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1016/j.jneumeth.2010.12.01 1 Steinmetz, M.O., and A. Akhmanova.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/   10.1016/j.tibs.2008.08.00 6 Szyk, A., A.M. Deaconescu, G. Piszczek, and A. Roll-Mecak.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1038/nsmb.214 8 Tischfield, M.A., G.Y.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"21:286– 294. http://dx.doi.org/10.1016/j.gde.2011.01.00 3 van Dijk, J., K. Rogowski, J. Miro, B. Lacroix, B. Eddé, and C. Janke.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10   .1016/j.molcel.2007.04.01 2 Verhey, K.J., and J. Gaertig.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.4161/cc.6.17.463 3 Wehland, J., and K. Weber.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1083/jcb.104.4.105 9 Westermann, S., and K. Weber.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi   .org/10.1038/nrm126 0 Whipple, R.A., M.A.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1158/0008-5472.CAN-09-461 3 Wloga, D., D.M.",Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
"http://dx.doi.org/10.1016/j.devcel.2009.04.00 8 Yuan, B., R. Latek, M. Hossbach, T. Tuschl, and F. Lewitter.",OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
http://dx.doi   .org/10.1093/nar/gkh36 6,Non-OADS,/arxiv_data1/oa_pdf/5e/25/JCB_201211017.PMC3563685.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
Online supplemental material is available at http://www.jcb.org/   cgi/content/full/jcb.201206010/DC1.,Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
Additional data are available in the    JCB DataViewer at http://dx.doi.org/10.1083/jcb.201206010.dv.,OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi   .org/10.1016/j.semcdb.2008.02.00 3 Bershadsky, A.D., E.A.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1002/cm.97019030 3 Bugyi, B., and M.F.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1146/   annurev­biophys­051309­10384 9 Cahoy, J.D., B. Emery, A. Kaushal, L.C.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1007/s11060 ­005­9090 ­0 Potokar, M., M. Stenovec, M. Gabrijel, L. Li, M. Kreft, S. Grilc, M. Pekny, and  R. Zorec.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1007/s10024­003­7068­ 5 Rowan, A.J., H. Lamlum, M. Ilyas, J. Wheeler, J. Straub, A. Papadopoulou, D.  Bicknell, W.F.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi   .org/10.1073/pnas.97.7.335 2 Segditsas, S., and I. Tomlinson.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10   .1038/sj.onc.121005 9 Shintani, T., Y. Takeuchi, A. Fujikawa, and M. Noda.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.0590­12.201 2 Su, L.K., M. Burrell, D.E.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/ 10.1002/(SICI)1098­1136(200004)30:2<143::AID­GLIA4>3.0.CO;2­ Z Wagner, O.I., J. Ascaño, M. Tokito, J.F.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi   .org/10.1091/mbc.E04­05­040 1 Wang, Y., Y. Azuma, D.B.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"10:75. http://dx.doi.org/10   .1186/1471­2121­10­7 5 Watanabe, T., S. Wang, J. Noritake, K. Sato, M. Fukata, M. Takefuji, M.  Nakagawa, N. Izumi, T. Akiyama, and K. Kaibuchi.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10   .1016/j.devcel.2004.10.01 7 Whipple, R.A., E.M. Balzer, E.H. Cho, M.A.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"68:5678– 5688. http://dx.doi.org/10.1158/0008 ­5472.CAN ­07­6589 Wiche, G. 1998.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1101/SQB.1982.046.01.04 4 Yabe, J.T., A. Pimenta, and T.B.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"30:483– 491. http://dx.doi.org/10.1007/s10571­009­9474­ 3 Zackroff, R.V ., and R.D.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4178­07.200 8 Dahlstrand, J., V.P.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1242/jcs.07635 6 Ehrmann, J., Z. Kolár, and J. Mokry.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1136/jcp   .2004.02123 8 Etienne­Manneville, S. 2006.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1016/S0076­6879(06)06044­ 7 Etienne­Manneville, S. 2009.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1007/978­1­4419­1145­2_ 3 Etienne­Manneville, S. 2010.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi   .org/10.1016/j.ceb.2009.11.00 8 Etienne ­Manneville, S., and A.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1016/S0092­8674(01)00471­ 8 Etienne ­Manneville, S., and A.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"421:753– 756. http://dx.doi.org/10.1038/nature0142 3 Etienne­Manneville, S., J.B. Manneville, S. Nicholls, M.A.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"170:895– 901. http://dx.doi.org/10.1083/jcb.20041217 2 Goldman, R.D.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"51:752– 762. http://dx.doi.org/10.1083/jcb.51.3.75 2 Helfand, B.T., A. Mikami, R.B.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/   10.1083/jcb.20020202 7 Helfand, B.T., P. Loomis, M. Yoon, and R.D.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1242/jcs.0052 6 Herrmann, H., and U. Aebi.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1016/   S0955­0674(99)00060­ 5 Herrmann, H., and G. Wiche.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1016/S0091­679X(04)78001­ 2 Jing, R., G. Pizzolato, R.M.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1002/glia.2015 8 Lee, S.H., and R. Dominguez.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1007/s10059­   010­0053­ 8 Lepekhin, E.A., C. Eliasson, C.H.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
http://dx.doi.org/10.1046/j.1471­4159.2001.00595.,Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi   .org/10.1146/annurev.cellbio.20.012103.09454 1 Nguyen, M.D., T. Shu, K. Sanada, R.C.",OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
"http://dx.doi.org/10.1038/ncb113 9 Okada, K., F. Bartolini, A.M. Deaconescu, J.B. Moseley, Z. Dogic, N. Grigorieff,  G.G.",Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
http://dx.doi.org/10.1083/jcb.20100101 6,Non-OADS,/arxiv_data1/oa_pdf/fc/ee/JCB_201206010.PMC3563686.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi - cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"After six months it is available under a   Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201204092/DC1.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
Additional data are available in the JCB DataViewer at http://dx.doi   .org/10.1083/jcb.201204092.dv.,OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc.E02-11-076 7 Au, J.S., C. Puri, G. Ihrke, J. Kendrick-Jones, and F. Buss.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1083/jcb.20060812 6 Bader, M.F., R.W.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1111/j.1749-6632.2002.tb04461.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1042/BJ2002153 5 Becherer, U., and J. Rettig.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1007/s00441-006-0243- z Bellei, E., E. Monari, S. Bergamini, T. Ozben, and A. Tomasi.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1002/ elps  .20100069 9 Bond, L.M., A.A. Peden, J. Kendrick-Jones, J.R.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1126/science.158977 1 Bryant, Z., D. Altman, and J.A.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/j.bbrc.2007.11.15 0 Buss, F., J. Kendrick-Jones, C. Lionne, A.E.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1083/jcb.143.6.153 5 Buss, F., S.D.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1093/emboj/20.14.367 6 Chasserot-Golaz, S., N. Vitale, E. Umbrecht-Jenck, D. Knight, V. Gerke,  and M.F.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc   .E04-07-062 7 Dernick, G., G. Alvarez de Toledo, and M. Lindau.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1038/ncb95 6 Desnos, C., S. Huet, I. Fanget, C. Chapuis, C. Böttiger, V. Racine, J.B. Sibarita,  J.P. Henry, and F. Darchen.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1228-07.200 7 Eichler, T.W., T. Kögel, N.V. Bukoreshtliev, and H.H.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1042/BST034067 1 Fonslow, B.R., P.C.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc.E03-06-040 2 Gurd, J.W.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/   S0197-0186(97)00022- 3 Hanke, J.H., J.P. Gardner, R.L.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1074/jbc.271.2.69 5 Ingley, E. 2008.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1074/jbc.275.12.843 9 Jordan, M.A., and L. Wilson.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/S0076-6879(98)98024- 7 Keller, P., D. Toomre, E. Díaz, J.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1038/3505504 2 Kisiel, M., D. Majumdar, S. Campbell, and B.A.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1083/jcb.137.7.158 9 Puri, C. 2009.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/   10.1074/jbc.M109.01232 8 Radha, V., A. Rajanna, and G. Swarup.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"5:31. http://dx.doi.org/10.1186/1471-2121-5-3 1 Riedl, J., A.H. Crevenna, K. Kessenbrock, J.H.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1038/nmeth.122 0 Roberts, R., I. Lister, S. Schmitz, M. Walker, C. Veigel, J. Trinick, F. Buss, and  J. Kendrick-Jones.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1016/0092-8674(89)90005- 6 Rudolf, R., T. Kögel, S.A. Kuznetsov, T. Salm, O. Schlicker, A. Hellwig, J.A.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1242/jcs.0031 7 Rusanescu, G., H. Qi, S.M.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/0896-   6273(95)90019- 5 Sarafian, T., L.A. Pradel, J.P. Henry, D. Aunis, and M.F.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1083/jcb.114.6.113 5 Saxton, M.J. 1993.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/S0006-3495   (93)81548- 0 Saxton, M.J., and K. Jacobson.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1038/nbt114 6 Self, T., T. Sobe, N.G.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1006/dbio.1999.942 4 Shyu, K.G., G.M.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1097/01.wnr   .0000189758.57164.8 5 Simon, J.P., M.F.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1126/science   .668167 6 Steyer, J.A., and W. Almers.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1016/S0006-3495(99)77382- 0 Toonen, R.F., O. Kochubey, H. de Wit, A. Gulyas-Kovacs, B. Konijnenburg,  J.B. Sørensen, J. Klingauf, and M. Verhage.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1038/sj.emboj.760125 6 Trifaró, J.M., and M.L.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/   10.1016/0166-2236(93)90079- 2 Turner, K.M., R.D.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1016/S0166-2236(99)01436- 8neuromuscular junction.,OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"12:65. http://dx.doi.org/10   .1186/1471-2202-12-6 5 Kögel, T., R. Rudolf, E. Hodneland, A. Hellwig, S.A. Kuznetsov, F. Seiler, T.H.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1111/j.1600-0854.2010.01048.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/   10.1152/physiol.00014.200 5 Lejen, T., T.D.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1111/ j.1749-6632.2002.tb04469.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1007/s10974-011-9279- 0 Malacombe, M., M. Ceridono, V. Calco, S. Chasserot-Golaz, P.S.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1038/sj.emboj.760124 7 McLachlan, R.W., and A.S. Yap.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc.E06-12-115 4 Mermall, V., P.L.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1126/science.279.5350.52 7 Messa, M., S. Congia, E. Defranchi, F. Valtorta, A. Fassio, F. Onofri, and F.  Benfenati.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1242/jcs.06844 5 Meunier, F.A., S.L.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc.E05-02-017 1 Nakata, T., and N. Hirokawa.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1007/s00424-006-0143- 9 Oheim, M., and W. Stühmer.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi   .org/10.1007/s00249005025 3 Ohnishi, H., S. Yamamori, K. Ono, K. Aoyagi, S. Kondo, and M. Takahashi.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1074/jbc.M70485620 0 Pang, D.T., J.K. Wang, F. Valtorta, F. Benfenati, and P. Greengard.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1074/jbc.270.3.133 2 Patton, C., S. Thompson, and D. Epel.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1016/j.ceca.2003.10.00 6,OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1091/mbc.E04-11-100 1 Vitale, M.L., A. Rodríguez Del Castillo, L. Tchakarov, and J.M.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/   10.1083/jcb.113.5.105 7 Vitale, N., M. Gensse, S. Chasserot-Golaz, D. Aunis, and M.F.",Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1111/j.1460-9568.1996.tb01296.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"http://dx.doi.org/10.1097/00001756-200308060-0002 4 Wells, A.L., A.W.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
"2:491. http://dx.doi   .org/10.1038/ncomms150 0 Westerink, R.H., and A.G. Ewing.",OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
http://dx.doi.org/10.1111/ j.1748-1716.2007.01805.,Non-OADS,/arxiv_data1/oa_pdf/0f/d0/JCB_201204092.PMC3563687.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
"http://dx.doi.org/10.1126/science.117537 1 Dryden, S.C., F.A.",OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
"http://dx.doi.org/10.1053/j.gastro.2010.06.00 7 Toivola, D.M., P. Strnad, A. Habtezion, and M.B.",OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.11.00 4 Yang, X.J., and E. Seto.",OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
"http://dx.doi.org/10.1016/j.molcel.2006.06.02 6 Kim, H.S., A. Vassilopoulos, R.H. Wang, T. Lahusen, Z. Xiao, X. Xu, C. Li,  T.D.",OADS,/arxiv_data1/oa_pdf/3f/24/JCB_201209028.PMC3563689.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/nature1065 8 Betancur, C., T. Sakurai, and J.D.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi   .org/10.1523/JNEUROSCI.0032-08.200 8 Hoon, M., T. Soykan, B. Falkenburger, M. Hammer, A. Patrizi, K.F.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1126/science.277.5331.151 1 Ishikawa, T., N. Gotoh, C. Murayama, T. Abe, M. Iwashita, F. Matsuzaki, T.  Suzuki, and T. Yamamoto.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1002/dvdy.2249 6 Jamain, S., K. Radyushkin, K. Hammerschmidt, S. Granon, S. Boretius, F.  Varoqueaux, N. Ramanantsoa, J. Gallego, A. Ronnenberg, D. Winter,  et al.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1002/ ajmg.b.3072 6 Klassen, M.P., and K. Shen.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"130:704– 716. http://dx.doi.org/10.1016/j.cell.2007.06.04 6 Krueger, D.D., L.P. Tuffy, T. Papadopoulos, and N. Brose.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi   .org/10.1016/j.conb.2012.02.01 2 Lein, E.S., M.J. Hawrylycz, N. Ao, M. Ayres, A. Bensinger, A. Bernard, A.F.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"445:168– 176. http://dx.doi.org/10.1038/nature0545 3 Levinson, J.N., N. Chéry, K. Huang, T.P.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1074/jbc.M41381220 0 Li, J., J. Liu, G. Feng, T. Li, Q. Zhao, Y. Li, Z. Hu, L. Zheng, Z. Zeng, L.  He, et al.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/   j.schres.2010.11.00 2 Linhoff, M.W., J. Laurén, R.M.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.neuron.2009.01.01 7 Litwack, E.D., R. Babey, R. Buser, M. Gesemann, and D.D.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.mcn.2003.10.01 6 Mah, W., J. Ko, J. Nam, K. Han, W.S.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/   JNEUROSCI.4839-09.201 0 Margolis, S.S., J. Salogiannis, D.M.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi   .org/10.1038/nature0175 5 Patel, M.R., and K. Shen.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1126/   science.116902 5 Peça, J., and G. Feng.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.conb   .2012.02.01 5 Penzes, P., M.E.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
http://dx.doi.org/10.1038/nn.274 1disorders.,OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.tins.2009   .04.00 3 Biederer, T., Y. Sara, M. Mozhayeva, D. Atasoy, X. Liu, E.T.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1126/   science.107235 6 Boucard, A.A., A.A. Chubykin, D. Comoletti, P. Taylor, and T.C.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"19:231– 234. http://dx.doi.org/10.1016/j.conb.2009.06.00 3 Bucan, M., B.S.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1371/journal.pgen.100053 6 Budreck, E.C., and P. Scheiffele.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
http://dx.doi.org/10.1111/j.1460-9568.2007.05842.,Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.neuron.2006.06.00 5 Chubykin, A.A., D. Atasoy, M.R.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.neuron.2007.05.02 9 Craig, A.M., E.R.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/   10.1016/j.tins.2005.11.00 2 de Bruijn, D.R., A.H. van Dijk, R. Pfundt, A. Hoischen, G.F. Merkx, G.A.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1159/00028029 0 Dean, C., F.G. Scholl, J. Choih, S. DeMaria, J. Berger, E. Isacoff, and P.  Scheiffele.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/nn107 4 Etherton, M., C. Földy, M. Sharma, K. Tabuchi, X. Liu, M. Shamloo, R.C.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10   .1073/pnas.111109310 8 Flavell, S.W., C.W.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1126/science.112251 1 Fujimura, Y., M. Iwashita, F. Matsuzaki, and T. Yamamoto.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j   .brainres.2006.05.03 0 Gauthier, J., T.J. Siddiqui, P. Huashan, D. Yokomaku, F.F.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2457-09.200 9 Glessner, J.T., K. Wang, G. Cai, O. Korvatska, C.E.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/nature0795 3 Graf, E.R., X. Zhang, S.X.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi   .org/10.1016/j.cell.2004.11.03 5 Graf, E.R., Y. Kang, A.M. Hauner, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
http://dx.doi.org/10.1523/   JNEUROSCI.1253-05.200 6,Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.ajhg.2011.11.02 5 Valnegri, P., C. Montrasio, D. Brambilla, J. Ko, M. Passafaro, and C. Sala.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1093/hmg/ddr41 8 Varoqueaux, F., S. Jamain, and N. Brose.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi   .org/10.1016/j.neuron.2011.11.02 9 Yoshida, T., M. Yasumura, T. Uemura, S.J.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.2136-11.201 1 Zhiling, Y., E. Fujita, Y. Tanabe, T. Yamagata, T. Momoi, and M.Y.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.bbrc.2008.10.10 7Pinto, D., A.T. Pagnamenta, L. Klei, R. Anney, D. Merico, R. Regan, J. Conroy,  T.R.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/nature0914 6 Piton, A., J.L.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10   .1093/hmg/ddn30 0 Poulopoulos, A., G. Aramuni, G. Meyer, T. Soykan, M. Hoon, T. Papadopoulos,  M. Zhang, I. Paarmann, C. Fuchs, K. Harvey, et al.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j   .neuron.2009.08.02 3 Prange, O., T.P.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
http://dx.doi.org/10.1034/j.1601-183X.2003.00037.,Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.neuron.2011.05.00 2 Scheiffele, P., J.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/S0092-   8674(00)80877- 6 Siddiqui, T.J., and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.conb.2010.08.01 6 Siddiqui, T.J., R. Pancaroglu, Y. Kang, A. Rooyakkers, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0470-10.201 0 Soler-Llavina, G.J., M.V.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1073/   pnas.111402810 8 Song, J.Y., K. Ichtchenko, T.C.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/nature0745 6 Sun, C., M.C.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1093/hmg/ddr20 8 Szatmari, P., A.D. Paterson, L. Zwaigenbaum, W. Roberts, J. Brian, X.Q.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1038/ng198 5 Tabuchi, K., J. Blundell, M.R.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1126/science.114622 1 Takahashi, H., P. Arstikaitis, T. Prasad, T.E.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1016/j.neuron.2010.12.02 4 Takahashi, H., K. Katayama, K. Sohya, H. Miyamoto, T. Prasad, Y. Matsumoto,  M. Ota, H. Yasuda, T. Tsumoto, J. Aruga, and A.M. Craig.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.4935-   05.200 6 Taniguchi, H., L. Gollan, F.G. Scholl, V. Mahadomrongkul, E. Dobler, N.  Limthong, M. Peck, C. Aoki, and P. Scheiffele.",Non-OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.0032-07.200 7 Vaags, A.K., A.C. Lionel, D. Sato, M. Goodenberger, Q.P.",OADS,/arxiv_data1/oa_pdf/22/60/JCB_201206028.PMC3563690.pdf
1http://dx.doi.org/10.4046/trd.2013.74.1.1   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:1-6 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/ed/e5/trd-74-1.PMC3563697.pdf
"Key Words:  Idiopathic Pulmonary Fibrosis; Etiology; Clinical Trial Address for correspondence: Eun Joo Lee, M.D., Ph.D. Division of Respiratory and Critical Care Medicine, Depart- ment of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, 73, Inchon-ro, Seong- buk-gu, Seoul 136-705, Korea Phone: 82-2-920-5048, Fax: 82-2-929-2045E-mail: nanjung@korea.ac.kr Received: Dec. 21, 2012 Revised: Dec. 26, 2012Accepted: Dec. 28, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction   Idiopathic pulmonary fibrosis (IPF) is a progressive  f i b r o s i n g  d i s e a s e  o f  u n k n o w n  c a u s e  a n d  i s  l i m i t e d  t o  the lungs.",Non-OADS,/arxiv_data1/oa_pdf/ed/e5/trd-74-1.PMC3563697.pdf
15http://dx.doi.org/10.4046/trd.2013.74.1.15   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:15-22 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/63/ff/trd-74-15.PMC3563698.pdf
"D iv ision  o f P u lm on ary  an d C ritical C are  M ed icine , D ep artm e nt  of Internal Medicine and Lung Institute of Medical Research  Center, Seoul National University Hospital, Seoul National University College of Medicine, 101, Daehak-ro, Jongno-gu,  Seoul 110-744, Korea Phone: 82-2-2072-4743, Fax: 82-2-762-9662E-mail: kauri670@gmail.com Received: Jan. 3, 2013 Revised: Jan. 14, 2013Accepted: Jan. 16, 2013 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Many patients visit the emergency department of pri- m a r y  c a r e  c e n t e r s  w i t h  a c u t e  s h o r t n e s s  o f  b r e a t h ,  a n d   their chest radiographs show bilateral haziness.",Non-OADS,/arxiv_data1/oa_pdf/63/ff/trd-74-15.PMC3563698.pdf
23http://dx.doi.org/10.4046/trd.2013.74.1.23   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:23-27 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/3b/af/trd-74-23.PMC3563699.pdf
"11, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Castleman's disease (CD), also known as angio- follicular or giant lymph node hyperplasia, is a rare  atypical lymphoproliferative disorder1-3.",Non-OADS,/arxiv_data1/oa_pdf/3b/af/trd-74-23.PMC3563699.pdf
28http://dx.doi.org/10.4046/trd.2013.74.1.28   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:28-31 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/19/07/trd-74-28.PMC3563700.pdf
"16, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Congenital cystic adenomatoid malformation (CCAM)  is a rare developmental anomaly of the terminal respira-tory structures with an incidence of 1 in 10,000 to 1  in 35,000 births 1.",Non-OADS,/arxiv_data1/oa_pdf/19/07/trd-74-28.PMC3563700.pdf
32http://dx.doi.org/10.4046/trd.2013.74.1.32   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:32-36 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/2c/d2/trd-74-32.PMC3563701.pdf
"9, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Breast cancer is one of the most prevalent cancer in  women and can result in various thoracic manifestations  from either treatment, its complications or tumor re- currence and metastasis1.",Non-OADS,/arxiv_data1/oa_pdf/2c/d2/trd-74-32.PMC3563701.pdf
37http://dx.doi.org/10.4046/trd.2013.74.1.37   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:37-40 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/68/57/trd-74-37.PMC3563702.pdf
"16, 2012 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Lung cancer is the most common cause of cancer-re- lated death in many countries.",Non-OADS,/arxiv_data1/oa_pdf/68/57/trd-74-37.PMC3563702.pdf
7http://dx.doi.org/10.4046/trd.2013.74.1.7   ISSN: 1738-3536(Print)/2005-6184(Online)Tuberc Respir Dis 2013;74:7-14 Copyright Ⓒ2013.,Non-OADS,/arxiv_data1/oa_pdf/3e/f5/trd-74-7.PMC3563703.pdf
"Key Words:  Nitric Oxide; Bronchiectasis; Nontuberculous Mycobacteria Address for correspondence: Ho Il Yoon, M.D., Ph.D. Division of Pulmonary and Critical Care Medicine,  Department of Internal Medicine, Seoul National University  Bundang Hospital, Seoul National University College of Medicine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam  463-707, Korea Phone: 82-31-787-7036, Fax: 82-31-787-4051E-mail: dextro@snubh.org Received: Dec. 19, 2012 Revised: Dec. 24, 2012Accepted: Jan. 11, 2013 CCIt is identical to the Creative Commons Attribution Non-Commerc ial  License (http://creativecommons.org/licenses/by-nc/3.0/).Introduction Nitric oxide (NO) is an important inflammatory medi- ator of biological function in the airways, regulating air- way smooth muscle contractility, mucus secretion and  vasodilation1 and its measurement in the exhaled air is  one of the useful markers for airway inflammation2.",Non-OADS,/arxiv_data1/oa_pdf/3e/f5/trd-74-7.PMC3563703.pdf
http://www.fda.gov/downloads/ AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/ UCM247160.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fe/4e/40258_2012_Article_5.PMC3563954.pdf
http://www.nice.org.uk/nice media/live/13016/57154/57154.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fe/4e/40258_2012_Article_5.PMC3563954.pdf
Maps and sequences of lentivectors are available at ourwebsite ( http://medweb2.unige.ch/salmon/lentilab/ ).,OADS,/arxiv_data1/oa_pdf/68/d9/125_2012_Article_2779.PMC3563957.pdf
The image series were analysed employing the ImageJ 1.32 software ( http://imagej.nih.gov/ij/ ).,OADS,/arxiv_data1/oa_pdf/68/d9/125_2012_Article_2779.PMC3563957.pdf
"The image analysis has been done by an adapted version of the soft- ware Circadian Gene Express (CGE, http://bigwww.epfl.ch/ sage/soft/circadian/ ), a Java ImageJ ’s plugin that we previ- ously developed for tracking cells in the context of circadian studies [ 26,28].",OADS,/arxiv_data1/oa_pdf/68/d9/125_2012_Article_2779.PMC3563957.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/20/d0/mss254.PMC3563967.pdf
"Amino acid content and codon usage were deter-m i n e dw i t hC O D O N W( http://codonw.sourceforge.net/ ,l a s t accessed November 20, 2012).",OADS,/arxiv_data1/oa_pdf/20/d0/mss254.PMC3563967.pdf
"Amino acid align- ments were used to guide nucleotide alignments in SE-ALv.2.0a11 ( http://tree.bio.ed.ac.uk/software/seal/ , last accessed November 20, 2012).",OADS,/arxiv_data1/oa_pdf/20/d0/mss254.PMC3563967.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3b/d8/mss258.PMC3563969.pdf
A l li n p u tX M Lﬁ l e sf o rt h ea n a l y s e sp e r f o r m e da n dt h e source code for the BEAST 2 add-on that implements the described methodology are available from http://code.google.,OADS,/arxiv_data1/oa_pdf/3b/d8/mss258.PMC3563969.pdf
Supplementary Material Supplementary ﬁgures S1–S10 and tables S1–S5 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/3b/d8/mss258.PMC3563969.pdf
Available from: http://tree.bio.,OADS,/arxiv_data1/oa_pdf/3b/d8/mss258.PMC3563969.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/99/mss259.PMC3563970.pdf
Source codes in R for the regression and geometric meth- ods are available at ( http://membres-timc.imag.fr/Michael.,Non-OADS,/arxiv_data1/oa_pdf/b2/99/mss259.PMC3563970.pdf
Supplementary Material Supplementary tables S1–S7 and ﬁgures S1–S11 are available atMolecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/b2/99/mss259.PMC3563970.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
"Materials and Methods Human miRNA Information The miRNA data ﬁles, miRNA.dat and hsa.gff, of miRBaser e l e a s e1 8w e r ed o w n l o a d e df r o m ftp://mirbase.org/pub/ mirbase/18/ (last accessed 29 November 2012).",OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
(Please also refer to http://genomewiki.ucsc.edu/index.,Non-OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
"1994 )(http://www.tbi.univie.ac.at/ /C24ivo/RNA/ ; last accessed 29 November 2012) was used to compute the folding energy of each of 1,523 human precursor miRNAs with the default settings, and obtained the 99.5 per-centile value of /C012.5 kcal/mol.",OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
2007) from http://www.cell.com/ supplemental/S0092-8674(07)00604-6 (last accessed 29 November 2012).,Non-OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
Supplementary Material Supplementary tables S1 and S2 are available at Molecular Biology and Evolution online ( http://www.mbe.,Non-OADS,/arxiv_data1/oa_pdf/25/c8/mss262.PMC3563971.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/be/43/mss266.PMC3563974.pdf
"For some of the analyses, we added a second Dmel sequence derived from the consensus of 5 full-genome sequenced indi-viduals from the Raleigh population of the 50 Drosophila genomes project (Release 1.0, http://www.dpgp.org/ ;l a s t accessed 7 Dec 2012).",Non-OADS,/arxiv_data1/oa_pdf/be/43/mss266.PMC3563974.pdf
Whole-genome CDS alignments were downloaded from the UCSC table browser ( http://genome.ucsc.edu/ ;l a s t accessed 7 Dec 2012).,OADS,/arxiv_data1/oa_pdf/be/43/mss266.PMC3563974.pdf
Preliminary Dbip sequence data were obtained from Baylor College of Medicine Human Genome Sequencing Center website at http://www.hgsc.bcm.tmc.edu (last acce- ssed 7 Dec 2012).,OADS,/arxiv_data1/oa_pdf/be/43/mss266.PMC3563974.pdf
"This is an Open Access article distributed under the terms o f the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e0/51/mss273.PMC3563975.pdf
"( A) Relative frequency of codon usage for each amino acid, cal culated for a list of 39 highly expressed ribosomal protein coding genes (from the codon usage bias database, http://cub-db.cs.umt.edu/index.shtml , last accessed December 16, 2012).",OADS,/arxiv_data1/oa_pdf/e0/51/mss273.PMC3563975.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)AQ2S is a novel neuroprotective drug TC Jackson et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/24/2c/cddis2012187a.PMC3563977.pdf
"A complete list of regulated genes isfound in Supplementary data (http://www.ncbi.nlm.nih.gov/ geo/, accession number AAH22499).",Non-OADS,/arxiv_data1/oa_pdf/f9/ce/cddis2012188a.PMC3563978.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Ephrin B3 as a radiosensitizing target in lung cancer S Sta˚hlet al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f9/ce/cddis2012188a.PMC3563978.pdf
"pI and MW were calculated at http://web.expasy.org/protparam/, with a serine to glutamate substitution representing phosphorylation.",OADS,/arxiv_data1/oa_pdf/f0/01/cddis2012191a.PMC3563979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Bak phosphorylation VH Tran et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f0/01/cddis2012191a.PMC3563979.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Cytoplasmic vacuolation death in TNBC PK Singha et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b2/fe/cddis2012192a.PMC3563980.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Glucocorticoid receptor isoforms and apoptosis IW u et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/bb/9a/cddis2012193a.PMC3563981.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Dopamine prevents glutamate-induced neurotoxicity A Vaarmann et al 6 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/9f/ce/cddis2012194a.PMC3563982.pdf
Protein and mRNA levels were quantiﬁed using NIH ImageJ software (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/c6/dd/cddis2012195a.PMC3563983.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)PrPSclimits A-beta clearance E Pradines et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c6/dd/cddis2012195a.PMC3563983.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ncRNAs in cell fate decision D Guan et al 6 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7d/ec/cddis2012196a.PMC3563984.pdf
"Furthermore, inhibiting autophagy by CQ markedlyaccelerated cell death by ADI-PEG20, implying that autop- hagy triggered by ADI-PEG20 is initially a protective response.Trials of the clinical formulation of ADI-PEG20 are in progress in advanced hepatocellular carcinoma, relapsed or refractory small cell lung cancer and malignant pleuralmesethelioma (http://clinicaltrials.gov).",Non-OADS,/arxiv_data1/oa_pdf/98/ee/cddis2012197a.PMC3563985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Epigenetic status of argininosuccinate synthetase N Syed et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/98/ee/cddis2012197a.PMC3563985.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Bax activation in TRAIL resistance A Berger et al 12 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/77/86/cddis2012198a.PMC3563986.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)The metastatic potential of MET-negative and differentiated RMS cells K Miekus et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/0a/e4/cddis2012199a.PMC3563987.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Salirasib sensitizes HCC cells to TRAIL N Charette et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/c2/b1/cddis2012200a.PMC3563988.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)TNF can activate RIPK3 independently of RIPK1 DM Moujalled et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/7c/20/cddis2012201a.PMC3563989.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Resveratrol and rapamycin in obesity OV Leontieva et al 7 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/cd/47/cddis2012202a.PMC3563990.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/RanBP9 and p73 in apoptosis T Liu et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ad/dd/cddis2012203a.PMC3563991.pdf
Data is freelyavailable at ArrayExpress (http://www.ebi.ac.uk/arrayexpress/) at the EuropeanBioinformatics Institute (Hinxton).,OADS,/arxiv_data1/oa_pdf/ef/23/cddis2012204a.PMC3563992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Caveolin abrogates TGF- bmediated hepatocyte death C Meyer et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/ef/23/cddis2012204a.PMC3563992.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Trap1 involvement in the Pink1/parkin pathway AC Costa et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e0/a5/cddis2012205a.PMC3563993.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Bisphenol A triggers b-cell apoptosis Y Lin et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/48/f9/cddis2012206a.PMC3563994.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/Imaging of cell death in cryolesions B-W Xie et al 8 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/f0/5f/cddis2012207a.PMC3563995.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Phosphorylated PTP1B promotes cell death DS O’Donovan et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/8c/f1/cddis2012208a.PMC3563996.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Meeting Report 3 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/82/93/cddis2012209a.PMC3563997.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Characterization of TICs in NSCLC L Lundholm et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e9/63/cddis2012211a.PMC3563998.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)TRAIL affects metabolism of fat cells M Keuper et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/b7/28/cddis2012212a.PMC3563999.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)Mitochondria shape change quantitation T Ahmad et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/48/93/cddis2012213a.PMC3564000.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Mast cells and implantation K Woidacki et al 11 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/d7/fd/cddis2012214a.PMC3564001.pdf
"In each picture, ﬁve measuring bars were setusing Image J software (freeware, http://rsbweb.nih.gov/ij/).",OADS,/arxiv_data1/oa_pdf/48/b1/cddis2012215a.PMC3564002.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)MS4A8A supports differentiation in colon J Michel et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/48/b1/cddis2012215a.PMC3564002.pdf
The membranes were scanned forinfrared ﬂuorescence at 680 or 800 nm u sing the Odyssey system (Licor) and the signal was analyzed quantitatively with the image-processing software ImageJ (http://rsbweb.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/e6/43/cddis2012216a.PMC3564003.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ORAI1 oxytosis N Henke et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/e6/43/cddis2012216a.PMC3564003.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/Ubiquitin ligases regulating bone formation NS e´ve`reet al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/66/4e/cddis2012217a.PMC3564004.pdf
"To view a copy of this license,visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Cell Death and Disease website (http://www.nature.com/cddis)Effects of RA and poly(I:C) on breast cancer cells AR Bernardo et al 10 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/59/27/cddis20135a.PMC3564005.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Tumor suppressor WWOX binds to DNp63 a Z Salah et al 9 Cell Death and Disease",Non-OADS,/arxiv_data1/oa_pdf/84/95/cddis20136a.PMC3564006.pdf
All data have been deposited in NCBI’s Gene Expression Omnibus and are accessible through GEO Series accession number GSE32504 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32504).,OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
"Further analysis of SNPs, haplotypes and genetic linkage Information on SNPs was obtained from the dbSNP data- base37(http://preview.ncbi.nlm.nih.gov/snp).",OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
"Polymorph- isms occurring in an eQTL were tested for pairwise linkageto SNPs in the neighborhood by tagging specific blocks ofgenetic linkage using Haploview 38(V4.2, HapMap V3R2) or SNAP39(http://www.broadinstitute.org/mpg/snap; using HapMap release 22 and 1000 genomes Pilot1) for CEUsamples each.",OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
The genomic regions of trait genes were screened for previously described copy number variationsusing the genome variation database from the Center of Applied Genomics (http://projects.tcag.ca/variation/).,OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
"We compiled an ADME gene set compris-ing 682 genes (Supplementary Table S3) from various resources including the PharmaADME Working Group list of ADME genes (http://pharmaadme.org/), the NURSA(Nuclear Receptor Signaling Atlas) Consortium 40and the PharmGKB knowledge base41(http://www.pharmgkb.org/).",OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
"This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works3.0Unported License.Toviewacopyof this license, visit http://creativecommons.org/ licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website (http://www.nature.com/tpj)Global ADME pharmacogenomics A Schro ¨der et al 20 The Pharmacogenomics Journal",Non-OADS,/arxiv_data1/oa_pdf/fd/7b/tpj201144a.PMC3564008.pdf
"The custom oligonucleotide primers (Supplementary Table S4) were designed using Primer3 software (http://www.basic.northwestern.edu/biotools/primer3.html), or based on those from UniSTS (http://www.ncbi.nlm.nih.gov/unists) and Universal Probe Library for Human (Roche AppliedScience, www.roche-applied-science.com).",OADS,/arxiv_data1/oa_pdf/11/f4/gene201249a.PMC3564018.pdf
"Cognate TFs regulatingidentiﬁed (common regulatory) sites were searched from differentprediction and repository databases: DBD (www.transcriptionfactor.org),JASPAR (http://jaspar.cgb.ki.se), TRANSFAC 7.0 - Public (http://www.gene- regulation.com/pub/databases.html) using ChipMAPPER, 22ConTra v2,23 Pscan24and IPA (Ingenuity Systems Inc.).",OADS,/arxiv_data1/oa_pdf/11/f4/gene201249a.PMC3564018.pdf
"ARRAY DATA ARCHIVE Array data are stored in the Gene Expression Omnibus (GEO) with accession number; GSE39148 at http://www.ncbi.nlm.nih.gov/geo/ query/acc.cgi?acc=GSE39148.CONFLICT OF INTEREST The views, opinions and/or ﬁndings contained in this report are those of the authors and should not be construed as ofﬁcial Department of the Army position, policy or decision, unless so designated by other ofﬁcial documentation.",OADS,/arxiv_data1/oa_pdf/11/f4/gene201249a.PMC3564018.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on Genes and Immunity website (http://www.nature.com/gene)Transcriptome response to battleﬁeld-like stress S Muhie et al 34 Genes and Immunity (2013) 19 – 34 &2013 Macmillan Publishers Limited",Non-OADS,/arxiv_data1/oa_pdf/11/f4/gene201249a.PMC3564018.pdf
"To view a copy of this license, visithttp://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on the Oncogenesis website (http://www.nature.com/oncsis).Pdcd4–Daxx interaction N Kumar et al 9 &2013 Macmillan Publishers Limited Oncogenesis (2013), 1 – 9",Non-OADS,/arxiv_data1/oa_pdf/94/86/oncsis201237a.PMC3564021.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7c/ed/srep01198.PMC3564022.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kim, S.H.",Non-OADS,/arxiv_data1/oa_pdf/7c/ed/srep01198.PMC3564022.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/19/srep01216.PMC3564023.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Zhang, A. et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/19/srep01216.PMC3564023.pdf
"1 http://dx.doi.org/10.3345/kjp.2013.56.1.1The role of the pediatrician in youth violence  prevention Soon Ki Kim, MD, PhD1, Nam Su Kim, MD, PhD2 1Department of Pediatrics, Inha University Hospital, Inha University School of Medicine, Incheon 2Department of Pediatrics, Hanyang University Seoul Hospital, Hanyang University College of Medicine, Seoul, Korea School bullying has become a major social problem in Korea after the emergence of media reports  on children who committed suicide after being victimized by bullies.",Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
"Key words: Bullying, Violence, Pediatrician, Child, Adolescent, KoreaCorresponding author: Soon Ki Kim, MD Department of Pediatrics, Inha University Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Korea Tel: +82-32-890-2843Fax: +82-32-890-2844E-mail: pedkim@inha.ac.kr Received: 20 August 2012 Accepted: 28 November 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(1):1-7 http://dx.doi.org/10.3345/kjp.2013.56.1.1 pISSN 1738-1061• eISSN 2092-7258 Korean J Pediatr Introduction School bullying has emerged as a major social problem in Korea after a 14-year-old  middle school student in Daegu committed suicide after having been harassed for months  by some classmates.",Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.1SK Kim and NS Kim • Pediatrician role in youth violence 2bullies, and the physical and psychological consequences in  children who were bullied.",Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
3 http://dx.doi.org/10.3345/kjp.2013.56.1.1Korean J Pediatr 2013;56(1):1-7 phones effective weapons for cyber bullying.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
http://dx.doi.org/10.3345/kjp.2013.56.1.1SK Kim and NS Kim • Pediatrician role in youth violence 4have been targets of bullying may experience long-term emo - tional and behavioral problems.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
5 http://dx.doi.org/10.3345/kjp.2013.56.1.1Korean J Pediatr 2013;56(1):1-7 of bullying that are revealed.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.1SK Kim and NS Kim • Pediatrician role in youth violence 6· Appropriate and timely treatment and referral for vio  lence- related problems identified · Maintenance of a database of community-based counsel - ing and treatment resources · Adequate publicly supported, community-based, behavioral  health services · Bullying awareness by teachers, educational administrators,  parents, and children, coupled with adoption of evidence- based prevention programs · The role of health professionals as appropriate public health  messengers through print, electronic, or online media, and incorporation of content related to youth violence  prevention in electronic health records, including screen - ing prompts and links to parent educational materials · Formal continuing medical education or professional  development programs · Learning about community resources for children and  adolescents · Contributing data to existing intentional injury surveillance  systems We recommend that children and adolescents receive some  form of education designed to help prevent bullying and criminal activities in schools, such as that in the Finnish  KiVa program 26).",Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
Available from: http://www.violencepreventionworks.org/public/index.page.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
Available from: http://www.mest.go.kr/web/60879/ko/board/view.do?bbsId=291&boardSeq=28751&mode=view.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
Avail - able from: http://edujikim.com/.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
7 http://dx.doi.org/10.3345/kjp.2013.56.1.1Korean J Pediatr 2013;56(1):1-7 matic pro  blems: a meta-analysis.,OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
Available from: http://www.kivakoulu.fi/there-is-no-bullying-in-kiva-school.,Non-OADS,/arxiv_data1/oa_pdf/dd/79/kjped-56-1.PMC3564024.pdf
"13 http://dx.doi.org/10.3345/kjp.2013.56.1.13Clinical characteristics of Kawasaki disease with  sterile pyuria Ja Yun Choi, MD, Sun Young Park, MD, Kwang Hae Choi, MD, PhD, Yong Hoon Park, MD, PhD, Young Hwan Lee, MD, PhD Department of Pediatrics, Yeungnam University College of Medicine, Daegu, Korea Purpose: Kawasaki disease (KD) is a systemic vasculitis and affects many organ systems.",Non-OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"Key words: Kawasaki disease, Sterile pyuriaCorresponding author: Young Hwan Lee, MD, PhD Department of Pediatrics, Yeungnam University College of Medicine, 170 Hyeonchung-ro, Nam-gu, Daegu 705-717, KoreaTel: +82-53-620-4381Fax: +82-53-629-2252E-mail: yhlee@med.yu.ac.kr Received: 14 September 2011 Revised: 12 June 2012Accepted: 19 October 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(1):13-18 http://dx.doi.org/10.3345/kjp.2013.56.1.13 pISSN 1738-1061• eISSN 2092-7258 Korean J Pediatr Introduction Kawasaki disease is an acute febrile disease frequently occurring mainly in infants  and toddlers under the age of 5.",Non-OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.13JY Choi, et al.",OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
15 http://dx.doi.org/10.3345/kjp.2013.56.1.13Korean J Pediatr 2013;56(1):13-18 Urine tests showed a total of six patients (the pyuria group  had 3 patients and the control group had 3 patients) who had  microscopic hematuria.,Non-OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.13JY Choi, et al.",OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"17 http://dx.doi.org/10.3345/kjp.2013.56.1.13Korean J Pediatr 2013;56(1):13-18 Besides blood and urine tests, there are some reports to  confirm the invasion of renal parenchyme in Kawasaki dis­ ease through radiological tests.",Non-OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.13JY Choi, et al.",OADS,/arxiv_data1/oa_pdf/eb/7f/kjped-56-13.PMC3564025.pdf
"19 http://dx.doi.org/10.3345/kjp.2013.56.1.19The efficacy of aspartate aminotransferase-to- platelet ratio index for assessing hepatic fibrosis  in childhood nonalcoholic steatohepatitis for  medical practice Earl Kim, MD1,2, Yunkoo Kang, MD1,2,*, Seungmin Hahn, MD1,2,*, Mi Jung Lee, MD2,3, Young Nyun Park, MD4, Hong Koh, MD1,2 1Department of Pediatrics, Yonsei University College of Medicine, Seoul,  2Severance Pediatric Liver Disease Group, Severance Children’s Hospital, Seoul,  3Department of Diagnostic Radiology, Research Institute of Radiologic Science, Yonsei University College of Medicine, Seoul,  4Department of Pathology, Yonsei University College of Medicine, Seoul, Korea Purpose:  Childhood obesity is associated with nonalcoholic fatty liver disease (NAFLD), and it has  become one of the most common causes of childhood chronic liver diseases which significant as a  cause of liver related mortality and morbidity in children in the United States.",Non-OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"Received: 21 February 2012 Revised: 30 April 2012Accepted: 2 August 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(1):19-25 http://dx.doi.org/10.3345/kjp.2013.56.1.19 pISSN 1738-1061• eISSN 2092-7258 Korean J Pediatr Introduction The world wide increase in childhood obesity is a significant problem.",Non-OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.19E Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
21 http://dx.doi.org/10.3345/kjp.2013.56.1.19Korean J Pediatr 2013;56(1):19-25 the clinical data.,Non-OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.19E Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"23 http://dx.doi.org/10.3345/kjp.2013.56.1.19Korean J Pediatr 2013;56(1):19-25 ter mining a therapeutic plan, and it can prevent further de - velopment of liver dis  ease17,18).",Non-OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.19E Kim, et al.",OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
25 http://dx.doi.org/10.3345/kjp.2013.56.1.19Korean J Pediatr 2013;56(1):19-25 MULTIVIRC Group.,OADS,/arxiv_data1/oa_pdf/16/ed/kjped-56-19.PMC3564026.pdf
"26 http://dx.doi.org/10.3345/kjp.2013.56.1.26Immune reconstitution after allogeneic hema- topoietic stem cell transplantation in children: a single institution study of 59 patients Hyun O Kim, MD, Hyun Jin Oh, MD, Jae Wook Lee, MD, Pil-Sang Jang, MD, PhD, Nack-Gyun Chung, MD, PhD, Bin Cho, MD, PhD,  Hack-Ki Kim, MD, PhD Department of Pediatrics, The Catholic University of Korea College of Medicine, Seoul, Korea Purpose: Lymphocyte subset recovery is an important factor that determines the success of  hematopoietic stem cell transplantation (HSCT).",Non-OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"Key words: Lymphocyte subset, Immune reconstitution inflammatory syndrome, Hematopoietic stem  cell transplantation, ChildCorresponding author: Bin Cho, MD, PhD Department of Pediatrics, Seoul Saint Mary’s Hospital, The Catholic University of Korea College of Medicine, 222 Banpo-daero, Seocho-gu, Seoul 137-701, KoreaTel: +82-2-2258-6187, Fax: +82-2-588-3589, E-mail: chobinkr@catholic.ac.kr Received: 14 September 2012 Revised: 2 October 2012Accepted: 8 October 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(1):26-31 http://dx.doi.org/10.3345/kjp.2013.56.1.26 pISSN 1738-1061• eISSN 2092-7258Korean J Pediatr Introduction Hematopoietic stem cell transplantation (HSCT) is now widely used for the treat­ ment of children with blood diseases.",Non-OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"27 http://dx.doi.org/10.3345/kjp.2013.56.1.26Korean J Pediatr 2013;56(1):26-31 phage, and natural killer (NK) cell, resulting in the restoration  of a functional innate immune system.",Non-OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.26HO Kim, et al.",OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"29 http://dx.doi.org/10.3345/kjp.2013.56.1.26Korean J Pediatr 2013;56(1):26-31 24.3; 95% confidence interval [CI], 1.95 to 4,118.36; P=0.0076).",OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.26HO Kim, et al.",OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"31 http://dx.doi.org/10.3345/kjp.2013.56.1.26Korean J Pediatr 2013;56(1):26-31 debated and unrecognized factors such as patient age and EBV  infection, in post ­transplant immune recovery.",Non-OADS,/arxiv_data1/oa_pdf/6b/5e/kjped-56-26.PMC3564027.pdf
"32 http://dx.doi.org/10.3345/kjp.2013.56.1.32Orthostatic symptoms does not always manifest  during tilt-table test in pediatric postural ortho- static tachycardia syndrome patients  Tae-Eon Huh, MD1, Jung Sook Yeom, MD1,2, Young-Soo Kim, MD, PhD2, Hyang-Ok Woo, MD, PhD1,2, Ji Sook Park, MD, PhD1,2, Eun Sil  Park, MD, PhD1,2, Ji-Hyun Seo, MD, PhD1,2, Jae-Young Lim, MD, PhD1,2, Chan-Hoo Park, MD, PhD1,2, Ki-Jong Park, MD, PhD2,3, Hee- Shang Youn, MD, PhD1,2  Departments of 1Pediatrics,  2Gyeonsang Institute of Health Science, and 3Neurology, Gyeongsang National University School of Medicine, Jinju, Korea Purpose:  Chronic day-to-day symptoms of orthostatic intolerance are the most notable features of  postural orthostatic tachycardia syndrome (POTS).",Non-OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
"Key words: Postural orthostatic tachycardia syndrome, Tilt-table test, Diastolic blood pressureCorresponding author: Jung Sook Yeom, MD Department of Pediatrics, Gyeongsang National University School of Medicine, 15 Jinju-daero 816beon-gil, Jinju 660-751, KoreaTel: +82-55-750-8161Fax: +82-55-752-9339E-mail: polo96@daum.net Received: 8 Februay 2012 Revised: 28 June 2012Accepted: 23 October 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Original article Korean J Pediatr 2013;56(1):32-36 http://dx.doi.org/10.3345/kjp.2013.56.1.32 pISSN 1738-1061•eISSN 2092-7258Korean J Pediatr Introduction Postural orthostatic tachycardia syndrome (POTS) is a recently recognized ortho- static intolerance syndrome that was first officially defined by Schondorf and Low1)  in 1993.",Non-OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
33 http://dx.doi.org/10.3345/kjp.2013.56.1.32Korean J Pediatr 2013;56(1):32-37 beats per minute (bpm) during standing or a HR of ≥115 bpm  during active standing and no obvious hypo  tension.,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.32TE Huh, et al.",OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
35 http://dx.doi.org/10.3345/kjp.2013.56.1.32Korean J Pediatr 2013;56(1):32-37 be more reasonable and suited to the actual definition of POTS  for the following reasons: Previous studies on ortho  static  intolerance have reported that the sensitivity of the tilt-table  test is low16).,Non-OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.32TE Huh, et al.",OADS,/arxiv_data1/oa_pdf/d8/5c/kjped-56-32.PMC3564028.pdf
"Key words: Pulmonary eosiophilia, Idiopathic, Respiratory distress, ChildCorresponding author: Young Yoo, MD Department of Pediatrics, Korea University Anam Hospital, 73 Inchon-ro, Seongbuk-gu, Seoul 136-705, KoreaTel: +82-2-920-5090Fax: +82-2-922-7476E-mail: yoolina@korea.ac.kr Received: 14 December 2011 Revised: 23 April 2012Accepted: 9 July 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(1):37-41 http://dx.doi.org/10.3345/kjp.2013.56.1.37 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Acute eosinophilic pneumonia is a rare disease that causes an acute onset of res­ piratory distress and marked pulmonary infiltrates of eosinophils1,2).",Non-OADS,/arxiv_data1/oa_pdf/d3/ba/kjped-56-37.PMC3564029.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.37HN Park, et al.",OADS,/arxiv_data1/oa_pdf/d3/ba/kjped-56-37.PMC3564029.pdf
39 http://dx.doi.org/10.3345/kjp.2013.56.1.37Korean J Pediatr 2013;56(1):37-41 or pleural pain.,Non-OADS,/arxiv_data1/oa_pdf/d3/ba/kjped-56-37.PMC3564029.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.37HN Park, et al.",OADS,/arxiv_data1/oa_pdf/d3/ba/kjped-56-37.PMC3564029.pdf
41 http://dx.doi.org/10.3345/kjp.2013.56.1.37Korean J Pediatr 2013;56(1):37-41  13.,Non-OADS,/arxiv_data1/oa_pdf/d3/ba/kjped-56-37.PMC3564029.pdf
"42 http://dx.doi.org/10.3345/kjp.2013.56.1.42Secondary paroxysmal dyskinesia associated  with 2009 H1N1 infection Yun Jung Hur, MD, Taegyu Hwang, MD Department of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea Neurological complications associated with 2009 H1N1 infection in children have been reported and  recognized worldwide.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/kjped-56-42.PMC3564030.pdf
"Key words: Paroxysmal dyskinesia, Influenza A virus, H1N1 subtype, Movement disordersCorresponding author: Yun Jung Hur, MD Department of Pediatrics, Inje University Haeundae Paik Hospital, Inje University College of Medicine, 875 Haeun­daero, Haeundae­gu, Busan 612­862, KoreaTel: +82­51­797­2006Fax: +82­51­797­0032E­mail: H00105@paik.ac.kr    Received: 29 June, 2012  Revised: 4 September, 2012Accepted: 10 October, 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Case report Korean J Pediatr 2013;56(1):42-44 http://dx.doi.org/10.3345/kjp.2013.56.1.42 pISSN 1738-1061•eISSN 2092-7258 Korean J Pediatr Introduction Pandemic novel influenza A (H1N1) virus has quickly spread worldwide following its  identification in Mexico in April 2009.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/kjped-56-42.PMC3564030.pdf
43 http://dx.doi.org/10.3345/kjp.2013.56.1.42Korean J Pediatr 2013;56(1):42-44 36.5℃.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/kjped-56-42.PMC3564030.pdf
"http://dx.doi.org/10.3345/kjp.2013.56.1.42YJ Hur and T Hwang • Secondary paroxysmal dyskinesias 44other underlying pathology or genetic predisposition, the  short latent duration after H1N1 infection and the lack of a  family history of movement disorders can let us suggest the  possibility of secondary PKD in our patient.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/kjped-56-42.PMC3564030.pdf
http://dx.doi.org/10.1002/ppul.21359.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/kjped-56-42.PMC3564030.pdf
"8 http://dx.doi.org/10.3345/kjp.2013.56.1.8Eosinophil-derived neurotoxin: a novel biomarker  for diagnosis and monitoring of asthma Chang-Keun Kim, MD Department of Pediatrics, Asthma ",Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
"Key words:  Eosinophil-derived neurotoxin, Biological markers, Diagnosis, Monitoring of asthma, ChildCorresponding author: Chang-Keun Kim, MD Department of Pediatrics, Asthma & Allergy Cen-ter, Inje University Sanggye Paik Hospital, 1342 Dongil-ro, Nowon-gu, Seoul 139-707, KoreaTel: +82-2-950-8832Fax: +82-2-950-1662E-mail: kimck@paik.ac.kr  Received: 17 April, 2012 Accepted: 9 August, 2012 Copyright © 2013 by The Korean Pediatric Society This is an open-access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Review article Korean J Pediatr 2013;56(1):8-12 http://dx.doi.org/10.3345/kjp.2013.56.1.8 pISSN 1738-1061• eISSN 2092-7258 Introduction Eosinophil­derived neurotoxin (EDN), an eosinophil degra nulation product, is  currently drawing much attention as a novel biomarker for the diagnosis and moni­ toring of asthma in both children and adults.",Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
9 http://dx.doi.org/10.3345/kjp.2013.56.1.8Korean J Pediatr 2013;56(1):8-12 asthma.,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
http://dx.doi.org/10.3345/kjp.2013.56.1.8CK Kim •  Eosinophil-derived neurotoxin: a novel biomarker  10throughout the study period19).,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
11 http://dx.doi.org/10.3345/kjp.2013.56.1.8Korean J Pediatr 2013;56(1):8-12 3.,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
Available from: http://www.ginasthma.org/guidelines ­ gina­report ­global ­strategy ­for­asthma.html.,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
Available from: http://www.brit ­thoracic.org.uk/guidelines/ asthma ­guidelines.aspx.,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
http://dx.doi.org/10.3345/kjp.2013.56.1.8CK Kim •  Eosinophil-derived neurotoxin: a novel biomarker  12 13.,Non-OADS,/arxiv_data1/oa_pdf/a2/43/kjped-56-8.PMC3564031.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/6f/c1/srep01221.PMC3564032.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Pai, D.Z.",Non-OADS,/arxiv_data1/oa_pdf/6f/c1/srep01221.PMC3564032.pdf
"Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: This work was supported in part by an industry grant from Japan Tobacco, Inc. License: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License.",Non-OADS,/arxiv_data1/oa_pdf/5f/05/srep01220.PMC3564033.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Cruz, G. & Lowe, G. Neural coding of binary mixtures in a structurally related odorant pair.",Non-OADS,/arxiv_data1/oa_pdf/5f/05/srep01220.PMC3564033.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Prasad, A.",Non-OADS,/arxiv_data1/oa_pdf/ed/21/srep01211.PMC3564034.pdf
"To correct for any un-evenness in the chromatography, the Orange-G dye front wasused as a guide for determining the elution positions of theproducts (see Supplementary Figure S2 at http://www.bioscirep.org/bsr/033/bsr033e022add.htm).",Non-OADS,/arxiv_data1/oa_pdf/3a/f1/bsr033e022.PMC3564036.pdf
"Free Mg 2+was 1.2 +−0.1 mM (estimates performed with WebMaxc Extended, http://www.stanford.edu/ ∼cpat- ton/webmaxc/webmaxcE.htm, last updated 7/3/09, accessed8/24/11 [ 39]).",OADS,/arxiv_data1/oa_pdf/3a/f1/bsr033e022.PMC3564036.pdf
Available at SSRN: http://ssrn.com/abstract 51644983 (2011).,Non-OADS,/arxiv_data1/oa_pdf/4e/06/srep01219.PMC3564037.pdf
"32. https://wrds-web.wharton.upenn.edu/wrds/ (July 1, 2011).",Non-OADS,/arxiv_data1/oa_pdf/4e/06/srep01219.PMC3564037.pdf
"33. http://www.fdic.gov/bank/individual/failed/banklist.html (July 1, 2011).34.",Non-OADS,/arxiv_data1/oa_pdf/4e/06/srep01219.PMC3564037.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Huang, X., Havlin, I.V.S.",Non-OADS,/arxiv_data1/oa_pdf/4e/06/srep01219.PMC3564037.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/40/13/srep01217.PMC3564038.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Tsukatani, Y. et al.",Non-OADS,/arxiv_data1/oa_pdf/40/13/srep01217.PMC3564038.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreportsCompeting financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/47/26/srep01205.PMC3564039.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Li, M. et al.",Non-OADS,/arxiv_data1/oa_pdf/47/26/srep01205.PMC3564039.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ca/fa/srep01222.PMC3564040.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Wei, Z.-W., Wang, B.-H. & Han, X.-P. Renormalization and small-world model of fractal quantum repeater networks.",Non-OADS,/arxiv_data1/oa_pdf/ca/fa/srep01222.PMC3564040.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/a3/a9/srep01215.PMC3564041.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Swindell, W.R. et al.",Non-OADS,/arxiv_data1/oa_pdf/a3/a9/srep01215.PMC3564041.pdf
Available at: http://www.who.int/csr/resources/publications /Brucellosis .,OADS,/arxiv_data1/oa_pdf/b5/ee/IJPD-22-319.PMC3564086.pdf
E Medicine 2011 Available at:http://emedicine.medscape.com/ article/213430-overview .,Non-OADS,/arxiv_data1/oa_pdf/b5/ee/IJPD-22-319.PMC3564086.pdf
"Available at: http://www.stats.gov.cn/tjsj/ndsj/2005/indexch.h tm, Access date: Oct 21, 2010.",OADS,/arxiv_data1/oa_pdf/2e/85/IJPD-22-326.PMC3564087.pdf
"Available at: http://www.Stats.gov.cn/tjsj/ndsj/2009/indexch.h tm, Access date: Oct 21, 2010.",OADS,/arxiv_data1/oa_pdf/2e/85/IJPD-22-326.PMC3564087.pdf
Available at: http://www.sgm.gob.mx/pdfs/OAXACA.pdf Access date: 26.2.,Non-OADS,/arxiv_data1/oa_pdf/77/61/IJPD-22-369.PMC3564094.pdf
Eplasty 2010:10.Available at: http://www.eplasty.com/images/PDF/eplasty - d-10-00011.pdf .,Non-OADS,/arxiv_data1/oa_pdf/be/3d/IJPD-22-425.PMC3564104.pdf
"April 2009, Availableat: http://www.mdpso.com/doc - uments/How_can_I_EnsureSucces_of_EHR.pdf.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
Availableat: http://www.yesser.gov.sa/english/documents/IT_Read - iness_Assessment_booklet_en.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
"Available at: http://www.ischool.drexel.edu/faculty/ssil - verstein/failurecases/?loc_home.Accessed: Aug 4, 2010.",Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
Available at: http://www.ehcca.com/presentations/hitsum - mit2/3_03_2_h1.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
Available at: http://www.wipfli.com/re - sources/images/11935.pdf .,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
Availableat: http://www.norc.org/6275/Module2/Community%20Clinic%20EHR%20Readiness%20Assess - ment%20Tool.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
Available at: https://www.bcmsonline.org/main/files/ehr-readiness-assessment-DOQ - IT.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7d/5c/AIM-19-224.PMC3564174.pdf
"Copyright  © 2010 by Oxford University Press, Inc. 2. http://www.pewinternet.org/Re - ports/2001/The-Internet-and-Edu - cation.aspx (14.06.2011) 3.",Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
http://www.rak.ba/bih/index.php?uid=1272548201  (11.07.2011.),Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
http://www.rak.ba/bih/index.php?uid=1272548201  (11.07.2011.),Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
http://www.gfk.,Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
9. http://www.internetworldstats.,Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
10. http://www.internetworldstats.,Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
11. http://www.internetworldstats.com/europa2.htm (13.07 .2011.),Non-OADS,/arxiv_data1/oa_pdf/a5/ea/AIM-19-196.PMC3564181.pdf
Intensity of ﬂuorescence was measuredby the ImageJ (http://rsb.info.nih.gov/ij/).,OADS,/arxiv_data1/oa_pdf/f3/b8/jcbfm2012172a.PMC3564201.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information acco mpanies the paper on the Journal of Cerebral Blood Flow & Metabolism website (http://www.nature.",Non-OADS,/arxiv_data1/oa_pdf/f3/b8/jcbfm2012172a.PMC3564201.pdf
"Cytokines in chronic respiratory diseases Sergei P. Atamas1,2,5, Svetlana P. Chapoval2,3and Achsah D. Keegan2,4* Addresses:1Department of Medicine,2Department of Microbiology and Immunology,3Department of Biochemistry and Molecular Biology, and 4Center for Vascular and Inflammatory Diseases, University of Maryland School of Medicine, Baltimore, MD 21201, USA;5Baltimore VA Medical Center, Baltimore, MD 21201, USA * Corresponding author: Achsah D. Keegan (akeegan@som.umaryland.edu) F1000 Biology Reports 2013, 5:3 (doi:10.3410/B5-3) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium,provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/3 Abstract Cytokines are small, secreted proteins that control immune responses.",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Page 2 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Pulmonary fibrosis Page 3 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Other more Page 4 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Subrata LS, Bizzintino J, Mamessier E, Bosco A, McKenna KL, Wikstrom ME, Goldblatt J, Sly PD, Hales BJ, Thomas WR, Laing IA, LeSouëf PN, Holt PG: Interactions between innate antiviral Page 5 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Page 6 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Hoshino M, Nakamura Y, Hamid QA: Gene expression of vascular endothelial growth factor and its receptors and angiogenesis Page 7 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Kang MJ, Choi JM, Kim BH, Lee CM, Cho WK, Choe G, Kim DH, Lee CG, Elias JA: IL-18 induces emphysema and airway and Page 8 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Page 9 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Page 10 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Wenzel S, Wilbraham D, Fuller R, Getz EB, Longphre M: Effect of an interleukin-4 variant on late phase asthmatic response to Page 11 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"Page 12 of 12 (page number not for citation purposes)F1000 Biology Reports 2013, 5:3 http://f1000.com/prime/reports/b/5/3",Non-OADS,/arxiv_data1/oa_pdf/16/28/biolrep-05-03.PMC3564216.pdf
"PKM and the maintenance of memory David L. Glanzman 1,2,3 Addresses: 1 Department of Integrative Biology and Physiology, 2 Department of Neurobiology and the Brain Research Institute, David Geffen School of Medicine, 3 Integrative Center for Learning and Memory, University of California, Los Angeles, Los Angeles, CA, 90095 USA Email: dglanzman@physci.ucla.edu F1000 Biology Reports 2013, 5:4 (doi:10.3410/B5-4) This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License (http://creativecommons.org/licenses/by-nc/3.0/legalcode), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
The electronic version of this article is the complete one and can be found at: http://f1000.com/prime/reports/b/5/4 Abstract How can memories outlast the molecules from which they are made?,Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Monkeys with better recognition memory(as assessed by the delayed-nonmatching-to-sample, orDNMS, test) were found to possess a greater proportionof dendritic spines coexpressing GluA2 and PKMzeta.Additionally, double-labeled spines in the dentate gyrus of aged monkeys possessed a lower level of GluA2 Page 2 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Impressively, even when the infusion of ZIP was delayed until three months after training [40], the conditioned Page 3 of 9 (page number not for citation purposes) F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4 of rats has recently been reported by Hardt [39], et al.",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"According to Sacktor ’s model, when a synapse undergoes memory-related enhance-ment, PKMzeta increases the level of GluA2-containingAMPARs at the synapse; the extra GluA2 subunits then act as a “tag”that captures PKMzeta, together with the Page 4 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Page 5 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Abbreviations AMPAR, a-amino-3-hydroxy-5-methyl-4-isoxazolepro- pionic acid-type glutamate receptor; CNS, central ner-vous system; CPP, cocaine-conditioned place preference;DAG, diacylglycerol; DaPKM, Drosophila homolog ofPKMzeta; LTF, long-term facilitation; LTP, long-term potentiation; mEPSPs, miniature excitatory synaptic Page 6 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Page 7 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Page 8 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"Page 9 of 9 (page number not for citation purposes)F1000 Biology Reports 2013, 5:4 http://f1000.com/prime/reports/b/5/4",Non-OADS,/arxiv_data1/oa_pdf/a9/e9/biolrep-05-04.PMC3564217.pdf
"4      http://www.jcancer .org 1  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 1-2. doi: 10.7150/ jca.5045   Editorial   Special Issue on I mmune Responses in Tumors and  Non-Transformed Inflammatory Microenvironments   Anahid  Jewett   Division of Oral Biology and Medicine, Jonsson Comprehensive Cancer Center, UCLA School of  Dentistry, Los Angeles, CA, USA     Corresponding author : Email: ajewett@ucla.edu   © Ivyspring International Publisher.",Non-OADS,/arxiv_data1/oa_pdf/56/88/jcav04p0001.PMC3564241.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/56/88/jcav04p0001.PMC3564241.pdf
"4    http://www.jcancer .org 2  nan discuss the duality of NK cell function in stim u- lation of the immune system, and also in the regul a- tion of immune responses to control the immune sy s- tem.",Non-OADS,/arxiv_data1/oa_pdf/56/88/jcav04p0001.PMC3564241.pdf
"4      http://www.jcancer .org 3  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 3-11. doi: 10.7150/ jca.5047  Review  Myeloid -Derived Suppressor Cells Interact with     Tumors in Terms of Myelopoiesis, Tumorigenesis  and  Immunosuppression: Thick as Thieves  Alexandra Sevko, Viktor Umansky  Skin Cancer Unit, German Cancer Research Center, Heidelberg and Department of Dermatology, Venereology and Allergology, Unive rsity  Medical Center Mannheim,  Ruprecht -Karl University of Heidelberg, Mannheim, 69120 Heidelberg, Germany .",Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
"4    http://www.jcancer .org 4  iv) a production of nitric oxide (NO) and reactive  oxygen species (ROS) that causes the nitration of T cell  receptors (TCR) or T cell apoptosis (1, 13, 18) ; v) an  express ion of membrane -bound TGF -β1 inducing  anergy of immune effector cells (1, 19) , and vi) a  down- regulation of the TCR ζ -chain expression disa- bling T cells to transmit activation signals (1, 9) .",Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
"4    http://www.jcancer .org 5  phages into the tumor was also associated with the  VEGF activity (40, 41) .",Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
4    http://www.jcancer .org 6    Figure 2 .,Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
"4    http://www.jcancer .org 7    Figure 3  Neutralization of the MDSC -mediated immunosuppression includes the regulation of myelopoiesis , the MDSC depletion and  inhibition of their activities.",Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
"4    http://www.jcancer .org 8  protein (TRP) -2, a model melanoma -associated ant i- gen (105) .",Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
4    http://www.jcancer .org 9  tic approaches will be strikingly dependent on the  neutra lization of MDSC -induced immunosuppre s- sion.,Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
4    http://www.jcancer .org 10  44.,Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
4    http://www.jcancer .org 11  90.,Non-OADS,/arxiv_data1/oa_pdf/60/43/jcav04p0003.PMC3564242.pdf
"4      http://www.jcancer .org 12  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 12-24. doi: 10.7150/ jca.5519   Review  Dual Functions of Natural Killer Cells in Selection and  Differentiation of Stem Cells; Role in Regulation of I n- flammation and Regeneration of Tissues   Anahid Jewett1, Yan -Gao Man2, Han -Ching Tseng1   1.",Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 13  expression of CD16 and CD56.,OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
"4    http://www.jcancer .org 14  A number of factors responsible for the su p- pression of NK cell cytotoxicity in humans have been  identified previously [4 -9, 10] .",Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
"4    http://www.jcancer .org 15  thermore, we have previously shown that the tri g- gering of CD16 on untreated or IL -2 treated NK cells  was found to result in down- modulation of CD16  receptors and in a great loss of cytotoxicity in NK  cells.",Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 16  (split anergy).,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 17  Blocking NF κB reverts the oral tumors to  more of an undifferentiated phenotype r e- sulting in an increase in NK cell mediated  cytotoxicity.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
"4    http://www.jcancer .org 18  NK cells are conditioned in the tumor or in  non- transformed inflammatory microenv i- ronment to drive differentiation   The theory of immunosurveillance was post u- lated by Bu rnet [59] to indicate that the key thymus  dependent effectors were responsible for clearance of  tumors [60, 61] .",Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 19    Fig.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 20  in vitro tumor induced CD16 - NK cells have similar  maturational pa thways since they have similar if not  identical functional properties.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 21    Fig.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 22  treated and IL- 2 treated NK cells.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 23  Competing  Interest s  The authors have declared that no comp eting  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
4    http://www.jcancer .org 24  non- adherent and adherent culture conditions.,Non-OADS,/arxiv_data1/oa_pdf/2a/f4/jcav04p0012.PMC3564243.pdf
"4      http://www.jcancer .org 25  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 25-35.  doi: 10.7150/ jca.5049  Review  Clinical Relevance of Natural Killer Cells Following  Hematopoietic Stem Cell Transplantation   Jeanne M Palmer1,2, Kamalakannan Rajasekaran1, Monica S Thakar1,3 and Subramaniam Malarkannan1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
"4    http://www.jcancer .org 26  DAP12 adaptor proteins, and 3) natural cytotoxicity  receptors (NCR) ( Table 1 ).",OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 27  NK cell subsets are classified based on phen o- typic or functional differences.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 28  Venstrom et al  2010 107 1087  KIR3DS1  copy  number  + URD  No difference  Less GVHD with  more copies of  KIR3DS1+  Improved TRM with  more KIR3DS1   Brunstein et  al.2009 38 257 KIR-L mismatch  - UCB - RIC  and MA  No difference  MA- no difference  MA- no difference in  TRM  + OS       (KIR -L-MM)  ATG      NMA - higher  aGVHD with mi s- match  NMA - worse TRM and  OS with MM   Cooley et al.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
"4    http://www.jcancer .org 29  In this model, patien ts are grouped according to ho- mozygosity for HLA -C group 1, HLA -C group 2, or  HLA -Bw6.",Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 30  can be either an activating or inhibitory71.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 31  Both conventional NK cells and NK -like cells  contribute to mucosal immunity.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 32  considered either lymphoid tissue ind ucer (LTi) cells  or NK -LTi.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 33  Competing  Interest s  The authors have declared that no competing  interest exists.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 34  Dutch Registry.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
4    http://www.jcancer .org 35  87.,Non-OADS,/arxiv_data1/oa_pdf/34/21/jcav04p0025.PMC3564244.pdf
"4      http://www.jcancer .org 36  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 36-44. doi: 10.7150/ jca.5046   Review  Dendritic Cells in the Cancer Microenvironment   Yang Ma1, Galina V. Shurin1, Zhu Peiyuan3, Michael R. Shurin1,2  1.",Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
"4    http://www.jcancer .org 37  DCs represent a heterogeneous hematopoietic  lineage with subsets of cells demonstrating differe n- tial morphology, phenotype and function in different  tissues under different conditions (Ma et al.",OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
4    http://www.jcancer .org 38  not detected in the lymph nodes (18) .,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
4    http://www.jcancer .org 39  been reported to be significantly higher than that in  normal endometrium (39) .,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
"4    http://www.jcancer .org 40  mor-mediated blockage of DC functionality repr e- sents a unique mechanism of tumor escape, in add i- tion to the tumor -mediated suppression of DC gene r- ation (dend ropoiesis) and survival.",Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
4    http://www.jcancer .org 41  ing/immunogenic phenotypes depending on the  signals received (92) .,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
"4    http://www.jcancer .org 42  than expected and include the control of tumor va s- culature, the expression of correct sets of adhesi on  molecules and chemokines and management of mu l- tiple inhibitory mechanisms.",Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
4    http://www.jcancer .org 43  32.,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
4    http://www.jcancer .org 44  76.,Non-OADS,/arxiv_data1/oa_pdf/13/df/jcav04p0036.PMC3564245.pdf
"4      http://www.jcancer .org 45  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 45-56. doi: 10.7150/ jca.5044   Review  Cystatins in Immune System   Špela Magister1 and  Janko Kos1,2   1.",Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 46  idues with conserved sequence motifs.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
"4    http://www.jcancer .org 47  proteolytic activity of major mite allergens, Der f 1  an d D er p 1, by  s tefi n  A b l o ck s  th e up -regulation of  IL-8 and GM -CSF release from keratinocytes stim u- lated with the allergens.",Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
"4    http://www.jcancer .org 48  version is also achieved with proteolitic cleavage by  so far unidentified protease action on the extended  N-terminal region of cystatin F. 75 Being glycosylated,  inacive cystatin F can be internalized through the mannose -6-phosphate receptor pathway and activa t- ed within different cells.",Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 49  For cystatin M a downregulated mRNA in  metastatic breast tumor cells was identified by  differential display when compared to normal and  primary breast tumor cells.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 50  the loss of inhibitory function due to aggregation and  lower concentration in brain can not be excluded.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 51  associated proteolytic activit y.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 52  and adhesion to an endothelial cell monolayer were  both independent of the inhibition of lysosomal  cysteine proteases.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 53  References   1.,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 54  multiprotein complex with cystatin B .,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 55  role of cystatin M/E in epidermal cornification .,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
4    http://www.jcancer .org 56  Deletion of the late cornified envelope LCE3B and LCE3C genes as a  susceptibility factor for psoriasis .,Non-OADS,/arxiv_data1/oa_pdf/3c/3e/jcav04p0045.PMC3564246.pdf
"4      http://www.jcancer .org 57  JJoouurrnnaall  ooff  CCaanncceerr   2013; 4(1): 57-65. doi: 10.7150/ jca.5048   Review  IL-22: An Evolutionary Missing- Link Authenticating the  Role of the Immune System in Tissue Regeneration   Pawan Kumar1, Kamalakannan Rajasekaran1, Jeanne M Palmer1,2, Monica S Thakar1,3,, and Subramaniam  Malarkannan1,2,4,  1.",Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
This is an open -access article distributed under the terms of the Creative Commons License (http://creativecommons.org/   licenses/by -nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
4    http://www.jcancer .org 58  under debate.,Non-OADS,/arxiv_data1/oa_pdf/14/73/jcav04p0057.PMC3564247.pdf
